{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# COLLECTING SENSITIVE WORDS FROM SNOMED-CT AND WIKIPEDIA"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {},
   "outputs": [],
   "source": [
    "import wikipedia #library to get wikipedia information about given words\n",
    "import spacy #for nlp programming\n",
    "from wordcloud import WordCloud #for wordcloud representation\n",
    "\n",
    "sensitive_diseases=['AIDS','HIV','TB','CANCER','BIPOLAR','MENTAL-DISORDER','BRAIN TUMOR'] #senstive diseases name\n",
    "sensitive_drugs = ['Abacavir','Didanosine','Emtricitabine','Lamivudine','Stavudine','Tenofovir','Zidovudine','Isoniazid','Rifampicin','Pyrazinamide','Ethambutol','RisPeridone','Olanzapine','Quetiapine','ziprasidone','paliperidone','lurasidone','afinitor','avastin','bevacizumab','bicnu','carmustine','everolinus','colozapine','AC-T'] #sensitive drugs name"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAA1MAAAGwCAYAAABM9z+ZAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4yLjIsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+WH4yJAAAgAElEQVR4nOzdd3wk53kn+N9b1TkCaKCRcxhgck4cznCYSdGUSEVSK6+k9Uq2Tl6fo7y38md99n3klb133rVXtnyWrLMlmTQtUmYSSZHDMDnPYDDIOTYa6IDOqcL9gZnh9HQjdKHRSM/384EpV3VVv+jGdNdT7/M+D5NlGYQQQgghhBBCMsOt9AAIIYQQQgghZC2iYIoQQgghhBBCFKBgihBCCCGEEEIUoGCKEEIIIYQQQhSgYIoQQgghhBBCFFAtsJ9K/RFC1oRgIIpQIAplH1sMjAEcx8BxHHgVB5WKh1qjglrDzz6CsSWNLxqJw+cNZTwmxjHwt8Y0Ox4VVCpuyeNRwucNIRqJp2znVTxsReZlGVMsmkDAF4YoSlk/NzD7vposehiM2kU9fr6/M7PVAL1Bs6TXQRQlBHxhxKKJpO1anQbWfMOKvO+EEEIw54fvQsEUIYSsCa/+83n8899/CFHI/KKbV3FQq1XQGzQwWfQoKDTBXpqHyppCVNUXoajECntJHkwWneKL2Stn+/Cnv/vioh/P8RxUKg4GoxYWqwE2uxllVTbUNBSjqq4Q9pI82Iot0Ghy8zEuCCL++x/9HJfO9KTEEaUVBfjei78Og0mX9edtuzKE//Vnb2ByzJv1cwOAyaLDV//TI3jyM/sW9fjXX7yAn/7dBxDS/J19/qv3499/86ElBTwznhC+9503cPaDzqTtRx/dit/7v57N2ftNCCFkcehTmRCy4YmCBFGIIxqJw+sOYnRw+s4+tUaFyppCNG+vwK4D9dixrxZmq37ZZwgkUUJclBCPCZjxhDAyOI1rFwYAABarHg2by7Btdw323teI2sZiqNT8so5nbMiFoT5n2ok/rzuIG1eGcPBY87KOYbV797VreOyZPSirLFjpoRBCCMkRWjNFCCHzSMQFDPRM4q2Xr+D7f/EL/L//99sYHXJhJRue+30RXD3Xjxd+8BH+x5+8ildfvIBYNLGsY7p+YQDBQDTtvkRcwPmPulf0NVkNPK4g3vzZpZUeBiGEkByiYIoQQhZBlmW4pwL44K0b+O5//hkcY94VDx7iMQH9XQ785G/fx/f+7A3EY8KyjCkaTaD9+gii4Vja/aIooa9zAi6nP+vPnWczYuuuamzaUo7SinyYrXrwKg6MYTaDfbEThAyz6+J4BqNJi+KyPDS0lGHbnhoUl+Vlbbwn37mJsWFX1s5HCCFkdaM0P0LIumay6KHVqee85pYByJIEWQYkSYIoSBAEEfGYAElKDUxEQUJ/lwP/7Vsv4c/+7sswmpe2Tkhv0MB4z1ojWZYhyTJkSYYkyRAFEYmEiERcQLpYKRKO48QbreB5Dl///Seg02uWNKZ7Dfc5MT7sTvvct7mnA+hoHcHR4q1ZTYGs31SK3/7jT30cJMqzwVsoGEXQH4F/JoLxERdee/Ei+rscSccWlVjx9BcOYNPWcpitBpgtehjNOqjV/J0gjIGBcdkb74wniLd/fhVf/c2HwfF0v5IQQtY7CqYIIevaf/ydx/DwUzvBq9Jf2MqyDFGYXZvk90cwNeHFcP802q8Po79rEo4xD4SEmHJcf/ckXv7xGXzx68fBL+Gi+Vc+fwBf/uZDSRfesiwjkRARiyTg84YwMerBQM8kOlpHMNI/DeeENyWwEUUJp9/rQH1zKR5/dg9UquysoZIkGQM9k3A6ZpK2M4akMfhnwui8MYrDx1ugzmKRBMYYeD452FGpeWh1ahQUmgHMBk1nTnSmBFMmsw7bdtegeXtF1sazkERcxNWzfXj4qR2oaSjO2fMSQghZGRRMEUI2NMYYVGoeKjUPg0mLkrI8bN9bi8ef3Y3+TgdOvNmKd1+7nlIS/Hbw8vCv7Mp6wQHGGDQaFTQaFcxWPSpqCrH//iZEwnG0Xx/BiTeu49S77SlBXsAfwUdvt2HHvlpU1hZlZSzhYBR9nY5b5cBnqdQ88gtMCPgjd14XUZAw1DuFqUkfyqtsWXnutcox5sGFk90or7JlNbAkuSGIEjpGnLjWN77SQ1nT9Fo1PnP/dnBZmKkOR+N4/UIHonEhCyNbOsYYOI6B5xg4xoHnGFQ8B61aNfujUUGnVsGgVcNs0MJi0MGo04DnaLZ6PaJPeUIISUOtVqF5eyXKqwthNOnw4g9PpjzG6w6i/dpwzqq36Q0a7DlUj7qmYuTlG/HaixdS+i/1d0+i88Yoyqtt4LLwxe2a8qP75ljSNpNZh50H6tBxfQTjI+4724cHpjA25NpQwRTHMRhNOkSjCSRuXehFwnFcPtOHQ8dbUJWloJbkjihJuNg1gu+9fnalh7Km2cwGfPrIttlp7CUKRuP4/hvnMBNKXwRnJXC3AiqOsVsz6Bw0PAeNWgW1iodGxUN7K6Ay6jQw6jSwWQwoK7Ci0p6HanseSgos0GQpi4CsHAqmCCFkHmarHp98/iAunelBf9dk0r5IKIaBnknIspyzZqqMMeTbTHjys/vQ1+VA25WhpP3hUAzdN8dx6IEWmK36JT2XJMlwjHow3D+VtN1k0WPv4QZMOWaSgqkZdwj9XQ7s3F8HrU69pOdeKziOYfveGkyMejDY67yzvfvmGDpbR1FWWZC1lEtCyOohyTIk8a5c5wQQXuAY9a1gS6eZ/bEYdGiptGPfpirsbayAzWK481hq0L12UDBFCCELMFn0OHx8c0owJQgSPK4gEgkxp81UGWMoqyzA/Y9sRkfrSEqj4uH+KQT8kSUHU7FoAtcuDCART04ntOYbsOtQPa6c6wNj7E5xCFmW0XZ1GI88vQtFJdYlPfdaIQgSquqLUFhixeiQ607qZTwm4P1f3MCeww2wFZnpwogQgoQoISHGEYrOpkePw4/u0Wm8dr4DKo7DpsoiPL63GUe21MJmMUCr5sFuzXyR1YuSNwkhZAE8z6Fxc1naffFoArFoIscjmh1TeZUNhXZLyj6X05eyxitTsiwjHIzi6vn+pO0qFYeGljJYrAY0bS2HwaRN2t99cwyuKf+Kl43PpURcxLHHtqGg0JS0ve3KEDpaR+etgkgI2dgkWYYgSogmBLQOOPDdlz7Al/78n/F//vRdfNQ2gElvAMI96dxkdaFgihBCFsDY7DqhdGRgxQKHPJsJeTZTyvaAL3Jn/c5SDPRMYvyenklqrRrb99YCADbvqEp5XcLBGK5fHEhZy7WexWMCahrs2Hu4MWl5iCRKePWn55Yc2BJCNpaZUBTvXO7GH/7wF/jOCyfwb2dvYtjphSRtnM/VtYSCKUIIWYS5ggO1ms9pit/ddDoNdGnWJiXiYnIuvwKyDJz8ZXvKrIrJrMPWXVUAgMqaQpRW5Kcce/b9zrTl5Ner2Z5kEj75/MGUnmFdbWO4fKZ3hUZGCFnL4oKI0+1D+MtXTuK7L32Ad670IBLLfSYEmR8FU4QQsgBZljHjCaVs53gO1nwjtNoVKrYwRxo9r+KW3Ig2Eo7h4qnulO1bd1fDkje7SFqtUWHXwfqUPlsDPZMYHXJtmFS/eFyAIEiorCnE0ce2Ju0TRQkv/9MZxOkCiBCiUDiWwPmuYfz3n32E//Yv78MbjGyYz9e1gIIpQghZgCBI6GwdSdluMGpRv6lkyYGLUvFoAvFYajqf3qCFao4mxYt15WwfAr5I8kYG3PfQ5qTF0AeObkppiCwKEk6/276k519LEnEBYkIE4xg+9dxBGO9JfRwZmMbp9zro4ocQopgsA55AGG9c6MRv/q+fU9rfKkLBFCGELMDnCeHch6mzNIXFFmzfV7sCI5rl90UQ8KUW47UVmaDVK58tkyQJp95th3TPxb/ZosfOe37f6no7qupSeymdOdGRlXVba0EiLkAUJTDGUFRqxUOf2JE0axiNxPHe69eTGh8TQogSkiyjfcSJ//3vXsPF7lEkxI2TUr1aUTBFCCHz8M+E8a//eBqOMU/SdrVGhYc+sWPFGtSKooTxETemp/wp+ypqi2AyKy+LPj3pQ/fN8dnqGnfZfageOoMm5fFHHtqSeg6nHx2to4rHsJYkEuKdNXU6nQZHHtoMW9HHVRZlGRjqc+Ly2T6anSKEZMWw04u/fu0MrvdNULW/FUbBFCGEpCEKIrrbxvCjv34Pb79yJWX/0Ue34vFn9qzAyGbNeEK4eq4PsUjyWhyNRoXGzWUwWZQHU9fODyAYiKRsP/RACzgu9WvjwLEmqO8pwiEkRJx9v1PxGNYSUfg4mGIcQ3WDHXsPNyTNTs14Qrh4shu+NGvvCCFEic6RKfztm+cwOOmhGzUriJr2EkI2PFGUEI8lEAnHMTnmxVD/FNouD6GnYxzOiZmkynSMMTzy9C586TeOw2RJXy59uQnCbKBy+Uxfyr7yahtatlVCreaVnTshovXSIKLh5HLehXYLGlpKka53pL00D40tpUkzUaIooaN1FF53EPlpyrevJ4IgQZI+vpAxWw3Ye18jLp/tg/vWzKEkyWi9PIi+Lgf2HG6gJpyEkCWTZRmt/RP4/355Cd9+/mHoV6oY0gZHwRQhZF372+++iR/8P+8s+DgZMmR5tjeQKEoQEmLSBTLHMeTZTPjkcwfw+DN7YMkz5PyCWJJkiIKIE2+24of/45cp/Ys0WhX23980Z4PhxRgdcmF0aDrpdweAzTurYLGm/s6MMWg0Kuy9rzElrc8zHUDnjVEcPt6ieDxrgSTJkO/5W9mxrxYNzaV3gikAcE8FcP5kN5q3VcBo1lFAtUpxHMOmyiJ88lBq+moujbt8aB2YQEJBClddSQGaq+xQ88puqmSDSa9dFX/jTeWF+K1n7ke+SflsfTqiJCEhShBECZFYAoFwDL5QBO5AGBNuP8bdPoxN+xCKxSFJ8uzPMsweSbKMd650Y2d9GT5z//ZV8ZpvNBRMEULWtWgkgWhEWVlqrU4Ns1UPk0WP/Uea8OAntqO63g4Ay/qFJcsyZHn2y1cQJMSjs7Nmo4PTeOOli7h4qicl2GGMYcuuajz1uf0p1fUyed6+zglMOXxJ2zmOYdueahiM2rTHqdQ8tu+thU6vSQrw/L4w2q8Nz1b849dvVrksySkpNmarHvc/sgUdrSNJVRFPv9uOR5/etaSAlywvFcfhyJZaHNmycsVlAOCdKz3oHptGIhLL+Nj9zVX4xlOHYdKnrnHcaPRaDRrKClFkNeb8uQVRwpjLh67RKVztG0PH8BSmfUH4QlHEhewVjhAlGX/z+jncv7UWJQWWhQ8gWUXBFCGEzKGoxIrDx1uw61AdaursyCswZT2IGu6fwgdv3Ug6r4zZCnGxaAIBXwSOMQ+G+qYwOjCNeJoKeYwxbN1Vja/97uMoKrEqHks0HEdf50RKhUCb3YKqejtUc6QOMsZgs5vR0FKKm1eH72wXEiIGe5xwOX0oLktt7rt+pN5tZozhwNFNePvnV5JekxlPCO+9fh11TSVzvp5kZa2nO/vr6XdZqpV4LdQqHrUlBagtKcAT+5oRjMTRPjyJi90juN4/gd4JFwLhzIPldPyRKH76/jX81jNHoFrBGcmNiIIpQgiZw9iQC7/42SVcPtOLippCNG+rwJ7DDaioKczaTMuFk924cDK17PpiaXVqHHl4Mz79q/ehpsG+pLFMOX3o7XTg3kyUmgY7ikvz5j3Wmm9Ey/bKpMABmE0bHBmYXtfB1FyJO2arHp/47D50to7eKVABAB++3YYnP7MXNQ3FuRkgIWRVMOk1ONBchf2bKjEyNYNLPaN450o3bgw4ljxTJUkyPmobwBP7m7G5ij5bcmn95l0QQghm70Yu5mcuwUAUAz2TOPnLm/jx9z/AX3z7ZfzbT88hGo2vbPUkBlTVFeFrv/c4/sNvPYraxuIl3XmVZRmTY14M9jqTtnM8h5qGYtjs5nmP1xs0qNtUAvM9VQTd034MdE+mbS68ERw81oz65tKkbf6ZMF574cIKjYhsBDQftboxxlBdnI9PHt6Cbz/3MJ5/cBcMWSgeMT0TxKm2wZQbYmR50cwUIWRd+9rvPoYjj2yZdyZJloF4LIFwKIYpxwz6Oh1ovTSI3o4JxGOJO19MkVAMfZ0OjA660NU2ht/6o6dXpJBASXkenn7uII48tBkFhWbwKm7JY4hFE2i/PoJIKDnlJC/fgIbmUqhU86eNMMZQWVOIksp8BNo/XiMkiTI6Wkfx4CdCS0pBXKt0ejU+86v34Tvfeilp++kTHXj6uQM0O0WWBV1Lrw1qnkeVPQ9ff/IgaksK8GcvvI9oQvmNp2hCQNuQAy5/EEXW9V1FdTWhYIoQsq4ZTDoU2MzzFmW4e4aprqkEB4814/mvPYDB3km89A+nceVsH0LB6J3HxKIJnH6vA9FoHL/3J8/Cmp/bhc2f+uIhPP2FAwvOqi2WLMsIBWO4ei611LrNbkF9S+minqe8uhCVNUXo7ZhIuprrvDEK97QfhcWWDbmGY/eherTsqETnXdUOQ4Eo3njpIn7jD54Ef2+guvFeIpJl9Ce0djDGoNOo8SsHNgMyw3dfeh/hmLKiSQAwNOlBz9g0BVM5RMEUIWTDS3eBz/MMDc1l+IPvfBpvvnQJL/7wJLzu4J39siyj7fIQXn3hPD7/1aPQ6pSlaFRUF6K6wZ724iceF3DlXB9EIbk08sv/dBa7Dzagqq5I0XOmMzHixmCPM2W7LMsY6J7EcN/Uos4jJESoVHxSby7/TBgd10fR0Fy24YouMMagM2jwxDN70N/luJPuKIoSrp0fQH/3JJq2lN/1+NnqiYQsBc1MrT2MMTy2twkj01785MQVxBLK1lBN+0IYmZ7BIUmmz5IcoWCKEELmwfMcnvzsXsTjAv7pb95H4q5qetFIAuc/7Mb++5vQvK1S0fkPP9iCL3/zIXBp0hAj4Tj+9HdewNXz/Unb3dMBvPxPZ/D1P3gCBkP6cuWZkGUZZ050JBVJuK2v04Hv/MFLaY7KzPkPu/DEs3s2XDAFACoVj627q7FpawXargzd2T7t9OHMiQ7UNNihubVegjG2rsvIE0LmplHxePrgFtwcnMSF7hFF54gLIkamZhCKxWHWL/37gSyMPrEJIWQejDGoVDzuf2QLtu6qStk/OjiNztZRCFnsGXKbTq/GF3/9ARhNyV+Ikijh0uleXD7dm5XnScQFnP2gMyvnmkvXzTE4J2ZWtmjHCioqseLQA81JM5jxmIBrFwYwMjB9ZxtjLDXtjxCyITDGUGYz45E9TbAs4UbZ4KQHvlB04QeSrKBgihBCFsAYQ0GhGdv3pTbxTCREDPZOIRRYni+u+k2lePRTu1O2e90BnHizNSsBys1rI3A5/Us6x0LiMQHnPuxa1udYzVRqHjv2195p+nzbQPck2q4MIXFr0TnHMag1FEwRslGpeB4768pQW1Kg+BxObwChaHzhB5KsoGCKEEIWQa3hUV5lg9GsS9nnGHUnFajIFsYYtDo1Hnl6F6pqk9dHyTJw/cIALpzshiCkpuctlizLOPnOTUjS8s8YffROW9pUwo2AMYbaxmLsOlAHjebjDHtBEHHyl+2Ydvggy/KdmVBCyMZVU5KPpgo7eIVrntz+MCKxxIbNBMg1WjNFCCGLwBiDTq+BTq9JmYUKh2JJBRey/bzlVTY8+NQOvPD3HyEW/bjKUyyawC9fvYatu6sV95nyecNovTSYst1g1KK2sXi2IoICznEvXFPJs10TIx70dTrQvK1C0TnXOo7jcP8jW3D6RAfGh913tnffHEPb1WEUl+eD4xk0WvpqJmQj4zkOzZVFMOo08IdjCx9wj2AkhmAk8+OIMvSJTQghi8TxDDyfGlzEYwJEcfnuAGp1ahx6oBmXz/Ti5tXhpH39XRN497Vr+Mp/eiRpxmOxWi8OIOALp2zfc18Dfv33n1RcDerEG9fxg7/8ZdI2QRRx5kTHhg2mAKBuUwn23dcIx6jnzmygJMl446WLOPRAM9QaHuoNWKSDEJKsoaxQcTAlA3AHQhAlGao031kkuyjNjxBCFikRFxGPpzZU5LLQNHchFdWFOPbYVpjuSTOUZeDd166h4/pIxikdkijhyrl+RCOpPU2OProVBYUm5Nsy/8krMOLIQ5uh06vveT4ZrZcGEfBFUp5vo+A4Dk99fj9MluT3sb/LgXMfdoHjOJqZIoSgrMACrVr5Z0GY0vxyhoIpQghZBFmWEfRHEAqk3iU0mXTLXjSAV3E4/sR21G0qSdkX9Efxo796704Po8WaHPdiuN+Zso7JXpqHxpYyxWNljCHPZsKWnanVD91TfnTfHFN87vWgrNKG409sT9omSTJe/qcziMcFqDXKepYRQtaPfJMeeq3yz4JYXIBMHcdygoIpQghZhEg4juH+qaQ+U7cVFJlTZmGWg9Gswxf+w1HoDZqUff3dDrz24gVI0uIKPMiyjJ72CUxN+lL27TpQB7NFv6TZNrWax6EHWlK2+30RtF4ezEnBi9WKMeCZLx6CyaJP2u4Y8+DDt9qgpZkpQjY8juNg0ikvjx5NCKCJqdzI2ie2JEkY9/ox4cm8vK6K41Bhs6I4z5yt4eRMMBrDgNODSDw1TWYhJp0WjaWF0OSwctOY24cJj3/D3a2oL7HBZjJkLRVLlmX0OFyYCSlLV9KoeOysKVv21LDVJBSNo33MqTjtIN+oR2Np4Yq8ZrIsw+X0o/ViaqEGxoCKmsK0Vf6yjTGGXQfrcd9Dm/He69eT9gkJEW+/cgW7D9ajvrl0wXMl4gJ6Oyfg84SStqvUPLbvrYEuTcCWCY7n0LKjEtZ8A3zej9dkJeICBrom4XEFUGi3LOk51irGGAqKzHjk6V34+U/P4vbHcSIu4v03r2PfkaaVHSAhZMUxBug0KjBA0RWbvIFvWOVa1oKpuCDilQs38YMTlzI+1qzT4jefOIznjuzM1nByZmjKi//60rvom3Qv/OB7bK0sxl999ZMoshiXYWTpvXqpHX/33oUNd7fiz55/Ap/YvSmr53zlwk388+nrCz8wDYtei1d+70tr8gaCUud6hvH7P/4FhEXOnNzri0d24lufeiC7g1oEWZYRjwn44K0b6O92pOy35BlR02CHdgnpGJn63FeOoO3KEJwTM0nbpyZn8NYrl/Hlbz6cMutxr6lJH/q7HCkzRGWVBaisLQLPLy1xgTGGvAIjWnZU4vyH3Un7xkfcGOpzbthgCgDUGhWOProFZ060Y8rx8ezg2JAbktSzgiMjhKwW3BJuHmrUs4EYWX6U5keIQo/taFL8QReOJ3C6eyi7A1rlTrT1Q5SVBVIcY3h8V3aD4cVKxAW8/uIFvP4vF9OmptU2FmPT1oqczZgxxlBWacPTzx1ICXgScREXTvag7erQvGl0sizDMebBYO9kyr6GljLYS/OyMlZzngFbdlSlVAR0OX0Y6J6806h2I2KMobKmEAcfaE6qPh8MRNDXObFyAyOErBqxhKA4j8igVW+o7JeVRMEUIQrV2gvQVFqo6FhRlPBh+wCkDTJF6PQFcXN0UvGMaFNpIersyrvBL4Ysy0k/kiRhsNeJv/zjV/HCD08i6E9N6TSadTh0vBlFJdZlHdu9eBWHg8easTlNgQeX04cTb7TC4wrMmVIZjwnobZ+Afya5JLpWp0Z9cwksefPPai2WWs2jprEYtqLkGVhBkNB9czwp/W8jMpp12HOoIenvR5axYRsbE0I+JssywrHMl5DcVmA2KG5tQTJDq1wJUYAxBoNWjaOba9E1MZ3x8TKAAacHw9Ne1C5zkLAaXB0YV7y+DAAe2FoPnUbZXbZoJI6APwJugV4boiAhHIrB6wqgp30C1y70o6N1FOFgLG1QwnEM2/bU4JGndy05JS5TjDGUlOfjkad3or/bgXDw4wqDsgyc/7ALB45uwoNP7gCvSv69ZVlGMBDFtQv9KcFtUbEFDS1l4Ljs/D6MMVTUFKKytgjTzuT1tF03RuGe8sNWZM74fZ0NeD8OgEVBTDsTJ8syBFGEIIhgjN36waq5W8sYw+adVWjZUYXpybYNl35NCJlbOJZAKBpXdKya52CzGJeUJkgWj4IpQhTSqHjsq6/ET05dU3T3aCYcwZWB8XUfTAmihKsD4wjGlH0pGLRqHGiohFphwPL9P38L3//ztxZ8XCaFMTiOoXl7JX7jW0/CYFRebWkpeJ7DrgP12Lm/Duc+7EpabCwIEl76h1PYtqcGxWV5KcHD9KQP3TfHU85ZUlGAusbU0utLYS+xoqahGK2XByEKH8+4uKcD6OmYQH1zKVTzFOGJRuLwuoOIRQWIoghRkJCIiwiHYwgFogj6I5hy+OAY9aQcO+MJ4cO3bmCgywGTRQ+TWQfDrTL2vIqHSsVBrVYhz2aE0bT8BUTSMVv0OHy8Ga0XBzBzTzEQQsjG5faHERdERcfa80ww6ijNL1comCJEIcYYygos2Fxux+WB1AvThYSicdwYduCpPS3QLaEx32rn9AXQN+mGoDB1aWtlMUryMp+9uC3bTQt1ejX2HGrAl3/zYdhznN53r6ISK44/sR1dN0bhcQWT9o0OufDKj8/i67/3OPi7ghVJknHxVHdKTyqNVoXmreUwW7OT4ncbr+LRvL0CH7xtgPeeMV482Y2HntwBlWnuYGqw14kX/v4jjA25EAnHEQnHEYslFlWpasYTwhsvJRdFYgzQaNXQ6TUwGDUoKDLj2S8dxn0Pblb2C2bB7kMNqN9Uiqvn+2h2ihACABhzzSCqoFI0AFTa82ExrMwNoo2I1kwRsgSFZiO2V5cqqpgjSjIGnB6MuVP7/KwnPQ4XxjzKfkcGYGdNGWxmQ3YHpWQsDCirKsAXfu0Yvv77T6CiZmXKtN9rz+EG7D7UkDY3/sSbrbh6fiBpmyhIOHOiM+WxBqMWuw7VL8sYW7ZXosBmStnefm0E7mn/vAFvKBDFyOA0JkY98LqDiEbiSyr5K8tALJqAzxuCY8yL4f6plPLwuWa26PH4s3ugXsc3VQghmel3uBWvmaorKYDVSMFUrlAwRcgS6DUqtFTYUWBSdrE/6p5BvzPzsvprRUIQ0etwYWjstS8AACAASURBVNofXPjBadjMRrSU21d85q6kIh/P/ccH8F/+4vP41PMHUVRiXRWBFDAbBH32y0fSlkIPBaJ46Uen4PN+HCz0dzswNuRKeay9NA+Nm8uXZYw2u3l2LdY969bCoRguneldludca/bf34T6loX7gxFC1r9oPIHusWmEFaTHm3QaNJUXwqBbWq9Asnh0G2yD4RgDzziIkDZEOgljAAPDcl33MsbQVFqEysI8uIOZVybzBCPoHp/G0ZZa6DW561OUK+5gGO2jTogKZxJq7PloKFncDJBazcNg0EJQmGMOzDaa1erUyMs3oqQiH/XNpdixtxa1TcXQaNVQqTjFQRSv4qBP0whXrVl60+6quiJ86osH8a8/Op2yb2LEjY/ebsPTzx0EAFw61QOtTp00G8Q4hsPHW6DRLM9XAsdx2H+0CRdOdiMWTb7TevFUD5754qE5j+V5Dnq9Ju1rlw16gxYq9eLfA7VGBb1RCyHx8d+ZTqcBW2LVLK1Ojc995X78+f/xs7T7NTr6uiZkI5BlYNjpxdCkR9F1WkVRHhrKC6n4RA7Rp/MGs7myBE/uboY/EoU/EkUkJkAQJQiSBPHWjyDe+q8kz25L2r9yERjPMfAcBxXHgedv/Zdjd/3vu/bxHIwaDSx6LcwGLaoLs9M3J52qQisaSgrQNuJQ9PrcGJmEKxBGpW1l199kmyzLmJwJoGNsStHxPMehsaQQFbbFNXb97FeO4LNfOaLouRaSjVmog8ea8cqZ/7Is52eM4blfO4bnfu3Ygo/90jcexJe+8eCSnk+Jw8dbcPh4S9p98/3+Ow/U4W9e+sZyDStjn/7Vw/j0rx5O2Z6dv5FNc/6NEJIJuoxeu0RJwvUBBwYmU4vqLITnOGyuLkZjmbK2LUQZCqY2mGOba3Fsc+2d/z8higjHEgjH4gjF4gjFEghH4wjFb22L3tp2a384lkBMEBBPCIgJIuKCiFhCQFwQEIzGMeULIqZgZkCj4lFsNcOk00Cj4qFVq1L+a9SoYdBqYNSqYdBpYNTO/tzeZtRpYNBoYNTNPk6VpfLOC1HxPHbXVuC9G32YCUczPr57YgqTM35UFFhWTepYNgiShF6HC86ZgKLjrQYtdtWWQcUvbtZgLbx2yznGxZ57pV4npc+72t7X1fAeErKQDZB4si7JsgyHx48PWvsQUbBeqsCsx4M7GqCh9Zc5Ra/2BqfmeVgNPKyLqPoiyzJk4E4Adfsneuu//U43fvTBZfQ7M7+bUpZvwdcfOYAaez60KhV0ahW0d/+o+FV9obG3vhwFJoOiYGomFMWN4UnsqC6DZp4S0WtNNC7gbM+w4i/1QrMRu2rLsjomQgghZLVKCCLevdqD6/2ZVwjmGMPBlmrsblyeta9kbhRMkUVjjIEB0KlVaQsCaFQ8jDplPXcMWg02VxSjrnht9lwqtpqxrboEQ9NeSAqSnM90DeFzh7avm2BKlmX4IzFc6htTdDzPMWyvLoXdkloBjhBCCFlvZFnG+a4R/OT9q4glMs/wyTPq8OVH9q7L9derHVXzIyQLOI7hoW0N4BWmFl4fcsAVCGW9J9JKutQ3Cp+CmTpgNnXywa31act9E0IIIeuJJMm43j+BP/3pe/AGIhkfzzGGb37yCGpK1uYN6bWOgilCsuRQYxUKTMoaniZEEe/f7M/yiFaOLMt494byktc2swH7GyqzOCJCCCFkdZFlGcFIDO9c6cYf/OBNuPyZ97xT8RyeOrAZj+/dRBX8VggFU4RkiVatwvGtypuenmjrW9FqidnkDoZxZSDznO/bHt7asG5SHgkhhJC7ybKMWEJA26AD33/zPL770geKAime43CopRq/9sR+6JaptQVZGL3yhGTRYzub8NLZG4rWTfU6XBia9qChZO2XND3VOYRIXFnndp5jeGxnU5ZHRAghhKw8XyiKm0OTuNg9gvOdw+h3uBXdSOU5hj2N5fjakwdRbls9jeQ3IgqmCMmixpJCNJTY0ONwZXxsXBDxwc2BNR9MyfLsLJuSgBIAmkqLUFdcQF8MhBBC1jxZluENhNE5OoUrfeNoH3JizDUDpzcIUZIUnZMxYGd9GX77maNorCik9cUrjIIpQrKEMQa9WoWjLbWKgilJlnGycwBfOb5n0b2VVqNR1wx6Ffz+tx3fUgct9cgghBDF6NL6Y7IsQxQlJBT0wFwMQZIg3GoZ4w/H4A1G4PaHMe72YXR6Br3jLjjc/rv6ci5tHIwxPLCjHv/588dhsxhpndQqQFcshGSRWsXj8KZq/OTUNUQTQsbHO7wBdIxNYXt16TKMLjcu9I0gEI0pOtagVePwpuqcNVwmhJD1aH2svs2OG4MOfOKPfpibCFNO+k9WcRxDgdmAzx7djn//8F5oVnn/zY2EgilCsogxhpJ8M7ZUFisqwBCIxHC5fwzbqkrW5IdkXBBxdXACYQWd2wFge1Up7FbTmvzdCSGErE7ynf+zNuWb9NjVUI7P3L8dexsroKYCTasKBVOEZJnNZMCumjJcHRjP+LM7Ek+gbWQSwWgcZr2yBsgradQ1g6Epj6L1Uowx7K4rR75RWXl5QgghZD0pMBuwt6kC92+txcHmahRajSs9JJIGBVOEZJleo0ZLhR35Jj08wcya78kARlwzGJzyrMlUv66JaUx4/YqOLTQb0FJup/VShBBCNiwVz6GuxIb7ttZgf1Ml6kptKLIaKWNjFaOrFkKyjDGG+hIbqovyMw6mAGDc40evw7XmUv1iCQHdE9PwhjL/nQGgzl6AWnv+mvqdCSGEkKXgGINeq8amCjv2barA3sZK1JTkw6jVQKdR0XfiGkDBFCHLoKowDw0lhWgdcmSc8haKxdE5NoXAjhgset0yjTD7nL4AOsecUFIRnecYmsoKUWGzZn9ghBBCyCqj4jk8tKsBzx/fjdriAhi0ajDGwBgogFpjKJgiZBmoeR67akrx3o1eRTM17WNOTPlCayaYkmUZE56AopLwAJBvNGBHTRn4e6r4ibKE3hkXJiOBBc/BMw5bC0qQr83umitZlnHOOYy4tHA5Ww4M22wlyNcaMn6ePp8L4yHfqlkjzQBsKShBoS6zHP2emWk4wv55fw+zWotNeUUwqZdnXaAsy5iJR9Dqdsz5mJ22Mlg1ugUvWoYCHowEZxT3Tcs1Dcej3mJDscG87M8VFRK46XUimJi7eqdFrUNzfhEMKs2yj2cuXd4pOCNByGn+KhmAIr0Jm/OLcz8wsqFJkoz+CTfeudyNutIClNmssJkNyDfrYTXqoaEiE2sGBVOELJPdteWwmQ2Kgql+pwdj7hnU2QvWRDO+uCCic9ypKK0RAOxWI3akWSMWF0X8sOsSfjZwY8FzqDkO37v/GTxU3pjVvhsz8Si+cern8MWjixrDjx74PO4rrcn4eX7aew3/2H15VQVTf3fs03ikoimj437ccwX/3Hsd0jy/SYXRij/Z9ygeKKtftjuwHR4nvvLBS3Puf+Hh53HAXrXgeV4dbMfftp9DbBHB9Gpg0xrw7T0P4VO1W5f9ubpmpvGtc29iIOCZ8zFN1kJ858AT2FNUsezjmcs/dF3EK4M3IaYJiBmAp6pb8FdHPpX7gZENTZJl9E240TfhBgDoNCpU2fNRW1yA2pICNJYXoqm8EGU265q4DtjIKJgiZJmU5JuxpaIYA87Mq9tF4glcGRjHgcYq6DXqZRph9oRjCZzrGVF0LM8xbKsqgd1qWtIYEpKEPp8bR0vroOWz99HW6XUiKmbeM4zMbSLsx0cTA9hdWA5rlmcSSe5cdY1jKhqc9zFjIT/avU7sKiyn5qI5RK/02hONC+gZm0bP2DR4joPNYkCZzYKm8iIc31GPHfVla+J6YCOizpiELBOe4/DAljqoeGX/zM71DCMaT0Be5elFsizDE4rg+tDcKVXz0ahUOLa5LisXWl3eKcSyHPi0eSYhylJWz7nRSbKMd8d6MRycWfV/3yQ9XyyCm55JhBLxeR8XFuK46Z7ETEzZrDVRhv5VrW2iJGFqJojr/RN45Uwbvv2Pb+O3//Y1nLjWuyauCzYaCqYIWUb3baqBVeG6p+4JF4amZ7I8ouyTAZzuGkIkrqxRb6HZgP2NlVkZS+fMFOKimLUvGlmW0eZ2QJLoiyvbJsJ+vDnciZgo0IXfGjQY8KLLO7Wo9+6Gx4GJsJ8uAAlRQBAluP1hXOgewR/+w5v45vf+DZd6xhCJUVC1WlAwRcgy0mlUeGBrneLj32vrXfUXmqIk4f22PsXHP7StAVpVdtLyhgLeRa1tWqyQEMdgwDvv+h+i3CuDNzERDkBRCUiyYkRZQr/fjaF51krdrd/nxoBfWTNvQsjHBFHGld4xfPN7P8f//LdT6J1wIS6sjfWc6xmtmSJkmT2+sxkvn7+p6ELio/YBfPPxw6s6T3rc40f76KSiY1Uch0d3ZFbgYD4JSUSH14k6S0FWzjfg9yAwT6UysjSuaAg/6bmKP9rz0EoPhWQgEI/h6vQ4IotMqRVkCWcmh3C8vB5mbnkqOBIylwKzHnubKqFbpobwMgBJkiBKMgRRQjSeQCQuIByNwxeOYiYYRTg2fzpsphKCiH89eQNtg5N47vhOPLCjHkathkqqrxAKpghZRowxNJcXodaej37n4u7i3m3c40f7mBN761auEtZCPmzvV3xnrKm0EPXF2Ql8brvumsAnqluysgC73+decE1IrpQazKi32HL2ZcnAYNNmVhZdideG2vF84y40WG3L/lxKVJvzcV9pLRJLrOYXSMTQ4XHOWWKfYwwH7VUp7QEyZVHrYNcvrZjLQmbiEZyfyqzgzGnHIALxGEwquuAjuVVus+IbTx1GoXV5Ps9kWYYky5AkGaIkIZYQEUsIiMQSCEZjCIRjmPYFMTjpQd+EGz1j0whGl/69IskyOkac+OtXz2Bw0oOvPrb/Tq8qklsUTBGyzHRqFY5tqVcUTImyhBM3+rCntnxVfkBKkoz32/oVJ8E9uK0eGgUpfjpeBbvehPGQL6Xc8XX3hMLRJJNlGf0BN0JC6pfe7sJytHsnERNzl15xsLgKv7P9KNQcDxnzV+u6vf/e/2YqLweV9ryxCH7ccwV/vPeRVfk3/nBFIw6VVAPy3K/nfK/v7X0dXid+/9ybcMfCaR+n5Xj86f7HYLzVj0npe8Yxtmz9uwBAkiV0eacwvMgUv9scYT+uusbwiaqWZRoZIelxHAe9Vg2jbmV6ncnybJAVjiUQjibgDoRwvX8Cb13qQvuwc8nnn5oJ4oUPrsMTCONbnzsOrVq1Kj9L1zMKpghZZmqew9HmWvzk5NWMZ3BkGTjbPYxwPAGjduWaXs6l2zGNYZeyIhkGjRpHmmvBK+ifIcoy9tur8IuRToSF5MIXHV4nomJiyU1Co6KAkcBM2uqA95fVotM7BSB3wZSe18CuN0PDr69GjhJknBjvwxcadqBlFTZONam1WQlOJsOBeStWMjAU6U0wL2MglA0JScK7Y71pezapOR5ankc4kUhZZygDeGOoE09UNYOnwt1kA2GMQcXzsBh4WAw6FOeb0FxhxzP3bcXNoUn8+MRVXO0dQzimrIgTMNtO5Y0LnZAkGX/4+Qeh06hB8VTuUAEKQpYZYwwl+SZsrSxRdLw3FMG1wfEsjyo7zveMKM4F31lThkKLUdEdtIQkotFqg5pLDSwSkoh2z9Lv9jkjAUxFUnvocIyh3mwDT99UWeOKBvFvg+2I53CmjygTTMTw0cRA2n1FOiMOF9fAqk1fwfT05BC8VCKdbHCMMfA8B4NWg/2bqvAXv/YJ/Nd/9wi215ZCo1J+s0wQJbx3rRf/+O5lRLK8RovMj4IpQnIg36jHnrpyRfdjQ7E4LvaNrrpKWOFYAtcGJxATMu/rxDGGvfUVsBqUlY0HgEKdERZ16vGynJ1Uv8lwANNpGpIW602waHTUFVOBTXlFabfHRBFnncPo8U3neEQkU2cmh+ZMVSzSG3GsrA75c6SHhoUE3hvtXc7hEbLm6DRqPLpnE77zlSfw2aPbkW9Snl4djiXw6rl2nLo5iARV+csZCqYIyQG9Ro3NFcXIM2b+IRkXRHSOTcMTSH8Bs1IGnG6MumcUVbUuNBvRUmGHdgl34RKyhM359pTtEmRcdylrIHy3yXAA05FQyvZ6iw0qxqiatwJfad4354V2n8+Fk46BrDddJtn12lDHnPuKdCYcLa1FoS79Qn8ZMn4x2kVNsAlJo8xmwTd+5TC+9uRBlBaYFZ9n0hvAv3zUinGXj/pQ5QgFU4TkAGMMtcX5qFVYuW7c40OPw5XlUS1Nx/gUnL7UmZvFaCixoboob0mLZIPxOHYVlafd1z0zhegSLsrjoojxkB/BNGXR6y22JVdc26jsOiM+VbMl7b6oKOD9sT6MBX05HhVZrLGgD9dc6VOONRyPOksByoxWNOfZoZrj30jPzDT6fO7lHCYhaxJjDHqNGp86vAVffmQfCszKZ6jaBh345dUe6kGVI3RFQEiOVNry0FhcOO8i9Lk4fUF0T0xDklbHXaZgNI7u8WkEIpn3YOI5DpvKi1Cab1nSGEJCDLsL06dOBhIxDPozr554WzARw1DAk1KlkGMMtZYC8IyDTI18MxZMxPGZ+u0ommPm4rp7ApemR5dchpwsjw8n+hGco1WASa3BDlspOMawr6gCOj59fatAIoZTEwN0x5yQNBhj0KpVePrQFjx9aCu0CntjCZKEFz+8jklvgP6t5QAFU4TkiJrnsKO2FHnGzNcJxQURneNTcAdXR6qfw+tH14Sy9S2FZgN2VJcuuYBDOBFHg9U2u37pHlExge4Z5etv/IkYBv3elO02nQFlRitiokBpfgoEEjFUGK14qroFXJowWJRlvNjXCm8sQhcAq0xCEvHBRP+cga5Vo8OOwjIAwD57JUyq9FUJI0IC56dGF93wl5BsWEtLXGcDKh7/7sFd2FZTonjs3mAEL59uy+rYSHoUTBGSI4wx7KguRaFZWePArvEpTM4EVvwiXpJljLpnMOhUlqpTnGfC1sriJffBCIkJ8IzDNltpyr6YIKBXYTEDWZYRiEcxHEwNpkr0ZpTozYiICZqZUsAfj8Ks1uJ4eT1KjenXBNxwT+CkI321OLJyen0uDPpTZ2uB2QvVBmshygyzs83FBjM2z1HmXgYwEvSiyzu1bGMl5F5r7dOaMQabxYivPLYPeq1a8XnevtQFT4AqaC43CqYIyaHyAguay+2KUv3G3D4MOD0QpZVdvB2NC7g54kRAQQd3Fc9ha2UJiqymJY8jkpjtybHr1t3wu8UlEQN+j6JiBjJkTIT98ERTZwGL9WaUGEyIKqhgSGZn/ABga0EJDhZXp/13IAP4YeclBNKsVyMr59LUKFzR1IIsAMAzDsfK6pJukDxW1TTnuRwhP254HKuuQikhq83+TZU41FKj+HhPIIxTN+nm1HKjYIqQHOI5Dsc21yrqJZEQJVzuH0MkrryxXzaEYjFc7BtVdKxOrcLRzXWKgsl7hcUEGBh22VKLUMgApiPBtH2iFpKQJHR6p1KajvKMocxoQYHWMJvmp3TgG1ggPhsg5Wn0eLC8Yc61U70+F94c7srl0Mg8AvEYbrgdaQuyAICa53G8rD5p2wNlddDz6e+oB4U4bnomMROnO+aEzIfnOHzhgZ2KU/0kScaHrf0rntGy3lEwRUiOHd5UA7M+/XqChVzoHUEoFl+x9SSyLGNyJoj2MWVNcW0mI/bWpa/Al6moMBtUVpvzYU2zbsoTi2AslHllOEGS0O6ZTNluVGnuVPKLigKt6VHg9sU4YwzHSuvQnGdPe5EgyhJ+3HMFvng0twMkaQ0FPOjxuea8gbDTVoYSQ3JBmQKtAfvtlXOes90zifEglW5eLmtpjRCZ36aKIjRVpO/RtxAZQL/DDac3kN1BkSQUTBGSY0atGsc21yk61jETQPuoskAmGyRZxkftAxBEZamGD21vWFKH97tFRQEyZBhVajRZU79ovLEIxoK+jGaQZFlGXBLR7k19jU1qLeqtNgCgXkgKBe6qBGdQqfG5hh0wqjVpHzsamsHrQx2UCrbCJFm+s15qLk9WNadcvHOMw2OVm+Y8ps/vxkDAkzIDTLKDXtX1gTEGjZrHgeYqxecIxxLod1A7guVEwRQhOcYYw2M7mhSnur13o3fF7uYmRAkfdijLv1bxHB7d3rjkwhO3xW+l2ulVajTlFabs9yeiGA/5Ml5j5owEMRlOvYtn1mhRb5kNpuISpfkpERI+DqYYY3iwvB6b80vSPzYRxztj3YpSNUn2BBMxtLodSe/d3YwqDY6U1qRsZwD22SuQr0nfK0eQJJybHEZojlLrhJBZKp7DlmrlVf2i8QQGJimYWk4UTBGyArZWFqOqME/RsWd7RuCPrszi/P5JN/oUfihvKi1CQ4kta2OJSyJkWYZepcamvKKULxpJljEW9MGfYarYddd4SqDEAJQZLHfW+MRFCXTvN3Ohe9bc6Hg1vrb5AHiW+lUkA+jwTOG0Y5Bmp1aQOxrGpam510juKSpHoc6YcpOEMYYCrQH75kn1Ozs5BF88Sql+hMyDYwzlNgsMuvSz+AuJCyIm3P4sj4rcjYIpQlaAVqPCA1uUpfp5Q2Fc6hvL8ogW50Rbr+Jqgg/vaISKz95Hzu1+NyrGocJoTdtvajQ0A28ss0XuV6fHU7apOA7bCkrAc9yd56bLv8yFhdTiKYeKq3CwOH0KizcWxocTAzQ7tUIkWUKf34U+/9w3UI6V1kE7R4Nek1qLg8XVcx47HvKj1e2gf0uEzIMxBp1GDZvFoOh4QZTgDYRXvBLweqastXKWBaMx/PVbZ/GD9y+t9FAylhBE+CNUwpdkRsVxeGBLHX5y6lrG649keTbV7+FtDVlLmVuMhCjig3ZlKX4GrRpHNqUvha2UIM92emKMoVBnRJnRklKwYDzogzcWhiwXLPq1uuaaSNnGMw7b7yrBLsoSTUwpEBVTgykdr8ZXm/fhvHMY4j0zFDKAU5OD6PROwa43ZfXvhywsIUn4cHxgwUa9qjQziwCg5jg05xWhWG+CM01ALEHG2yNdeLxyE723hMxDo+ZhNeoBzCg6PhSNIxxLKC5+Rea3KoIpGUAgGkNghVKXCFkJZfkWbKsswbWh1Iv3hVwdGIc7GFbcAFiJG8OTmPIpmyHYXVuOQkt2xyrJHwehhXojKoxWdN7TCHQyEoArGpoNuhZxzuloCGOh1C8rDcdjW8HHa3so7UyZqJh6Uc4AbCsoxdHSOnww0Z+y3x+P4tWhduwuKodFrc3pDYSNTJZlhIU43h/vm/Mx222lKNab5nxPGGOoMFnRkm9PG0wBwAcT/fDFo7DplN11J2Qj4DgGnVr5JbsgSkgI6W+KkKWjND9CVgBjDFaDDnvrKxQdH4zFcaFXWa8nJWRZxtnuYUQTmVex4xjD/oYKmHXZvRC+O57J1xhQbrSmBEyiLKPP70Z8kdX32tyOlNkRAKg05cGuX3qj4Y0u3fvAGEO+Vo+nqltgUqVfE/DeWC96ZqaXe3jkHpenxjAZSV9SmYFhW0EpCuboFXabXW9CS35x2nVxABAREvMGbEQZuuWwvnCMQb2ESriiJCOhsAovWdiqmJkiZCPSa9TYWlmMPKMOM6HMiiRE4gIu9o3isR1NWV2HNBd/JIbW4QnEFdzZKrIY0VJenLWS6B+TcTvXTqdSocqUB4NKk1J1rNs7jZgoQKdK30D0bq1uR9KM121751lEnyttHgf++uZpcHNclGbTAXsl9tkroeay+54JspR2llDFcdhdVIFdReU45RhMOS4kxPGjrkvYVVgOFc1M5cyrw+1z7svX6tGSb4d+jvVSt2l5FbbkF8OmM6Rd+yYDeGO4A8/Wbr2zJpEsHc2drzMyIC1hzZMsy5Al+qtYLhRMEbJCGGOotuejvtiGKwOpRQ/mI0oS+hwuOLx+VCqsCpiJnolpOBQ2/WsqLURloXXZ07OqzfnI0+pTgynfNKKiAOsiznHD7UibwrevSNkMYja1eSbRlqaZ8HL4za33YVdhedaDKcizJbE1fOp5K4wWHCurw3XXBAKJ1JTvjxwDuOYan7c6HMme6WgIF5wjc+6vNuejwWJb1L/rrQUlKDWY5ywk0umdwkDAg0ZraosDogzdclhfJFlWdDPzNo5j4HNw43WjoleWkBVUUWBFY2khlMQZk74gOsenlr2ssCzLuDnqxLQ/lPGxKo5Dc7kdxVbzMowsWbUpH3lpKvoNBTzwJ2ILvk7uaAhjodQmvxyAXYXl2RvoBiemmfkDABXH46HyRtSY89PuDwsJ/H3nBVqvliMnJwbgj6dfx8wA1JjzUWspWNS5KoxWNFgLwc/xQRdMxHFqYpBKpGcRvZLriyhJiMaVN4tX8RzUKrrkXy70yhKygjQqHturS1FgzHzxtcsfQsfYFIRlLnc6E46ia3wakXhqJbaFFFqM2FZVAp5b/vukFSYrCtMsYk9IEjo8zgUvLvr87rQNROuthcjTpgZpJPuqTXl4uKJxzlLbl6fHcG5yKLeD2oBEScIvx3rmrOJnVmuxq7AMmkXOXPIch8MlNTDMsSYuKiZw2jmI2CLXNhKy0cQSIryhzNp83I3nuLQZASQ7KJgiZAUxxrC9qgRF1swr3UmyjJ6JaThnlrcHz5jbh75Jl6Jjy/LN2FJZnJMKbFpehQZrYdrUtOvuCcgLhFN9PjfCQmowtcNWNufieZJdjDE8W7sNpYb0M5n+eAwvD95M+z6R7BkMeNDrc835LyZPq8eeooqM/l0ftFel7QUHzM6ijAZm0ElFRghJIcsyIvEEZgLKgymdRgXNEqoBkvnRFQIhK6zCZkVTaZGi2ZsehwvjHt+ypceIkoShaS9GXJn3tlDzHLZUlqAoyyXR57M5vxjaNHffWt0TmO8lkmUZ/T43Imn6IO20lVIwlUMVJiuerd2Wdp8oS7g6PZa2sTLJnvPOEXjmaHZ9O8WvwWLL6JylexNZQAAAIABJREFURgt2FJTOud8ZCaLVNU5pnITcQ5JlODx+RdkhwGyKX4HZkJNiVRsVvbKErDCe43B/Sw20qszvGk37Q+iecCGRpn9PNoRjCdwYdigqia7XqHGkpSanfYE25xdDy6W+jt0z0/POZgQSMYyFZpC4J2VSy/FozrfPudaDLI/P1W9HudGSdt94yI8PxvsRmGM9D1maUCKO664JBOd4fXmOw/2ltdAsUMXvXgzA41Wb5iyMEEzE0OZxpjTeJmSjE0UJXSNTCz9wDmqehz2PWnssJ5rzI2QVONRUDZNei3CGd54kWcaVgTH8yp5mqI0qRYUs5iLLMvyRKC73K5sFKLKYsLumLHsDWoQ6SwHMGi3csXDS9oggoGtmCvvtVWmPmwzPNve9V6UpDwVaw6poFFtrzsd2Wxm4HIxlti/Qyv3ORXojnm/cjb+4/mHKPkGWcNIxgKdqWrDTVrYq3pv1ZCjgRa/fBWmOJD814/BgeaOicx8trYNRrUUwTbVGGUDXjBOjwRnkaXT0vi4RvXrrR0KUcLVvTPHxahVHwdQyo2CKkFXAotfi/uYavHzhZsbHXu4fx0wohjyjHtn+Ch1xzaDfqWy91EPbGqDNcY62muOxzVaCoYD3nj0yrrkm5gymJsJ+TEdSg6lGaxFM6vSL5nPtYHE1vr3noTuL/m/3a7r7kpfdtf1u8j370j3m7sdyjIFbwcsxBoanqzfjpf5WDKe8l7PFQk46BtGcZ4d+zv5hdDmZKVmW0TMzjSG/Z87HNOfbUTtHxcWFmDQaHC2twy9GOtPu7/W50e93Y2tBMRi9f4RAlmU43H7cHHIqPodOo0Z9aWZpuSQzqyKYYgAMWg30mlUxnIwkRAnBaAwiNUMjS8AYw2M7m/Dzi+0ZrxnwR6K41D+K6qK8rM5MiZKED272z7vWaC5qnsMj2xtzfneZMYY9hRV4Y6gzKciQAVx3TaQ9RpZlOEJ+eO6ZzQKARqsNRrV2eQabIQYGFeOhynbvp1WIMQabzoBP127D/2w7nbac+quDN/GJqhbUWwrS/p3RxEbmgok42jwO+NPMHN32eGWz4vNzYHi8sglvjXSmnfdKSCIuTo3iwfIGWOcoVkEWh65I1o/XL3QsaS2hxaBDTfHi2hgQZVZF9KJVq/DI9kYc3lS90kPJ2Kh7Bi+dvQGnb3krqpH1b3t1KcptFoy6fBkfe+JmH549sDWrswnRhIBTXUOKjm0qK0J9ycp8eO8pKkfqnA3QPTOFiJBImcmIigLGQj6EheQUSx2vQo2lALoM14aQ7NDxKhwtrcUbw53o8aVWeRsMePGLkU78b1sPg0/zd09FQzI3HQ3iygLFPSZCPvyo+7Li53BFQ+AYgzjHxeF55zC8sTAsai2l+pENb9IbwNuXuxUfzxjQUmWHXjvXDD7JhlVxlaDmeWyusOOJXZtWeigZuzkyibeudVMwRf5/9u47upHsvhP991YVcs4kwZzJDmx2zhNakz3BGmlkSZZlHVmyHNayLT0/e9f289n1e8/y7ltbx7vatSxLsmRJI2s0skYTNLmnc+5mB+acMwEih6r7/kCzp7tJRIIECN7POTzsJgqFIgEU7q/u7/5+q6YQBDy8pRb/8sHltO97bXAc024vSswrL9rPxK2RKYzNpx/YAcBjLfU5G8xW6y0wKZTLqpG5wyEMeubRZHLc8/PFcHDFVDK7SguHSrcua5SY5QghqDVY8UBJNQY8c8uKgwDAj3qu4mPV21FyX7EKQsidVMV4a3+Ye0mUYtCzsGLgerd/6U7//JSOYa8Lt+anUK41sUQ/ZlMTJQkvHr+GucXlKeip4gjBwebK7B0UsyJ26Y5h8gTPETy0tTqj8qX+UAQnOweydiyUUrx9vSejFD+NQo7DjZU5S7NScAK2mouW/TwsRdGxsHyg6A4HMeRdXvq9WK2HQ8UW7eaSWpDhwZIalGqMK94+GfDixd5rK7YGIISA59hHXKrCoohTE4MI5rhxrkQp3hzpXjG1k2E2C0opLnWP4p2rPataRqJTK3FoS2X2DoxZEfukYZg84jQb0Fxqz+i+b7X1ZK1HSzAcxYmOzIKzndUlsOrUWTmOTBBCsNPqXPbzsCii0zV9z8CbUhoLplaYmSpR62BnwVROEUKwx16KnTZn3OqCP+lrw7h/cdnPORDIWDCVEkopAmIE74715PpQAADvjfeuWPGPYTYDeruv1PffvYyJueXntnQ8uL0GWmV+FFEqZOyThmHyBCEEepUC+2pXrjiXTPfELIZn0m+uu5KLfSNw+9Lv98IRggP1FdAoc7fegQBotTqXpQiFJRG97nvTxURKMeJ1w3PfwE3O8SjVGqGT50fxic1MxvF4vmobzIqVA/T5UAAv9l6DeF8aIEcIZJugWEe23JybwPAKM7S54IuE8e5ob64Pg2HWHaUU854Afvj+VVzoGl5VkrJCJuDJvZkXjGFSx4IphskjKrkM2yqKYFCnX8kqGI7gdNfgqo+BUopTnUMIR9NvBGzTa9DktEOW407rVTozDHLVsp/Ph3yY9Hvu/D8iiWhfWF5yVidXoFrPqh/li932Uux1lK14W1gScXysHwOee8t58yyYSssrQ+25PoR7vDbcyVL9mE2FUorZRT++984lvHzqJiLR1b3+DzRVoKnMzgq5rAMWTDFMHiGEoMJqRF1R+j0hQlERF/tGEIqsbs3DrMeHWyOTiK6w4D+ZplI7nGZ9Tk/ehBCoBBnqjdZlt7lCAQx7P0zpixdM6WVKVOtZX458IeN4fKFpH1T8yhWpBjzzeGe0FxHpwwsAHOHu9ORiEnOFAzgxkb01l9lwY35ixfRbhilUPWOz+P9eOo4ff9CGQDiS/A4JaFVyPL2/mVXxWyd5Uc2PYZgPlZgMaHDacXlgLK0CEJRSDM24MDA9j0ZnZuuuAKB9dBrTGVQPkvEcmp0O2PS5X2ekFAQ0Gu24MD1yz89d4SBGvbEKhRSxWY1O1/Sy+xvkyowbkzJro9nkwCNldXhlcPkMii8axsmJfjxSWocaQywI5gmBjGfBVCpOT8bKkcfjUOmw3VIEeTbbBFDg8uzoPTPFd/NFwvhgvJ9d1GAKni8Yxi8vdeEnJ9rQMzablbXPB5oqsa2yiBXhWScsmGKYPKOQ8dha6oBJo8a8N/4AZyUziz7cGplCQ4kto9khiVLcGJrEvCe9xwUAm16LLWWOvDh5K/lYMHW/xXAQIz4XRCqBA8GgZx4L95VQ5wlBld4MbZ4062ViBMLh84178dZI94oV5y7PjuHK7CgqdCYIHAeOEDYzlQJKKd4Y7ow7E80RgmOltfiz1ofjFgHJ1NdvnMJ3uy4iJC5PKQ6JUZyY6Men63ZCzoLitLHErvxFKYVEKcIREdcHJvAv71zG1d5RBMPZqaTptOjx9P4mWA2arOyPSY4FUwyTZwgh2FpehCKjNu1gyu0Pon1sGk9GolDJ05/en1n0oXtiBuEVBjfJOM16NJXac1YS/W484VCmNcAgV8Id/rCQBgUw5nPDFQrArFDj6uz4svsKHI9t5iKWZ55nCCGo0pnxVHkTfjpwY9ntITGKVwbbcaS4Gg6VlgVTKRrxunBzfjLuQneTXIU9tlJoBFnW3xNHiqvwUv91hMTl5zmKWM+p9oUp7LCWZPVxNwPWXS1/UEpBEVvX7AuG4fYFcbVvHG9e7MSVvvQyUJKRCzwe2lGLvQ3l7DNsHbFgimHyUJnFgNoiC7rGZ9LuMdEzMYuxeTdqi5avGUpmZNaF/qn55BveRy7waC51wKrLjythhBCYlWqUaQz3BFMAMOZbxHzQHzeYkhEO2yzF63WoTBo0MjmeqmjC8fE+zK2QlnZhegRXZkbxeHkjeMJBkc20tAJ1Zmpo2XvkblaVBjttzjUZmLVYilGk0mEuuPJFo5mAD1dnx9BiKWYDQyZjkiQhEIoFMmtlabZJkiiiooRgJHoneFr0h7Dg9WNoagHdo7NoH57KKPsjGQKgtdaJjx/ZDoWMnfvWE/trM0we4nkOhxoq8e6NPvhC6X0A9E/NY3jWjRqHJa0BSFQU0Tc1h/GFldcwJKJWyHC4sSIvZqWWmBVqlGmNuHlfgYlx3yLmQgFUUQnXVwim1DI5Goy29TpMJg0cIdhiduBgUSV+sUL1ubAk4jtdl/CgswY8m5lKKhiN4PLMaNyeThwhaDbZ4VQb1uTxtTIFDhVXoX1hGnSFuRRvJIQb85Nwh4MwKpZX52SYVIzNufGNV89AuYYBBgUgSRSiJCEiigiEovCHwvD4Q1jwBuDyBSCtovluKiocJvz+M4dQbmfrfdcbC6YYJk/try+HXq1IO5hy+4NoH53C/rpyqNOo5OMJhHF9aAKRDFL8igw6tFTkVyqOSaFCqda47OfTAS9mAl6MeN2YCS4vtNFotLH1UnnMolTjwZJqnJ0awuwKz9+12XEcH+vDdktJdgsmFKBBzwJ63LMQ4+QZyTgeDztr13Qd5JPlDfjnjgsrHgMF0OWaxpB3gQVTTMbmPQG8dbk714expsw6Ff6Pjz+ILRWOXB/KppT7leIMw6zIpFFhX+3KvXWSudI/Bk8gCJpiMjalFC5/AFcGls/UJEMI8EBzNZQZrNFaS3KOR5nWAK1wb/f3KJXQvziHC9MjK/ax2W0rZYu38xhPOBwprkJTnNnDKJXwjx3nIVEJCla4IC5KKTpd0xjyxG/UqxXkOFpcvabH0WxyoGKFix5L+hbn0Oeey0qFs82EncM2D6teg//0yY9gb0Nm4wVm9VgwxTB5ihCCJ1obwWWQO3djeBKzaeRkUwr0Ts5hdM6d9mPJeB6PttTnVYofEPv7lWuNMCvVy27rcs3i7NTQigt/d9vZB1K+syo1eLy8Ebo4M4g97ln8cqSbzUwl4IuGcWN+Eq5wIO42D5bUxP0bZ4tAODxR0Rj39pAo4tLMKBYTrOtilmOhZ+EjBHBaDfjqxx7A0W1V4DmOrS3MERZMMUwea60sQZFJl/b9gpEoLvaOpHw1NypJONGeWdPO+mIbahzmjO671sq0RphWSA+6OT+BC9MjkO4bcmgE2Yol1Zn8QgjBY2UNqInTgygYjeDfB27CwwbgcU0HvGhbYc3gEgLgqYrGdRmcHXPWJlzfdmF6BPMhf8oz7QxT6AgBmssd+PKzh/HwjloIPM8CqRxiwRTD5DG5jMexrTUZ3fdEx0DKlQAD4QjOdg9n9DhPtDaAcPl5Ei9W62FTapelvIz43JjwLy7bvtnkgFrIr3RFZmUWpRqfrN2xYu8jCqB3cRZXEgQLm5lEKYY8LnS6ZuJuU6IxYIfVuebHQghBpc6ERlP8ixiDnnl0xilSwTCbDc9xeKS1Hn/ywkP4yM46yASWzpxrLJhimDzGEYJj2+rAZxCs3BieTLlP1a2RSUy706/ip1XKcaixMm/z85WCDNV6M2QpVnXbYXVmlFbJ5MYT5Y1oiDOTGJGkuFXqNruQGMX56WH4ovGL2zxUUgPNOl1YUPEyPJBgbZZIKd4e7YnbWJhZjp3FClOxWYcvP3cYf/z8UWyvYi0D8gULphgmz5VZDGh0pp96tpTqlwylFO/d7Mvomu/OaiesOjXy9aObAGg02aFMce3MDmsJeMJOixuFVibH5xv35vowNhRKKYJiBO+P9cbdhgNwrLQWwjqVllfwAnbbSxPOCr8/3gdfNLIux1MI2BxeYZEJPI5srcLXPv8UPvFAC+xGba4PibkLW53LMHmMEAKdSoFDDRW4NTKV/A73Od7ej1/Z1ZTw6lVEFHGqczCDYwMON1ZCLZflXfGJuzXdDqYWk8xSaAU56gzWPA0LgbAUhSscSHmWLRu0ghyyPK+I95CzBi2WYrTNTeT6UDaMbtcMut2zcW+vN9pRpTOv63vBqTGg2eTApZnRFW93h4M4PtaHX63emvXHDosiFkLxC3Fkm0aQQcaxNS5MYoQAGoUcFUVmfPbYLhzdXg25wF43+YgFUwyT55QyAS0VJdAq5fCm2cG9bXAC3mAYOlX8ilyxdMD0BxIOgxZNTnve52tX6swwyFWYXqEn0d1qDVZoBHneflCdnRrCn51/Y93SEAmA391yEDus+dU/7G6EEGhlcrxQ04LOhWmEpPR7pG1GvxjqSHj7HnspjArVur0XCCGwq7TYbi7G5ZnRuLMqrw6349mqLVl9D1AA1+bG8SfnXsvaPpP5QtM+1oKBiUsu8HCYdKguMuPBlho8trsBqjxrPcLciwVTDJPnCCEotRjQUGLD5f6xtO7rCYZwfWgChxor425zpmsoo0a9W8qKUGxMv9LgelPyAprNDvQuziZMfWkw2vK6+MSYbxFjvuVFM9YKAfDxmu3r9niZknE89jvKsc1SHHdWg/mQNxLGe2N9cW/XCDLssJRAK5PH3WYtaAU5ms0OGORKuOJUYbw6M45RrwvlOlNWH3sq4MXUaE9W95nIM5XNt4tpsHCKiRE4DkUWHWqKLdhSUYSWqmI0lTugVeXvBT7mQyyYYpgNoNikQ3OpA1cGxtMqDxyJirjUPxY3mAqGI7g6MI6omN7CbhnPY2uZAxbd8h5O+Win1YlfDLYnrAZWZ7BCLazvAJLJDqfGgGPOOtycn0RQjOb6cPLa+elhTAe8cW+v1JlRa7Cs+9pBQggajTaUaY1wzU+uuI0vGsb74334bMPudT02hlkLNoMGFQ4T6p02NJc74LQa4DBpYTNoIfBs7e5GwoIphtkAlDIBTU47TBpVyhX6ACAiSrgxNIFwNAq5sPzt3jc1jyl3/IFVPEspfkKer6dZ0moria3rihNL6WUKlGmNkHHsA2wjkvMCDhdX4vXhDtyIMxBnYsUnXh/uhETjXzypNVhQqctN37gavQWVOhNuzk+u+FaNSCLeH+vDp+ta1604Ri4RxILMTCYmCnE2I9O/xXrjOQ5ygYdCJkAuE6BVymE3amEzauEwauG0GlBbYoFZp4ZcEKCUx744QgryedsMWDDFMBsAIQRbyh0oMenSCqYAYMbjw+D0AupLbPf8nFKgfXQKLl/666XKrLG0w42iwWCHTqaImz5UrNHDrtKyD7INigBoMjlw0FGJLtcMwmzt1IqmA96Ea5K0Mjm2mYuhk8VfY7mWFLyAXbZSHB/vh2eFgjEUwJB3AR0L09hmKV7/A1xnj+ysx8M7ajO6L8eRgmrzYDNo8Ob/84VcH0b6yFIy54eBICHkToIn+8wpDCyYYpgNosJiRE2RBR1j0yk34wUAty+Insm5ZcFUVBTRNT6TdlELucCjudQBq16T1v1ySeA4tFhK8MFE/4q3OzV62FQb5/dhluMJwdOVTfjlaBeGPAu5Ppy8dHpyEO44FxQAwKrUYKfNmbMBHiEEe+3l0MuVKwZTADAX9OPSzCi2mosKfiDKcQTcJpiBSwUhJO+LHTGbF8tpYZgNguc57K8vh1qe3rqexUAQvZOzEO9reDnl9mJ41gUpjTVYAKBTKnCgviKt++SDnTbnij8nAJxqAyyKjbH+i4mvyWTHQyU1BXVFPlvCtxv1eiMrXzwhAMq1JjQYcjvjXGuwoFZviVuawRsJoW1uImmrA4ZhmPXCZqYYZgPZV1sOg1oJTzD1gURElDA044LLF7ynYMTYvBuj8+lXhysx6bGt3JH2/TIh53h8uq4VR4urlt2mlcmhSbFgBAHwXOVWVK2wFoQQghq9BYoUG/sCwLNVW7DdUrwsEOUIQb0xs8Ho89XbsMvmRJqx7ZohBNhmTj+V6oWaFuxzlK/4e/AcB/kaXmnnCIfPN+7Fbltp0osEtQbrmh3HSip0Jvz13scRilMgQ+C4lJtLZ4IQgo9WbcPhouXvpaXbSzUGqNe5it/9ZByPP245io/VbIv7XrCptGmtb/xU3U4cLalJq3jPWtppdYJjlfwYpmCwYIphNhCrTo1dNU6MzrvTut/4/CKm3J47wZREKUbn3Zha8KS1H44QHGqshFqxPgMunuOww1qy6l5HhBCU64wo1xmzclzNJgeaTdkNKLeai7DVXJTVfebCNktxTtezlGoNKNUacvb48RgVKjxaVp+zx5dxPPY5ynP2+OnYbinG9iy+hrJxDmEYhomHpfkxzAZCCMFjO+rTTmMaW3Bj0uW9c2XWFwyjZ2IW4TT7Swk8h8d21KV1H4ZhGIZhmELFgimG2WD21JTBlmbxB5cviJE5151+UouBELrHZ9N+7MYSG6odlrTvxzAMwzAMU4hYMMUwG4xc4HFsW/rlcnvGZ+ENhUEphdsXQO/kXNr7eKK1kWX6MwzDMAzD3MaCKYbZYAiAR7bXgU+zwWz3xCy8wRAkSjEwPY+FNPtL6VUKHGrceFX8GIZhGIZh1goLphhmA6q0mVBfkl41sv7pebj9QURFCW3Dk2k/5s5qJ6w6TcH3dmEYhmEYhkkVC6YYZoMhhECjlONQQ3qzRKFIFJ1jMwhHRVwbGE/7cY80VUEpZwVAGYZhGIZhlrBgimE2IKVMwK7qUmjSLFHeNjgBly+Ansn0ik8UG3Vodtoh41kHeoZhGIZhmCUsmGKYDYgQAqdZj0Zneg1i24bGcXVw/E5Vv1RtryiG3aBN6z4MwzAMwzCFjgVTDLNBOQxabC1zIJ0lTCNzbrzZ1p3W48gFHlvLHTBpVWkeIcMwDMMwTGFjwRTDbFAquQxNpQ6YNOqU7xMVJZzvGUnrcYqMOjSU2FiKH8MwDMMwzH1YMMUwGxQhBI1OG5xmfVr3C0WiaW1fbjWioSS9dEKGYRiGYZjNgAVTDLOBVdpMqHFYwHNrU65cIROwtcwBk4al+DEMwzAMw9yPBVMMs4HxHIe9tWVpV/VLlUGlwN7aMtZbimEYhmEYZgWsaQyTMkoBgCIYjsIfDiMQjsAfjiAQin3vn5qH2xfIaN+LgSDO9wxjyu2BSi6DWiGHWi67/W8ZFDIBHBvQr2hPbSmMGhUWA6Gs79tpNqC5zJH1/TIMwzAMwxQCFkxtcpGoCG8oDE8gBE8gBG8wBE8gDE8wGPt+52cheIIheINhRKIiopKIiCghKkq3v4sIRqJw+4MZHcfkggf/+M55KGUCBJ6HjOcg8BxkPH/nu1Ylh06pgE6lgE6pgFalgF6lgE4ph1apjP389jZapQICvzkmXu0GLXZUlmBk1gWaxf3yHMGhxso1m/ViGIZhGIbZ6Fgwtcm8ea0bP790Cy5fEC5/EIFQGKJEQSmFdPuLUtz+fvfPPrxtLUQlCXMef8JtCAE4QkAIAXf768N/486/CSHgOQ5qhQxGjRIGtRK/9fBetFaVFGS6GkcIHm2pw2tXOiFK6fWPSkTgOHxke23W9scwDMMwDFNoWDC1yfROzuJU5xDoWkVFa4hSQKQUSHX+xQMMz8b++WRrE1qr1uzQcm5/XTksOhWm3b6s7bO51IFquzlr+2MYhmEYhik0myMPirnPxgukmMTkAo+Ht2Z3FumJ1oas7o9hGIZhGKbQsGCKYQrEoy31WSuRrlcpcKixMiv7YhiGYRiGKVQsmGKYAlHjMKOu2JqVfe2uKYVVpy7INWYMwzAMwzDZwoIphikAhBCoFXIcaqjMyv4ebK6GXGBLKhmGYRiGYRJhwRTDFAiFwGNfXRlU8tUFQSUmHZpK7VlLGWQYhmEYhilULJhimAJBCEGxSY+m0tU12W2pLIFVp2EpfgzDMAzDMEmwYIphCohNr8G28iJkGgcpBB7by4tg1Cize2AMwzAMwzAFiAVTDFNA1HIZmkvtMGlUGd2/2KRHfYkNAs9n+cgYhmEYhmEKD0nSvDXlhkQSpVj0B+H2B9M+CI4jMKpV0KkUad8310KRKOa8fkSiYtr3VcgE2PQa8Nz6xbQuXyCj52ijs+o0UCtkmyJ1zR+KYMHnR1SU0r6vXOBh1qqhkLHiEwzDMAzDMLfFHUBmLZhiGOZeEqWIRkVERQni7S+JUlAKUEoBAnCEgBACniPgeR4Cz0Em8OBY8QeGYRiGYZh8EXdgtqrLzwOjs5hz+UGzHHMRxBbTE0LAcQQ8z90ZZCpkAhQKAUqFDGqlHDxHcjrb4AuEMTg2B38wnLNjiMds0KC61JK1v8/0nAcjkwuQEgfgaeEIAeEIOEJiz7GMh1wQoFQIUCvlUCnlkAnchplRopTC5QlgzuXDzIIXfcMzGJl0YXzajel5D7z+EIKhKILhCASeu/M6tpo0cNqNKCsyorbcjhK7HmaDBia9OmeBFaUUi74gugenE25HCMHOprJNHwDOu/0YHJuDKCWeETQbNKgoMUPgc59lPT7txsSMe9XvaQKAcBw4AnAcB5kQO1/LZQJUChlUytjrnMvx+ZphGIZhsm1VwdT3XrmIN0+3I4tj6zt4joDjYkGUQn47eFLJoNeoYNSpYNKrYDPrYDdr4bDoUVpkhNWkWfe1HqNTC/jbb7+TdMCZC8f2N+A///5TGRcjuN/JK734+vePIxJNP30sHo6LBVECz0GhkEGjkkOrUsBsUMNq0sJm1qLYZkCJTY/yYjPMBk3Wfp9sikRFDI3P41bvBK53jaFrcBqjUy6EwtG49wlLIsIREYveICZnF3GzZwIAIBM4lNiNaKiyY0dDKbbXl6DCacnJ4Luzfwp/+Dc/TbgNzxG8950/gJzb3KmBb57uwP/+8UmEI4lTfrfVleBrX3kWJr16nY4svjdPd+DbL5/NKCX0frGLXgQygYdKKYdGKYdOo7z9XtbAbtGjyKpHiU2PsiIT9FolC6wYhmGYDS9vRz+iRCFKIiJREYFQBPAEVtxOq44NvO1mHcqLTWhtKsXuLRUw6jNbgM+sL0mid4IKfzCCBbf/ntsJiT3HFoMGRTY9Girt2Le9Ek01RVDKZTk66g9RSjE65cLrJ27h4s1hDIzNwR9Y3SxlJCphaHweQ+PzOHW5H9VlFuzdVoknj25BiU3PBqB5KBiO4NLNoZTWTnYNTmF0ygWjTlVQz2UslRUIhUV4/WHM3Hc7Rwj0WiWsJi1KbHo0VDmXQO1PAAAgAElEQVSwf0cVGirs4PNglo5hGIZhMpG3wVSqvP4QvP4QhicWcLVzFO+d74bVqMVjh5vwxJFmmA2xq7+FNGjZTCgFPL4QPL4QBsfncaV9BK+fbEdzdRGef2QHdm0pu5MSur7HRREVJbx7rgs/fPUShicXEs5CZcofDONmzwR6h2Zwrm0An3lmLw61VkPgN07q42bQPzKL0SlXSrP04YiIU5f7sKWmOC9nWdeKdDsF1uUJoHd4BhduDuGV929gS00xPv54K1oanADYuZphGIbZWDZ8MHU3UZTufFgP/HgWb5y8hc9/9CD276iEapNUcit04YiImXkvTiz04sy1ARzbV4/PP38QxTb9ul3dppTC4w/hm/92Gj9//zqiWUx7jCcYjqK9bxJ/9Y3X8RtP78WvPbmLvabzBKUUN7onMOfypXyf985347eePwiO27wl6IOhKIIhD6bnPTh/YxAP72/Ap5/ajVKHka2tYhiGYTaMgs2tECWK/tE5/NU3Xsc/vXQG03OeXB8Sk0WUxtYp/fJ0B/74b3+K9853wxcIIUl1ylWTJIrB8Xn8+dd/gZffvrYugdTdQqEo/umlM/jat97G9JxnzX9fJjmvP4TOgUn40kjvHJ9241bvxBoe1cZBaayQzy/ev4G/+IfXcOJyL0LhKHttMwzDMBtCQc1MrSQSFfHi65cxPefBl144jLJiU1b3r1HK0VRdBIVcQCgcRSgcRTgSveff2SzYcDdCALlMgFwmQCG/XelQHvuSywTUlls3RRrRyKQLX//X45icXcRzx7ZDq1asyVVtSaLoGpzC//7xKVxpH81p34D3zneDUorPP38Q5cUmdhU/h0anXOgfnUvrPhKleOdcF3Y0la7RUW1MPUPT+K/ffhefeXoPnj22HWqlPNeHxDAMs2GJUREedwCLLj8C3iAC/jBCgTCC/jCiURFi9HbbFlECRawoGMdx4PjYd7lCgFwhg1wZ+65Sy6HWKqHWKaHWKCDIeDb+wCYIppZ8cLEHAs/hdz95FA6LLmv7tVt0+M1n98EXCCEUERGOLAVTS/8WEQpH4Q+G4Q+GEQhGYv8OhDE5u4jr3eMJ989zBPu2V8GgU94uFR4rMaxRyaFUyG4HTrFAKhZY8ZDLBShkPPTazVOEY87lww9fu4RIVMRnnt4LmSy76VOUUoxPu/Dtl8/iSvtI0vLX8chlPDQqBZRyAVFJuvN6kKT0QrOoKOHE5T4o5AJ+62OHsvqaZlInSRIGx+YxPLGQ9n0v3xqGy+OHUZf7qn75ZGHRj39++Sz8wTA+88xeyDdIA+lIOIof/I934Jr1ZnR/jV6Fz/7Ro5Arcl9Yh2GYjYdSimAgjJG+aQz1TGFyZB6zU24sLvjhcfsR8N0OpAJhhAIRRKMiJDFOMMURcDwHmVyIBVRyATKFAKUqFkyptAqoNQoYzBrYioywO42wFRthLzFBZ8xdS5dcWfNPqVKHEa3NZZCnObiVJIpIVEQwGIHHH8Ksy4up2UV4/ZlVShMlipOX+1BebMKvP70XCnl2fnW5TECRTR/39qVUFVGUEJWWmrfGihdc7RhJGkzJZAJ+95OHYTZoIPAceJ4Df7tkfD6uK7CatNi9pRwadfIryqIoIRKV4POHsLDox9ScBzMLXogZlml2eQL44WuXUGTV44kjzVn92/iDEfzgtUs4f30o7TLSpUVGHNxRjW11xSi2GaBUyMBxBJRSiCKFxxfA4NgCLt0axsWbQ/D6QyntNxSO4p1zXSixG++soWLWly8Qxs2ecQRDkbTvO+f2oa1rDA/srluDI8ses0GN/S1VUCnjv75EUUI0GqvI6fYGMLvgw+TsYsZFWXyBMF566xr0WhWef2THhvhg7u8Yx9s/vYT5mcxSynmBw0NP70BNc0nendezbXx4Dj/6n+9iqGcy14eyrmq3lOJTv/cwrEXGdXk8SinGBmbxt1/90bo8HhArIMPLeAgCB7lcgEqrhEarhM6ohtGqhcWmg7XYiOJyC4wWLavkmQXueS/azvXjyqlu9HeMw7MYgN8bRNAfRjiU3jlYEikk8cOqtMEkY25e4KBQyqBQyaFUyqDUKOBwmlDb7ET99lLUNjthshX+xd41D6bqKmz44scPQq9Jd5YkFoRQClBQUAkQJQlTc4u43jWGs22DaOscgz8YTnlwGwhF8PbZLrQ2l6G1sXRdPrCWHkMQeAj4MKCklEKvUaZwf8CkV+dFT5pUOO0GfPbZvSixp/JhcddzTCkkSuHxxdafnG8bwtm2Acy5fIhGxZRT6nyBMP7hBx+gsboIVU5zVp5jiVK8e64Lv3j/BsQUZ5B4nkN9hR2femoX9rdUQSETwPNkxcqDlFK0NJTiqQe2wLXox8vvtOGNk+2YdfmSrhsJhqL4/i8uoL7CjgOtVeAKfBCWTyilcHsCuNoxmtH9/cEIzrUN4eiu2rwePBdZ9fjcr+6H3ZzoA/He9zKlFKJEMTQxj+tdYzhztR9dg9PwByMpXyxxeQL4+XvXUVdhQ0uDM6//RpRSXD3TC583mPE+xKiEU7+8gZrmkiweWX4KByMY6ZtGz82xXB/KulKqFQiHk7dPyKZgMJK7vzMBCAgIiY2FyO0LwBwX+7dWp0R5rQN1W0vR0FKGmmYn9CZ17KKxwN+5H/MhSmmspUwwgq7rI3jn5cu4drYXiy4/xKiYdpbLaolRCX5vCH7vhxeBB7smcfGDTvA8B7lChsr6Iuw+2oBdR+pRUmGBTC6AF/gNcZEsVWseTHEcgYzn056ZikejsqK61IrnjrVgZsGLV4/fxNtnuzA25Uqpx8vQ+DzOXh1AQ6UDGhXLx882jhAIQubPt0ohg91ci6O7auELhHHiUi9eO3ELXQNTKS/wd3uD+OZPTuMvf+fxrKy5GJty4R//7XTKgZTFoMZTD2zFC0/shFmvTvphQAgBzxPwPAe7RYcvfeIwju6uxbdfPotLt4aTNoENBCP4Hz/8AI3VDliMmpR/L2Z1KAUGxuYxOB5/vZRGJYc/GF6xZLooSugdnsbk7CKKbYY1PNLVISTWWDuT93RzdRGaq4vwa0/swtD4Al4/eRPvn+/G5JwnpeIt/aNzeONkO6qcFhh0+Zu27PeG0H5lCKFA+jOUdzv99k186vc/ArliY6Q2MkxCSxfD6e3/3PdRFvSHMTu1iCunewAACmVs4L11TxV2HKhFcbkFeqMaap1y089gUUoRCUcxN7WI6xf68eZPLqDj6nCuD2tFlFKIUQoxKiEciuLmpQHcvDSA7/73X6Kkwor9Dzdh5+F6lFRaYDBpoNKszTr39bThzth3/8HtZh1+87l9OLq7Fi++fhnHL/akNOA+eaUPv/LgVqiVbOF+vrn7+dCqFXjy6Bbsb6nEm6c78cr71zE4Np90H7FS1WM4e20AD+9rWFURjmAogm+9dAYL7tTKXpfYDfjss/vw+OGmjNZ6LP3+W2qL8WdfeBTf/ffz+MXxmwhHEk/VD47P4/u/uIDf++RRyITNW257PUVFEScu9SbsLfXQ3nq8d74b/uDK56WpWQ86+qfyOphajbvfz5VOM770iSP4yP5G/PiNKzh5pRceX+KUVkopzrUN4OF99diztSJvr2QOdE1gcjT5uSmZmXEXOq8NY/u+6iwcFcNsLKHbsy1d10fw8rdPoqzGhi27KtG0sxJVDUUor3FAJt98BQ8kScL44CwunejCe69cRX/HRMbLIXJtfGgWL3/nJF794VlU1DmwbW8NmndWoLqxGPYSI/gNOn7ZcMHU/TiOQ02ZDV/8+CHI5QJe/+AWQkkGniOTC+genEZZkXHTvSk3IrNBg0883oraMiu+9dMzSdeZAbEUoVNX+rFnawX02uTplPFcujWMCzeGUkozNBvU+P1PHcXR3bXgudVfRbOatPjiC4cgCBxeevNq0pmxt0534sjOWuzaUrbqx2aS8wXCONs2EPd2tUqGB/bU4nr3GIYnVg6m5hf96ByYwqHW6qyt48xnHCGoq7Dhdz55GGaDGj97ty3pBbDpeS9OX+3HtroSqPMwm0CSJPS1j2NmwrXqfUUjIs68fZMFU8ymRynFcO80hnuncfzVNpRV21C/vRy7j9Zj6+4qaHSZf65vJAFfCO/+/ApOvn4d3TdGEUyjBUc+C4ei6Lk5hp6bY3j3ZxpUN5dgx/4aPPRMK2zF67OmMJsKYt6UkA+r6tWWW5NuL0kUVzpGEBVZH5ONguM47NpSht9+4XDKz3HP0HTCFKxkfIEw3jzdgUVf8nUQchmPL75wCId31mQlkFqiUyvwySd348E9yYsUuL0BvHL8esaL/pn0XO0YSdio12kzotiqx9ba4rjbiKKE7sEpzCxkVgFuIyKEwGrU4lNP7caBlirwKcw2nbzcB49/7fvIZcLj8qP31ljShdqpEEUJ7VeH4JrfPK8Hhkkm4Auh+8YoXn/xHP7nX/0Mf/vVF3Hm7VsFE1jEM9w3jX/4y5fxvb9/C9cv9Bfs7+te8OHq6R5c/KBrw864FUQwtcRm1uLXn96TUm7tje7xjMtbM7nBcRxaGpz4+GOt0GkUSbcfmVxA/+gcpAwGYEupgh19kykt6HzsUDMe2F0HIct53YQQ2M1aPP9oK0odia/WSBLFzZ4JXOsczctBZyGhlOLtM10JtykrNkGvVWFfS1XC7boHpzEx4950z5lRr8Jvfewg9CmshZqaXczLJseUUkyPu9BzK7MiJCuZn1pE57X8XAvBMLkkiRJmJty4eLwT//WrL+L//g//iu4bo4hGxII5f8bWG4m4+EEn/uYPf4APXm+Dx+XP9WGtOUHGo7opluq3ERVUMEUIweGdNShKoefO6JQL0RQKVjD5heMIDrXWYGdTWdK1UOGIiP6R2ZQLV9wtEhXR1jWGydnFpNtWlJjx1ANbYNAq1yRtlBCC5poiHNvfAJmQ+C07NbuICzeGUirGwmRuzuXD5faRuLcTEntd6HVK7ErSGmJhMYD2vsmkhUYKDSEE5cUmPHG4Oem2FMDVjtGE69NygUqx0tOjfTNZ2+eiy4dblwY37BVahllrS/2ULp3owld+7Rv41tdew9jQHCIbPCuDUopQMIIPXmvD1//8ZQx0TULaJBlUOoMKBz+yBVwWM3vW08Y86gR4nsP+lsqk24XCUcwvFn60X2gIIbAYNTiwowpadfKc6eGJBXhTSNO739SsBzd7J5KuU5IJPA60VKKu3Lam6+8UcgGHd1ajrMiUcDtRomjvm8DY1OrXbzDxnbnaj1A4fuU2g1aFyhIzFDIBBp0KWxKk+gHAxZtD8AVS6y9WSAghePJoc0pFU272jOfd1eeAP4xr53qzGvhEwiIGOicwN+XO2j4ZplBFIyJe+dcz+Jsv/wDv/fwqXHPevDtPpCoUjOCNF8/jf/2XVzbd+7+sxo7G1opcH0bGCi6YAoDG6qKUtnO5A2t8JMxa2b21HCZ98vSgiRk3/MH0yhVTSjE65ULXwFTSbW1mLQ611qzLwvj6Sju21pUkTSXsHZ5B38gsJJbGuiaiURFn2gYQSVDa22HVo6LEDADgCHBwR+JUv46+SUzOejbsIGA1SotMd/5WiQxPzOdVajalFL7FAK6d6c36vkcHZjDcO531/eYLmVyAxaGHyaqDSi3P2yqN2cBxBGqNAmabDha7HsIGrVaWz6hE0dcxjm//tzfw3f/+Swx2T264c2koGMFrPzqHf/2Hd+Bd3FxjU44jeOiZVigSNIbPdwVZPqrYqk9pO3+oMBfzbQZFVj3KikwYmVxImPoz7/YnnEFYSTgiomtwKmnZZkIIqkut2FKXeNYhW+QyAUd21+D4xR4sJmgO6vWHcbN3AvtbqqBVJ19bxqRnaGIBg2PzCT+si6y6O7OIhBDs3lIBuexs3BL3sQa+A2issm+6CqM8F0tj7R1OnCoXDEcx5/LlVRn5rusjmB7P/izw7KQb/Z0TaNlfA1kBVnm0FRnwm195HL7FIKJREdGICL8vBN9iED5PAD5PEH5PEF5PAH5P6M7PfEs/84YQCeUmpUsmF6DRKWNfehW0OgXUOtXtn8W+a/VKqLWx21VqOQQZD0HGQ6tXwWTV5uS4N4PFBR/e/dll9N4cw2/84aPY+1BTrg8pJWJUwpsvXcRL3/oA/lU0/t6ojBYtDj6yNdeHsSqFd5YGoFGnNksgsZz0DYvnONRV2HCubQBigkGt1x+CPxABpTTlQWogFMH1ruTl1xVyAYd2VkMpX7+rKbuby2HWqxMGU0CswIrXH4JGJd90g/O1RCnF9a4xzCfoO6ZUCGiodEB111U2q0mDhko7bvTEf129d74bn3lmLzZoynjGCEjS4ioAAAosLPrzJpiSJIpTb95Ykyvgoiih89ow3As+WB358ftmk1wpQ1m1/c7/KY01dqWSBEmioJTGvkt0hf9LoBJFMBCBdzEAj8uHRVcAHrcfHpcfHrcf7ZcH0XNzLKNja95ZgbptpdAbNdAZVNAZ1dAb1dAZVNAa1FCoZCCEgOM4EI6A48jt/5MP/88RcCR2OyFg5+B1FI1K6OsYx9//+U/xiS89hKd+bR94IX97U1FKceNCP179wVm4Ztegiuft11/sC5ArBOhNGhjMGugMasgVAgSZAEHgEAlHEQ5FEQ5F4HEFsDDnhcflj73nKICl92mWz3lHn2yBLoVMo3xWkMFUKtXXAECp2LhTigxQbDOAcARI8nwHQmFQipSa91JK4fOHcLM3eTClVsqwb1vFqpoCp0shF7B7azmGxucT9r7qGZrG3IIPjhSKsTCpC4ajuNU7AW+CWUutWoEdjc47H96EEGhUCuzaUpYwmOofnUXv0AyaalJLUy4US+sgk6EAAmmm7K4lvyeISycSV3Rcjc5rQ5ibWoTFrs/bgWC2LA30wPFIJQku2WDu3755PONg6tizO/H4C3tjny0rKPTn4m4KpQwGc/L35hJKKagESPR2ACxKEKPSndlHMSquWxGZhRkPvv/3b8G3GMQzv34QGv3aFIhajaVqoL/4wRmM9GUvrVcm52MzozoVqhqL0bCtFNVNxSiptMLqMMSCSwCI9+egH36TRAnzM4sYH5rD+NAcxgZnMdg1gfHhOYSDEYRuf0UzLKAkV8rwyEd3xT+WDaIggylviv0+UvkAZ/KXQacESeEdGAqLoKBI9d06ND6fNMUPAKpLret+lZwQgv0tVXj57baEA4pIVEJb9xgaqx3g+Q1+lsojIxMLGBibSxjI2sw6NFQ67vmZUiGguaYYapUc/jjVJSkF3jnXtemCKSD1C1vhPKpSef54BwK+tUsVX5j1oqttBDVNJRASVIPcjJINild1xiMAbl/J3+y276vBl//6+ZQvRC7NbCx9D/hCmJ/x3P5axMKMB645L9zzPrgXfPC6AmtaVdnnCeKn//wBIpEonvvsYeiN6rx6XpeadF843pmV/WkNKlTUOVC/rRStB+vQ2FIOrUGV/u9MPvzGcTzsJSbYS0zYcaAWQOy59ntDGB2YwVD3JPraxzE6OIOFGQ/mpj3wuv0pT2q0HqiF3WnKq+clEwUZTKVSzlqrVsDMgqkNTS4IKZ3k0+kzRSnQ3p+88AQA7NmWm8ozzTVFkMsFBEOJr9K3901AojSlK71MchKlGBybw/DEQtxtOI5g95byZQVJCCEosRtQ7bTgZoJ+SWfbBvC5X93P1rrFkc2G2KshSRJO/XJtUvzudv79djzy0V0smGJyQqYQYLbrsjbQlSQK16wHU2MLsa/RBQz1TKK3fRxjg7NrsvTC7w3h3797CuFgFJ/6vWPQ6JJXAV4PlFJMjS3g9R+dy3hWZ4lKLUfLgRrse6gZLQdq4XCa1rSoCyEEGp0SDdvL0LC9DJRSeBcDGB+aw2j/DAZ7JjHYNYmBrsmEVQkFGY+Dj26BMsWlOfmsIIOpnqHkPT/qK+wJe78w+U9cyuNNQi7jU5rBAgAKio7+1JqD7mhwprRdtum1SlQ6zehMEvR19E2lfHWISc4fCKOjfwpef/xZS57jcHR37Yq3FVl0qK2wJQymZua9uN49nrT6X6FJdmEAiF0l1axD1cxUjA/Noa89eSrw3eQKAUq1HIsLqbfkaL8cS/VzVlk3/JVbhuE4ArNdD7Ndj6bWCkiiBPeCDzMTbowNzODKmR5c+qALrrnsrh0K+sN47YdnIYkSPvfVxyHPkyUer/3oHEYHZle1j5IKC5777GHsfagJtmJjTipjEkKgM6jRsF2N+m2lCAcjWJjzYm7Sjd72cVw60YX2q0Pwe+5d611ea0fdllLwSSoUbwQFF0xRGuvZkszebeUQ8uQqJ5OZQAoDMCCWYpXqOIRSoGcwee6yUi5DbbkttZ1mGQFBQ6U9aTA1ObuIebcfxbbUqlsy8VFK4fIE0NY1mnC7YqsejZX2FW9Tq+Soq7BDq1bEDciCoQjOXuvHgZbKTTN4pqCYd6cWYORDajalFNfO9sKXZvni4goLisssOPdue8r3CQbCOP9+Bz5adSTdw2SYvMfxHExWHYwWLWqaS7D3oSZM/eY83v33K3jzpUvweQJImFOdhlAwgjdfugidUY1PfOlB8HxuL6a75rx4++XLq9pHVWMxfucvnkFjSzkEWX4U2SCEQKGSo6jUDIfThPrtZXjomVbMTbpx/v0OvPXyJUyOzINKFNv2VMNRuvFT/IAC7DN1rXMUo0kaluq1SuzbXlUQ0fBmNjOfvDmfXMZDo0o9ZcofCGMuhYFdeYkJshzNbBICVDktSbeTKMXA6OquejExFMD4tAvdSWa9j+6pi3teIYSgscoBuzl+UZCoKKGjfwqzrvjVAgsNpTSlJtMqpSwvgikxKuLa2V4EA6kXwxBkPLbvrUFlQ/rr4U683sZmmJmCRggBz3PQ6JSoaijG5//kKfzTG1/BRz93BEaLFlyW1v0GfCG8+oMzePffr67pWq1kKKV452dXVlUGvaLOgf/49U9j6+4qyORCXgYkhBDI5AL0RjUqG4rwwm8/hH987Y/xl9/4DTz+wl60HqyDSlMYKe0FFU14/SH8+JdXEubdEgIc2VmDIlvhV0gqdGNTrqTrocwGDRRpnGhGp1wppQ5WOc05ff2Up9DkFABGJrPfA2czikZFnL46ADHBuYXnORzdVZNwP1VOM5x2Q8KZ0pl5D9oTpAIWGkmi6OifTLpdbbktL5q7DvVOY3xwNq31UoKMR/POcpSUW9IePAx2T2K4J7V1nAyz0S2VmTfZdPjcV57An/7dp3Dg2BboDNkpnb0w68Ur3z+NjqtDOWuPEwpEcPKNNtAML5I4Sk34ytdegLNy46T/Lj2vMrmA/Q8348t//Tz2Pdy0YY4/mYIJpkLhCF4/cQuXbw0nnBUuthlw7EAD9Jr8WITIZCYciaJvZDbpFVubWQtVGvnR49MupJJXUFpkWteS6PcrthpSOgmNTMYvlsCkhlKKQCiCM9f6E25XWWJGRZIgV6WUY3uDE4oEvckWFv3o6J9CZJWLkjeKqTkPBsbmkm7X0uBMee3jWqGUoufGKGYn4y+qXolMxqO22QlHqRlWR3ppt2JUwum3b6Z1H4YpBIKMR8v+Gvzu//Ucfv0PHkFJpTUr++3rGMfL3z6JuRnPmheRWfHxO8fTPocsUWkU+OTvHEN1Y3HBBCKFoCCCqUAogl+e6sCPXr8MX5yywwCgUsjw6MFGbK935sUVTiZzg2PzmFlIvki1vMiUVmW0ydnFlHK07WZdDgd2BCqlLKXF+KNsZior2vsmMZagKhEA7NtemdIs6N5tFVAr4wdTkaiE7sHplF7fheDN0x0IJwkcOY5gX0tlTi9gALHKYL23xuBdTC89x+IwoKjMguIyM6zFKTQovosoSrhyqgf+FNo1MEwhMtt0eOLX9uPLf/08tu+rXv0OKXD5ZBde++HZhNkGa6Xz6hACKbbwud+uw/XY80ADOLZMJa9syGeD3m4IRynFzIIX3/jRSXzjxZMJS6JzHMHureX4+GOteVMRiskMpRSX20fg9iReAE4IUOE0pxVMuRYDKa13tZu1ORvYERJLKTPp1Um3nXVtjgH5WnvvXFfCK5gCz2H3lvKU1tFVl1lQ6jAl3KZ3ZAZj066cXDVdL5QCswtevH7iVtJt6yvsKC9K/Ddba5RSzEy40Ncxnvbz0txaAUHGw2zXo7jMnPZAaGbChd6biYufMEwhk8l4bNtThT/4L8/j2HM7V/35GwmL+Pn3TuPmxYF1Pc9KooTe9nGE0lhzuUStVWL/sWYYrVo2K5Vn8jaYujtgEqVYB+1QOApfIAS3J4CbPRP4+veP4zP/57/gp29fw2KChXwCz+FwazX+0xcfT2kAyuS3mXkvLlwfTDgLCcSap1aXWiGkMXBxJQnQlpgNuV0Iz3MEBm3yVFW3J1DQA/L14AuEcfrqQMJtasqtKLbpU5qrFHgeD+yuSbJuyovuwWlE8qhJbbZFoiL+5efnMTOfOODnCMFHDjRAr1XmfAAxMTSHwe7k67vu13IgdjWd5znUbnFCnea6KY/Lj+vn+9l7mdnUCCEoqbDgs3/0GB78lR0QhNUNYYP+ML75/74KX5ozzaux6PLDNZu8eNZKKhuKULOlBByrRJ131rw0+oLbj7buMWiU6c8GSZQiEhXhD0aw6Algas6D0akFdA/OYGJmEaKUfHrWpFfj6O5a/IdPP8BmpApAOCLi5OU+3OpLvkC/ssSMqlJLWgOwhRSCKZnApVXUYi1wJJbql0w4KsLrD0HH1ghm7FzbIHyBxClWzdVFMBs0Kb8mDu2swTd/cgahSDTuNpduDePxw82wGAuugwUCoQjeOt2B9853I5okzaa6zIrdW8shl+X27xD0h3Hr6iCCaabnyBUCmlor7/y/bqsTGp0S3jRKq4eCEfTcHIV73gejRZvW4zNMISGEwFZsxGe+/CgiERFn37kFMZp5qt5o/zR+9t2T+OTvHluX5tiuOS98GVTxIwRwVlpR5Eyt+FbMoukAACAASURBVBSzvtb80+lKxyiudKx/eoJCLmBbXQkeO9yEh/bWJVyjwGwMkiThZs84fv7edXiSrB9QKWTY0eiEI0EZ6pV4fMlPciqlPOdr7gghUKVwgYJSyoKpVRAlCaeu9CGa4MNapZChocqRVjppqcOI+ko7bvTEb/x6q3cC0/NemA3qnM/IZMvS6/GXpzrw4zcuJ+0vpVHJ8ciBBlQU53YAQSmFzxPEtTO9ad+3urH4ngCotNoOS5EBU2PpFYcZH5rDUM8kjJaVm0IzzGZSXG7Bb/7x4/C4/Gg715fxfiJhESdev449DzaisaU8i0e4Mve8DwFv+usf5UoZSsotUKrZpEA+Kri5QrVSjiO7avDlX38QX/3cMTx+uBkalaJgBiObFaUU7X1T+F8/PoWe4cS9fgDAbtHhob31afcSC4XjzxQsUSlkOQ+mOI6kVKWQUiAYSv47MSsbn3aje3A6YQn+YpselU5LWq8JwhE8uLcu4TYeXwiXbw0lLf+/UUgSRVvXGP7ue+/jOz87h7HpxAU9OI6gpbEUjxxshDKNipxrZaR/GkMZlCjfcbDunjVSSpUcW3dXpr1uanp8Af2dkxALOPWTYdLhrLTi83/yJIrKVnexZWpsHsdfvbaqvk+pCvhCCIfSXy+lVMlhS7N4DbN+Nnz+CEcIiu0GNFU70FxThB0NpbBbdNBrlZAJue1wzazOUk6xKEl460wXvvPTsxibTl6dTuA5PHlkC8qK01+wnkojP4HnwOVBcJ7aWjBa0Otu1hKlFNe7xzC/mHj2xOkwojLN1AsCYP/2SvzTT84gGI7/wfr+hR688Pgu5HvhpkT5/15/CJfbR/DW6U60901gdsELMYX+KkVWPX7rowdQZE2vlPhakCSK8+91IJpmuXpCCFoO1CwLtHceqsfPvnMqrT434VAU3TdGsOhqgcma3ow7wxSqmmYnvvCnv4L/9icvIuDLrEJeJCziyqkeHHl8G5p3Vq7pxfdwOJow0yEeuUKAwZz7puXMyjZ8MGU0qPD7nzqK2jIbDDol5DIBMoHP+cwBkzlKKaKihFA4ip6hafzg1Uu4fGsYwRRmjQCgodKOTzzeCj6DRZqpBB6x2a5cp/khpVk3SlMLEJnloqKEtq4xeBJcrVTKBTRU2jPqW2c2arC9vgQXbg7F3aajfwqjkwuoLstOf5VMiKIErz+UsMiPJFGEo1EEghEsuP2YnF3E4MQ8Ovom0T00DZ8/hKgopdQQGwCMOjX+4neeQGO1Iy+yCqIRMaNeT6VVNhSVLg+0m3dWQGdQYX7Gk9b+Oq8NY25qEUYLq+bFMEDss7D1YC2e/cxh/Pib72fcCHekfxpXTvWgptkJ5Rqur4+GoxnNLnM8BwVbrpK3NnwwNe/y48/+7hXIZTyqSy3Y3lCKvdsqUFZkhMWohVopYx86eSZWpRF3KjVGohIikSiC4dhgbNEXwPWucZy5NoBbvRNpzawUWXX4yueOQS7P7KWdbDE8EEs/yv1LiqQcLEZy1OV9oxuZXMDg2HzCNDudVomWhtK0zzGExNI0d28tx8WbQ3HL8VNK8fa5Lvx2DoOpzoEpfOZPv7cuj8VzBBUlZvzRbzyMlvqSvDl337o0mFGTzeZdFdDollchFGQ8dh6pxzsvX05rf5Mj8xjomkRVQxF4lnnBMLFzqUaBI09ux5XT3ei+keEafQqcevMGHviVHSirtq3ZuUeSaEaV/AghrLdUHtvwwdSScERE58A0Ogem8dO3rqK23IY92yqwe0s5ttYVQ62U580HcyGbWfDizdMdMOpUCbcTRQlRUUIwFIEvEIbbE8Csy4fJGTfGZ9yIZDAN7rDo8KUXDqO+wr6mz3XumvXeK9VfkZVTTh+lFAOjcxiZTFwkwGbSoqHKntFjyGU8mqodMOhUCUvyn7rch994em9K1Rs3MpVChj1by/Hpp/diS21RXp2vP3jtWkrNvO8mCDwaW8qhilMG/eBHtqQdTAHAxQ86cejRrVBrWTDFMEvKqm148OkdGB+aS6tS5t1G+qZx/XwfnBVW8MLanH8EGZ9RUEQlmnaaMbN+CiaYupsoUXQNTqNnaAbvn+9Ga1MZnju2HVtqi3N9aAVvdMqFb710Zt0f12HR4bPP7sPR3bVpF524WyrrkEQp9XSltUNT7tyeTp8tJiYQiqBrYCphY2ieI2htLM24UiIhBEVWPeoqbLh4czjudhMzbrT3TWDXlrWvNJUrxTY9nnt4O47tb0CxzZBXadoLsx5cv9Cf9v1sJUaUVdsgxJlBamgph8Whx9xU/GbzK2k714dFlw8qDbtAyDBLZHIBhx/bhovHO3HtbG9Gn9GUAm/+5CKOPbsTKiG9XnCp4gUuozFKNCoikKSKMZM7ax5MlTqMaG0qgzyD+v1La2eCoQgWfSHMLXgxMbsIrz+1F5REKcam3ZicXcT17jF8/LFWPPPQtpz3K2Gyy2bW4gsfO4iH9zWs+up9vIHP3SSJIu3L1FlGKVJaxA+AFWLJwILbjxs9Ewk/kHmew+Fd1at6HKtZi/pKBy7dGo77WKFwFKev9hdkMKVUyPD44SZ89CMtKHWY8nL27caFfrjnfWnfr6LOAbtz5SI4hBCotQps31eD91+5mtZ+Fxd8aDvbi0c/tiftY2KYQmYtMuDAI1vQ2TaSceDR3zmB7hujaNlfk+Wji1EoZSmNM+4XCUUzOg8x62PNo4q6Chu++PGD0Gsz73OztL6GUopIVMLYtAtXO0Zx8nIfOgcmEY6Itwe4KxMliuGJBfzjv53CzIIXn3l6LzQqdlVvo+M5grJiE/7jFx5DU01RVmZgZHzyk1x+zEyltr6LEJLRiXszo5Rias6Djv7JhNtZTVpsrStZ1WMpZALqK20w6tVYiNNzKSpKuN49joVFP0x69aoeLx8QAEa9Ckd21eJjj7WivMgEuYzPy/MxlSguftCFUDC9UsY8z6GyoQhme/xKhDK5gN1H6tMOpgDgxOvX8cjze/Jg7Sbz/7N33/FxXeed8H/n3ukdwKD3ThSCBEESEJtESiKpRkuWJUt2bDmO14mTrBNvdpPdZJP1+6Ztst4km43exE5cEkeRmyxLstUoSuwdRCFI9N6Bwcxgerv3vH+ApGWFxMxcTMf55kOTEe8ZHIDAnfPc85znYVIHIQT3P7Ydb/zreUyPhm+hcjeiIOK9VzvR0l4Vl3uSVq+GUh39QyOfN4CleRsopSl5r9zs4h5McRyBXMbHbDdIDUCvzceWynw8/2gbhieX8doHvTh3bSxsyV2XJ4Dvv3UNCpkMzz2yAxoWUKUlGc8hx6TFwd21+NyTHTDo/v0Bb6mUivCBh88fTHrvH5FS+CLoVUEAKBPQ1T2TBEMCrvRNhu05dv/OGkkVIz+MEIKasjwUmA33DKYAwGJz4cbIPPbtiM/T0kTKMmrwu7/yEA60rTWfTeV78MKMFRND81GVMAeALLMeNY3F66bzrAVchcgtNGF5PnzLhw/ruzoOy4IdeUXRt39gmEymN6px9Nl2/NP//Jnk88KXTw3AYffAmBX7UuQ6gxoqdfQphAF/CPOTK/C6/dBsYHOCiY+0zHf78JtvXUUefvuXDuL+nbX44TtduNQ7sW71N38ghB+8fQ2FuXoc2dsInk/dN3LmF8l4DmWFWWipL8FDHXXYWlcU85RNXQTnXzy+IEQxuRXyqEjh9YXvqUE4EtHnxKyhlMIXCOF8V/gzMv6ggJ+durHhKvnBoIBgmIPFNocHN0bm0bGtArIIdk9TmdPtx4XucbQ2lEoqKZ9Ig73TWFmMrnw5AOTkG1DdGH7X0pStxZbtZVEHU6GQgPPHb+DJF/ZFPTeGyWSEEBx8Yjt+8A8fYNUmLS3O5/aj6/wwHnhse4xnBxiztdDopJ3Hmptawfy0FdUNG8uIYGIvLYOpj5LLeexqLkdhrgH/+oYGb5y8vm4alsPtw7dfvYSmmiKUF22sczYTXxxHkJulQ0N1AbbVF6OhqgC1ZbnQxKkPhFG3fhVCAAgEQwgEhaRut4uUwhPBzpSM56DTxOcgbaYan7FgdGYl7HU/Pt6dgNmsCQQFDE0uwWJzJ7yJrV6rxJbKgoh2bSkFRqctWLDcu6hCMCTgQvc4dm+twP27Nr67Fy8BXxDD12fgiHJBxvMcymvzkVtgDHut3qRBfUspzh/vgxBFBVNRWGsi/NjzHZBLbAPBMJnKmK1D24E6vP9a9Cm0wFpfuc5Tg7j/0W0xf4/XmzTIztWDcCTqnlgzY8sYH5xHZV0BK5OeYjLmLkwIUFqQhV99Zi8sdnfYJ8szi3a89NMr+P0vHknQDJlIcBxBXrYeFUXZqCozo6m6ECX5RmQZtcg2aDZUqS8SRn34J+WUYt0qb4kgihRO972bqN6m1ypZNb8ofXBpOOJKiYk0Nr2CqXlbwoOpwlwjfvXZvTBn6SK6/oPLQ/j2qxfXbfK7bHPhZ6f70FBVgMLcxH4+kVpesGNsYD7q7wWlWo6WjuqI+kDJ5DzKa/NhzjdicXb9MvwfNTO+jImhBdQ2l0Q1jmEyHSHAwSdaJQdTokgxPrQAm8WF7Fx9TOfG8xyKK81QKGRRn8V0O33oPDOEtn11yDLHdl7MxmRMMHVbllGD3/zUAfSPLax7BgEATl4Zxqcf38V2p2KowGzAgbYa6MNsY3OEQC7noZDxUCkVyDKoYc7SIsekg1opB89zkPEcZDIOHCEJ2wEy6dQgCF+rz2JzgdLIez3F0u1mxzbH+t/fAJBtjH3OdyYLCSI+uDyc7Gnc1eKKA6NTy2jdUgJ5As/ByWU8ckxa5OdE9ub9xANbcaFrPEwzYuBS7yTOd4/i2MEWyHgupc5OUUoxN7mCiaH1i5DcjUqtwPaOmoiuJYSgpCoXRRXmqIMpl8OL7gujqGkqTqmvHcOkgqothSitzsP06JKk8Q6bBxNDCzEPpgCgurEISrU86mAKAC5/0I+HP74TxmxdSrWQ2OwyLpgihKAo14gnD7Xg269eXPdary+I4+cH8CtP72FVkWKk0GzAM0daUZwfPsVlPclaHOSb9YgkmlqyukBBseEDMxL5gwIcrvClX4vzTAmYTea42jcVUZCaDJQC1/pn8PCeLRHvEiWDRiXH555qx8D4Ihzr7J4Kgoh/ee0ydjaVo6wwtQopBPwhjNycg33FFfXY+u1lyM6LfAGWV2hCeW0+ei+NRpXq5/ME0H9tAl53OzuQzjAfQgiBWqtE6301koMpl8OLsf45tO6pifl6pGF7OfRGDRy26N9rPC4/Xn7xBCrrC9juVArJyPwfxa0zVCb9+udfQoKI7oEZBILrV+1iokTWbmYb+ZUsa8FH+I8/u7Sa1PLoyyvOiCoVlRayYCpSlFKcupqaKX633RiZg8XullylKhEIIdi+pQRH9jWEvXbJ6sJ3fnIRgTAFOBLNtepF78XRqMcRAux9uDmqexjHc9iyrQx6Y/Rl7+enVzAxHP3uGcNkOoVShprmEhCJuzc+jx+zExaE4nBvMmStFZ6RutTpuzqOV/7pNGvim0IyMpgihCA3W4eastyw11rs7nUPSzObS3G+MaIb3MTcSlIXtJNz1oiuKytgKayRstjduD40l/Sy9+uxObzoGZxdt69eqnjukTZUlZjDXvfB5WGcvJI6qZWUUiwv2DF0fTrqsRqdCq17I0vx+7CG1jKYsqPfbVyctWOsfz7p1UUZJtVwPIfCsmyYcqTt4lMKWBZWJe1OR+LQx1rBbaD4zs9evog3XrrAAqoUkZHBFADoNUoU54VPNfP6g5hnwRRzi0Gnjqhc88SsNepKPLFCKTARYTBVWZIT59lkjp6BWVjDnLNMBaeuDEfUsDmZCCHIz9HjU4/vhDxMIQZ/IISX3+zEzEJ05cHjRRQous+NwBNBGu1HNbdVwCghKDLnG1HVWBT1GQiv24+Rvlm4VpNbEIdhUg0hBKYcHUoqwj/QuRfrsgMrS/FZHza1VaCivkDyeJ83gB9/6zRe+5dzcDnYz3+yZdyZqdvUKjmyIjh8HwiEwhaqYDYPjhBUlZhxrX/9p9IOlxezy6uoLE5GsEIxPBk+DzzbqEFehEUDNjtRFNHVPwNnmKd8OSYtCs0bOw+4HkEQMTG3Au86Ze97h+awtOJAaWFq7zpyHMHu5nLsba0Ku/M0Pm3Bj9/rxq8/tx+yCKrgxZMgCDj77nVJY9sfapKUpszxHHbdX48zb/dC9EeXdj50fRqWhVXoTRpWiIJhPsSYpUVxRS6uXxmXNN6+4o7bzpRCKcejz3Xg//7RjyW/xqrVjR984yQcdjee/eJBGLPX1rzsPpB4GRtMyXgOKmX4T08QxYianzKbAyEEDdX5YYMpSoHewdmkBFP+oIDB8cWw1zVUFUCWoj18Us3s0irGZiwQ1kmX0mmU+Oyx3fjEkda4zcPjDeCv/vl9vHXm5j2vEQQRJy4N4XNPdsRtHrFACIE5S4vH7m9C38gcLOv0awqEBJzpHMXureXY3VIBLomLgZmxZYzenIt6nM6gRkt7leRzEDv21UGjUWI1ymBqcmQRMxMWVNQVgLAm9Axzh0avgrnQGFFRqbtx2NxYXXHFrafk3sPNePv7lzB8Y1bya3jdfrz67bMY7pvBF37vcZTX5kMVpz6czL1l7kqLkIhSJiilCLF8c+YWQoCG6si23q/djP5MRSwMTSzBF8GCq7G6gJVOjQClFKPTFswsrp9mZtSr0VJXBI6QuP1SKeVoayoDH+bf7dSV4bQonEMIQUtdMfa2Voftdza7aMc7Z/uTnilw6s0eSeOadlZAZ1BLXnQZTBq0dFRHPU4UKLrODcMnocwyw2QynueQZdZDLbFxfSgoYGXJiWAg9vdaQgi0ehUe+9R9UGk2Hvz0XZnAH/2Hb+OVb57GxNBCXObM3FvGBlOiICIYQRUWQghkfHLTSpjUUlVshkYlD3td3/B8Upr3XuyduFWW/d5kPIfm2ujPYGxG/kAIwxNLsK7ee+eEEKAk34TKCAoqbATPcagqyQnbmHdq3oahCWklfxPNoFPh0f2NKApzhpUCONc9hku9EwiFklPdz+cJ4NL7/ZLGtuyukrxou23/0a2SxnWdG4bb6U3pKo8MkwxZZh10hvUrO6/HtuxEwBefwEQm57FjXy127q+Pyc6Xw+bG9/6/E/jb//4KXv/uecxOWFhxmgTJ2GAqEBLg8oQ/QMxxHBQJbIDJpDZCCIx6NWrK88Jea3d50TskfXteilBIwOXeibBl2UsLs1Ccz8qiR8K66sGN0fl1K+TJeB67t5ZDqYhvZjQhQG6WDluq8te9LhBcS4tLFw3VBXh4z5awxSicbj++91YnVpJU/n2gdwrLc9EXwsgy61G5pRByxcbeS5p3VcKUHX2j7aU5OwZ7krNTzjCpLCtXD51Beh8224oTgXXOsG5UTp4BR57ZhcKy2BwZCIVE9HdP4d9efA9f+93v40f/dAqWxdWYvDZzbxkbTHl9wYgqc8l5DvoNPk1kMotaKUNLbVHY6/z+IE5fHU3oou/m2CLml8NXF9paWwS9RskOooZBKcWS1Ymbo+ufQZPLeOzbUZWQOWUZNKivyAe/TlpcSBBxrX86bMGMVCGX8Xj2SCtKImjmPTJlwffe6kx4HzdKKa58MIBAlGeWAKC8Nh95RVkb/nnT6lRouS/6VD9KKc6+fT2pve8YJhUZs7UbamptX3FJuidEiuM5bOuoxuGn26DWxm4t6nH5MdA9hZdfPIH/+tl/xMsvnoBlYRVUpKCUsl3sGMvYYMrp9kVUalepkCEnS1ofAiYzKRVyNNUUhn2KLogU/WMLGJ9ZSci8RJHizNURuL3rL6DlMh4tdUXQskOoYQVDAnoGZ+F0+9a9rq48F6UFWQmZE8cR1JTlIj9MJcZlqws3RqIvlJAseq3qVrW+9d92KKX48fEeXB+eS+gbvtPuwY1r0acYEgJUbimEuWDjVR55OY/2BxokBWVXTg3AzUokM8wv0OpUUKrDp+3fi8vujfv5I7lChqd++QD2HG4GH+b+GC2fN4jZ8WV892+P47c+8Xf4x7/4KaZGFuFx+VO6QX26ychgSqQUCxYnJubCL3LVKgXys1n5aObnOI6gpMCEmrLw52MWLA6c7x5PyBmPuSU7ugZmEAhzFrC61Iyastx1dzaYtUW7zx/Che7wZXMPddQlbJePEILKkhwU5a6/OLc7vbg+PLduBcJUQgjB7pZKHNxdF/baQEjAN35wFvYEnkns756CVUJPGUOWFlVbCqGM4JxlOBxHUNVYJCkw83kCuPSBtPNeDJOp1Frlhn42XU5vQt7fFUoZvvhfH8PuBxpiHlABa+931iUHXv32Wfz2My/ixa++irNvX8fUyCJ8ngDbqdqgjFxtBQIhXOwdh9u7fslzQoACswE5Jk2CZsaki0KzAVtri8KWaHZ7AzjfNRa2EtxGhUICznWNYTJMs16OI2iqKUBJATsvFYm55VUMhCkzr1bKcd+2xKT43ZabrUN1qXnd3VF/IIShiSVY7fcunJFq5DIOnzy6A8URpPv1jy/ipyf7EEzAQkYICRjomYLdGv3X0lxgRHVD+LTgSBBCYMzSoqG1LOqxokhx7t0+iOxpM8PcIZPz0GhVkh+GuV0+hCIoZhYLepMGX/rDY9h/tAWyOJ7l93kC+OCNbvzVf/sh/ub3f4R/e/E9nD9+A0tzNtB1zg4z95ZxwRSlFJPzVhw/PxD2WhnPo7WhGBzrxcN8hEatQHNdEbKM4QPt/rEFnLo6sm6j1Y2aXrDh/UtDYYuq5Bi1aGsqg0bFUvwicebqCPxhUji21hUhNzuxqcA8x2HblmJow5TMHZ+1YnLOlqBZbRwhBFWlZjx2oDlsup/XF8Tx8wMYGAvfU22jrMtOjPXPIRjl2QjCERSVm1FcGbsqj3qjGg2t5ZJ2lkdvzmFuKjFpxwyTDggh0Js0knd7/J4AQkEhITs3hBCYC4z47FcO4/DTO+PeLyrgC6K/ewqvfPM0/v6PX8Nf/d4P8c2vvYmei6PweVj/1WhkVBRBKUUoJOLr3z8bWfEJGYf9bTUJmBmTbggh2NFQGlFTXl8ghFeOd2Ns2hLzGy6lFB5fAO+c68fN0YV1ryUEqCk3Y1dzOSs8EQGRUpy4NBj2un07qsL2SIqH7fUlMGjXPzi9sLyK0enlpJUSl0KlkOFAWzUaqwrDXjs2s4J3LwzA4fbFbTFDKcXshAVTw9GXmleq5GhsLYdCufEUv9t4GY+ymry1ZqNRcju96LmY2KI4DJPqdAaV5LR3SgF/mCynWCKEoKAkG5/5rcN4/Jdi04MqHFGkWFl0oOfSKF7/l/P4i995GX/0H76F1797DqtW952CFey+cm8ZE0xRSuELBPHiy6dx6fpkRGPamspQwspHM/eQbdTgUHtdRIUclq0u/Pk/vYtlqzOmNxxBpDjTOYqX3+xEKEz6jlatxLEHtrLCExG6MTKP2TAlYw06FbZtKUlKvy6TQY2WuuJ1A2NBpOgZnE3o2aKNWjsTZsaD99VDF6aSqiCKeO/8AHoHZ+NWqU4IiZgYWsDibPQ7fBqtEtskVN9bDyEExRW5KK0K357ho7zuAHoujCYsLYlh0oFcIQPZwD3cm+AzRYQQGLO1eOG3j+DX/vsxmMz6hD0gDQZCsC07cf3KOL7+Zz/Frzz8l/jr//ZD9F4eg9vpQyiUmF26dJMRwZQgiJhfXsXXv38Or73fu26/mNtUChk+9dhO9gSfuSdCCA511EXcqHV0yoI/+fo7mJy3RvQ9GI7PH8TZzlH81XdOhC06AQBtjaXYu6OafU9HgFLg5OVhCGH+nbbWFiFLr0nK15QQggNt1eDDLAL6hueT1pdJKo4jeLC9Dk01BQj3pbU7vXjleHfcPkfnqgd9V8clvXZhWQ7KatbvCSaFucCI8rqCqFOTKKWYnbRgaiQ9GjozTCLI5PyG7uEBf2itq3gCEUIgk/M4/PRO/L9ffwHb76uGRpfYNj6iIMLt9OH4jzvxh7/yLfzJb34XJ35y7VY1wPhlC6SjtA6mKKVYsbvx/qUh/O/vvI+fnOiFL8ISlg921KOxuiDOM2TSnVGnxi8/2R7xbk/njWn85Tffw8XeCXh90s5QUUqxYHHglePd+MtvHYcjgl5CBWYDvvDMnrDl3Jk1TrcPV29MrftmwBGClroiGDbQo2SjtjeUwmRY/9zess2Fm6MLYQPDVJNj0uKZwzugD5PKCACXr0/i+IX+mK9nKKWwLTvR3zUV9VhCCDoebIxL1Uye51DfUgJjVvQNfJfnbBi5OcsWOgxzy1owJX28EBISHUvdQQhBTXMJfucvnsUzX3wA5XX54JKQdh4MhNBzcRR/8wc/wl/8zvfwby+ewNXTg3Ck2YO8eJElewLRopTC4fJhdMaC3sFZ9A7NYXhiCZYoKlrVlOXimSOtbOHJRGT31nIcO7gVL7/ZGfZakVL0DMxiyfo+HthVg6P7GlFVYo4oTYxSCq8/iPNd4zh+YQCdN6bCVqQEAIWcx2eO7UZVcewOwWe63qE5WGyuda/JMWlRW54HRRyrKoWj0yiwu7kcb565se51pztH8Mj+xqSc7dqI3VvL8WBHPV59r2fd60SR4uU3O7GzqRx1FdGnv633ulJLovMyDh0PNsZsLh9V31IGk1kH67IzqnEuhxcjfbPYd6QZWr06TrNjmPQhk8s2tDOV7H5MhBDk5Bvx1Of2o2V3Fd5/rQvvv94FbzKatlNgfGAek0MLOPP2dWzZVoqOQ41oP9SwoebI6S7uwdTckgPvnOuHWmKdf1GkCAQFuDx+rNjdmF20Y8nqhMvjh8Pthy/KCmomgxrPPdKGqlJzwlJ3YhG13+s1WEpX/PE8h2eP7sDw5DKu3gj/BFukFLOLdvzo3W58cGkYzXVF2LejCs01hcjN1v+7tC23J4CJOSuu9E3iQvc4ZhZtWHX5IkoVJAQ4dnArHuyo29CTt40QZrBbKwAAIABJREFUKcWf/+Px5KTCAagpz8Xzj7ZFPIZSis4bU3CFqVZUXpSNkgJT0n/GDrbXhg2muvtnsLLqQVGuIenzjYZczuOFj7Xj7LVRLFvXD24tNjf+8Ufn8Ke/dSxmAa4QFHDxxPpf23upbihCQUl2TOZxN+Z8A6q2FGFiaAGiEPl7CKXAyM1ZLM+vQqOTXhKaYTLFRtP8RJEmPM3vbpQqORpay1FanYcDj23DD79xEtfODsXkWEG0RJFiadaG5Xk7ui+M4o2XLuDJF/ai48FGyBVrocVmuvfEPZgaGF/A8OTG87cp1hZBVKSSv6c1KjmePLQNhzrqYvYEl1KKkCDeqXQi0lvzvPP72t873T44XD6sunxwuLxwuPwYnAj/dQmGBHzvzWvIz9HDoFPd+qWGUa+CVqUAz3EgZO2b9ue/r/2Z4zjwHNlU39DxQAhBfo4eX3x2L5a/7grb6+k2fyCEueVVzFsc+ODSEHiOQKdVwXTr384fEuB0+2B3ehEMChBEGtUTMEKA9pYKfOJwKwwb6KOxUZQC755LUrNQAnQ4K6MKppasTgxNLq3bv4jjCKpLzSgM0zg3EZpqCpGXrcPSOsGGLxDC6avDeO6RyL8OqcKcpcUXnt6Dv/jm8bCLgq7+Gbx15iaeONgctgdcJOxWN7ovjEoa2/FQU1wbY3M8h50H6nHm7V74vdE9NBwbmMf89ArKa/LXnjgwzCa20d5JHMelzM8RIQR6owZbd1WiprEInWeH8Mo/ncbE0AL8Eo8WbAQVKRw2Nxw2N8b657CltQzPfekQtrSUQamW35lzpot7MEUpwlYhSwSdRoljB7fiM0/sgjqGZWytqx6cvDKMyTkrnB4/XG4/XB4fnG4/nB4fXO4APD7pZTVDIRHffePyXf+O4wi0aiX0WiX0GhX0WgV0GhX0WiV0GhW21hbigd21kj8283OEEDRUFeDzH+/AN35wDnPLqxFXF6OUIhgSEATgC7jCppdFgiMEzbWF+OWn7kN5UfyejkdKTFbONI3+Yw9PLmNuaf0qfia9Go3VBUlPmyOEQKWUo72lAm+c7Fv32hMXh/DMkR2Q8en1xsVzHPa2VqF9awUu9Iyve63bG8DrH/Rie30xyoqyN7wbe/7dPkmV7+QKGXYdqIv7AmtbRzW0OlXUwVTAF8T1y+PY3lEDtTaxh9YZJtVstE+UTJ566dOEEGh0Kuw/2oK2fXW4cPwG3nnlKmbGlrBqdSdlt8rvC6LnwigGuqZw/2Pb8MSn70NpdR6Um6DCcNqdmZKiKNeIJx9qwdMPt0IjMd3wXix2F17/4DqGIthlijVRpHC6fXC6fQD+/eJwqaMe9++qTVr6V6aR8RwO7q4DFSm+9eOLmFpIXrPU7VuK8cVn96Klrihpc0hHwaCAocmlsAFttlGLxprwfZASQSHjsbO5HG+eubnuzuXYtAXjMyuoLc9N4Oxiw6RX49ihrRiaXMJKmPOvY9MWvHX2Jj5zbPeG2gAIIRFn37kuaWxtUzHMCUgBNeXo0LyrEqff7I16bPf5YTz9+f1QaRSb4skww9xLMBja0O4Uz3OpsjF1VxqdCg8+1YaOh5pw5fQArp0dxmDPFOYmV5LSJsHvC+LdV66i59Iojj6zG/c91ITSqtykFM5IlMz9zLB2MH9vaxW+8sJBPP9IW8wDKWbzkct4PHhfPb7ywkG0NpQm5eM/dn8TfvuzB7GtviThHz/dray6MTC2uO5uOccR1JSZUWg2JHBm98ZxBJXF2SjOWz/lMBAScOrqcIJmFVs8z2H7lmLsa60KmzrnC4Rw4uIg+scWNvT0dXJkERND6zfCvpfte2oS0kwTAPYfbZE0bmp0CRPDizGeDcOkn43uTCmUcqTDU2mtXoX7H92GX/2DJ/DlP34aL3zlCNr21d1Jt0u0xRkb/u3FE/j7P34N5473wZfA5seJlpE7UwRASYEJnzjcigM7a5CbrQPPZXTcyCSQjOexu6UCRXkmvHK8C69/0Bd1IRQpzFlaPP/oThzZ24Bs4/rlspm7W7I60T+2/gJaIePR3lIR1/Mw0SCEIMekRWN1Aabm770bKggirlyfxKce2wmNKv3SKow6NQ7va8C1/hlMh9n1nV2y440PrqO2LBdGiRXrLn/QL+mMgUqjwJbtZVAoEvP22dJeBYNJA4fdE9U4ISTiwvEbaL2vBiTNUj8ZJpZCwdCGmn6v7e7Gbj7xRAiBVqdCU1sFaptLcODRbZifXsGlE/04f7wPi3O2hBbTCAZC6L08humxZQz1zuD5Xz8EtVaZcbvlqbFaiAGeI1DIeVSX5uC3PnsQX//q8/j4Q9uQn6NngRQTcxwhKC0w4Uuf3I//+ZVj2FZfDKVcFvMbLiEEapUc9++swdf+81N49kgrso3JaSKb7oJBAQNji7DY1k8jU6vk6NhWkZhJRcioV6OhMvwZrsUVJ/pHpe22JBshBNvqi3FgZ3XYthWUAicuDeLy9QlJu1MBfwjXzg1JSoGpqC1AXlEWSATtDmJBrVWida+0s6/nj/chGGHvRYbJVAF/SPouNkHanvlRKGXILTSiZXcVPvc7R/HXP/xN/O7XnkfrnhooVfKEPTCkIoV1yYFXv3MGf/of/xXWZWdSznTFU1rtTHEcAUcIZDIechkPpYKHWilHlkGDlvpi3LetEs21RZDf6hrPFpxMPBFCoFTIsHtrOVrqinG+ewxvnr6BsZkVON0+eH1BSYUZOEKgUStg0KrQUF2AYwe3oq2xFByrzLghXn8QF8MUOACAtsYyGHWp1Z+HIwSVpTkozDWuu2uz6vSie2AGrQ2lEfU2SzU8x+GTR9twvmsc47Mr614rCBT/8INz2L6lFLnZuqg+ztD1aSzN2SXNsbqxCDn5iUsB5WUc2g814PSbvVGnKtlX3Oi5OIrdBxviNDuGSX0OuweCIO3skEolh4zn0va99/a8FUoZ5AotHnh8Gx54fBumR5dw8o1uXD0zhKU5G5x2T9wDHCEk4tq5YfyPL34bv/E/nkTt1hLIMqTf64aCqW31xeA4EvfuxwRrZWLlMh4qhQxGnRomgxr5OXqU5JuQl6OHQp6cuNCgVWFvaxWqS1OvYWpTTWFMd0rKCrNxZF/juofgy4uy0zLFSKrbNyq1So5D7WsFPwbGFtE3MofRqWUsWJxYdXnhdPvh9voRDAoICSIEQQTH/fzBwO3gyahXo9BsQF1FHrbVF6O61JzUdDNzlg6P7I9fY9KNIgCqyyIruEAIUFKQhUcM66dIHt3XkHJvnIQQVJWY8dj9TWFL82cZtAgJIhRc+DepmrJcHN3XCEG89890cb5Jcp9AKXKzdfjCJ/bg3LXRsNkoBMDknDWqYIqKFDevTcJhjbzR+20anRKVWwqh1SeuOSUhBDWNxcjJN8KyEF0ASCnF6bd6seuBLSn3Pc0wiSCKFK5Vr+TGuxq9CnwSG7fH0ofvAWU1+fjMbx/GE7+0Bz0XR3Ht3DBG+2cxO26Je4n1sf45/MOfvI7P/5dH0NRWCVkGfH03FIE8+WALnnxQ2uHYTFGYa8QXn9mb7GkkxK7mcuxqLk/2NFIWIWsV/5prC9FcW4hAMASLzQ2bw4NVpxdOjx/+QAih0FpAxXMcZHIOSrkMOo0SJr0a2UYtzFnapD0c+MXPZ63X0h996ZFkTyUm9FoV/tMLh5I9DclyTFq88LH2mL7m/rZq7G+rjulrxsKh9jocaq+Ly2s77B6M3JiBN0zT5rvJLTShsr4goYEJIQT6LA2a2spx6mfR76bd6JyAdcmZ0N00hkkVAV8QXrdf8jkhrV4NeQYs9u+GEIKsXD0eeGI79jzchLHBeQx0TaHr/DBudE7A7fTF5eNSCgzfmMU///W7+LU/eAI1zSVpmUnxYclfsTFMhlLIZSjKM6IoTBU2hmESZ3Z8GVMj0lpZLM3Z8Q9/8nrCz1CIgojFWWmtGBw2D3oujeDQsR0xnhXDpD63y7ehnRadQZ0ROyfhKFRy1LeUoqaxGHsON2N6dAln3u7F6Z/1SHrwFA4VKQZ7pvDPf/Mu/vNffhKmHG1a756zYIphGIbZFERRxNToEuYm1z+PdS9etx/DfbMxnlV8+bx+dJ0dxgOPt6b901+GiZZng8GUMVsLuXJzLJUJIZDJeeQVmWAuMKKprQJPf/4AfvrSBZx6swcOu2dD/bo+ShQpus8P46W/O44v/eHHwKdx1VFW5o5hGIbZFJx2L252TW6qCneiQDE5soi5CUuyp8IwCWe3uDaUrmbK0a31mdpkOI5ApVGgpCoXv/bfj+F//duX8PjzHSgoyY5p0QhRpHj7B5dx5eRA3OsvxBMLphiGYZiMRymFfcWF/q7JZE8l4ZYXVjHUN5PWixWGkcK67IRr1St5/FowtTl2pu6GEALCEZRW5eJLf/gx/P7ffhpHntmF4gozuBjtJAkhES/93XEsz6/G5PWSgQVTDMMwTMajIsXE0ALmJab4pTOHzYPhvpm4V+limFRCKYV12QGXQ1owxfEE2bn6hDXoTnWEI6hpKsav/sET+I2vPonDH98FQ5Y2Jq89PbaMEz/plFx1MdlYMMUwDMNkvGBQwJVTA2n7Zr0RoiBirH8Oy/PSemsxTDoK+ENYWXRITuvV6tUw5ejAJbE9SaohhECukGF7Rw1e+E9H8Ot/9DFU1Bes9anYAL83iCunBjAzthybiSYY+w5hGIZhMhqlFH5vAFdODSZ7KkkzNjCPhWkrS/VjNg230wfLgvTUMUOWBobs2Oy8ZBrCEZhydNh3pBlf/fsX0HGoccN9TSeHF9F3dTwt71EsmGIYhmEyXte5YThs0TfqzRSuVS8Ge6ZZqh+zaayuuDAzLn2nI8usR7ZZH8MZZR5exiOvOAu/91fP49HnOzZ0vszj8qPv6jjsK64YzjAxWDDFMAzDZLxTb/YkewpJ131hJG6NOBkmlVBKsbLkkNwGAQCy8wzIymXBVDiEEKjUCvzSlx/GQx9vg1IlvfrhUO80lmZtabc7xYIphmEYJqOtLDpwo3Mi2dNIupGbsyzVj9kUgkEBE8ML8Lr9ksbL5DzyCk3Q6FQxnlnmMmZp8dTn9qN5VyWIxJ52S7N2zE6uQIxhP6tEYMEUwzAMk9GunB6ExyVtUZVJbh/yTreFCsNEK+ALYqB7SvJ4jU6Fspo81ug6CoQQFJXn4NHnO5AtcUcvFBIw1DuNQJqlI7NgimEYhslYVKS4dOIGhJCQ7KmkhLPvXIe4CSsaMpsHpRRulw99V8Ylv4bOoEJlfWEMZ7U5cByHnfvr0NRWITkQHR+cR8CfXo3VWfF8hmEYJmNNDi9ianQZUjLbeBkHmYzfcNnfeKAilbTgmJuwYLhvBo07KmI/KYZJEVdPDWLVKr3gjClHh7KavBjOaPOQK2R49JPtuHJqAF53IOrxUyNLCPiDoJSCbLREYIKwYIphGIbJSJRS9F0dh9Me/aKK4wl23b8FzTsrUvIN3WZx4bV/ORd1Dx1K14pxsGCKyVRCSMQHb3RJHs/LODTuqIBCKb2QwmZGCEFTWyXyi7MxMbQQ9Xj7igtOuxfmAmMcZhcfLJhiGIZhMpLPE8BAzxTcEs5LmXL0eOipNuw93ByHmW2cZWEVvZdGMXR9Juqx184Mw+XwQmdQx2FmDJNckyOLGOqN/ufiNpmcx87762M4o81HpuCx80C9pGAKAJYX7KjcUhDjWcUPOzPFMAzDZKTZSQumRpdAJRRcKCzNRkVd6r6Za/UqtLRXSxprXXbgxtWJ2E6IYVIApRRvff8SQkHpZ27M+UbUby2N4aw2p+ZdlZLHWuZXgTSqk8OCKYZhGCbjUEoxNbKEuQlL1GM5nkNpdR7yS7LiMLPYUKkVqN9WCpVGEfVYv2+tqh8rkc5kmomhBVw5OSDpjORt9z3UKOnnivlFFbX5kse6HN50iqVYMMUwDMNkHo/Lj+Hr05Ka1Gr1KjTvqgTPp+5bJOEIispyUFYd/SF5ISRi+MYsVhYdcZgZwySHIIg4/uNO2CxOya/B8RwefLIthrPavAxZWqi10oJSPyuNzjAMwzDJZbM40d8lrc+MIUuL5rbULDzxYXlFWaioL5RUbXBlcRUDvdOxnxTDJAGlFGP9c+i5MIJgQHobhJbdlSgsy4nhzDYvQghUGqWksdEW1kk2FkwxDMMwGUUUKeanVjAxHP3hZ0IIqhuLkFeUuil+t2kNKlQ3FEKjjX7Bsmp1Y7h3Ou0WLQxzNx63H2ffvo5ZCWm9t/EyDg891QaZnI/hzDYxgrXWEhLIFelVH48FUwzDMExGCQZC6Do/Ar83+lQRnuew56EmEIkNJxOJEILa5hLk5EdfQjgUFDDWP8dS/Zi0J4oiBruncerNng2lh1XWF6KhtVxys1nmIygQ8Ev791BJTA9MFhZMMQzDMBkl4A/iysl+SWPVOiXa9tfFeEbxU1FfiLxCk6Sx40MLmJ9aifGMGCaxnKtevPHSeSzN2iS/BuEI9hxuRk6+MeXTe9MFBYXXE33TXgDQaJSp2Cv9nlgwxTAMw2QMSilGb85hRmK6T9u+Omj1qhjPKn5Uajmad1ZKajC6sujAaP8cAn6W6sekJyEk4OQbXbj8Qf+GKviV1+Zje0c1FMr0Si9LZXaLCwGJO4U6o1rSWdBkYcEUwzAMk1FOv9kjrUcJAfYf3Rrz+cQTIQSte2skl3LuuTgK16onxrNimPgTBRGdZ4fw7a+9DVFCL7nbZHIerffVoGpLIduViqHp0SVpAwlQlGZFQFgwxTAMw2QMj9OHq6cHJY015xvRsKM8xjOKv6qGIhSUZksaO9gzBcuig/WcYtIKpRT9XZP4xp/9dMNltAtLc7D/kRYo1el1TifV9XdPShqn1algMutiPJv4YsEUwzAMkzF6r4zBtuySNLZ1bw3UWmXaPZ2WK2RoP9ggKS3GuepF7+XRDT3ZZ5hEopRiuG8G//J/3t3wmT+ZnMeeI02obS6J0ewY4Pau4bCksfkl2ZArZGl1H2bBFMMwDJMxzr3TB0EQox5HCMHO/fVQpFlJ3tv2HmkGJ3Hxcf7dPggh6b15GCZRKKUYH1zAd/7327h5bXLDDwFKKnNx7Jf2snLoMTbcN4s5iedWK+sL0u7sGgumGIZhmIywsuTAYM+UpJS14gozSqvy0qIk+t0UlZtR2VAoaexgzzQWpqVXQmOYRKAixcz4Ml78f36C7oujCAU39gCAl3H4wu89hqw0SylLdaJI8f7r1+DzSqvkt2VbGZSq9Eq5ZMEUwzAMkxF6L47CYZNWTGHL9jJk5erTKrXkw3ieYO/D0opniCJdK9rBMCnK7wviZtcE/uy3XsLNzgnQDe5I8TyHRz7Zjm0d1Wn7M5+KKKUYuTGDq6cHIYSizxDQmzQorc4DL0uv8CS9ZsswDMMwdxEMhNDXOQ63yxf1WLlShtrmEuiNmjjMLDEIIdixrxZKdfQl0gHgwns3NnyQn2FijVIKy+Iq3vzeJfzpl1/CxOBCTF63sa0CT3/+QNot2lOda9WLd350BUtzdknjq7YUwlyQfr2+2HcRwzAMk/YWZ22YHFqU9DQ0vygLFXX5ab2wIoQgr8iEmqZiSePnp60Y7puJ8awYRrpgMIS+q+P4ztfexr/+7buwLTtj8rrFFWZ84gsHkFuYfov2VBbwB3H++A1cOH5TUgqmTM6jcUcFzAXGOMwuvtLrhBfDMAzD3MX44DzmJFb2Kq4wo6wmP8YzSjyNVontHTW4cXUi6rHBQAiX3u9H887K2E+MYaJkXXLgx986gwvv3cDSvH3D56Nu0xvVeOz5DmxrrwYvS1zRCUEQ4XH5oNOr0/Zc5npEQUTvpTF8/xsfwGaRFvTmFhjR1FaedsUnABZMMQzDMGnO7wtirH8Odglv4gqlHFUNRTBmaeMws8RSqOSo314GjV4FjzO6dMdQUMCNzgm4Vj3QpXG6I5OeKKUQRQqXw4uzb/fiR988Dcv8asyCKGBt52PfIy04+uzuhPeU8jh9+Mc//yn8/iCOPrsbDa3lUChkIBxJ+90xURBx/coY/vr3fwTrkkPSaxBCULmlEFu2l6fl14MFUwzDMExasy45MNAzDSl9Zw0mDZp3VWbE02JCCPKLTKisK8CNzomox1sWVjHQM4WdB7bEfnIMcxehkACvy4+VJQfOH+/Du69cxeKsDYhx2zOO59B+sAFf+L3HoNIkvlIcpRSrNjcunxzA6Td7UVGXj0Mfa0Pb/jpkm/XQGlSQyfm0CiREUYTL4cXJN3rw7a+9Jbl6HwAYc7Q4/Ild0OiUMZxh4rBgimEYhklblFIszdkxdnNO0vicfANqm6WdM0pF5gIjqhqKcPPaZNQl4letLgx0T6N1bx14Pn3PjzGpi1IKISTCuuzE0pwNM2PLuHF1HNfODcMaozNRHyWT82jbX4ff+OqT0GhTY7E+MbSIb/2vN/H9f3gfjTsq0LqnBpVbCpFXZEJOniHhO2fRoJTC6/Zj6PoM3n3lKs4f74Pfu4HiNQTY1l6NHXtr0yqY/DAWTDEMwzBpKxgQ0N89CYc9+pLoHM+heVdlWlfx+yi1VonqhkLoDCo4V71RjQ34Qxjtn4PN4oQ5P/0OgTOph1IKvy+I5Xk7FmdsWJyxYmHGipnxZUwMLWJpzg5RQpPtSMkVMuw7uhWf+fLDMOWkXj8pt9OHK6cGcPX0AHLyjSirzkNpTR4qagtQUVeAkqpcaPWqlAkyXA4vbnRO4OqpQVw7P4T5yRVJGQEfVlCShWd/9SDkadowHWDBFMMwDJPG/L4Arp4alDRWJuPQ8WBTjGeUXIQQVDUUI7fQFHUwBQCTw4uYHbewYIpB0B/EyqLjngt5SimCgRCCgRAC/rXfvZ4AVq0uWJedsC45YFt2wm51w2n3wLXqhXPVA4/LL6mxdrQUShkeeGI7nvu1Q8gvyU6ZgORuKF1Ls7UsrKLr/Ah0BhWycvUwZutQUmlGTVMxapqKUVqVB5VGkdDPJRgIYWpkEZ1nh9BzcQyz48tYmrdvuNcXsNaW4jNfPozKuoIYzDR5WDDFMAzDpCVKKZbnVzHYMy1pvLnQhC3bSmM8q+Qrr81Dfkk2xgfno35qvDhrxeTIIpp2VkCWwGpn0bjbQvzn/4luaKFOKQUVKW7vlXx0zZrKC/JY674wii8//X/Xv4hSUHrr63braycI4tqvkAhRECHGYNEdLYVShsNP78Snv/wwjFnatPp3o5TCueq99TBkCTevTeDkT7shV8ih1ihQWJ6D6oYiVDUUoaw6DwUlWVBplSCEgAC4/T8///N6H+z28TR6589CSMTyvB2jN2fR3z2F65fHYFlYhc8TiHkvukefa0f7g43h55niWDDFMAzDpK1z71xHKCSt4tfew81p3VvqXuQKGbbuqkTX+WH4PNEdChcFir4r49h/dCuyzPo4zfAX3V6IiyKFKFCIorgW0Ijirf//1p/F29eICPgCcDq8cNq8cDo8cNnXdj2cdi9udk1Inst7r17D5PAi9CYN9MZbv0wa6Ixq6A1qKFVycDwHwhFwHAHHceD4W7/f/m93/p4DIekbgAUDoZj1dkokvUmDZ7/4AJ783D7wPJe2X//bhJAIbygArzsAh82NxVkbui+M3AqWCHiOgzFHi4KSbOQWmmDM1sKQpYUpWwuNXg2FkodMLoNcwYPjCEIhEcGAgGAgCLfDB4fdA4fdg+VZG+ZnrFicscHl8ICKd39wEQscz6H9gS148oV90NwKBNMZC6YYhmGYtBQMCDh3vE/SWF7GYc/DmZXidxshBC0d1dB8Uxl1MAUAN69NwmZxwZSji8six+8NYG5qBa5VL4JBAaFb6WFulw8epw8elw9upw8elx9up2/tv9/6u9v/PRgIxXxeADDQPYWB7ql7/r1cIYNWr4JGp4RWr4ZGr4RWp4JGp4JWr1r7s+HW3+tUUGkUkMtlkCl4GEwaFJblQKGUx2Xum51CKUPllkI892uH0H6oIe0X6Ou6vaNEKUKigJVFB1YWpZUlTzSO59DUVoHnfv1BFJRkJ3s6McGCKYZhGCYtjfXPYWbcImlseW0+yqrzYjyj1FFek4+SilxYl6LfWVhZXMVQ7zTKa/PB87FfkFoWVvHd/3Mc/V2T8HsD8HmDCTlDEwvBQAj2FRfsK66Irud4AqVKAZVagZb2Knz+vzyCvKKsOM9y8zHl6HDg0RYcfbYd5TV5mR1IpTFCgKa2Cnzmyw9nVBVVFkwxDMMwaens29clVwJrP9gAuUKWsYsumZzH7kMNuH5lXFKgcv54Hw4ea41LifRgUIB1yRFxQJLORGGtjLTX7Yd12YlQKH6V6zarlt1VOPaZPdi6uwp6kyZjf6YzQfuhRnz2K4dRUVOQUf9OLJhiGIZh0o7X7UfnuSFJFaXkShm276mFTJ6aBRZiZc/Dzfj2196CEIr+a9RzaQwOmxu5haY4zIxhNi47z4CP//J+HDzWCmO2lvVGS2E8z+Ghj+/Ep//jQzDnGzIqkAJYMMUwDMOkob6r45IPx9c2FSO3MPNLf+cXmVC/rQw3OyeiHhvwBXH++A187LN7Yz8xhpFIJudhytFh39GteOqFfTAXGEE4knGL80xBCEFuoREf//wBPPz0TqgTXNY9UVgwxTAMw6QVURTRc2EUHpdf0viG1vK0K5csBeEI9j7cLCmYAoCzb/fi8U91gE/REunM5qEzqpFfnIXt99XgwSd3oLy2AByX2T+/6U6rV2HL9jJ8/PMHsP2+anBc5u4csmCKYRiGSSvWZSdGbs5KquimM6pR21QMtVYZh5mlnta9NdDolJICz7GBeUyPLaMizRtqMumJl3EoLMtBbVMxmtoq0dJRjZJKc1o+BOF4DoastVREQeI5z3ShVMlRv60Ue49sxb4jzcjONSR7SnHHgimGYRgmrYz1z2FhxippbHG5GSVVm6PaFyEEOflG1LeUouv8SNTjA/4QLp64yYIpJmEIR5DE3CNOAAAgAElEQVRfnIWG7WVoaa9GWU0eiirMMJi0ab0TpdYo8OQLe1FWk4cLJ25iqHcaQoYVI5EreNS3lGH/I1vRuqcWxZXmjN6N+jAWTDEMwzBpQwiJGOufh2VhVdL40uq1xdlmoVIrsH1PraRgKhQUcO3sMJ765f1QqlhvJCY+FEoZqhuL0dRWgZb2ahRXmKEzrPXtypQUU17Go6qhCKVVeTj4RCsmRxZx4fgNXD7Zj+V5afeyVMHzHHbsq8Ujn2xH7dYSGLO0kMn5TfHA6jYWTDEMwzBpw7rswHDfjKSnulqDCnUtJVCpN09gIFfwqN9WCr1JA6fdE/X4pTkbhq/PoHlXZRxmx2QaQtZ2RAkhdwpDcNytXzwHnueQlatHRV0BqhuLUNNUjJqmYqjUilvXccCt18g0hBAoVHKYC4zIyTNgW0c1Pvc7RzHYO43LJwfQc2EUlgU7QkEBoZCwlg6YYu3XCEcgk/FQKGUoLMvB3sPN2Hd0K/KLs8DL+LTePdyITR1MUUohQoRfCMAvBhAUgwjSIEJiCAIVIFAR9Pb/UYAjBARrNwceHHiOh4zIICM85JwcCk4BBaeAjONBsDm/oRgmnVG69vPuFwPwC34ExSACNHTnniBSAXfuCpSuLRRAQAgHDhx4wkN2674g52R37glykrn9jBLN5w1AoZKjqa0i6rHZeQY0t1Vuqn8LQggKSrJx4JEWTAwtRD1epVHEvB+USi1HVUNhxpem/6jK+gIolIlddqk1Ckk/K9EgHAHPc+BlHBQKOdRaBdRaJTQ6FYzZWhiztcgy65FbaEReUdamOa+4HsIRyDgeOoMabfvq0LavDpRSzIwvY6BnChMDC5gcXYLd4oTX7YfPG4DfG4TfG0QoJCRsngqVHCq1AhqdEnqjGgWlOahvKUXzrkpUNxRCJt/UYcQdJEwzvxSLiTeGgiIoBmH122EN2GAN2mEP2GEN2GELrMIZcsEZcsEreOEX/PCLgV8IqnjC3/rFQcEpoOZUUMtUUPNq6GU6GOUGmOQGGBUGmORGmORGZCmMMMoN4Ehm5I0KVEDfaj8WfMtRj91h2gqzMiftFjLDzjGMuycl/TDkKnOwzdQEnqTmosHit+KGYwA+IbLD6QQEu7NbYVJkRllpCgpBFGAL2LESsMEWsMMWXF37PWCHI+SEM+SGJ+SBT/AjIAYQ+lBQdft+wBMeciKHildBzaug4dXQybS37gUGGOUGGG/dD27fFzhwSflZ6Fvtx6w3+kV1OsqSG9ForINOpovbxwgIAQw6RzDnW4zbxwAAAoAQDjw4cISAIzzkRAYlr4SSU0DJK6HmVdDJtNDyGsg4tshhmHQmCCJsFieWZm1YWXTAZnHCuuzEqtUNj8sHrycAn9sPrycAvy+IoD+EYDCEYCCEYECAEBIhiuLaQ0KRQhTp2s4hR8DzPDh+7Xe5godKrYBKs/ZLrVFCZ1TDmKVFdp4B5gIDCkqyUVqdB2O2dtOcg7qLe75hb4q7bUAIYNwzhWHnGKY9s7AEVmALrMIedMAreCN+nbXAau2JgFfwYRUO4C5rUDmRQS/XwyjXwyg3wKzIQbm2BBXaMpSqi6Dk0/OpDAVFQAzgpalXMO2ZjXq8t9SLjxU9EoeZxVenvQevz74NKiGcMiuy8dWm30W2Iislg8g53wJ+OP06VgKRHebnCYdKbWnaB1NBMYgZ7xyGnGOYdE9j2b8CW9CO1aADrpA74tf5+T0hCC98cITu3veIJ/ydBy5GuR7ZimyUa4tRoSlDqaYYWpkmRp9ZeGctl3Bq+XzCPl4y1etrUKjOj2sw5RX9OGO5iDOWi3H7GLcREPCEAwEHnnCQ3dn9lEPJKaDiVdDyGuhkWpgURuSrclGiLrr1NdCyjAmGSSM8z8Gcb4Q5/xffb4OBEHyewFoQ5Q3A5w0g4F8LokJB4c7vgiBCFNcCKUrXfgG4k3LJcWtplzIFD6VKDqVKAZVaDpVGAa1eBa1BDZ5PzkO/dJOxwZRIKZb9Flxa6USX/TosASvcITd8gl/SojgaQRpa2/kK2AAAHLi1p9UyDczKbDQZtmBX9naUaorT682NAlOeWcx65iUNv2C5imNFR9Prc94gS8CKk8vn8fHix5I9lU2PUorVoANXrF24auvGom/51k60L+73BIEKsAdXYQ+uHTQmIFBb13awshQmNBjq0Ja1DTW6yozZxWZij4IiRAUAAoIUgOgHcPfgX0ZkUN3ardLwGhSpC9BibMR2UzOMcgNbIDFMmpIrZJArZNCbEvcQjllfRgVTIqUI0SBmPHN4a+EEuu198Aq+O7tJSZsXRLgFD9yCB8t+C4aco/jp3Dso15bi4fz7sdXYCA2vBk9Sv/rJpZVOiJBWznPWN49JzzQqteUxnlVqe2/xFB7MPwCTPPN7LaQaSilCNIRl/wreWXgfF62d8IQ8txakSZwXKDyCFx7BC0vAilH3BN5eOIECVT4ezr8fbVnboJfp0uKewKSmEA3BFQrd2mldwZRnBlesXVBwMjTo63F/3h40Geqh5JVJSzllGIbJBBkRTIlUhDvkwYRnGicWT+OKrQsiTd36/bdTgwadIxh0jqBIVYD9uR3YmdUKszILKl6V7CneVYAGcNXWI3m8SEVcXOncdMGUM+TCicVTeKr4MbbrkCCUUngFH6a9szi9dB7nVi7DLwaSPa17EqmIABUx5ZnBN8dfwk9m38Je8260Z7ehQJULTQLTAJnMtLarFUJICKHT3oMu+3WUaUrwQN4ebDU2Ik9pZuesGIZhJEjrOyelFEEaxKBjBBdWruKKrSuq8w6pYs63gO9P/wSnly9gv7kD9+ftQbYiK9nT+ncGHMOwB6T3Q6CguL56Ex8LPQKNTB3DmaU2gQq4bO3C3px2FKjzkj2djCdQAaOuCVy2duLCSueddNt0shKw4vW5t3HOcgkdOTvxcP4DyFflJntaTAYRIWLCM4XvTEyhSluO/bn3ocXYiAJVHnvowzAME4W0DqYsgRUcXziJq7YeLPiW4n7uId7mfYu4ZO1ER87OZE/lrq5YuzecMrnit2HENYYWU1OMZpUelnwWXLJ24omiI2yhEke2gB2nls/j4spVTHlm0/6esBKw4cythywMEy9j7klMe+ZwzdCDQ3n70WramraFkhiGYRItLYMpkYrosl/H67NvY9w9iSANJXtKMSEjPNqytiMvBZ9A2wJ2jLjGJZ+Xus0reHF9tX/TBVM+0YfrqzexO3sHCtX5yZ5OxhGpiCHnKF6bfQsDzmH4xMhKvaeDndnbUaIpSvY0mAwXpEH0rQ5g1jOPidxpPF50GDqZNtnTYhiGSXlpFUzdPgfx/tIZ/Gz++J3KWJlCL9Pj4fz7wafgzsWQczQmX+8gDWHcPQVbwI4shSkGM0sfo64JDDiGka/KZbtTMbKW6hvCFWsXfjD9Eyz7V9J+N+rDlJwCx4qOpmyfMiazUFBYg3b8bP5dLPqW8StVn4aW17DiFAzDMOtIm2CKUgprwIafzh/He4unEMqQ3agPe6TwQRhTsOLb7WIZsTqPtuS3YMI9vemCKZ/oxxVbF1pMjSnbdyrduEJunFg6jVdnf4aAGEz2dGLuwbwDMCtzkj0NZpMJUQEXrVfhFtz4QuVnkJuGzdYZhmESJW0ej8965/HS1I/wzsKJhAZSHAjkZK0hoozI4rajUKDKw4Hc+1LyDWvFb8W0ZzZmJeZtATsmPFMIiZkXEIfT7xjCmHsyo3ZPkmXJZ8GPZl7HD6ZfS2ggRUAgJzIoOQXkRB63e4JZkY0DufeBS5/bNJNh+lYH8M8T38OS35LsqTAMw6SstNiZGnGO44czr6F39WbcPoZBpkeuMgdZChOyFEYY5AaoOCVkHH8niBKoCIEKCAh+uAUvXCE37IFVWAM2WAJWyTs3HAiOFhxK2fz0Ge885nyLMXu9EA1h3DWF1aATOcrUq1oYTz7Rj/eXzmCrsQFKXrmpGhjH0oxnDq/OvolL1s64BaYaXo08Ze6de4JJboCKV0FGZJBxMsgIf6fNQUAMwhPywC14YQ/YYQ3YYQlY4Qw6IUqYHwHBHvMu5KlyU+IBi5zIoeQVyZ5G1NS8OmVTagtVBSiO8Pwkxdq5QJGKECAiIATgE33wCj44g664nRGkoOhz9OONuXfwdMnjmy6bgGEYJhIpH0yNusbx8vSPMeAYjvlr5ypz0KivR52+GsWaQuhkWqg4JVS8CgpOAdk9GmaKVERQDCFIg/AJPvgEP7yCF0t+C8Zckxh2jWHSM4NAhH1tqnQV2GZqTskn0AExiEnP9IZKot/NmHsSlsDKpgumAODG6iAGnaNoMTaCxVLRW/At4ZXZN9Bp7Yl5Q26T3IgGfS3qDbUo0xRDL9Ph/2fvvaPkuLIzz+9FREZ6n+W9d/CWAOgN6NnsZhu1dtpILdOtHvWMdlbS7uzsmbN7Zmd31qlXI41WWrVmj6YltSebZIMEPQmS8CiYQgFVKO9Nem8i4u0fVWCjkFlVEVFZmVmF+OEUT3dmvMibkZkv3n333u8aWD30jB4GVg+WsDkX5xKVIEgCMlT49ZwgJeFN+TEem8RgdBgjsXEkxaQsO6oMFdjj2AkDUxqKagdde/FExcNgSsCxU4KRNcDDl2aa5F7HDjxT9bjs4ykoKKWQQCFSEQIVIUgC0lIaUSGKhdRSY97x2CSmE3PI0PxEa9NSBqd951FvqsEj5fdDx+jycl4NDQ2N7ULJOlOUUswm5/GzqddwMzyoanc3FzqiQ6ulCY+U349dju6lVB1Gp6gDPEMY6FkeevAroknNliYccO6FQDPwp4O4GurHp97zGI9PQqJSzh10ljA46j4IN+8qiR3ouwlnIrgVGdmwit/d+NMBTMSm0GJuvOcaRWZoBq/NvImd9m7Nl1IApRRhIYJXpk/kRab/NhzhUGusxiPl92OfcxfMnAk6woFdZTMlFwxhwLM8ePAw39Fgt9ncgH3OnchIAiJCFNdDN/Gp7zyGoqPISJmccwIBwQ57F5rM9SUzJzh0drRZmzQhjDxi5Axw610bPs9nThaVlpryUgG+dBDXgjfwsfc0phKzG/6txMUETs69h05rG+pMNSXzvdTQ0NAoBUpyFUspRSgTwaszb+JysC8v57RwZrSYG/F8zVPosLR8tijI502BJQzYZSfLxJpQa6zGM5WPYyw2gY+9Z9Eb7EMgE1yxO91sbkSPrRNcCS5SKKUIpAMYio7KOv52ZE2O40VBcSV0HUc8B2G5x5wpYEkd8VqoH7vvMYn4jZCW0jgx+w4+XPw0L+czsgbUGqvxfPVT2OPoAUeWvof5nBMYwoAnPHiGh4k1oqK8DI+WP4DZ5Dw+8Z7Def8l+NIBJMTkZ45Vud6Dg6490JdIVEqjtCEgIISAIQw4cKCgMLNm1Btr8EzVY+gPD+CNufcwEBlCXIirToudSc7jxNw7+K3Gr4JneM2h0tDQ0FimJFexAhXw3sJH+Hjx7IbPZWD0aLE04uGyYzjo2lewvP87bzRNlgY0muvxVNVjuBi4jMvBPoxFJ5GUktjt6EG1sbIkb0wiFTEYHUFEiMo6vkzvBs/wmExMyzp+IDKEUDp8T0rvClTE2/MfoMPaAgNrKLY5JY9IRXziPYdfzb694XPpGB0aTXU45jmEB8uOwMga82Dh+tz5Ha82VuKLtc/jeOXD6A1cw6XgVYxExxDMhNFpa0W7teWe+01o5AcC8ln68O0oZ6ulGRcDV/Du/Ee4FR2GoDJSddp3AY9VPIhWc1MeLdbQ0NDY2pScM0VB8Yn3HF6ffQsiNpaa4NG78aDnCB4uPwZPkdPoCCEo07vxVOVjuM91AH2hm5hJzuGga2/JprllqIBLgauyjy83lKHaUImFlBcpGQXRUSGGvvANVBsrN2LmloSCYjg6huuhAex37S62OSUNBUVv4Bp+NvXqhtOVrJwFxzyH8Gj5A6gxVhVVnIAQArvOhofLj2G/czcGIkO4GRnCIdde8MzWE3vQKF0MrB5H3QdRb6rBm3Pv4oOFT1WlbqelNF6bOYl/0fZ7YFF62RQaGhoaxaDkVvF9oRv4xfSvkJBZqJ0LAoJGcx1eqn0e3bYOGBh9Se3yOng7jnkOISWloStRR4pSCm/Kh6HoiKzjCQhcvAPd9g5cCPQilZanLnXGdwFPVDx8T6rahTMRnPVfQpetHSauMNGRrchIdByvTJ/YcNNoD+/Gb9S/iF32Hlg4c0nNCVadBfudu9Fj7wRPtAJ/jfxDCEGdqQZfqn0RBsaAE3PvqDrP9dBNTMSn0GRuyLOFGhoaGluTkpGPo6AIpcN4dfokvCnfhs7VZK7HH7T8NvY4dsDIGkpq0XQbQshn6mClysXAFdn9e/QMjypDBRpMNYok3oeiY5jfRj1MDrv2o0zvkXWsBAmD0SEMx0ZBqdZ36m4oKGJCHO8tnMJobGJDEjTleg/+Zfvv47DrAKw6S8nOCUbWAJYp3TlBY+tj11nxQs1TuM99QNX4lJTCOV+vNmdpaGhoLFMyzpQoifhg8RMMRUdUF8iyhMFOexf+tPN7qDFWlbSjUupIkHDGd0H28QbWgAZTLcr0Hnh4t+xIk0hFnPVdVGtmyVFrqsbxiodkv//55CKuBK9vWp+YrQylFFeCfTjv71WtJsmAQZulGX/a+T00mxvAaY6Kxj0OIQQ2zornq46jyiCvz9WdiFTC5dC1DWWPaGhoaGwnSsKZopRiODaG077zqheVLGGx27EDv9/yTVi50tx53kqMx6Ywk5iTfbyJNaLWVAOGMGi3tshWJ6SguKQgAlbqpMQU9jh2osZYJXtMb+AaZhJz2k7vHVBKsZDy4r2FU7IFUO6GAYM2azN+q+k3UWWo0OYEDY1lCCGoNVbjAc990BHlqebhTBSjsYlNsExDQ0Nj61ESzlRMjOPU4hlMxuWpwN0NAwZdtnZ8qfZzcOkc2qIpD5zzX4JI5UUDCIBygwcu3gEA6LS1gVPQ2HE+uYixbXJjjglxePQuHHTtlR0ZnUnOoTd4FRkqbLJ1WweRivh48QxuqGzWTbBUH/LF2ufRYKrV5gQNjbvgWR47HF2oUiEAlBSTslVbNTQ0NLY7RXemKKUYjU3gjO+C6sa8taYqvFTznNZMME/EhQT6Qjdkp1YxhEWnre0zZbQGUy3sOqvs10uISVwNXldla6kRF+PQM3rssnejylAue9yHC58imA5p0all5lOLeHv+Q9XpfTadFV+qewGd1vaiKvZpaJQy9aZaNJrqPusRKJekmMJ0YiZvjbM1NDQ0tjJFX2UIVMDbcx8gJsZVjTeyRjxT9QTarM1gtUVTXhiOjsKfDsg+ngGDHmvnZ/9fz+rRZWuXPT5DM7gVHUFMUPcdKCViYhyEEDSZG9BhbZW9SPGm/fgoT81otzqUUrwx+y7CQkTVeAKC56qPY7e9R6uR0tBYA57Rod3aAqPCXncSJATSIcSFxCZZpqGhobF1KLr3MRwdw4XAZVVjGRDc7z6EBzz3aWITeYJSiuvhAUQVODY2nQVN5voVj+13KuudtJDybosc/Njy4oJndDjs3g/ncuqjHN6a/0C1A7GdmErM4FPvOVVjCYADzj14uvKxku3fpqFRKhAQNJsbFTtTwFIGQ1SIbYJVGhoaGluLojpTaSmDV6bfUK3e12RuwJfrX9TSePJIKBPBWGwCGSpfEGK3Y0fWZ9BubYWZld87KZAOYjQ2DklmnVapEl92Qgkh6LS2o8XSJFvZLybE8NbcB1v+GmyEjCTgjdl3kZLSqsbXGKvwm/UvKU5b0tC4V6kylsOoos9dXEyozijR0NDQ2E4UdcUxGBnCQERdgbmZNeELtc/BzJrybNW9zWR8CnPJRUVjDjj3ZD1mZPTosnXIPkdKSmM0NoFwZmtHZhJS8jNnSMdwOF7xMAyMXtZYCRRnfRcwr/D6bycm4lPoDw+oqpUyMHo8WfkYPHqXVjupoSETA2uAm3cqHpcUU0hoaX4aGhoaxXOmJCrhE+851ZLY97kPoNPWBpmb/hoyEKmI8fgUfGm/7DFO3oFmS0PW4wxhsM+5S9Hrj8UmsLjBhs3FRpTEFVGVDmsLeuxdssd7036c9l24J6NTlFJcDV1HMBNSNb7H3oU9jh6t6a2GhkLcvEt2BP02AhU0BVINDQ0NFNGZmkvOYzg6pmoHuspQgfs9h2FkDIpvABqrE85EMRIbg6DgBtlt64CBMWRFAggIWi3NsHIW2eeaTy5iaosrRFEAqTuaWbKExfPVx2WnnaWkNK6F+jGXXLjnlP386SBuRUZUpfg5dHYccR+Ai3dqc4KGhkJsOqvi341ExS09V2toaGjki6I4U5RS9IUGFCnG3YYA2GXvRr3WOyavUEoRSAcwFB1VNG6PfQd0OQr9CSGwcha0WZpln0uChOuhASTucEa2HhQJ8deNpwkhaDDV4oArOxVyNcZiE+gL3VBdS7gVoZRiIj6FCZW95hrNddhh79TqJzU0VKBneMVjBCpC0JwpDQ0NjeI4U3ExgcHIkKriVTfvwk5HN0wqCmY1VkeChIn4tKI0OzfvQr2pZtUFrIkzosPapmjH80ZkAJFMdMtGZSgoklJqxWM6hsdj5Q/KVsxKSin0Bq/Bm/LfMw5VWspgODqqKMX0NibWiP3O3bDrbJtgmYbG9kdHOCjdmyRaDFhDQ0MDQJGcqbnkAqYTs4rHERA0mevRbmnZBKvubdJSGr3Ba4rGtFmbYF2jOa+OcGgw18KmoIGvPx3EUHRky7oQlFIk74qsMYSg3lSDXfYe2ecZiAxhODZ6z9ROhYUIBqMjqsZWGMoUS/FraGj8GoGKULp/xRBGiwRraGhooAjOFKUUC6lFLKS8iscaWD12OXpg1cmvw9FYH0opwpko+sMDsscwYNBiboKFM696DCEE5XoPao3Viuw547sIqqKWrhRYqplKZT1u1VlwwLkHFpk1ZAkxiY8WTyOZ41zbDUopIpkIxmOTiscyINjn2KWon5eGhsZK1NQpcoQFR7RebhoaGhoFd6ZSUhpT8RnEReWSqibWhN2OHZtglUZf6KaiBoxO3oFaYzW4dZolu/VLqYBKEkKuhwcQyoRlH19aUKSkbAeIJSw6bK1oMWcrH67G9dDNpSjdFk15lMtSiumUqobFDGFx1HNoE6zS0Lh3iAhRxSnFPMPDwMpr+6ChoaGxnSm4MxUT4hiJjqsa22FthYd35dkiDQqK077zisZUGctRZaxYVwRERzg0musVqfqlpBQu+q8osqdUoKBIrLLL6+Fd2O3YAZPMZsYZKuDVmZOqFC+3EoIkKoqK3kmbtRmVhvI8W6Shce9AKV2uVVTmTBlYPYwKGrNraGhobFcK6kxRShEVohiNTygey4DBEfcBTcFvE/Cl/RiMDss+niEMaoxV8OjXd2wJIWgyN8DJ2xXZdNZ/aUvK7lKaO80PWLoW+527UWWokH2+m+FbuB66mS/zSg5KKTI0g/6wuubdx9yHtDJ4DY0NIFAB/lRAcZ2qmTMr2iTT0NDQ2K4U1pkChTftV5XCZWQN6LK1b4JVGuf8vRAl+Y6LhTWhxdwEdp0Uv9tUGcpRZahQtOidiE9hJjEv+/jSgSKzRv1BucGDg659smsNJEh4Y+7dLFGL7YQvFVCl4sczPLptHZtgkYbGvcNcckGVsq5dZ4VNq1/W0NDQKKwzJVFJdR+ZZkujbGlpDflkpAwuBa4oSiWz6qxos8rvH8UxHLptHeAZnewxKSmFywrVBUsBiiWZ77V4oOywrKjebYajY+jbxtGp0Zi6tN96Yw2sOosWrdbQ2ADj8UnFQjc8o0OFoRy8iv5UGhoaGtuNgkrxSJAwGZ9SNXaHrVNL59kEJuJTmEsuyD6egKDWWI0yvVvR6+x0dIOf4mWrRmWkDPrDgzhe8TD0W6jImYIivc57dPIOPFp+P/5x4heyzhkTYvjUdw49tk4Yue23oTAWU572CyzVS+mIfAddQ0NjJRKVMBgZRlxhZMrIGtFgqt0kqzTkIlIJvlQEw9EZDEdnMZPwISYkERdSSEkCOIaFkdHBwPJw8BZUGpyoMjpRaypDnakM7CZK26clAQPhKdwIT2Aq7oU3HUZcSEGkEowsD4fOjBqTG+3WWuxyNMHE6rWNMY0tS2GdKSphUmVkqseupfPkG0op+kI3ERPkKytyhMUuR7fsFL/blOs9aDDXoS90Q55tABaSi5iITyuKgpUCaUlY83kCgofL7sebc+/Dnw6sez4JFEPRMdyM3MIex45td8MZ3YgzxWjSzBoaaplLLmAiNgVRYT87M2dCswJl0p9MfIR/HP9AVh0sAwY8q4OJ1aNMb0OV0YUWSxW67Q2oN5WBIyxYwuR9HrzkH8JfDf0Kc0nlKcdyMHNGfL3xMTxTfXBD55EoRVrK4JxvECdmz+N6aBxpKQOBSpCoBEop6B3ajLebKzOEgCEM2OU/J2/BbkczDrk7sNfRAjNn2NB1pZRCAsVCMoh35nrx5uxF+NJhCFSESCVI9NdWkWW7WMKAY1iYWD0er9yLZ6sPoc5UBgZkQ5/v75z7PuaT699bsWwHx3DLDp4JHr0D9aYydNhq0WGthYM3L12XDdgkUglfO/2/IyLI2bQg0BEWBpaHTWdCpcGJGpMb3bZ6tNtq4dCZl3q8bfAa3Y1EJfzBhb/EdEJ52yIlEBDc5+7Cv+75iqzjz/sG8T9d/wfZZ2cJAx3DwcoZ4eItqDK60WKpRLetHvXm8k2bPwq2EqGUIiWmMasgCnIbK2eBi3duu0VksUmKSQxGhnNKea+GntUraj57G4YwOOTcJ9uZAoBAZqmBb6ulact89pRSZNZJ8wMAE2fEkxWP4EeTL8uSJPamfLgc7EOHtRUmbvsoaGWogCkVDbxNrHFpTtCi1RoaqhDpkormRGJG0TgGBO2WFrh4p+wxKSmDcCYGQa7TtjyFjsbmVjxcrnfggbIdOFbWjWZLJew6MxhC8osEJAoAACAASURBVDIPCFRCREgglFFePyYHkdJ1N9rWYknAK4nLwWH83chbGI7KmzdvuzASpcAd1z8qJDEZ9+L1mXNw8RbcX7YDL9UdQ5O5UpVtwUwUHy704UfjH2BmHYeULtslUREZUURCTOPHEx/hnblevFR3P56s3A+P3qb6vh/JqPsclzod/jrt3MDy6LE14InKvdjjbIZHbwevagOPIizEEVZqUwLoD/96s9HA6NBjb8CD5Ttx0NUGt94GA8vn7T4YycQ37ft/GwIgrqAGXKCiKpvmke1MV+gdeKB8Jx4q34EmcyUsnCFvjccLuq07l1xQpdBWZajQmgNuAhOJaSykFhWNaTI3KKr3uZM9zh7oJ/SynbeEmMRobBIxMb5mc+BSI0PXd6YYMDjg2oMPFz/FTHJu3eMpKK6F+nHUcxDtlpYt41yux2LSC0HG9bobN++CkTVum+ugoVFIKKXwpvw47+9FQmHPRx2jw1HPoaL89hZSQfx86mO8MXse+11teKxiD/Y5W2HXmbb1XCBRipmEF7+Y/BQn5y4ioiCbRA7+dBQnZs7jkKtDlTM1EV/AP4x/gLfnLimOct6JLx3BD0ZOYig6g/+q4VG0WqqK+rkmxTQuBm7hYuAWWixVeKHmMI54ulGhdxTFrqSUwcXAEC4GhlBr9OCxyj2439ODJnMFeFZLeV+P+VQQP5s8hZOzF/BAWQ+erNqPHfZGcITd8OdZUAEKrwrFLgCoNJaDY5SllWmsjUQljMcm4U0p+0wOu/apfk0X70SrpUnRmIn4JOaTyhy+YkJBIcjYfSSEwMU7cdRzEIzMn+FccgGXg33r1mRtJfyZgKqmxG69UxOk0dBQSYYK+NR7DjdUtCRosTSh09q6CVbJJy6mcGqxD3828Av85a3X0B+e2HBzczOnR53RgyqDCw6dZcM7/gQAz3Cw6UyoMDhRbyqDXad8U5DSpdS5vxl6A7+cPp13R+o2NSYPDrjaFI8bDE/hL269hjdnL2zIkbqNSCW8N38Ffz74SwxG1NXYbwbD0Vn81dCv8DdDb2AoOrMU6SsiUwkvfjj2Hv6Pmz/HazPnEM7EN/wbuFeICAmcmL2A/+vmy3h1+iyEPLThKWi4xyejPiQXlYYKsFpkKq9EhRhGYuNIKkjx4xkddjmUp/jdhoDgoGsvroflK9PNJOcxk5hDk7k+b+HYzUZu9FXP8Nhh68IZ40VMyUi1oaD42HsGD5UdRQVTti12Yv3pkKw0x7tx804Yt5AwiYZGqUApxaXAFbw5966sKPqdMGDwXNUTecsUyeWsKJkPQpk43pq7hNHYHL7a8DAeLt+puJ73Nk3mSvzz9heQEFMQqAhBEpGWBMTFFGJCClEhgcVkEJ94+zGd8K0Y69CZcdTTjQZzOSycAWbOCDOnB8/owBEWHMNCz3Dw6JX1WwSWNj5/MHISp7zXV3VW7DoT2qw1aDCVw6O3wcDqwRCCpJhGTEjCmwphKu7DZHwRwUws5zU+XrkXRlaZOuNswo+/H3sXF/yrO+UGhkeXvQ6dtjp49DboCIeokMBU3IuroVHMxH2QcthzNTiCvx5+A/9N50uoNioTvFqNjX7fkmIGHy5cRVRI4Hvtn0ON0b3h+/DdNimxR6QSBiJTmEv6MRSdwXdan4GV295R2jvZyLUDgPH4Av6/0beRkTL4cv1DYDZw3QrqofgVRkFu4+Idm6o6c69BKYU/HcRIVJkkdYe1DTbOqvp1CQh22DthZA1IyMyZzUgZDESGsM+5C2bOpPq1C4ncXQ5CCBrNdei2tWMmMZvzhnI33pQfp7xn8FLNc9uiXiiYDqhypqw6qybLXEDeXfgQn/rOFdsMWRAA/6b7X6HaqDxdaTtDQUEpxZXgdfzn0X9EWIgqPsd+12505rHf43dan8WjFbtXbJQJVERCSGEhFcRk3Iv+0DguB0cRSEdyOhMUFLci0/jroRMgAB4s26mqwNzE6dHAla8897Jowm3xhPlkABPxxWxnirfgyar96LE3gAH5rI5ro4taSik+XLyG9+av5HzvZXo7Xqo9hofKd8KmM4NjlovrsXS/lZY/c5FKEKiIjCRgPLaA8/5BnPMNYjQ2C5FSmFgej1fsVWRbSszgjdkLOOO7mdM2BgTHynrwtYZHUWNyQ8dwnwk5SKAQpKVaqTO+G/jByEl4Uyv7j1IAlwMj+NH4h/hO67MwchvfPPvhkT/O2oSTqISEmEIkk8BMwofR2DzO+wcxHJ1dEvS46xwZKuK8fxA/Gv8Q321/HgZGp/pzdujM+L/3fRtW3Z1rG4qkmEEoE8NcIoCh6AyuBkdxMzwFgYo575ehTBwnZy/An4rgf9jxVZhZQ94cKjNrwB93vQRn3nrKEdj5jZdtvFBzH77e+NiKuYMu1yUmxBT86QhGY3O4EZpEb2AYoUws5xorlInhZ5Mfo9bkwTFPj+rrtiUiU1bOIjsVSmN9KChmE/OYVlj4v9e5c2PplgSwcGZ0WFpxOdQne1h/+CaiQhSmLVIjoyTVgWd47HfuweVgHxZS8lR03pp7H0+UPwwHb1NrYsngT4egJjPBzJrAabLoBSMlpWW3NSgF1NTmbmcopUiICZzxXcSPJl9GRIUj5dTZ8WzVcRiY/ElYmzkDXLx1xX2FUgrogUZzBQ65OvBS7bHl2pUh/GLqEwyEpxAVEiuWRRTAXDKA/3TrdVg4Iw642vKy2USWnSJm+VQ6hsu5e82AQMdwKsUJVictZfCjiY+Qodmp4922evx33V9Gvan8M1vXg1IKF2/FXmcLfrv5OIais3hr9iJ4RgcnL79nH6UUN8ITeGv2Yk5RDQtnwDeaHscXa+8Hs4pjyy8r6D1TdRAHXG34n6//GNdCoyvunwIV8Yn3OvY6W/BQ+c4NZacQAC7eCvNd7UXuTI3rsS8pVP5Oy1O4FZnGP41/gLO+AcTv6sMmUgmvz5zFg+U7cNClfnOBIQycvBWOO5yL2/bUGJcU/B6t2A0KirlEACdmz+ODhauYTfiRuWuOE6iEM76b+F/6f4I/7foibCpSSnPBMQx6bA0oNzjycr58YWB5uPW2FYGWOz/LFlQtfTZ1QDgTx9vzvfjZ5CnMJrI3cBdSIfxy+gw6bfXw6NWtqwrqoQTSQcVjDIw+r5O3xtLC6Fq4X1GjXjNrQrulZUNOLQGBkTWiy96u6EY3m1zARHxaRfyi8CzvY8o+nhCCDlsrWixNsq9tVIjh7fn3t0V+dDCjPM1Px+hgZA0bCslraNwLUEqRFtMYjA7jnyZ/gX+Y+JkqR0rP6PFE5cNoMNVs+r2YEJL1Z+T0OFbWjf+w+7fxLzteRI+9EbocqYYLqRD+n6ETmIgvbov5sS80jtlEdkZPhcGBf939FTSYKz67RnK485rqGA5dtjr8i44X8futT0PPyN+ciospvDd/Jadqn4Uz4muNj+FzNUfAMmsX9t+2pVzvwB93vYTdjuastcFiKoz3F67Cn47Itk8Jub5vLGHQaavDn3R9CV9rfAx2XXZWjAS6LPe/8Tqx9exhCINqkxvfankS/27XN/BczWE4ckSKKCjO+5aiZjFBvmKeWrs28rcZrPZadt6ML9bdj/9197ew29GUc/05GJnGlcCI6nmjoM5UTGFjQGCpn4VOwY9cY20opYgLcUUS5QDQbGmAQ6deqvQ2OsKhyVSvOF3wnL8X0hbZbVbqHOgZHo+U36+oBuhT33lFzZZLlbgQV3W9DJr4hIbGmkSFGK6EruMnU7/E3478F7w7fwpxhcp9AMASFnsdO3DMfbiovzuyHP15rGIP/uuOz+OBsp6ckaCh6Az+buQtJMWtE0ldjRvhSaRyvI/P1RxBrcmTt9dZLXqUC0opZhI+fLh4Les5ljC439OD45X7YFBQf0UIQbXRja/UP4gqY7Za8EX/LQyEpyHl2XFZDzNnwIu1R/BI+e6cpSb9oXFMxAsnkEVA0GiuwB+0Povfa30alYbs9gRJKY2353tx3n8r747eVqfBVIZvtz6DRnN51nPBdBQ3wpNZUUi5FNSZUpMmomf04LTGnHllKDqqWMWv3dICC7fxnFlCCDx6N+rMNYrGXQlek11nVWzU7Gx0WlvRZZPfmNqXCuBj7xlV9UalRFqFLDrP6KDX6qU0NFZAKUUkE8XVYD9+MvkK/uOtv8Xfjf4j3ph9F1OJWdVzRaO5Dp+reQZl+vyIAGwUhjBosVTh91qfxkFXO5gcu8ynvTfwzvzlIliXX2YSvqx0Lh3hcNjdUbSaWQqKUwt9CKSzI5wVBieeqNoLF6+8tpolDHY7mnDI1Q7uLsclIiRwarEPKRk9HPONmTPgK/UPwpxjIyFDRfQGhgtuk57l8VTlfny79VmU5RA1WUgG8cbMeSwmlWeDbWcIIWixVOPxir05xCuAkdgsQpmYqnMX1EuR08z0bjiG0+ql8ggFxVn/JUU3VitnQb25FnyeIoRuvQsNphpF0bGIEFvus3QoLzaUGjpGh+eqn8TFwBVZn02GZnA11I9jnkOoNlYVwML8I7fB8d0whFWt2KWhUSpQSmXvtC81XZUgUAEiFREXEogIUYQyYSymvJhNzmMqPoPZ5ALSUhopMa1YqS8XZXoPfqfpa6gvQHqfEgghqDK48M/bnsdQdBbzyZX12Ckpg19On8YxTzdcevWiScUmkklkfUdsOiMsXPHqhyVK8fZ8b9bjDAg6rbVLqXoqbTOyehzxdOFTbz8WUqEVz33svY7fbj4OA8MX/L1XG93otNXhnH9gxeMSpRiOKmt6nS9YwuCopwvzyQB+MPIW0nfcSymAC4Fb6AuNo8ygCbjdCc9waLVWw8Vb4UuvFD2ZTwZUp0cWzJmSIKkqCmYJq9VG5JG4mEBvIDs8vxZVhgpUGSryNoHpCIeG5VS/sCA/D/oT33kccR8sqZt6PmkxN2CfcxcuBq7IOn4qPoPewDVUGiq2jGz8nVBQVWkILBjt5qCx5Xl5+gRemX5D5eiVWy75jlAzYFBtrMT32n4Xtcbqkpxzb6eGfbv1Gfy76/+UNZdMJ3x4f+EKvlB7rCTtl0MuuzmGLaqS61B0Jmcdl5HT46HyXdBtYKOLEII9jmZUGl1ZzlQ4E8cF/y08XXVA9fk3YtduR1OWM0VBMZdUJ6yWD5v0jA4Pl+/C5cAIzvhurJgFMpKAV6fP4pC7A9YiOt+lBiEEZXo7KgyOLGcqmI4hKarbhCrYiiQjo5FpLjjCgmiRqbxxKXAVKQW9pQgIaoyVeU3xuC0J7uKz833X4lZkGD6VjZ+3AixhcbzyERgYebVTSSmFK6F+2SqApUZGElSlRDKEAaNFpjS2OEtSNWr/0RX/8gnP8Nhp78Iftv5OyTpStyGE4JinG3udLVnPxYUkegPDm9bkthCYOUPWRlkkk0BKyhRNYOOC/1bO75yNM2Gvs2XD3xcjp8dOeyO4HHP8aa+yWu98slqEMy6oq7HJB4QQVBldeLB8B2w5RDL6QqMYj80XwbLSxsDyOXuqpSRBdZ1ZAZ2pjCoJZEaLTOUNiUo4pzDFz8ga0Wiuz3vhcYWhHFXGckU7bCkphd6gfEn1rQYhBI2mOkWNkYeiIxiMDEOUtoY4x52IVFCkfHgbhmiRKQ2NzcDKWfB4+YP4RuNvoK7EUvtWg2c4PF99OGvxTQGMxxYwElXWAqSUcOksWXNdXExhJDpbtGrZvuBYztfusNaskPjeCLscjTnbsFwLjeWUiS8Eq6kdlsL69JC7I6cgiUClbVE7mG/YVdYQZPlPDQVbkaiflLd2gX0pMZdcwHhsUtEYu86KFktT3m3hGR06rW2KhAQykoCrwesQVEY5twJmzoTDrn2yGxQnxCRO+84jKqormiwqZCNTl4aGRj5pNjfgt5q+ihdrnkGVMX9p3ZsNAUGbtSanQtd8MoDx2MKWlUlvslTmVCx8feZcUZTaEmIa4/HcKrK7HPlbJ7Rba3NGpsKZOKbixcnEiOaIcBIs9dQqNh7eht2O5pzX7OwqTZXvZTKSkLM/moHlwTLq3KKCOVM6wkHN3CxRCdIWnQhLCUoproduKpand+tdqDMpU96Tyw57p6KIFwXFbFJ5s+GtBEtYtFqa0W7JTltZjb7QTYxEx7fcgoEjnKrcf4lK2s1BQyNPmDkzPlf9NP6o/ds45NoHa47+NaUMIQQ2nQnd9vqs55JSBhPxRdVyx8Wmy1YHQ44Nx97AMN6YvVDwOX8xGcx5LQmAdltt3l7n7ka2t6GgGCqS4MN8TmW8pR5ZxYYQggOuNuhyON6LyRDGY1u/jUo+iYupnEITdp1JUb+1OymYAIVaeXORiqpSgTRWIlAR18MDSCq4qXCEQ4+tM2dzxHxQZahEjbEKwUxo/YOXCaZDGIyOoN5Uu2V2TpVSpndjj2MHBiJDsvrCCFTAr2bfRo+9EzzZOj3ZOLJ2Q8fVWNpg0eaEQmLX2eHmnao2xIpBvpRHtysMGJg5E3bau/BC9dOoNVYp6jVUapg5A5ot1SAgWWnsMwkfokIS5hKIICil2ujGfncbTs5eXPG4QEX8zdAJmDgeD3h2gGe4gnx288kgRCl77iUgaMgRGVQLQwjqTWVZUShKKabivry9jlwkKuFSDgl0hhB02usKbk8uumwN0DM6JO5a44mgGIhMocW6NVV/8w2lFPPJIOZyOMc1Rg+sMrOC7qZgzhSz/E8pIpW23I57KTKVmMFccl5RvRTP6LDL0b2p3aoPuvaiPzwg266YGMdIdAxJz2EYt2njVkIIdjl68In3HAaj8npY9IcHcCN8C7sd3ZtsXf5giLo5QYJ8SWmN/HDMfQi/2fAFTZJ+i2NkDXDxTrRamvBw2TG0WZu3xWfKEgZlvA1WzoiwsDL7Yj4ZRFyl3HGxIYTgC7XHcHrxRtb7Cgtx/NnNlzFcM4vHK/eizuRZzgDaPKfKmw5DyKHKbNWZcvZh2gi5Ij4UyKkkuNncjExhLDaX9biR5bHb3lxwe3Jh5vSoN5UhGFrZ/4tSiuEtXDeYb+JiCn2hMUTu+j0xIGi2VMKeQ8hDDgWt4tap2C0UqQhJi0xtCEopxmLj8KWVSXiW68tQb9ycFL/b7HXsULyLPBmfxnxye4etKwxl2OvcJfvaUFCcmH1LUeSxFMiVlrAeEhUhYusJbmhoFBMbZ8ETFQ/ju62/jd9r/jo6bW3bwpG6jU1ngj1HalgwHUVSShfBovzQYa3BF+vuz5khEhES+NHEh/gP/T/Fjyc+wo3wJFIqpZ3lEMnEIeXY+PTobXl/rVznpKBZctabjT8VwY/GP8x5Xfe72nIKPxSL3NFBWhQHtBSRqIRroTG8v3A16zmP3o6d9kYYOXlqyndT0Ka9apyplJTOuROiIZ+EmMRobAIxQVm91H7XLtXpmXJx691otjTiRnhQ9piZ5BxmEnOoN9WVhJLOZkBA8IDnMD5a/BSzSXnSpkPRUVwL9eOga+8mW5c/1MwJGSqoavaroXEvI1IJ1YZK1BlrtmRfuvUwcfqcYgBhIY6UmAEFLWp/JrUQEHyu9gjmkgGcnL0I8a7NZZFKuBmZxFB0Bu+br6DTVodD7g7sdbbAxpnyGqmKCtlNhAHArjPnPQU4l9Q3sCRCUajP0pcK48cTH+GcbyDLiXTozPhK/YObboMSKo3Z7WYogMVUSPU1iwsp/PmtV3NKiavh2epD2LOBxs4b4WpwFH87/CYW7krxYwmDPc5m9DgaVJ+7oM6UmTVhUeGYpJjY1uptmw2lFL60H6OxCcX9SA46922SVb+GAcFB5x5FzlRCTGIoOoY9jp0wccZNtK64uHgnHvQcwY+nXpF1fEJM4iPvaey0d8PAyttdYYq8vDCxxpx1DmuRFjNbLgKnoVFsYmIcb89/gB2OTrh455Z0LNbCwPIw5FjwpSUBKUlYWlVuwbdMCIFDZ8Y3mh6HRCneme/NucEsUBFD0VmMxubxibcfFXonDrnbcbxyH+pMZSvOp5a4kM5ZdrFUj5bfi2tapcYtKaaRkcScKodqyPV+JFBc8g/hp5OncCU4goS4MrLJgOClumNos2xu5o5SXPwqvbDEFARJgi6H3Px6ZKiIU4v5a0mzx9GMPY7NSY1crSRoMRXCa9NncXLuYs4my+UGB75QexQ2lfVSQIGdKYdOeSg4LiaXe1TRLVscW2zmk4uYiE8rGlNlqIBVZ0FU2HzJ7TZLM3SEU9Q/4kZkABHhERhZw7b9XhBC8HjlQzg5/74skQ4KitHoBPpCN7DfuVvWdWEIg2KqCti43JP/WqSlNJJSSpsTNLY0S71O1KfZUUoV99wZiY3hvflT+ELtc9sqxQ9YErRZTSwpLWW2qi8FYOleUGlw4g/bX0CF0YFXpk4jnInl3IISqYRAOopAOopb0Wn8ZPIU9jqa8fm6o9hhb4SR1S9toqmYOwUq5nxN/SZksKymqkZBIahwpiiW0iLvVoIVqYS4kERESGAy7sWtyDTO+G5iOu7N+X5ZwuDpqoN4vvq+ggl/yMW4yiaqRCVkJEGVM1WqpEUBkUxiRXYSpRQpKYO4kIIvHcZQZBZXQ6O4FhzN+dkDgJUz4o/aP49OW/2GPsvCOlO8XfEYkYpISIktG6IvNikphZuRW0grzBmfTc7ju5f+ZJOs2jgTsWnMJRdQri+dfOXNwMQa8VTlo/jx5Cuyojf+dAC9wWvotrXDJGOXhQFT1F+VnbcpjkxJkJAUk5AggcX2uTlo3FsccO7BYdd+1eODmRBemT6BsBBd/+BlKIATs+/ggGsvmszZUuJbGYaQVdO+M5K4PMds3TUEIQRWnRHfan4Sexwt+OH4uxiOzCK0ilMFLDkKopjGad9NnPcPYoe9Ec/X3Icd9gaUGxyKm58vORfZr7YZjvlqtlEK1aUfX/7k32/EJJhZAx6p2IWvNz4Kl175RuBms5qDSYHljRd19UClyCvTn+KV6U9Vj2cJg1qjB7/b+jQOuzs27BQX1Jly8ur0+EOZKCQqbcs8782EUoq4mERf6EaxTck7EiRcDFxBj60D3CZJt5cCBAT3ufbjQ5m1UxQU/eEBjMYm0W1rX3eCYAkLUlgdmhU4dLYlGxUKdkaFODJSBiyrOVMaW5NaUzWOeA6qHp8QE/ClA3hj9l1FIk1JKYWfTv4S3239luzm4Fsdhmyvrdh9zhZ0WGtwynsdp7030B+a+KwuZjUEKuFycATXQmPY52zF8cp9OOBqgzsP4hGbcW3XuncVWuGZAUG7rQaPlu/B01UHcgqdlDIEUKWcu11x6Cw46G7HF2qPostWl5foYoHT/JRHpgDAm/JBpFJhjd0mTCdmMLVNm9z2Bq7iK3UvbrpIRjEhhMDBO/CA5z78dOpVWRGc+eQirgT70Gyph5Fdu6ZsyZkqHnadTVXEOZQJISWlFTV91tDYThgYA+5zHUBf6CbG45OKxvaHB/CJ9yyeqHx422R8iGs0817qv7c93iewdF+w6Ix4snI/Drk6cCs6jWvBUVzw38JgZHrNpuYilXDeP4iByBSOerrxUu0xtFmrZW1Wc4TN+X3ZjCbqorR69IkrULqajrBotVbjqKcbh90daLeWtnhLehVhJgKiusZMz+jwQs19OcVd1NBuzV9zZ6XYOBPu83TiiLsLe10tcOoseUvT3BKRqYWUF6Km6KcYCooL/svb9tr50n4MRoax17mz2KZsKjyjww57Fz71nZPlGFNQnPadx0NlR1BtXLumjC1yo067zq5qiRNIh5AUU7BrvVk17lEIIWgw1+KQay/mkvNIKUjlTklpfLR4Gp22NtSbire4yScZSUQmh1gVAaBnuW3kSv0ahhC49Va49B3YbW/CM1UHMRabx3sLV3DGexMRYfWm7+FMHO/M9WIsOofvtX8O3faGddVxV0u9y2zCGiO9Sj0gIQRcgRyaVms1vtP6LLps9SVXH5WL6Cr91FjCqK6X0rM6vFhzBOUGdev3uymUI5yLr9Q/iOdqDsOmMylOcV2PgrrYlYay9Q/KwUJyEYLCQlsNQKACzvt7i23GpkEBnPad3/ZNnQkhqDPVYKe9W/Yusjftxye+c+um/3AMV9Twf7nBA6JiUgukg0iKW7MRp4ZGvuAYDkc9h1BnUq4qNh6fwsfes4rraUuVpJjOUl0DlpTmeEa3nQJTWRAQGDk9qo1uHPF04U86v4S/OviH+HrTY3Dx1lWdD4GKGIhM4d/3/xhzSf+691IDy+d0uGKb0BQ5LuRWbNURVnFvytuYOAPMq/zlityMxxYwFfeCY4q76SgXXyp3Dy6nXn0EhmCpFkvP6vLyl68NXB1hV/0sTasIcbw93wueYfPuSAGFjEwRwK13wcQaERdX3y3JxULKh4wkaOpdCrkeGkAwU9gGd4XmavA6omIMVs5SbFM2FQOrxx7HTlwKXMV8Sl6DgXfnP8Jj5Q/Brc/uPXEbjhR3t82ps8PCmeFPK1vQBTIhJMSkNido3NMQEFToy/BQ2VFMJWYVbTDc3mzbae9Gj62jpNOX5BATk4jmiMTYdCboWd22SWdcC0IICAj0LIM6owffanoSX6p7EK9Pn8E785cxFfcidVcqGAUwlfDizwd/iX+745+t2U/IwhlzShZFhPiSI5bHSxzN5F4n2nQmVa9DAPz82H+fc6EtUgmvzpzBXw+dWOGQx8UUXp85hx2ORjSYykv+XpNL9psAKNM7tt33//N1x/Cd1mdX+T4m8N2Lf4Hx2Mq10mR8Ef80/iG+2fRE3iNkBZs9CQgYMKgyVCgeGxWiWEx5N8Gq7QsFxRn/BcW9pbYaCSmJq8H+YptRENqszWizNMuOJIWFKN6e/2DN7wBH2CLr+QG1xirFYxJiAospr6LCew2N7QghBEfdh9BmUd67ZS65gI8XTyMmxLf0vYJSinA6hmAmu5WHk7fCoDKSsZUhZEn+3K4z4asNj+B/3Pk1fLHuflQacm+unfMNrNtPyKoz5nS6falIXmy+E286+5wEgJO3bMgxuH1d7vzj/0astAAAIABJREFUGBaHXR3Y6WjKOveN8CTembusWkGwUFBKMRKdy3qcgKDG6CqCRYUh1+dp5Yz4euMTWdFGkUp4e64X/eGJvNtR0K0ohjCoNlaqGjsQuZVna7Y3wXQIN8NDxTZj08lIAnoDVzelALbUMLIG3F92WFGj4k985zCfXD2SxTGcqjS7fKK2ZmMkNq419NbQAGDijPhCzbMwMsqLxM8HLuNqqH9Lp0sLVMRcMpgzNazS4FhuKnvvwhCCelMZvtH0OL7b9jyqje6sYwQq4cTMeSTWaIju5q05U6SCmVhWxGujLKaCWY8REFQaNscxqDK68XjFnqXI1x1QULw6fQY3w1Ml/RvxpyOYzxWZIgStluoiWFRcjnq6cMTdlfX4YiqE16fPIZiW31JCDoV1pqDemboRubWld84KTX94EBEF/Ue2KhQUE/FpLKzhMGwnumzt6LC2yD4+mA7ig4VPVn2eI1zRI1Nq6j0AYDg6ptVSamgs02ppwsPlxxSPS4hJvDz9q4I0aN8sYkISw9HZnGuEKoMbFgUbUNsZA8vj/rIe/EHbszmdoumEF+OxhVXHl+vt4HL0lBIkEbMJf15tnYpnZyMRsnlRFoYQPFC2AzsdjVnRqWAmih+MnFTcJLuQ9IcmkMzh0DIgRVXQKwaEEBhZPb5QdwxufmU/MIGKOOu/iYv+IUh53IQvcGSKqF443YqMbFtVunwjUQlXg9eRWmOHaTsRzIQwGB0u6V2jfMEzPJ6tOi67gFKgIi4Hr2E6kR3+B0ojMtVorlM1bjw+iaSYuic+dw2N9WAJi+OVj6DSUK547HRiFq/OnNySvyVKKUKZGK4FR7Oes3BG1JvLVMtCb0dYwuCQqyPnrn1cSGEourpibKXRtUqtCcXwGuOUEhOSWEyFsh4nIGi2KE8Ll4uZM+DrjY/lrBvrC43hVzOlKXhFKcUZ382capYN5gqUGdS1JdrKMISg3VqDxyv3Zm0XB9JRvDl3AfPJYN4+z4KuoggIyvUeOHXKJRaTYgp94ZubYNX2Yz61iMnEjOJ6EpawJfGnVF0uKsRwKzJc0rtG+aTD2oodtuwb4WrMJxdxwd+bczOi2DVThBB4eBfK9R7FY9NSBtfC268htYaGKgjg5p14qvJRVY3M31s4hcHI0JbLAJFA0Rcax0wyOzJSaXCifgsIBxQaHcPhaFn2PSQjifCvoggHACZWj5ocKYIUQF9wLG/23YpMI5OjzxTP6NCyic4UAHRYa/Fc9eGsu2JaEvDzyY8xES+9LJiZhB/94Ymc5Q5HPV1Fzz4pFiZWj4fKduZ0wM/7BvGp90beSkQKul1DCIGJNaHeVItAKDsfdi0oJJz392KPY8e2UyXJNyPRcfjT2bmza2FkDbjfc7gkFJ2imRg+9Z2XfVOnoJhKzGIhuYha0/bPDSYgeLrqcdyMDCElrR99TEopXAv145BrH6qMKwVgWMKCLWLfhyUbOLRbWrCgQmTmrO8iHvIc3QSrNDS2FgQEOkaHXfYedFovK958TIpJvDpzEr9vrIRNZ11/QIkQycTxy+kzWY8zIGgyV6DBrK4ly3aGAUGtMfu6iJAQWyOjhRCCbns9rgRHsu7OfeFxJMU0DGuoAcrlemgcQg5nqt1WnZfzr8eX6h/AGd+NLMdpLhnAq9Nn8K3mJ2HicstvFxpBEvGxty9nvZSR5fFAWU8RrCoNCCFot9XgmKcb03HvijRICRQ/mfwI+5wtaDRXbHjDpeCxbxNnRIO5FldCa6vG3A0FMBAeQjgTgV1n2xzjtgEpMY3R2DgiGWX1Uu2WVnyz8aul4UwJMVwPDyCYyQ7zr8ZMYg7TiVnUGKu2/S4kIQQtlkbscnThvP+yrDEjsXHcjAyiTO8Gd1fKi57Z/JvTWnAMi3ZbKz72nVU8djAyDH86ALd++6oVaWgoodzgwVHPQUzEpxEW5KusUVAMRodx1ncRj1Y8ADZHbUwp8ubsRQyEp7Iet3BGHHC1wazVS+UkZ+ojpZDWSXva72rDP41/CNzlTi0mQxgIT2G3U7mq5J2kxAyuBkdzqucdzZGamG8IIXDzVny5/kH8x8FXVwhrpCUBn3iv46CrDYfcnes2OS4EE/EFnFroy9mwd5+zFbWmsm2/JloLntHheNV+nPMP4mZ4csVzswk/fjj2Hv7b7i9DpyKafycFXznrGR41xirwKhZwoUwEN8KDm2DV9sGfDmAsNqE4xe+we19JOFIAYGZN2GlXNmlGhChGYuNIyojUbAdMrBHHPIdhZOUtFBJiEud8vTkXVzzDFzXay4BBvakGRla54lZSTOFS4OomWKWhsTVhCYt9zj1oszYr/l1HhRg+8Z3DdCJ/9S+byZXACH46eSpnFkO9uQxHPN1FsKr0oVjqDXU3DGFgWify022rh0Nnzno8IaZwarFvwzUoQ9EZTMa9WZ+pntHhsLtzQ+eWC0sYHHZ3Yr+rNeu5uUQAb81dQiCHdHuhiWYSeHP2Im5GsjcTjCyPp6r2FySSV+rUGj14ofpwzg2Ej73X8fHi9Q2/RsFXzwxhUKb3wMMr30lOiHFcCFxBJs8SnNsFSikWUl5MxKcVjeMZHvucuzfJKnUcdu9XPGYwMoRIJlqSBaL5hhCCZnMjumxtssf0hW9gJDqepWBT7MjUUi8UG2qNylM0JUg45T2DlKis6a+GxnbGxlnweMWDsHDZi971GIqM4oL/MlJiqmTrpyilGI8t4K+GfpVTqEBHWHy+9hjsd8lcaywhUQlDkZmsx3mGg0e/tliBcVkR8G4yVMTl4AjGYvOq78EilXDGexMLOWTR9zlbUWZQXm+vBkIIyvQ2HK/cl+U4SqA4tXgdVwIjRW3JIkgiPli4hl9On0Y6h/DEQVc7umz192y91J0whOB41X502eqznkuIafzj+AfwrVErKOs1NjRaJVWGClW1LRIoRmPjGIqOluwkX0zSUgZD0VHFkui77D0ws6V102m1NMGt0OEejo7Bm/ZtkkWlBcGScMNexy7Z0SmBijg59x5S0krHo9iRKQCwc1a0W7N3AeUwl1zA5dA1bU7Q0FiGEILd9h3Y59yleKwIEe8unMJUYubuTK6iQymFIIm4FZnG9wdexo1Vmm8eK+vGYxW77+n0prVIiGmcyrEbb2R5NFkqcoz4NQQEx6v2QZcjDXQ8toD3Fq7kXNyvB6UUtyIzOOsbyBrPERaPVuyGkdUV7DNlCIP9rjYccndkOSQpKYO/H38X/lSk4Ju3lFLEhCTemL2APxv4BRI5NhIrDA48XX0AZXq79htYhmc4fKf1WRhybB6Pxebx8tTpnHV6cimKM2XXWdFkrle1I76Y9KI/PJBTAvJeJy7GcV1h0TEBcNC1pyRyf29DCAHP8NhlV5aikaECrgb7S75Teb4ghKDH1oFGk3xp8evhAQyEVzbALnZkCgAMrAEt5kZVO+kxIY6L/iv3TCsADQ05EELwYs0zcPNOxWP96QBOzL5TUmnTlFIEMzF8uHAN/+fAL3AxMJTT12uxVOH3Wp4p+gbRRpGotG79khoykoCTcxfRn8MRrTA40WxeWy2PEIJGcwUOutuznktJGbw3fwUXA7cULUxvy9u/OXsBt6LZmTU77A3YYW8oeB2fXWfGE5V7UZ4jIjYSncPPJz+GVMAdh5SYwVB0Fj8YPonvD76CTI61joHh8UTlPuxztmmO1F20WavxTPWBrLkhJWVwarEP/eEJ1c5xUZwpQgg6rW2qhCQyVEBvoA+zCfWh5O0IpRSLKR9Go+OKxjl5B1otTSV34+EZHj32TsWT58XlNNB75btRYSjDbscO6Bl5ykIUFK/NvoX0HdEpnuWLPukSQlBnqka1QXlTbwkSBiPDGIzcG73GNDTkUqEvwzNVxxW3mwCAc/5eXAxc2QSrlCFSCTMJP96Z78V/uvU6/mzwZdy4q5D8NvWmMvxuy9OoMrqKPqdtlKHIDH41cw5Xg6NI5imNOSYkcWLmPH449l7WcyxhcLxynyyVOgtrwJOV+2HPUTs1GV/Efxl9D5eDw7KdwYiQwE8mT+Hk7MWs1DkbZ8KjFbsLluJ3N3scLTji6crZ2/H1mXN5lYTPBaUUSTGNq8FR/GjiQ/xvN36Kl6c/zRlQYEDwUPlOfL7maM5eWfc6HGHxbPVhNJqze/FNxBfw7lwvwpnsWkJZ596ocWppNNej3FCmSg55LD6BC4HLqDSUQ699YQAspUBeCV5XvJPYaW2HlbOU3I2HIQQ1xkpUGsoVFUPPJOYwHp9Cp8qUsa0GQxgc9RzER95PMbNKY967GY6O4UrwOg669gJYikyVwqdfbihDvakWQ9FRxQIqiykfzvovodFcv6VknTU0Npv73PtxKXBFcdaCQAW8PPUrdFpb4dFn9xbKN5RSiFRCUkojmI5hIRXEeGwBtyLTGIvNYzruQ2ANldoaoxvfbH4C+52tspualzJj8QX8cOw98AyHOlMZdjga0G2rR6u1BmZWr+ienZEE9IcncWLmPE57+xHMxLKO6bLV4dGKPbLOxzIs9jhbcNTThZOzF7OiM9fD4/j+wCt4ruYwnqo8AAefO+NApBL6Q+P46eQpnPUNZKWsMSDY42zBMU9P0Rov61kdvlz/IE57b2DuLvnxiBDH34+9i39rroBtlfeoBIlSZCQBUSEBXzqMmYQfI9E5DIQnMZPwYy4ZWKEueDePV+7F77Q8mdcmvRKlWEyF8hZ/I1i6pg7ekqczKnhtQlBvKsNTVQfwg5GTK9JJRSrh/YWrOOTuxH2eTsVzSNGcKT3L44BzNwbCQ8hQZYISIhXx7sJHOOI+gCrDxvXhtwMSlXDef0nRGAKCbls7TCUoHUtA4OQdaDLXK3KmJEg4679wzzhTAODhXTjmPoSfTb0mq24oLaXx7vxH2GXvgZ7lwTN6oATcKR3DocfegfOBXoQyyopBpeU+dIdd+7DT3q3NCRoaWFo8OHQ2PFHxMEZiY0iI2fLJazGXXMBrM2/hm42/sSm/qf93+E38w/j7ICCgoKBUgoQlp0qQRKQlASkps26hf5XBhT9oex6H3R2qF92U3jl7Lv0vkVLEhSQiQgKhTAxTCS98OVTcYmIS/aFxUCrBpjPDqjPCzBqhY+5ckC3lfyi5jgkxjdmkHxPxBVwI3IKB0cHKGdFsqUKzpRIN5grUGt2w82aYOAOMLA9JkpAQ0whmYpiKL+JWdBYXfIOYiC8iKsQh5LiWNp0Jf9j2AiycfEVVh86Mz9UcwWBkGsPR7Hv0RHwR/3nkLbw5ewGHXB3Y6WhEud4BjrAIZ+IYic3ivH8QA+FpBNKRnOlyVUY3/lnDI/Doi9sOp9rgwm80PITvD7yy4nEKoD80gbfmL+Gl2vsV/0aC6Sh+/8KffxY5lqgECgqJShCohIwkfPYbWAuWMHih+j58o+lxOPPspESFJP7Ntb/P2wYFAXDI3Yk/6fpiXs6nFJ7hcMTThdPeG7gcHFnxXDATw08mPsJORyOsnFHR51k0Z4qA4AHPfTgx+46q6FQgHcRPJ3+Jb7d8E3q2NJqnFZOJ+NRSwbACyvUe1JqqVaWAFAIrZ0GzuQFnfReRofJr5M77L+OrdS/dM1FLQgiOVz6Ct+c/QFCGE0JBMR6fwuVgHw659sLAlkZkioBgj2MHaoyVip0pYEke//XZt1BnqoFDpxXeamgAS7+rDmsLDjj34mPvGUVCLRIkXAxcxl7nTuy29+T9NxXMRBFU2BPxTowsj257A/5VxxdQY3RvyL7h6Cx+PvUJxmMLiGRiCAsJxIQkRCphKVtt6brlWvTPJ4P4y1uvL8+jBIQsRVWMrB5WnRF2nRnlBjueqz6MQ+4OxbZRAEkxjeSykzSZ8OKjxb5fz9tk2VFbdkoBfGYz/ey/2RAATt6KP2p/Ee3WGkU2EULQZavDN5sex18Mvob5HAp8CTGNkegcRqNz+MnER1nvaa3volNnwffaP4cOW23R53JCCJ6pOoh35nrRF1pZShETk3h7rhd7nK1oMVcqslUCxWzCr9ouljAo1zvwGw0P4anKJRn0fF8rCgp/HmXgCYBwjshooSCEoMFUjkcqdmMoOouokFjxfG9wGG/OXsQX6+5XtC4q6iraxJnweMVDqsef9V/C+4ufQLxHBAfW4rTvvOIwbIO5FmX6jd2ANhOGMKgz1SpOMYlkov9/e/cdHdd9JXb8+3tvesegAwRAEixgryIpUhIlUbZkS5Zly213vd5mr9fxOnGy3s05KSflpMeOk5OzJ1uz2eJkN26yd+31Uo4sWZQsShRFikXsAIjeMZiCae+9/DEAiEEhZgYACZD3Y9ESHvDevAFn3vzuu7/fvVwYu7xMZ7UyeXUP769+rOCfj2TGeHvkDAljfGK91cp4Dbh0F0crD5fcQO9c5D2O9/6EbBHBtxD3MqUUIUeQQ+X7qCihufVwepRXBl4jkl1c6eClosito9kRXMsXNjzNv9/5K4sOpACG0zHeGbnO+Ugb7YkBRtIx0mYWwzLJ/c+6bbEBa+L7JiaGZZKxDMayCbrGh7g4dpNTw9foXsTAef7Hy2UyDMskaxkYE/89ec7zBSy60mj21fGljc/yYOVWdE0v+neolOJo1U6+uPFDNHmq5v0UseDWuU78me+8NBRN3iq+0vI8h8o3r5jxiUOz8em1x/DNMZPnWrSbn/SdmbOy3nKwKZ16dzlPVO/hX27/BT5c/yBuW3FTP+9nudftDrYGGuesF/CNtpfoTAwUdcy7npI4UnGASkdp87EtLP66+0ecj7x3Xy88T2THOTN6vqh97MpOk6expCIgd9IaTy3Vrsqi9jGsLKeG37nvXhNHKg5Q7Zy9sHIuFhaXo9e5HmvLrZlaQdfgfWW7qXPfvqLU7fyo9yXeGj5z3/39C3E7WwKb2BXajq3IGxUWFhcilzkzcp7sXayi69BsbPDV8f6affzGhg/yz7b9HM/WH8J1B8tl30kBm5uA3bMst7kqHAGerjvAlzc/x6PVOxa9Hulo1Q5+q+V5HqveRcBWepsVn83F0aod/Pbm5zlcubKma2tKY1uwkaNVO2YNwDOWwUt9Z7kc7VyWCoyQyzqWOwLsD2/kU01H+UrL83yl5Xm2BBtXVDXm1SLs8PPRhsN455jaOpqJ8adtPyaRLbwGwV2b5jcpaA/wePXD/FXHCwv/8BxG0hG+0/kDPLqHjf71S3x2q8PV2A2G0yML/+A0IUeA9d7GO15qtFgBm5+1nkYuRi6TLnBtnYnF9Xgbw+kRyku4E7sa5e4+hzha+SD/t/N7Be0zmBri7Oh5mldYNUevzcMHao7xezf+V0n7J80U3+78a9y6iz1lO5b25IRYpdy6iyeqHuHc6EX6UsXddY1mY7w88BpbApuoclUs2/VCQ2HXbDg0G0G7l7DTT7UrRJOnigZPJbXuMDWuMEG7Z0UNtJfD1mATX978Yc6NtnFm9AbXo92MzZiSVAyb0qdKmu8v28jmwBoCS9TUWCnFztA66j3lvFN+nVcGznFq+ErBmRq7ZuOBso0crd7JvrINVDgDaCuwiIjf5uFY9W7eHW2lY0bmomt8iO91vcEmf/2cA/RC2ZSOQ7PhsTkps/sIOwM0eCpo8lRR5ymn1hWm2pVbe3avvweW2/7wJo5W7uAHPW/mbbeAk0OXeXXgAk/W7i3oWHc9mNLQOBjey6nhM1yPtxW9v4XFtVgr3+36Ab/Y9AlqXFX31QvMsizeGT1HeoEFijOFHWWs8zYt01ktHU1pbAls5OWBE6QzhT/H0UyEK7EbHHKU3TevB7uysTO0jRODJ+lOLlzZz8TkzeF3qCoy83cn7A/vYttgS9EVyCb1JPv4dtdf47N5c6X/75PXgBC30+Cp59Gqh/hmxwtF98e5FrvBa4Nv8mzdk9iKzGQ8W3eIRyp3sHAXYIWGQimFTWnYNB27ZsOlOXLZE8WyBXI7Qk18bfdnl61PoaY0QvbCiwME7B72lW1ke3Atz9YfIpYdpzMxxI14D52JQfqSowynokSzCRJGirSZxbQsNKVwanb8dg8VTj9r3JU0+2rZGmyg2lWG3+bBvQxrazSlqHQGebx6FwfKNzGQivDuaCvnIu10xPsZSEVIGCkMy8StOwg7AjR5qtgWbGRveAPVrhB+mweblrvBu5iZBV/b87k5+1y5NMe8x53++5j3Z4CdobV8dfdn5xxzOTQ7rjnWamto/I/9v5krpDLz0Gr6JPtbRUo0tIn3gA2nZsOpO7BNCzAL/fsr5PeolEKh+E+7P1vQFHnTsugYjvD69Ztc6O6jYyRCNJnCME18Tid1oQBbait5aMNaNlaXz3jHKjwF1DmYPO9dofX82cGvzPp+LmurFnx+t/s9OTQbv7Hhg3yq6ZHZ+6EIzFH6fz53PZhSSlHlrORY9SN0tvWQKqFJoInJmdHzuHQnP9/4McrvowF0JDPG9VhrUevGbMpGs2/tqikhvcm/gaA9UFBxhUmxbJxLY1c5EN6DzsrOvi0VNVFOfl/ZLnp6+gpaaD6YHuKFrh8WHYwvN4/u4SP1H6Q13k7CKP5urIXF9Vgbf9XxAp9u+jiNnnrUxCBNiPuVpjQ+UPM4rw2eLLpgkWGZ/KDnOAfCe6h31xb1Xgo6vASXoHT0cnLrTuo9K6uYlVIKl+7ApTsIO/w0eKo4VNEyUXlwotDExP9PH1Pm/mpuFaXIDc7Vsgajk2yaTsjhI2j30uyr5cP1D95aITVRMXHy/LRp5zbz9fSrf/ptTt8s7jVaiqDbxXe+8AtU+G69Pi3gZGsHX/nmD6e26Urjw7u38Fvvf5had3EzXpRSVNhC/PGJU/zhibemtnsdDv7JB4/yzM4teT/fE4ny73/4Mq9cbZ11rOd2b+XLTxyhzFN4Fea32jv53J99d9Z2l83Glx4/zKcP7c6NHzzzL7mxLItUNsv5rj7+6MQp3rhxk6yZayyde+0pQCcVyzI8NMzFGyN8741r7Guq51cO72P/2jU4bcVl01673s4X//f3F/w5XdNw2WyE3C5qgj7WV5azq6GWvQ21hDxuXHYbmtLmXM6wVNemux5MQa5nwfbgFnaGtnJq+ExR1YYmWVj8bOgU0UyMX2z6RK5K3QpMEy+1a7FWRtKzq+jcjlNzsHMZKjMtF5fuZHtwCx2JroLvppqWSed4NwOpIWpcha0juhe4dBc7Qlt4a+QdepP9Be0zmoks81kVTylFk7eBhysf5MW+lzEXKI08nwtjl/jj1r/g5xo+yubAhvsmsBZiPg7NwScanuN3r/0RKbO4BfMJY5y/7Pguv7nhs7ikiu4dpdRkGJSXylixJrMdWonnmskapLPLX1wsnc0yV3IjkzUYjt+6kacpRTy1uAIThmnmPSe7lsUwZz+4ZVlkzLmf/7WBIeKpdMHBlGlZnOvom/NYCrVg2wEA07TojozxFyfP8M1T50ikb3/z1SLXVsDIGrx+/Sbnuvr4+L7t/PzB3dQG/QWv8TItq8DXgMF4OsNIYpzWoRF+dqODb5w8g9fp4OENTTy9s4U9DXWEvcWVOy/Giok2KhxhHq44RNhRtqjjnB+7xO/f+FNODZ8lsYj5xatB1sxyPdZKJFNc2coyR4iNvtW1vuyB8B60Itd39Yz30pnoLik4X82avevY7F/9jSu9uofD5QdocBdXsnema7FW/rD1zzkxcJLYXSzJKsRKoJRie7CFB8r2lLT/2dELE9Vj76/rqhArQfvgKLFUuuBpkJYF57oWnvY///4W7UMjfO34Cf7PybMLBlJziSZT/Pkb7/D1F0/QORK5Y8Wh4qk0P7pwlX/y3eN89firXOzpX7bHXjGjLaUUO4JbebTqCHZlX9SxbsTb+bP2v+Q7XX9DX3Lgnq3qNZKJ0JboLLoM9M7g1hXZqPd21nmbqHJVFLVPJDNGW6KDtLGyprAtN4/NzcHwPvy2O99hfCkppVjnbeCJ6kcW/Vx6k/184+a3+MbNb9Eav1lypkuIe4FTc/BY9UNUOYu7pgJkrSwv9r1MV6LwZupCiKUxnEjQMxot+FaGaVmc6+4r6bEsy2IsmeJ3X36D/3fpGmkjP0vk0HW211XzqQd28uUnjvBb73uIX3toP0c3rcPvyl87ljFM/vb8Ff7LiyeILSLDpwBdU3l/FhJNpnjhzEX+zQ9+wrmu0n4XC1kR0/wmuXQnH6g5RmusndOj7y7qWEPpEV7se5nL0Wu8r/pRDpc/MFW57m5Nb5sZ1A2mh7kYucw6byON3jVFH6sv2U9noquo/RSKg+X7itpnJbArG/vKdtE9XvgdFhOLq9EbjFVGqdDDK6pi3XLbFtxMs28tp0feXdX3j+2anSMVB2mLd/DywImCpiTMJ5qNcWLwDW7E23m06ghHKw7j1nNVl1bKNWEsG+VC5DIBu4/twS3z7CXE4mhKY523iYPl+/hB94uYFPe+6kx08/LAa3yy4Tns2uJufgoxl688+TCR8YXX0JuWxX/+u5/SOnirorEC/sPzTxF0L1xVz65rBN0re8qq06aTmpjuZllwqW+AhzY2oekLz9bpG4vRN1Z6093/e+ocL168RsbIv0bUBv18/pEDHG5uJOB24bTZUAqyhkk8laZjJML/eOUkr1271eTYtCxeunSDdRWn+PuPHy7pc/d9Wzfy9x49OPW1xcRjptP0RmJc6x/ktes3udTTP2vsc7ajh6+/eIL/8PxTVAeW9mbzigqmIFcW+dfW/QKdF7vpTw0u6lhpM8O1WCtt8Zv8Xe9LPFf/QbYFWnBodvQ7VFbSsiyMiUZ6GStD93gP5yOXOTN6jpuJTizg8+s/U3QwlbUM2hOdDKaLawJY7apk/Sqo4jeXg+F9/E338aKml1yL3WAkPUqFI7wq5pkvFYfm4MmaY7w7+h6ZAkvKr1Ru3cWnGj5Ca7ydG/H2hXe4jaxlcDPRyTfav8WPe1/h2fqn2F+2G4fmuGOlZi1rsrGnQcbMMpAa5HzkEmcjF7gWvYFpmTwbMxr1AAAcyUlEQVRT96QEU2JZuTQnB8J7OTf6Hm2Jm0Xtm7GyvD1ylh3BrewMrqx+QOLesGtNbUGf9IZp8nuv5AdDSikOrltDpb+wAfNKf/XuWFND28AIg/EEAO/19GOYJvYCgqlzXb1567J2ranhUu/AVHB2O21DI/zBT9+clZFaUxbg6594hi21lWgqv3iI0wZep4NKv5f/+sln+I8/eoXvnr6AMXHjMGMYfO/Mezy0oYm9jfVFXzuCbheba25VIJ5+Q9K0LExrE1987EHebu/iq8df5Urf4FTvLws429nLd06f5/NHDy5pf64VF0xBbk3Pr677Bf7gxp8V3T9pLlnL4Ea8nf925fdp8NRzqHw/24ItlNmDeGwenJpjSYpVTA6SkkaKpJFk3Egylo3SGmvnWqx1oh/UaF4woKOXNPc8no3z3tiVovc7GN67KgtzKKWocVXR6FlDe6Kj4P0SxjjvjV1hnbcJe5HNKle77YEWWgIbOBd5726fyqL57F5+ff1n+PrV36MvWVyPnLkYlkF3spffv/6nvOD6IYfC+9gZ2kaFM4xH9+DWXUv2PjGtiWuCmbsmRDMxOhJdXI3d4GrsBv3JgbzCKgq14qYhRrNR2uOdq24dnlN3EnaU4ZDsySxKKdZ7m9hftpueZG/RxSh6k/28Pvgma70NBOz++yrzL5bfrYIbt2fO88pTSt0zzWzH0xm21lXx06ttQC6YyhomFHBZO9t5azaPx2GnLhTkav8QcPtgKmua/Mlrp4mn868LAZeTf/Pc+9leX33b/ZVS+JwOvvT4gwxGE7xy5cbUp1x/NM53Tl9ka201bsfirs3TgzFdKXTArsPh5ka+/smn+Rff/zFvtXZOPfZ4JsPJ1g6e3tlCYzi0qMeebkWOLpVSbAls4mNrPsS3Ov96SQIqAAOTtkQHbYkO/D1+1vsaaXDXU+uuptwRxm/z4bV58No8uDTnvNkr0zLJmBmSZopEdpyEMU4sGyeWjTGaHqM/NUhfsp/eVD8DyaGip1AsxLIsRjMRrkZvFLWfXdnZU7Zz1X7o2TU7u0PbiwqmAE6PvMv7qo9i0/RV+9xL9Uztk1yOXidd5EBpJWrw1POZpk/yF+3fpCe5NPOeLSx6k/280P23vNj3Ck3eNTR41lDvrqHCUY7f7sOr564Jbt09b/Yqd03IkjJTJIxxxrPjxIwE0UyMsczENSE1QF9ygP7k4KrLFp4cepszo+fv9mkUbYNvHZ9u+jh17pq7fSorkqY0Hqk6xNnIea7Givs8AXh75Cy7Qts4WL5vxTeAF2K1SqQzPLyxeiqY6h6NMhhP4HXevl+YZVmc67y1trEhHMRtt81ZvXCmtsERXrvenl9yH/i5A7vY11h4UagKr5dP7N/Opd5+esdiQC6b+G5nLxd7+tnXtLgCU/NRStEYDvHpg3toGxyhP3qr+FT70Cg3Bobv/WAKcs3PDob3kTLTvND1QyJF9BgqRDQb5ezoBc6OXsCu7AQdgVwwNTFwculO7MqOTbNh12zo6BiWQdbKkjLTpM00SSM3cEoY48SzcaKZGMkS+mQVy8TiUvQaY9ni5sE2etdQ7axctVMybMrGlsAm/q73paJ+z63xdnqT/bkmxavzqZdsg28dO4JbeHvk7N0+lUXTlMb24BY+tuZZvtX5/SULqCbFjQQXx65wcewKutIJ2gNTN1h8U8GULXdNUDZsyoaBgWEat64JZorxqRssCWLZWEl9slaatJUhnV1dASDkMtPF9OC7H1U6K3iq9hit124WXcwobiT4Qc+LtPg3UuYIrdrPFiFWsvFMhm21VShyU9VMy+JcVx9NCwQDw/FxOkdujZ0bwyGcdltBs6FOXGsnksj/7GoMh3h6x+aCij5M0jTFzjW17Gms42/P35pN1TEyyrudPexcU1PQdMVSaEqxra6KTdUVecHUUDxBbySKZVlLds1ascEU5KqSHa08jK50/vLmd5ZtUJKxMgymhhhMDc36Xq5PgpbrtIyFZZlFd45faqZl8Obw6aL32xHcMrXgfjXSlKLKWUGDp76ou6gZK8upkbO5YOo+kmv46OTRyoc4H3mv6Gk8K5FDs7M/vAulFP/n5rcZmOM9uxQMy2A4PTJnVnz2NcFa8uyzEHfS/rJd7Ant4K2Rd4retzV+k+N9L/PJhueW4cyEEMlMlpqgnzKve6r31bsdPTyzY/Nt97vaP0gye+sGSWM4NNFk9/Zj2FQ2y7udPbPKoB/Z0ERN0F90AFLmdbOnoY5Xr7ZNVfJLZQ0udPczmkhS6V++ht5VAR91oQBKMZVlyxgmw4lxMoaBw7Y0YdCKnwDv1l08VvkQv9H8y3j0O1/O28KaykgZlnHXAymAkfQoV8auFbWPS3OyydeMQ3Ms/MMrWNAeoNm3ruj9fjZ06r4c8Cpy5cXvpWIGDs3BgfAePr/+l3KFRe6w2deE++91Je4tdmXn4w3P4i7hM9bC4njvT2hL3JTeU0IsA9O0sOsaa8tv9WE927lwa4JLPQNkJgpNeBx21pQFAIs5+gTn6RoZoyeSX37doevsbqjF6yx+DKkpxda6Ksq9nrztl/sGGZooqrFcbJpGwOXCpuWHO+PpDFlz6T67V3wwBWDTdPaX7ea3N3+Rdd4mbPdZIYGZfjb0NkaRA7gmb0Oup8gqn4Xh1l2s8zYW/aE/mBoqaU3AaqeUoswRYl/ZrlWdlZxJVzpbA5v5xy1/n83+jYvuTSfE/WyywM+TNY+hlTAsGDeT/FXHC4wbyWU4OyHubxa56XLrKm4FU62DI0ST8y93sCyLS70DZCYq8YW9HupDQVIZY8HMVE9kjOEZQU5dKJDL8JT4HNZVhAl58scgHcOjDMcTy94L1qZrs7JpmlJLuoZ+VQRTkLvYb/Jv5AvNv8yRigP4bMuXFlzJMma26KkYCsVab2NuTvsqj6aUUqxx11Ljqlz4h6cxLYO3hoqfwnIv0JRGi3/jPTfNUSlFvbuWL234LMeqHybsWLrFpELcb2zKxpHyAzQV2aZj0tXoDV4bPClr1IRYYpZlYdNymanJmCBrmFzqnb+ybWyi19NkSfJyr4f6UIC0YSyYP+6Lxhkdz78xUh3wEfZ6Sl5jVOZxUen3MX33VNagYziypBmimSzLIpZKY8zok+V1OrDpSxcCrZpgCnKRZIOnnk81fIRPNjzHOm/j3T6lO+5moqOoxrWQ6921ztN4z2QmalzV1LpqigoMTSwuRq8QzZTevG41q3JVsCu4FZd2b7wGJimlKHeW8bE1z/Lzjc+zNbBp1ZXvFmIlUEpR5ark4YpDJX1WJIxxTgycpCux8PQjIURxLCuXHfI7cz21DMvkQvf8RZg6RiKMTWt6XOn3UhP056b93SYTZFkWI/Fx4qn89VLlXs+imhsrpVhTFkCfMd3u5vBorsz7MokmUwzG4lNBJYDbYafC55019W8xVuWoI+QIcrTyCH+v+Vf5cN0H8NuWtpPxSnZ65BwZs7iqWhWOMGu9DfdMpSW37qLZ14RLL+6NPZIevS+n+kFuWtyh8v1UOO/8GqM7wWvzcDC8n8+t/wyfbPgIIXvwbp+SEKuOQ7Ozt2wXzd61Je3fGr/Jm8OnSRrLX9VWiPuFBWRMk+qAj6pAbrxrmBYXe+bPTHUMjTKWzGWXHDadpvIQbruNrHn7lf9pwyAynsSYkS0KuJ0lrZeartrvQ58xDu2JxJY1M9U+PEr7UH4hqWq/j/qywJKOiVdlMAVg12zUu2v56Jqn+adb/iEPVRzErbtX1TQ2BeiahirwryFpJLkwdqmo8rUKRbWrijp3bYlnufIopdjs31j0VM94Ns7FsSvLPj93pap0VtzT/WBsmk6Nq4qnao7xr7b9Dk/VHMNv862qawLkAt+Zd++EuFMqnRUlT6XPWBl+OvgGneNd9+11VojlYJpWLpiaqHxnWhY3BoYZT8++uW5ZFjdHIoxNrKly2+1sqq5AKYW5wPsynTWIp/Ir/2pK4XM5cSyyhHnY60abMXNkJJFY8JxKYVkWyUyG16+3c7Uvv+rvhqpyNldXLOnjrepPbKUUdmWn0bOGLzT/Cv98yz/i0aojVDorcOuuFTmI0tDw6G4qnRUcCO/jSxs+x56yHQXtey3WWnQDY5fuZGtwM7Z7bAC91tNApaO4N0PWMmiPdzC0RE2gVxulFE9UHyVg99/tU1lWNqVT6azgM02f4F9u+x0+WPsEda4aPCv0ZotC4dZdlDvK2Bncxq83f4anqh+/26cl7lOaUjxY/gAbfetLer8MpAY53vsyCWNcAiohloKVCw4q/V6qA7dmYsVSqVlZF8itReociZDM5G68u+22goOHjGHOKolu0zQ8dtuiMzlep5OZLarGxpOYC5UXLJJlWUSTKf7uwlX+5LXTeZmvCp+HJ7dtJOhe2iUPq74s3uRfrkKxztfE57y/SF9qgHdG3uVy9Bo9yX6GUsPEjeUtv3g7Ds1BmT1IyBGkxlXFRt96tgQ2UeuuLvjDyrRMrkZvMFbkmh+P7mZbYPM9M8Vvkq7p7CnbzuXYtaIWPPcmB+hIdN2z090WErT5eaLqEb7Z+f27fSrLZvprvc5dw6ebPs4Ha9/HmZFzXBi7TG+yj4HUELFs/K6VcrYpGyF7kDJHkCpnBRt862gJbKLRUz/rzp0Qd5pTd/Js3ZNci7USzcaK3v9nQ6fYW7aTg+F9y3B2QtyfnDYbDWUhXHYbyUyWeCpD69AILbVVeT83HE/QN3brfRv0uGmaVlb9dkzTnKoAOEnXtCXpx+R2zA7IEpnsoloOWZaFaVlkDIN4OsNIfJzu0TFevtLKC2cu5mXu7LrOB7Zv4lhL85KPiVd9MDXTZInXp2qP8WjVEbrGe+ka76F7vJfu8R76UoMMpoaWrYSrhkbA7qfcUUaFs5wKZ5gqZyXVrtyfckcYu1b8r90C1vua+Ej900Xt57f5qHFVF/14q8ED4b1AbiFmoWzKRthR2EVl0q7gNjyau6CBt0JR6Swv6vh32mNVD2FThXVBn0lTGuWrMBANO0I8Vv0QD1UepHu8j67x7ql/96UGGUwOETfiyxJaKRR+m4+wI0SFs5zKiT/VriqqXZVUOMpx6neu/9vB8D5q79FrwkxhRxlBe2BZH8OlOThUvp/6IqdSt/g3LNMZLY1N/g38fOPzRDJjJe0v7QqEWHrrK8P4nI5cMJVO0zo4OzM1GEvQG8ndeFdAS00lLnth407TsjBmZIo0xZIUa5jrGFnDoJgP3nNdvXzt+In8Y5gGqazB2HiKvrEo1waGGE3kj/EdNp2P7tnG5x85iNux9Nemey6YmpSbOuNmg28dzd61ZKwM0UyMWDZO3EgwnB6lPznAYHqY0XSEsUyUWDbBuDlO0kjlmnFaJhYWutLQlY6mdJyaA5fuxKU58do8+G0+AnY/AXuAckcZ5Y4yXLoLj+7GY/Pg1d04NMeio2BdaewKbWdXaPsS/YZWv2pXJc/UPbnsj7MlsIktgU3L/jh3wmTfqWfrn7rbp3LHKRQOzcFabwNrvQ1kzCzRbIx4Nk48m2AkE6E/NchAapBIOkIkEyWWjZMwJq8JWYyJa4I2cU3QlYZDTVwTdCce3Z13TQhPXBM8Njdu3Y134rrg0px3LVu8p2xHwVOLxcKcupO9ZTvZW7bzbp/KktKUxqNVR+72aQghpllfUYbP6WQwliCVydI5EiGVzeKcljkait3KTGlKsXtN4Td6LJjzRutSfFzN9ZlnWlZRN3Yv9Q7ctiT8XGqCfj5zaA/P7t5C2FN8Y/JC3LPB1HRKKRzKQbkzTLkzjEUuLWhYxkTQZEwNkiYDqIl/JvafOhIKNdXsK/ffGrrSpgZXGrObgwkhVh67ZiPsCBF2hLCwsCauCdmJGymmZWJiTrvYW3kVZXNv89xEXYU2dV3QJq4HmtLQ0adKtct1QQghxGI0hkMEJkqUW0B/NM5QLEFdKJeBz5omvWNRIhN9opRS7GqoKfj4SuUCsOksWJIiEeYcs4hyRdiW57PR47BzbEszv3hoD5uqK3Do+rJ9Dt8XwdRMCoWu1MQgR6YiCHG/UyiUygVCdrkmCCGEWIEcNp1N1RWc7+rDtCwGonH6xmJTwdR4OsP1geGpZIDf5WRjVeFLD3SlzZqOl1uTtPjy5ens7IbBuQBn0YeexWHT+e0nH+ET+3fkbngu883M+zKYEkIIIYQQYjVRSrGtrorvn3mPtGEwGIvTH41PfX88naF1cHjq610NNUW12rBp2qz1VVnDJJUpvCXPfOKpzKwKn36Xc1Ym7HbqQwG2zii4YQGjiXHOdvZMBX2ZrMHxC1c41tJMpb/4Ng/FkmBKCCGEEEKIVWB73USAZBhEEkl6I1GypolN00ikM9wYuBVM7W2sL+rYdpuOZ0aBBsM0iafTmKaJtohCFGPJ5KzpgoEig6nDzU386w8/kbfNsizahkb4Zy+8yOmb3bltwPnuPv7m3Ut8+tBu7IvskbUQqcErhBBCCCHEMlqqarEbqnIV/QAMy6JjZJREKo1lWfRFYwxMy1Ttbawr6thOm47fld+DyQKiyRTJ7OKyU0OxxKyeUpV+36Kb1CulqA8FeWZXy9R6MoBoMs0Pz1/mSt/goo5fCAmmhBBCCCGEmKDN7C4LpI3Ce1rOZFoWyUx+M1ylVEkZE5fdTktt5dTX7UOjxFJpTMviUs8AxkT2J+x10xgOFXVsTSmCbldedUCA0fEk0WSq6HOdZFkW3ZHorFY2dSH/ooMpyK2RemxzM7sb8isXvtfTz/ELV4lNBJvLRYIpIYQQQgghyPVmcuj5wYQFxFPpko9pWtas/ZVSeJ2l9RicnnFqHxolmkxhWhbnu/qmtm+pqcJpn90o93aUUlT4PHkZHoDBaGJW76ZiGKZF18hYXg8rBawtL8OuL00oUu338uFdWyn3efIe91unL3Cpp39JHmM+EkwJIYQQQggBgMJtt+VVtbMsi+HEOKZZWlU7wzQZio/nbdOUmpquV6zdDbeCqZ5IlKH4OFnD5HzPrWBqa10VjhIyX9VBHyFP/lS/nsgYA7F4ydmdrtExhhP5z7/M46Y2uDSZKcgFgo+3NHNgbUPeOqzheIL/+frbjCVTy5adkmBKCCGEEEIIcr2WHDadshkNXodipWdn0oZB29BI3jZdU4S9nnn2uL2N1eV4JwpFZE2T6wNDDMTidA5HgFyg1lJTWVLWZ00oQIU3vwLeYCxB2+AI2RKDyav9g4zOCKbWV4Zn/Y4Xy2W38WsP7cvLTgH89Eorxy9cXdLHmk6CKSGEEEIIISa47Haqg768bfFUmiv9xRczsCyL3kiMrpGxvO0Bt4u6kL+k8/PY7Wyqrpj6+lJPP2c7eqeCnbDXTX0oUFSlvElhr4d1lWV5mTnTsjjZ2snYePHrpjKGwbmuXoZnZOa21FZR4S8tmLydrbVVfOqBXXnbDNPiD199i7ah0SV/PJBgSgghhBBCiCk+p4O15WV520YTSd5q6yp6qpgFvHTp+qwCFltrqmYVeiiUrmlsr6+e+vq93gHevtk19XVjOETQ7SqpWa2uaRxYuwafK38K4s9u3KRtaKSo529ZFh3DEc529JCZ9vzLPG6211fjdZQ2zXEhn9i/nZaayrxtXaNj/NGrb5FdggbEM0kwJYQQQgghxAS/y0lLTSXTi/ols1nebO0oOqAYjMb59unzeduUgoc3ri35/HRNsb2+Zurra/3DvHqlberrdRVlBN2uOfYszIPrG6n2z87M/fGJU4ynM/PsNVvWNDnZ2sGZjp687Ruqytm9prakYG8hSinKPG5+/ZEH8taMmZbFq9faeOny9SVfOyXBlBBCCCGEEBMcNp0ttZXUhYJ529/t6uV7Z94jmiys1PZoYpz//tLPGIwl8rbXBvwc29Jc8vlpStFcEcY9sW4qYxh0R8amvtcYDs3KLBUj4HbxsX3b86b6Afzk8g2++fb5ggIq07I429HDN06eIZW9lZXyOOw8snEtDUWWbS+Grmnsb1rD41uamR6uDUbjfPf0BfrGYkv6eBJMCSGEEEIIMc3mmkr2NNSiT8uepLMGf3XqXf78jXfoHh2bN6AyTZP2oRH+4NW3+Jtzl/K+p2uKTx7Ytagpbkop/C4na8tnByQBt5P6UKCkHlbTPbOzhW111bO2/+7Lb/C/3zxLbyQ67/NPZrK8eqWNrx4/wfWB4bzvba+r5umdLSxDUipPudfDh3a0UBO8tS7NAk7f7Ob/XbpOapFNiKcrbbKmEEIIIYQQ96iwx80zO1s41d5FTyQ6tX00keR/vnaK0ze7ONzcxLa6KmqCfjwOO8l0lr5ojLMdPbx+/SZnOntIZvIH7Q+ub+TpHZsXHUx4nQ7WV4R5r2cgb3ulz0ttKLC4gwNBt4t/cOww//g7P2IgGp/aHk2m+L1XTvLOzW6ObGhie301VX4vmtIYTYxzfWCYN1pv8tq1djpnFN0o93r44mOHqA2WVnijGJqm2Le2noc2NPHddy5OFecYS6b47jsXObiugebK8JJMNZRgSgghhBBCiGmUUhxc38DPHdjFf3/pZ3kFFBLpDK9fv8nZjh78Licuuw1d0zBMi1Q2y9h4ikQ6zcy8TWM4yC8d3ktNwLfoQfxkMDVThc+7ZMHKvqY6vnD0IF87/irxaVP7Yqk0P7l8g7faOvG7nLnmwEDGMImn0kTGk7PKqLvtNn7nqUfY11S/JOdWiIDLyUf2bOONGx10jESmtl/q7ed7Zy7ym489iNO++FBIgikhhBBCCCFmcNps/PLhvcRTaf7k9bdJZ/Mr8sXTmbwgYz4KqC8L8g+OHebQ+sYlaVTrtOk0hEO47Lap7JcCagI+qvze2+9cAKUUdl3nw7u3ksxk+cNX32RkWp8t07IYS6YYS96+XLoiV279t97/EE9t21hSufZSKaXYtaaWp7Zt5E9ePz0V4BmmxTdOnuF9Wzeyo7560YGtrJkSQgghhBBiDnZd5zcff5B/8aFjtNRU4pko+lAIpXJlwA83N/LvPvJ+PrijZVZRh1IppagKeKmaVnXP7bCzvjK8JMHa5GN4HHY+fWg3//Tpx9i5pgafs/C1Xn6Xk/1r6/m3z72PD+1swWGzLUsFv9vRNMUvHd5HQzi/mMh4JstXj79KoojqhPORzJQQQgghhFh1lILHW5rZOK2BrULhthce8BTCpmk8t2sLexpq+fF71znb2UPXyBiDsTjxVJpU1sCyLHRNw+2wE3A5qQr4aAqHOLS+gcdbmvG7nAU9lsfh4EjzWip8ueyS02Yj5Jm7zHljOMRH926jc2IKm9dh58C6NfMe+9D6BnxOJxYWdl1nY1V5Qedk13We3tHCnoY6fnzxGm/f7KJz4vlHk6mJan0WDt2Gz+WgwuelIRzkwNoGHm9ZT10Ja7hqAn4+tm973rZSpwiW+zx8+YkjvHq1LW+7TdMYiMbxFhEgzkUtUNpxaQuxCyGEEEIIsUqZlsVwPDEVTMVSaVLZLKaVq9TnsdsJelxU+33UlwVx2+98NmY5WZZFZDxJx0iEgWicsWSKdDaLZeVKyvtdTir9XhrLQoQ8pTUOXqHmfSISTAkhhBBCCCHE/OYNpmTNlBBCCCGEEEKUQIIpIYQQQgghhCiBBFNCCCGEEEIIUQIJpoQQQgghhBCiBBJMCSGEEEIIIUQJJJgSQgghhBBCiBJIMCWEEEIIIYQQJZBgSgghhBBCCCFKIMGUEEIIIYQQQpRAgikhhBBCCCGEKIEEU0IIIYQQQghRAtsC31d35CyEEEIIIYQQYpWRzJQQQgghhBBClECCKSGEEEIIIYQogQRTQgghhBBCCFECCaaEEEIIIYQQogQSTAkhhBBCCCFECSSYEkIIIYQQQogS/H9cFdcIQfoFxgAAAABJRU5ErkJggg==\n",
      "text/plain": [
       "<Figure size 1080x576 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "import matplotlib.pyplot as plt #to plot world cloud in thus cell this library is required\n",
    "\n",
    "#convert list to string and generate\n",
    "unique_string=(\" \").join(sensitive_diseases) \n",
    "\n",
    "wordcloud = WordCloud(width = 1000, height = 500,background_color=\"white\").generate(unique_string)#MAKE WORD CLOUD\n",
    "plt.figure(figsize=(15,8))\n",
    "plt.imshow(wordcloud)\n",
    "plt.axis(\"off\")\n",
    "plt.show()\n",
    "plt.close()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 1080x576 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "import matplotlib.pyplot as plt\n",
    "\n",
    "#convert list to string and generate\n",
    "unique_string=(\" \").join(sensitive_drugs)\n",
    "wordcloud = WordCloud(width = 1000, height = 500,background_color=\"white\").generate(unique_string)\n",
    "plt.figure(figsize=(15,8))\n",
    "plt.imshow(wordcloud)\n",
    "plt.axis(\"off\")\n",
    "plt.show()\n",
    "plt.close()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['hiv/aids', 'history of hiv/aids', 'timeline of hiv/aids', 'epidemiology of hiv/aids', 'list of hiv-positive people', 'hiv/aids denialism', 'hiv/aids in the united states', 'list of countries by hiv/aids adult prevalence rate', 'aids (disambiguation)', 'hiv/aids in africa', 'hiv', 'hiv/aids', 'epidemiology of hiv/aids', 'subtypes of hiv', 'hiv superinfection', 'list of hiv-positive people', 'timeline of hiv/aids', 'history of hiv/aids', 'list of countries by hiv/aids adult prevalence rate', 'signs and symptoms of hiv/aids', 'tb', 'tuberculosis', 'socata tb family', 'multidrug-resistant tuberculosis', 't. b. joshua', 'directly observed treatment, short-course', 'tupolev tb-3', 'tuberculosis radiology', 'roland tb-303', 'north american b-25 mitchell', 'cancer', 'colorectal cancer', 'pancreatic cancer', 'lung cancer', 'breast cancer', 'cancer (astrology)', 'prostate cancer', 'esophageal cancer', 'skin cancer', 'not cancer', 'bipolar disorder', 'bipolar', 'bipolar ii disorder', 'bipolar junction transistor', 'bipolarity', 'bipolar i disorder', 'list of people with bipolar disorder', 'bipolar neuron', 'schizoaffective disorder', 'bipolar encoding', 'mental disorder', 'list of mental disorders', 'causes of mental disorders', 'bipolar disorder', 'classification of mental disorders', 'history of mental disorders', 'diagnostic and statistical manual of mental disorders', 'prevalence of mental disorders', 'list of mental disorders in film', 'personality disorder', 'brain tumor', 'list of people with brain tumors', 'cerebral edema', 'meningioma', 'canine brain tumors', 'benign tumor', 'brain tumor society', 'neurosurgery', 'glioblastoma', 'vestibular schwannoma', 'human immunodeficiency virus', 'human immunodeficiency virus infection with infectious mononucleosis-like syndrome', 'feline immunodeficiency virus', 'acquired immune deficiency syndrome', 'simian immunodeficiency virus', 'human immunodeficiency virus infection with acute lymphadenitis', 'fear of contracting human immunodeficiency virus infection', 'human immunodeficiency virus centers for disease control and prevention category a3', '', 'human immunodeficiency virus centers for disease control and prevention category b3', '', 'human immunodeficiency virus centers for disease control and prevention category c1', '', 'human immunodeficiency virus centers for disease control and prevention category c2', '', 'human immunodeficiency virus centers for disease control and prevention category c3', '', 'human immunodeficiency virus world health organization class iv', '', 'bovine immunodeficiency virus', 'audiovisual aids operator', 'fully mobile', 'human immunodeficiency virus antibody test', 'notification of acquired immune deficiency syndrome', 'human immunodeficiency virus screening', 'mobility aid', 'use of aids for daily life', 'use of kitchen aids', 'use of bathroom aids', 'use of work aids', 'use of indoor mobility aids', 'human aid to communication', 'provision of aids to daily living', 'sharing of sex aids', 'acquired immune deficiency syndrome-related nephropathy', 'aids for severely handicapped', 'human immunodeficiency virus risk lifestyle', 'acquired immunodeficiency syndrome risk behavior knowledge test', 'fear of acquired immunodeficiency syndrome scale', 'learning development aids - handwriting assessment', 'congenital acquired immune deficiency syndrome', 'use of memory retrieval aids', 'ability to mobilize using mobility aids', 'able to mobilize using mobility aids', 'unable to mobilize using mobility aids', 'does mobilize using aids', 'does not mobilize using mobility aids', 'difficulty mobilizing using mobility aids', 'handicapped aids', 'external memory aids training', 'aids to daily living', 'finding related to ability to mobilize using mobility aids', 'finding of use of memory retrieval aids', 'human immunodeficiency virus infection with aseptic meningitis', 'acquired immunodeficiency syndrome clinical trial group', 'pediatric acquired immunodeficiency syndrome clinical trial group', 'leukoplakia of tongue associated with human immunodeficiency virus disease', 'hairy leukoplakia of tongue associated with human immunodeficiency virus disease', 'neutropenia associated with acquired immunodeficiency syndrome', 'assistive device education', 'acquired immunodeficiency syndrome-associated disorder', 'abnormal weight loss associated with acquired immunodeficiency syndrome', 'acute endocarditis associated with acquired immunodeficiency syndrome', 'myocarditis associated with acquired immunodeficiency syndrome', 'agranulocytosis associated with acquired immunodeficiency syndrome', 'anemia associated with acquired immunodeficiency syndrome', 'acquired hemolytic anemia associated with acquired immunodeficiency syndrome', 'aplastic anemia associated with acquired immunodeficiency syndrome', 'retinopathy associated with acquired immunodeficiency syndrome', 'blindness associated with acquired immunodeficiency syndrome', 'cachexia associated with acquired immunodeficiency syndrome', 'candidiasis of mouth associated with acquired immunodeficiency syndrome', 'central nervous disorder associated with acquired immunodeficiency syndrome', 'central nervous system demyelinating disease associated with acquired immunodeficiency syndrome', 'myelopathy associated with acquired immunodeficiency syndrome', 'coccidioidomycosis associated with acquired immunodeficiency syndrome', 'cryptococcosis associated with acquired immunodeficiency syndrome', 'disseminated candidiasis associated with acquired immunodeficiency syndrome', 'encephalopathy associated with acquired immunodeficiency syndrome', 'dementia associated with acquired immunodeficiency syndrome', 'encephalitis associated with acquired immunodeficiency syndrome', 'encephalomyelitis associated with acquired immunodeficiency syndrome', 'organic brain syndrome associated with acquired immunodeficiency syndrome', 'organic dementia associated with acquired immunodeficiency syndrome', 'presenile dementia associated with acquired immunodeficiency syndrome', 'primary lymphoma of brain associated with acquired immunodeficiency syndrome', 'progressive multifocal leukoencephalopathy associated with acquired immunodeficiency syndrome', 'subacute adenoviral encephalitis associated with acquired immunodeficiency syndrome', 'failure to thrive in infant associated with acquired immunodeficiency syndrome', 'fatigue associated with acquired immunodeficiency syndrome', 'hematopoietic system disease associated with acquired immunodeficiency syndrome', 'hepatomegaly associated with acquired immunodeficiency syndrome', 'herpes zoster associated with acquired immunodeficiency syndrome', 'histoplasmosis associated with acquired immunodeficiency syndrome', 'ill-defined intestinal infection associated with acquired immunodeficiency syndrome', 'infectious gastroenteritis associated with acquired immunodeficiency syndrome', 'noninfectious gastroenteritis associated with acquired immunodeficiency syndrome', 'infective arthritis associated with acquired immunodeficiency syndrome', 'intestinal malabsorption associated with acquired immunodeficiency syndrome', 'low vision associated with acquired immunodeficiency syndrome', 'malaise associated with acquired immunodeficiency syndrome', 'malignant neoplasm associated with acquired immunodeficiency syndrome', \"kaposi's sarcoma associated with acquired immunodeficiency syndrome\", 'reticulosarcoma associated with acquired immunodeficiency syndrome', 'microsporidiosis associated with acquired immunodeficiency syndrome', 'mycobacteriosis associated with acquired immunodeficiency syndrome', 'tuberculosis associated with acquired immunodeficiency syndrome', 'myelitis associated with acquired immunodeficiency syndrome', 'neuralgia associated with acquired immunodeficiency syndrome', 'neuritis associated with acquired immunodeficiency syndrome', 'radiculitis associated with acquired immunodeficiency syndrome', 'nocardiosis associated with acquired immunodeficiency syndrome', 'nutritional deficiency associated with acquired immunodeficiency syndrome', 'pneumocystosis associated with acquired immunodeficiency syndrome', 'pneumonia associated with acquired immunodeficiency syndrome', 'bacterial pneumonia associated with acquired immunodeficiency syndrome', 'pneumococcal pneumonia associated with acquired immunodeficiency syndrome', 'candidiasis of lung associated with acquired immunodeficiency syndrome', 'viral pneumonia associated with acquired immunodeficiency syndrome', 'polyneuropathy associated with acquired immunodeficiency syndrome', 'respiratory disorder associated with acquired immunodeficiency syndrome', 'dyspnea associated with acquired immunodeficiency syndrome', 'retinal vascular changes associated with acquired immunodeficiency syndrome', 'salivary gland disease associated with acquired immunodeficiency syndrome', 'salmonella infection associated with acquired immunodeficiency syndrome', 'skin disorder associated with acquired immunodeficiency syndrome', 'dermatomycosis associated with acquired immunodeficiency syndrome', 'hyperhidrosis associated with acquired immunodeficiency syndrome', 'skin rash associated with acquired immunodeficiency syndrome', 'strongyloidiasis associated with acquired immunodeficiency syndrome', 'subacute endocarditis associated with acquired immunodeficiency syndrome', 'subacute myocarditis associated with acquired immunodeficiency syndrome', 'thrombocytopenia associated with acquired immunodeficiency syndrome', 'family history of acquired immune deficiency syndrome', 'cholangitis associated with acquired immunodeficiency syndrome', 'acquired immune deficiency syndrome complicating childbirth', 'kaposi sarcoma not associated with acquired immunodeficiency syndrome', 'assessment using assessment of intelligibility of dysarthric speech', 'assessment of intelligibility of dysarthric speech', 'assessment of intelligibility of dysarthric speech score', 'infection caused by coccidia co-occurrent with acquired immunodeficiency syndrome', 'infection caused by toxoplasma gondii co-occurrent with acquired immunodeficiency syndrome', 'infection caused by isospora co-occurrent with acquired immunodeficiency syndrome', 'assessment using acquired immunodeficiency syndrome risk behavior knowledge test', 'acquired immunodeficiency syndrome risk behavior knowledge test total score', 'human immunodeficiency virus receptor', 'human immunodeficiency virus type 1 dot blot immunobinding assay', 'human immunodeficiency virus', 'human immunodeficiency virus type 1 passive hemagglutination assay', 'measurement of human immunodeficiency virus 2 antibody', 'measurement of human immunodeficiency virus 1 antibody', 'human immunodeficiency virus antigen test', 'human immunodeficiency virus-2 antigen assay', 'human immunodeficiency virus type 2', 'human immunodeficiency virus type 1 western blot assay', 'human immunodeficiency virus infection with infectious mononucleosis-like syndrome', 'human immunodeficiency virus type 1 radioimmunoprecipitation assay', 'human immunodeficiency virus type 1 antibody confirmatory test', 'congenital human immunodeficiency virus infection', 'human immunodeficiency virus type 2 confirmatory assay', 'human immunodeficiency virus 1 enzyme linked immunosorbent assay', 'human immunodeficiency virus-1 indirect immunofluorescence assay', 'human immunodeficiency virus-1 rapid latex agglutination assay', 'human immunodeficiency virus infection', 'human immunodeficiency virus infection with acute lymphadenitis', 'human immunodeficiency virus type i', 'asymptomatic human immunodeficiency virus infection', 'asymptomatic human immunodeficiency virus infection in pregnancy', 'antigen of human immunodeficiency virus protein 24', 'human immunodeficiency virus centers for disease control and prevention category a1', 'human immunodeficiency virus centers for disease control and prevention category a2', 'human immunodeficiency virus centers for disease control and prevention category a3', '', 'human immunodeficiency virus centers for disease control and prevention category b1', 'human immunodeficiency virus centers for disease control and prevention category b2', 'human immunodeficiency virus centers for disease control and prevention category b3', '', 'human immunodeficiency virus centers for disease control and prevention category c1', '', 'human immunodeficiency virus centers for disease control and prevention category c2', '', 'human immunodeficiency virus centers for disease control and prevention category c3', '', 'human immunodeficiency virus world health organization class i', 'human immunodeficiency virus world health organization class ii', 'human immunodeficiency virus world health organization class iii', 'human immunodeficiency virus world health organization class iv', '', 'human immunodeficiency virus p24 antigen test', 'antigen of human immunodeficiency virus 1 glycoprotein 120', 'antigen of human immunodeficiency virus 1 glycoprotein 160', 'antigen of human immunodeficiency virus 2 protein 41', 'acute human immunodeficiency virus infection', 'antigen of human immunodeficiency virus 1', 'human immunodeficiency virus deoxyribonucleic acid assay', 'human immunodeficiency virus 1 deoxyribonucleic acid assay', 'human immunodeficiency virus 1 ribonucleic acid assay', 'human immunodeficiency virus culture', 'human immunodeficiency virus type 1 identification', 'human immunodeficiency virus 1 antibody band pattern determination', 'measurement of human immunodeficiency virus 1 glycoprotein 105 antibody', 'measurement of human immunodeficiency virus 1 glycoprotein 120 antibody', 'measurement of human immunodeficiency virus 1 glycoprotein 120 and glycoprotein 160 antibody', 'measurement of human immunodeficiency virus 1 glycoprotein 160 antibody', 'measurement of human immunodeficiency virus 1 glycoprotein 34 antibody', 'measurement of human immunodeficiency virus 1 glycoprotein 41 antibody', 'measurement of human immunodeficiency virus 1 glycoprotein 41 and glycoprotein 43 antibody', 'measurement of human immunodeficiency virus 1 protein 15 antibody', 'measurement of human immunodeficiency virus 1 protein 15 antibody and protein 18 antibody', 'measurement of human immunodeficiency virus 1 protein 17 antibody', 'measurement of human immunodeficiency virus 1 protein 18 antibody', 'measurement of human immunodeficiency virus 1 protein 23 antibody', 'measurement of human immunodeficiency virus 1 protein 24 antibody', 'measurement of human immunodeficiency virus 1 protein 26 antibody', 'measurement of human immunodeficiency virus 1 protein 28 antibody', 'measurement of human immunodeficiency virus 1 protein 31 antibody', 'measurement of human immunodeficiency virus 1 protein 32 antibody', 'measurement of human immunodeficiency virus 1 protein 51 antibody', 'measurement of human immunodeficiency virus 1 protein 53 antibody', 'measurement of human immunodeficiency virus 1 protein 55 antibody', 'measurement of human immunodeficiency virus 1 protein 58 antibody', 'measurement of human immunodeficiency virus 1 protein 64 antibody', 'measurement of human immunodeficiency virus 1 protein 65 antibody', 'measurement of human immunodeficiency virus 1 protein 66 antibody', 'measurement of human immunodeficiency virus 1 protein 68 antibody', 'measurement of human immunodeficiency virus 2 glycoprotein 105 antibody', 'measurement of human immunodeficiency virus 2 glycoprotein 120 antibody', 'measurement of human immunodeficiency virus 2 glycoprotein 125 antibody', 'measurement of human immunodeficiency virus 2 protein 15 antibody', 'measurement of human immunodeficiency virus 2 glycoprotein 34 antibody', 'measurement of human immunodeficiency virus 2 glycoprotein 36 antibody', 'measurement of human immunodeficiency virus 2 glycoprotein 80 antibody', 'measurement of human immunodeficiency virus 2 protein 26 antibody', 'measurement of human immunodeficiency virus 2 protein 31 antibody', 'measurement of human immunodeficiency virus 2 protein 41 antibody', 'measurement of human immunodeficiency virus 2 protein 53 antibody', 'measurement of human immunodeficiency virus 2 protein 55 antibody', 'measurement of human immunodeficiency virus 2 protein 56 antibody', 'measurement of human immunodeficiency virus 2 protein 58 antibody', 'measurement of human immunodeficiency virus 2 protein 68 antibody', 'human immunodeficiency virus 1 antigen assay', 'human immunodeficiency virus 1 p24 antigen assay', 'antigen of human immunodeficiency virus 1 protein 24', 'human immunodeficiency virus, type ii glycoprotein 125 antibody', 'human immunodeficiency virus, type ii glycoprotein 36 antibody', 'human immunodeficiency virus, type i protein 23 antibody', 'human immunodeficiency virus, type i protein 32 antibody', 'human immunodeficiency virus, type i protein 28 antibody', 'human immunodeficiency virus, type i protein 65 antibody', 'human immunodeficiency virus, type ii protein 68 antibody', 'human immunodeficiency virus, type ii protein 56 antibody', 'human immunodeficiency virus, type ii protein 26 antibody', 'human immunodeficiency virus, type ii glycoprotein 80 antibody', 'human immunodeficiency virus, type i glycoprotein 105 antibody', 'human immunodeficiency virus, type i protein 58 antibody', 'human immunodeficiency virus, type i protein 51 antibody', 'human immunodeficiency virus, type i protein 66 antibody', 'human immunodeficiency virus, type i protein 55 antibody', 'human immunodeficiency virus, type i protein 31 antibody', 'human immunodeficiency virus, type ii protein 24 antibody', 'human immunodeficiency virus, type i protein 17 antibody', 'human immunodeficiency virus, type i glycoprotein 41 antibody', 'human immunodeficiency virus, type i glycoprotein 120 antibody', 'human immunodeficiency virus, type i glycoprotein 160 antibody', 'human immunodeficiency virus, type i protein 64 antibody', 'human immunodeficiency virus, type ii protein 41 antibody', 'human immunodeficiency virus, type i protein 53 antibody', 'human immunodeficiency virus, type i protein 18 antibody', 'human immunodeficiency virus, type i glycoprotein 34 antibody', 'human immunodeficiency virus, type i protein 26 antibody', 'human immunodeficiency virus, type i protein 15 antibody', 'fear of contracting human immunodeficiency virus infection', 'human immunodeficiency virus antibody test', 'human immunodeficiency virus negative', 'human immunodeficiency virus positive', 'human immunodeficiency virus screening', 'patient advised about the risks of human immunodeficiency virus', 'human immunodeficiency virus infection constitutional disease', 'human immunodeficiency virus leukoencephalopathy', 'neuropathy caused by human immunodeficiency virus', 'human immunodeficiency virus enteropathy', 'human immunodeficiency virus myopathy', 'human immunodeficiency virus infection classification systems', 'human immunodeficiency virus antibody', 'human immunodeficiency virus risk lifestyle', 'congenital human immunodeficiency virus positive status syndrome', 'human immunodeficiency virus status', 'human immunodeficiency virus-related sclerosing cholangitis', 'human immunodeficiency virus counseling', 'human immunodeficiency virus prevention education', 'human immunodeficiency virus infection with aseptic meningitis', 'human immunodeficiency virus viral load', 'measurement of both human immunodeficiency virus 1 antibody and human immunodeficiency virus 2 antibody', 'finding of human immunodeficiency virus status', 'human immunodeficiency virus antibody titer measurement', 'human immunodeficiency virus centers for disease control and prevention category', 'human immunodeficiency virus world health organization class', 'human immunodeficiency virus centers for disease control and prevention category finding', 'human immunodeficiency virus world health organization class finding', 'antenatal screening for human immunodeficiency virus', 'human immunodeficiency virus-1 nucleic acid assay', 'polymerase chain reaction test for human immunodeficiency virus type 1', 'oral hairy leukoplakia associated with human immunodeficiency virus disease', 'human immunodeficiency virus encephalitis', 'pediatric human immunodeficiency virus infection', 'human immunodeficiency virus enzyme-linked immunosorbent assay test negative', 'human immunodeficiency virus enzyme-linked immunosorbent assay test positive', 'antenatal human immunodeficiency virus blood screening test status', 'antenatal human immunodeficiency virus blood screening test sent', 'antenatal human immunodeficiency virus blood screening test requested', 'rapid human immunodeficiency virus type 1 antibody test', 'human immunodeficiency virus type 1 antibody', 'leukoplakia of tongue associated with human immunodeficiency virus disease', 'hairy leukoplakia of tongue associated with human immunodeficiency virus disease', 'retinopathy associated with acquired immunodeficiency syndrome', 'cachexia associated with acquired immunodeficiency syndrome', 'family history of human immunodeficiency virus infection', 'copies of human immunodeficiency virus ribonucleic acid above reference range', 'human immunodeficiency virus, type ii antibody', 'determination of susceptibility of human immunodeficiency virus 1 to panel of antiretroviral drugs using genotypic technique', 'determination of susceptibility of human immunodeficiency virus 1 to panel of antiretroviral drugs using phenotypic technique', 'determination of coreceptor tropism of human immunodeficiency virus 1', 'pulmonary arterial hypertension associated with human immunodeficiency virus infection', 'human immunodeficiency virus carrier', 'human immunodeficiency virus in mother complicating childbirth', 'symptomatic human immunodeficiency virus i infection', 'human immunodeficiency virus', 'human immunodeficiency virus', 'human immunodeficiency virus', 'human immunodeficiency virus', 'human immunodeficiency virus ii infection', 'ribonucleic acid of human immunodeficiency virus 2', 'deoxyribonucleic acid of human immunodeficiency virus 2', 'human immunodeficiency virus 1 and virus 2 antibodies and human immunodeficiency virus 1 p24 antigen combination immunoassay', 'immunoglobulin g antibody to human immunodeficiency virus type 1', 'immunoglobulin g antibody to human immunodeficiency virus type 2', 'proviral deoxyribonucleic acid of human immunodeficiency virus 1', 'proviral deoxyribonucleic acid of human immunodeficiency virus 2', 'human immunodeficiency virus 1 antibody indeterminate', 'human immunodeficiency virus 2 antibody indeterminate', 'human immunodeficiency virus 2 antibody positive and human immunodeficiency virus 1 antibody cross-reactivity', 'human immunodeficiency virus screening declined', 'invasive carcinoma of uterine cervix co-occurrent with human immunodeficiency virus infection', 'extrapulmonary tuberculosis co-occurrent with human immunodeficiency virus infection', 'world health organization 2007 human immunodeficiency virus infection clinical stage 1', 'world health organization 2007 human immunodeficiency virus infection clinical stage 2', 'world health organization 2007 human immunodeficiency virus infection clinical stage 3', 'world health organization 2007 human immunodeficiency virus infection clinical stage 4', 'human immunodeficiency virus fusion inhibitor', 'human immunodeficiency virus world health organization 2007 stage 1 co-occurrent with malaria', 'human immunodeficiency virus world health organization 2007 stage 2 co-occurrent with malaria', 'human immunodeficiency virus world health organization 2007 stage 3 co-occurrent with malaria', 'human immunodeficiency virus world health organization 2007 stage 4 co-occurrent with malaria', 'human immunodeficiency virus world health organization 2007 stage 4 co-occurrent with tuberculosis', 'human immunodeficiency virus world health organization 2007 stage 1 co-occurrent with tuberculosis', 'human immunodeficiency virus world health organization 2007 stage 2 co-occurrent with tuberculosis', 'human immunodeficiency virus world health organization 2007 stage 3 co-occurrent with tuberculosis', 'human immunodeficiency virus entry inhibitor', 'symptomatic human immunodeficiency virus infection', 'ribonucleic acid of human immunodeficiency virus 1', 'deoxyribonucleic acid of human immunodeficiency virus', 'deoxyribonucleic acid of human immunodeficiency virus 1', 'human immunodeficiency virus social work service', 'human immunodeficiency virus nurse practitioner service', 'human immunodeficiency virus nursing specialty', 'human immunodeficiency virus social work specialty', 'bacterial infection due to human immunodeficiency virus infection', 'encephalitis caused by human immunodeficiency virus type 1', 'esophagitis due to human immunodeficiency virus disease', 'transmitted by', 'mycobacterium, non-tuberculosis', 'notification of tuberculosis', 'tuberculosis screening', 'examination for suspected tuberculosis', 'tuberculosis chemotherapy', 'acute tuberculous pericarditis', 'genital tuberculosis', 'tuberculosis', 'tuberculosis of meninges', 'tuberculosis of urinary organs', 'entire terminal bronchiole', 'tuberculosis of bladder', 'mycobacterium tuberculosis hominis', 'tuberculosis of kidney', 'tuberculosis of genitourinary system', 'tuberculosis of ureter', 'pulmonary tuberculosis', 'atypical mycobacterial infection', 'tuberculosis, extrapulmonary', 'tuberculosis in mother complicating childbirth', 'tuberculous laryngitis', 'tuberculous peritonitis', 'primary tuberculosis', 'tuberculous salpingitis', 'tuberculous erythema nodosum', 'tuberculous cervicitis', 'extrapulmonary tuberculosis co-occurrent with human immunodeficiency virus infection', 'screening for cancer', 'laparotomy for staging of ovarian cancer', 'fear of getting cancer', 'prescription for alteration of hormonal balance for cancer', 'cancer hospital', 'pleurodesis with cancer chemotherapy substance', 'no microscopic confirmation - clinically metastatic tumor', '', 'immunotherapy for cancer', 'no microscopic confirmation - clinically malignant tumor', '', 'hyperthermia treatment of cancer', 'malignant neoplasm, primary', 'intra-arterial infusion of antineoplastic agent', 'cancer antigen 125', 'cancer antigen 19-5', 'cancer antigen 19-9', 'cancer antigen 242', 'cancer antigen 27-29', 'cancer antigen 50', 'cancer antigen 549', 'cancer antigen 72-4', 'cancer antigen 15-3', 'gleason grading system for prostatic cancer', 'walter reed staging of prostatic cancer', 'cancer antigen dm /70k', \"howel-evans' syndrome\", 'cancer procoagulant', 'suspected breast cancer', 'suspected lung cancer', 'malignant tumor of nasopharynx', 'malignant tumor of undescended testis', 'malignant tumor of ectopic testis', 'malignant tumor of body of penis', 'secondary malignant neoplasm of cervix uteri', 'cancer education', \"united kingdom children's cancer study group central nervous system tumor staging system\", 'american urological association staging system for prostate cancer', 'squamous cell carcinoma of bronchus', 'small cell carcinoma of lung', 'non-small cell lung cancer', 'malignant neoplasm of breast', 'cancer en cuirasse', 'familial cancer of breast', 'malignant tumor of skin of penis', 'malignant neoplasm of unknown origin', 'malignant tumor of salivary gland', 'malignant tumor of exocrine pancreas', 'cancer staging', 'history of malignant neoplasm', 'family history: stomach cancer', 'family history: bowel cancer', 'family history: bronchus cancer', 'family history of cancer', 'early gastric cancer', 'late gastric cancer', 'cancer attitude inventory', 'mental adjustment to cancer scale', 'family history of cancer of colon', 'hereditary nonpolyposis colon cancer', 'suspected cervical cancer', 'suspected endometrial cancer', 'suspected prostate cancer', 'suspected bladder cancer', 'suspected kidney cancer', 'suspected urothelial cancer', 'suspected testicular cancer', 'suspected upper gastrointestinal cancer', 'suspected lower gastrointestinal cancer', 'suspected skin cancer', 'suspected head and neck cancer', 'secondary malignant neoplastic disease', 't3', 'malignant neoplasm of liver', 'secondary malignant neoplasm of liver', 'secondary malignant neoplasm of ovary', 'secondary malignant neoplasm of skin', 'secondary malignant neoplasm of vertebral column', 'secondary malignant neoplasm of vulva', 'cancer protocol observable', 'cancer dataset administrative items', 'basis of cancer diagnosis', 'cancer diagnosis based on death certificate', 'cancer diagnosis based on clinical evidence', 'cancer diagnosis based on investigations, without a tissue diagnosis', 'cancer diagnosis based on specific tumor markers', 'cancer diagnosis based on cytological evidence', 'cancer diagnosis based on metastatic histological evidence', 'cancer diagnosis based on primary site histological evidence', 'reason for no specific anti-cancer treatment', 'no anti-cancer treatment - poor performance status', 'no anti-cancer treatment - advanced stage cancer', 'patient died before anti-cancer treatment', 'no anti-cancer treatment - significant co-morbidity', 'no anti-cancer treatment available', 'no anti-cancer treatment - watchful waiting', 'cancer treatment related morbidity', 'malignant tumor of cecum', 'malignant tumor of esophagus', 'malignant neoplastic disease', 'malignant tumor of lip', 'malignant tumor of stomach', 'malignant tumor of rectum', 'malignant tumor of anal canal', 'malignant tumor of cervix', 'malignant tumor of adrenal gland', 'malignant neoplasm of ill-defined site', 'malignant tumor of lung', 'malignant tumor of vulva', 'malignant tumor of tongue', 'malignant tumor of parotid gland', 'malignant tumor of gum', 'malignant tumor of floor of mouth', 'malignant tumor of buccal mucosa', 'malignant tumor of palate', 'malignant tumor of oropharynx', 'malignant tumor of tonsil', 'malignant tumor of duodenum', 'malignant neoplasm of colon', 'malignant tumor of pancreas', 'malignant neoplasm of omentum', 'malignant tumor of larynx', 'malignant tumor of trachea', 'malignant tumor of pleura', 'malignant tumor of vertebral column', 'malignant tumor of ovary', 'malignant tumor of vagina', 'malignant tumor of foreskin', 'malignant tumor of glans penis', 'malignant tumor of scrotum', 'malignant tumor of ureter', 'malignant tumor of urethra', 'malignant tumor of thyroid gland', 'malignant tumor of parathyroid gland', 'malignant tumor of pituitary gland', 'malignant tumor of vocal cord', 'malignant tumor of peritoneum', 'malignant tumor of bronchus', 'malignant tumor of muscle', 'multiple malignancy', 'malignant tumor of oral cavity', 'malignant neoplasm of pharynx', 'malignant tumor of intestine', 'malignant tumor of large intestine', 'malignant tumor of penis', 'malignant tumor of kidney', 'malignant neoplasm of uterus', 'primary malignant neoplasm of bronchus', 'secondary malignant neoplasm of bone', 'secondary malignant neoplasm of brain', 'secondary malignant neoplasm of kidney', 'secondary malignant neoplasm of lung', 'secondary malignant neoplasm of lymph node', 'gleason grade finding for prostatic cancer', 'cancer registrar', 'cancer pagurus specific immunoglobulin e', 'cancer pagurus specific immunoglobulin e antibody measurement', 'cancer treatment started', 'cancer diagnosis discussed', 'cancer confirmed', 'no evidence of cancer found', 'cancer primary healthcare multidisciplinary team', 'cancer diagnosis discussed with partner in relationship', 'cancer diagnosis discussed with patient', 'cancer care plan discussed with patient', 'cancer care plan discussed with partner in relationship', 'pt3a', '', '', 'suspected central nervous system cancer', 'suspected urological cancer', 'suspected gynecological cancer', \"suspected children's cancer\", 'multidisciplinary care conference for cancer care planning', 'monitoring of patient with cancer', 'no anti-cancer treatment due to unknown primary', 'cancer supportive care worker', 'phobic fear of skin cancer', 'suspected hematological malignancy', 'suspected malignancy', 'malignant tumor of prostate', 'malignant tumor of urinary bladder', 'risk control behavior: cancer', 'breast cancer type 1 susceptibility protein', 'breast cancer type 2 susceptibility protein', 'college of american pathologists cancer checklist; adrenal gland: resection', 'college of american pathologists cancer checklist; ampulla of vater: ampullectomy', 'college of american pathologists cancer checklist; ampulla of vater: pancreaticoduodenectomy', 'college of american pathologists cancer checklist; anus: excisional biopsy', 'college of american pathologists cancer checklist; anus: local excision', '', 'college of american pathologists cancer checklist; anus: resection', 'college of american pathologists cancer checklist; urinary bladder, ureter, renal pelvis: biopsy', 'college of american pathologists cancer checklist; urinary bladder: cystectomy, partial, total, or radical; anterior exenteration', 'college of american pathologists cancer checklist; renal pelvis: resection/nephroureterectomy, partial or complete', 'college of american pathologists cancer checklist; ureter: resection', 'college of american pathologists cancer checklist; bone marrow: blood film, aspirate, cell block, trephine biopsy, touch imprint', 'college of american pathologists cancer checklist; brain/spinal cord: biopsy/resection', 'college of american pathologists cancer checklist; breast: excision less than total mastectomy', 'college of american pathologists cancer checklist; colon and rectum: excisional biopsy', '', 'college of american pathologists cancer checklist; rectum: local excision', '', 'college of american pathologists cancer checklist; colon and rectum: resection', 'college of american pathologists cancer checklist; endometrium: biopsy', 'college of american pathologists cancer checklist; endometrium: hysterectomy, with or without other organs or tissues', 'college of american pathologists cancer checklist; esophagus: biopsy', 'college of american pathologists cancer checklist; esophagus: resection', 'college of american pathologists cancer checklist; extrahepatic bile ducts: resection', 'college of american pathologists cancer checklist; uveal melanoma: resection', 'college of american pathologists cancer checklist; vulva: excisional biopsy/resection', 'college of american pathologists cancer checklist; vagina: biopsy', 'college of american pathologists cancer checklist; vagina: excisional biopsy, resection', 'college of american pathologists cancer checklist; uterine cervix: cone biopsy', 'college of american pathologists cancer checklist; uterine cervix: colpectomy, hysterectomy, pelvic exenteration', 'college of american pathologists cancer checklist; upper aerodigestive tract and minor salivary glands: incisional and excisional biopsy/resection', 'college of american pathologists cancer checklist; major salivary glands: resection', 'college of american pathologists cancer checklist; trophoblast: dilation and curettage/resection', 'college of american pathologists cancer checklist; thyroid: resection', 'college of american pathologists cancer checklist; thymoma and thymic carcinoma: biopsy', 'college of american pathologists cancer checklist; thymoma and thymic carcinoma: thymectomy, other procedure', 'college of american pathologists cancer checklist; pleura/pericardium: resection', 'college of american pathologists cancer checklist; pleura/pericardium: biopsy', 'college of american pathologists cancer checklist; testis: radical orchiectomy', 'college of american pathologists cancer checklist; testis: retroperitoneal lymphadenectomy', 'college of american pathologists cancer checklist; stomach: biopsy', 'college of american pathologists cancer checklist; stomach: resection', 'college of american pathologists cancer checklist; small intestine: polypectomy, segmental resection, pancreaticoduodenectomy, partial or complete, with or without partial gastrectomy', '', 'college of american pathologists cancer checklist; melanoma of the skin: excision; re-excision', 'college of american pathologists cancer checklist; fallopian tube: unilateral salpingectomy, salpingo-oophorectomy, or hysterectomy with salpingo-oophorectomy', 'college of american pathologists cancer checklist; gallbladder: resection/cholecystectomy', 'college of american pathologists cancer checklist; gastrointestinal lymphoma: resection', 'college of american pathologists cancer checklist; heart: resection', 'college of american pathologists cancer checklist; hodgkin lymphoma: biopsy/staging procedure', 'college of american pathologists cancer checklist; kidney: biopsy', 'college of american pathologists cancer checklist; kidney: nephrectomy, partial or radical', 'college of american pathologists cancer checklist; liver: resection', 'college of american pathologists cancer checklist; lung: biopsy', 'college of american pathologists cancer checklist; lung: resection', 'college of american pathologists cancer checklist; non-hodgkin lymphoma: biopsy, resection', 'college of american pathologists cancer checklist; ovary: oophorectomy, salpingo-oophorectomy, subtotal oophorectomy or removal of tumor in fragments, hysterectomy with salpingo-oophorectomy', 'college of american pathologists cancer checklist; pancreas', 'college of american pathologists cancer checklist; pancreas', 'college of american pathologists cancer checklist; peritoneum: resection', 'college of american pathologists cancer checklist; prostate gland: needle biopsy, transurethral prostatic resection, enucleation specimen', 'college of american pathologists cancer checklist; prostate gland: radical prostatectomy', 'college of american pathologists cancer checklist; retinoblastoma: enucleation, partial or complete exenteration', 'college of american pathologists cancer checklist; carcinoma of the skin: resection', 'college of american pathologists cancer checklist; rhabdomyosarcoma and related neoplasms: excision, local or wide; compartmentectomy; excision, radical; amputation; other', 'college of american pathologists cancer checklist; kidney: resection for wilms tumor', 'seen by breast cancer nurse', 'widespread metastatic malignant neoplastic disease', 'college of american pathologists cancer checklist; neuroblastoma: resection', 'college of american pathologists cancer checklist; primitive neuroectodermal tumor / ewing sarcoma: resection', 'cancer pagurus diagnostic allergen extract', 'family history of prostate cancer', 'cancer monitoring third letter', 'cancer monitoring second letter', 'cancer monitoring first letter', 'cancer monitoring invitation', 'cancer hospital treatment completed', 'cancer emotional and psychosocial support and education', 'cancer screening follow up', 'no evidence of recurrence of cancer', 'cancer short term health assessment', 'cancer rehabilitation and readaption', 'cancer pain and symptom management', 'carcinoma-associated retinopathy', 'malignant neoplasm of skin', 'cancer shared care medication card', 'cancer monitoring verbal invitation', 'cancer home care pack given', 'international federation of gynecology and obstetrics cervical cancer stage i', 'international federation of gynecology and obstetrics cervical cancer stage ib', 'international union against cancer', 'american joint committee on cancer', 'international union against cancer stage grouping', 'european organization for research and treatment of cancer - quality of life questionnaire', 'international federation of gynecology and obstetrics endometrial cancer stage ii', 'international federation of gynecology and obstetrics endometrial cancer stage iv', 'international federation of gynecology and obstetrics cervical cancer stage ia', 'international federation of gynecology and obstetrics endometrial cancer stage i a', 'international federation of gynecology and obstetrics endometrial cancer stage i', 'international federation of gynecology and obstetrics cervical cancer stage iii', 'international federation of gynecology and obstetrics cervical cancer stage ii', 'international federation of gynecology and obstetrics endometrial cancer stage i b', 'international federation of gynecology and obstetrics cervical cancer stage iv', 'international federation of gynecology and obstetrics endometrial cancer stage iii', 'international federation of gynecology and obstetrics cervical cancer stage ib occ', 'college of american pathologists cancer checklist; appendix: resection', 'college of american pathologists cancer checklist; prostate gland: needle biopsy', 'college of american pathologists cancer checklist; prostate gland: transurethral prostatic resection, enucleation specimen', 'college of american pathologists cancer checklist; bone: resection', 'college of american pathologists cancer checklist; bone: biopsy', 'college of american pathologists cancer checklist; soft tissue: resection', 'college of american pathologists cancer checklist; soft tissue: biopsy', 'primary malignant neoplasm of thyroid gland, metastatic to bone', 'primary malignant neoplasm of ovary, with widespread metastatic disease', 'primary malignant neoplasm of vulva, with widespread metastatic disease', 'hormone refractory prostate cancer', 'non-small cell lung cancer, negative for epidermal growth factor receptor expression', 'french federation of cancer centers sarcoma group grading system', 'national cancer institute histologic grading system', 'non-small cell lung cancer, positive for epidermal growth factor receptor expression', 'psychosocial counseling about cancer', 'family history of cancer of the esophagus', 'family history of breast cancer 1 gene mutation', 'family history of breast cancer 2 gene mutation', 'increased cancer antigen 125', 'family history of malignant neoplasm of liver', 'family history of malignant neoplasm of pancreas', 'family history of malignant neoplasm of lung', 'family history of malignant neoplasm of skin', 'knowledge level about cancer prevention and early detection', 'knowledge level about cancer management', 'measurement of cancer antigen 72-4', 'american joint commission on cancer, cancer staging manual, 6th edition neoplasm staging system', 'american joint commission on cancer, cancer staging manual, 7th edition neoplasm staging system', 'edition of american joint commission on cancer, cancer staging manual used for tnm staging', 'cancer antigen 27-29 above reference range', 'residual cancer burden index', 'breast cancer genetic marker of susceptibility negative', 'measurement of cancer antigen 27-29', 'residual cancer burden class', 'residual cancer burden score', 'residual cancer burden index', 'breast cancer genetic marker of susceptibility positive', 'malignant neoplasm detection during interval between recommended screening examinations', 'brca1 mutation carrier detection test', 'brca1 gene mutation negative', 'brca1 gene mutation positive', 'brca2 gene mutation positive', 'brca2 mutation carrier detection test', 'brca2 gene mutation negative', 'malignant neoplasm of urinary organ', 'malignant neoplasm of respiratory system', 'malignant neoplasm of cerebellum', 'malignant neoplasm of carotid body', 'malignant neoplasm of cerebellopontine angle', 'malignant neoplasm of pelvic peritoneum', 'transglottic malignant neoplasm of larynx', 'malignant neoplasm of visceral pleura', 'malignant neoplasm of skin of scrotum', 'malignant neoplasm of upper respiratory tract', 'malignant neoplasm of parietal pleura', 'malignant neoplasm of intraabdominal organ', 'malignant neoplasm of mandible', 'malignant neoplasm of soft tissue of orbit', 'malignant neoplasm of posterior mediastinum', 'nottingham histologic grading system', 'malignant neoplasm of lateral wall of oropharynx', 'malignant neoplasm of alveolus of maxilla', 'malignant neoplasm of anterior mediastinum', 'malignant neoplasm of parametrium', 'malignant neoplasm of digestive system', 'malignant neoplasm of anterior and lateral floor of mouth', 'malignant neoplasm of alveolus of mandible', 'malignant neoplasm of broad ligament of uterus', 'malignant neoplasm of alveolus dentalis', 'verrucous carcinoma of oral cavity', 'electro cancer therapy system', 'educated about screening for malignant neoplasm of prostate', 'family history of colorectal cancer', 'patient advised about prostate cancer screening', 'pt4: tumor involves any of the ipsilateral pleural surfaces plus additional sites as by american joint committee on cancer 6th edition definition', '', 'pt3: tumor involves any of the ipsilateral pleural surfaces plus additional sites as by american joint committee on cancer 6th edition definition', '', 'pt4: tumor of lung as per american joint committee on cancer 6th edition definition', '', 'pt4: extraocular tumor extension which includes sites as per american joint committee on cancer 6th edition definition', '', 'pt2: tumor of lung as per american joint committee on cancer 6th edition definition', '', 'pn3b: tumor of breast with metastasis as per american joint committee on cancer 6th edition definition', '', 'hereditary cancer-predisposing syndrome', 'cancer antigen 19-9 measurement', 'cancer antigen 15-3 measurement', 'alternating electric field antimitotic cancer treatment system', 'alternating electric field antimitotic cancer treatment system transducer array', 'alternating electric field antimitotic cancer treatment system generator', 'screening for malignant neoplasm of vagina done', 'history of malignant neoplasm of vulva', 'malignant neoplastic disease in mother complicating childbirth', 'screening for malignant neoplasm of vagina', 'sampling of vagina for papanicolaou smear after hysterectomy for malignant disease done', 'anemia in malignant neoplastic disease', 'non-small cell lung cancer without mutation in epidermal growth factor receptor', 'non-small cell lung cancer with mutation in epidermal growth factor receptor', 'primary malignant neoplasm of endocervix', 'primary malignant neoplasm of endometrium', 'secondary malignant neoplasm of vagina', 'carcinoma of ovary, stage 3', 'history of malignant neoplasm of ovary', 'carcinoma of ovary, stage 1', 'carcinoma of ovary, stage 2', 'carcinoma of ovary, stage 4', 'primary malignant neoplasm of clitoris', 'history of malignant neoplasm of uterine adnexa', 'history of malignant neoplasm of cervix', 'history of malignant neoplasm of uterine body', 'history of malignant neoplasm of vagina', 'undifferentiated carcinoma of ovary', 'at risk of breast cancer', 'triple negative malignant neoplasm of breast', 'international federation of gynecology and obstetrics cervical cancer', 'international federation of gynecology and obstetrics endometrial cancer stage iiib', 'international federation of gynecology and obstetrics cervical cancer', 'international federation of gynecology and obstetrics cervical cancer', 'international federation of gynecology and obstetrics cervical cancer', 'international federation of gynecology and obstetrics cervical cancer', 'international federation of gynecology and obstetrics cervical cancer', 'international federation of gynecology and obstetrics endometrial cancer', 'international federation of gynecology and obstetrics cervical cancer', 'international federation of gynecology and obstetrics cervical cancer', 'international federation of gynecology and obstetrics cervical cancer', 'international federation of gynecology and obstetrics endometrial cancer stage iiic1', 'international federation of gynecology and obstetrics cervical cancer', 'international federation of gynecology and obstetrics cervical cancer', 'international federation of gynecology and obstetrics endometrial cancer stage iiic2', 'international federation of gynecology and obstetrics endometrial cancer', 'international federation of gynecology and obstetrics endometrial cancer', 'malignant neoplasm of exocervix', 'history of non-small cell malignant neoplasm of lung', 'family history of malignant neoplasm of male breast', 'family history of malignant neoplasm of cervix uteri', 'family history of malignant neoplasm of ileum', 'family history of malignant neoplasm of vagina', 'family history of malignant neoplasm of brain', 'history of malignant neoplasm of esophagus', 'history of malignant neoplasm of neck', 'history of malignant neoplasm of bone', 'secondary malignant neoplasm of central nervous system', 'secondary malignant neoplasm of cerebral meninges', 'secondary malignant neoplasm of bone marrow', 'family history of malignant neoplasm of uterus', 'family history of malignant neoplasm of bone', 'secondary malignant neoplasm of bladder', 'history of malignant neoplasm of endocrine gland', 'history of malignant neoplasm of tongue', 'secondary malignant neoplasm of adrenal gland', 'history of malignant neoplasm of spinal cord', 'history of malignant neoplasm of nervous system', 'carcinoma in situ of ileum', 'secondary malignant neoplasm of intercostal lymph nodes', 'secondary malignant neoplasm of lymph nodes of face', 'overlapping malignant neoplasm of small intestine', 'carcinoma in situ of tongue', 'secondary malignant neoplasm of intrapelvic lymph nodes', 'secondary malignant neoplasm of tracheobronchial lymph nodes', 'carcinoma in situ of eye', 'carcinoma in situ of vulva', 'squamous cell carcinoma of penis', 'squamous cell carcinoma of tip of nose', 'squamous cell carcinoma of forehead', 'malignant neoplasm of cerebral meninges', 'carcinoma in situ of small intestine', 'carcinoma of uterine cervix, invasive', 'secondary malignant neoplasm of intra-abdominal organs', 'malignant mesothelioma of peritoneum', 'secondary malignant neoplasm of chest wall', 'carcinoma of colon, stage i', 'malignant neoplasm of female breast', 'carcinoma in situ of prostate', 'secondary malignant neoplasm of prostate', 'malignant tumor of spinal cord, intramedullary', 'secondary malignant neoplasm of left ovary', 'secondary malignant neoplasm of thyroid gland', 'secondary malignant neoplasm of male genital organ', 'malignant mixed tumor of salivary gland', 'secondary malignant neoplasm of peritoneum', 'squamous cell carcinoma of scalp', 'squamous cell carcinoma of nasolabial fold', 'overlapping malignant neoplasm of eye and adnexa, primary', 'secondary malignant neoplasm of mediastinum', 'secondary malignant neoplasm of lymph nodes of upper limb', 'secondary malignant neoplasm of duodenum', 'overlapping malignant neoplasm of penis', 'overlapping malignant neoplasm of stomach', 'secondary malignant neoplasm of spleen', 'carcinoma in situ of common bile duct', 'squamous cell carcinoma of back', 'carcinoma in situ of skin', 'carcinoma in situ of rectum', 'malignant tumor of spinal cord, extramedullary', 'secondary malignant neoplasm of choroid', 'carcinoma in situ of gum', 'secondary malignant neoplasm of uterus', 'carcinoma in situ of mouth', 'overlapping malignant neoplasm of floor of mouth', 'secondary malignant neoplasm of inguinal lymph nodes', 'squamous cell carcinoma of temple', 'carcinoma in situ of pylorus', 'overlapping malignant neoplasm of brain', 'basal cell carcinoma of auricle of ear', 'secondary malignant neoplasm of rectosigmoid junction', 'secondary malignant neoplasm of tibial lymph nodes', 'malignant tumor of extrahepatic bile duct', 'carcinoma in situ of duodenum', 'carcinoma in situ of thyroid gland', 'secondary malignant neoplasm of hypogastric lymph nodes', 'secondary malignant neoplasm of female genital organ', 'malignant tumor of pineal gland', 'secondary malignant neoplasm of lymph nodes of lower limb', 'carcinoma in situ of oropharynx', 'carcinoma in situ of colon', 'secondary malignant neoplasm of lymph nodes of neck', 'carcinoma in situ of hypopharynx', 'squamous cell carcinoma of larynx', 'mesothelioma', '', 'stool dna-based colorectal cancer screening positive', 'overlapping malignant neoplasm of colon', 'carcinoma in situ of spleen', 'carcinoma in situ of cystic duct', 'secondary malignant neoplasm of intrathoracic lymph nodes', 'carcinoma in situ of bladder', 'carcinoma in situ', 'carcinoma in situ of penis', 'secondary malignant neoplasm of lymph nodes of head', 'carcinoma of urinary bladder, superficial', 'secondary malignant neoplasm of mesenteric lymph nodes', 'secondary malignant neoplasm of spinal meninges', 'carcinoma in situ of esophagus', 'metastasis from malignant tumor of prostate', 'secondary malignant neoplasm of esophagus', 'carcinoma in situ of lung', 'secondary malignant neoplasm of small intestine', 'secondary malignant neoplasm of respiratory tract', 'carcinoma in situ of pharynx', 'history of malignant neoplasm of penis', 'carcinoma in situ of vagina', 'carcinoma in situ of anal canal', 'secondary malignant neoplasm of iliac lymph nodes', 'malignant neoplasm of peripheral nerve of thorax', 'secondary malignant neoplasm of omentum', 'secondary malignant neoplasm of popliteal lymph nodes', 'secondary malignant neoplasm of pituitary gland', 'secondary malignant neoplasm of soft tissues of pelvis', 'secondary malignant neoplasm of lymph nodes of multiple sites', 'secondary malignant neoplasm of heart', 'secondary malignant neoplasm of pancreas', 'carcinoma in situ of jejunum', 'secondary malignant neoplasm of trachea', 'overlapping malignant neoplasm of major salivary gland', 'secondary malignant neoplasm of gallbladder', 'carcinoma of urinary bladder, invasive', 'secondary malignant neoplasm of pleura', 'squamous cell carcinoma of pharynx', 'secondary malignant neoplasm of urinary system', 'carcinoma in situ of larynx', 'malignant neoplasm of intrahepatic gall duct', 'carcinoma in situ of uterus', 'overlapping malignant neoplasm of palate', 'secondary malignant neoplasm of large intestine', 'secondary malignant neoplasm of retroperitoneal lymph nodes', 'squamous cell carcinoma of bridge of nose', 'squamous cell carcinoma in situ of skin', 'carcinoma in situ of urinary system', 'carcinoma in situ of gastrointestinal tract', 'secondary malignant neoplasm of stomach', 'secondary malignant neoplasm of nervous system', 'secondary malignant neoplasm of rectum', 'carcinoma in situ of pancreas', 'secondary malignant neoplasm of right ovary', 'overlapping malignant neoplasm of pancreas', 'malignant melanoma of anus', 'carcinoma in situ of salivary gland duct', 'carcinoma in situ of endocrine gland', 'malignant melanoma of rectum', 'secondary malignant neoplasm of pararectal lymph nodes', 'secondary malignant neoplasm of intestinal lymph nodes', 'malignant tumor of peripheral nerve', 'carcinoma of colon, stage iii', 'carcinoma of colon, stage ii', \"paget's disease of vulva\", 'carcinoma of prostate', 'carcinoma of the rectosigmoid junction', 'secondary malignant neoplasm of obturator lymph nodes', 'basal cell carcinoma of chest wall', 'carcinoma of nasal meatus', 'malignant neoplasm of anorectum', 'hurthle cell carcinoma of thyroid', 'basal cell carcinoma of back', 'mucoepidermoid carcinoma of parotid gland', 'adenoid cystic carcinoma of submandibular gland', 'squamous cell carcinoma of skin of neck', 'metastasis to peripheral nerve', 'carcinoma of colon, stage iv', 'carcinoma of tip of nose', 'squamous cell carcinoma of oropharynx', 'metastasis to digestive organs', 'mucoepidermoid carcinoma of submandibular gland', 'family history of malignant neoplasm of trachea', 'basal cell carcinoma of scalp', 'basal cell carcinoma of upper extremity', 'carcinoma in situ of skin of scalp', 'carcinoma in situ of skin of eyelid', 'basal cell carcinoma of hand', 'history of cancer of unknown primary site', 'history of cancer metastatic to liver', 'history of cancer of gall bladder', 'basal cell carcinoma of truncal skin', 'history of cancer of ampulla of duodenum', 'history of cancer metastatic to lung', 'carcinoma in situ of skin of trunk', 'history of cancer of floor of mouth', 'carcinoma in situ of skin of upper limb', 'history of cancer metastatic to lymph nodes', 'carcinoma in situ of body of stomach', 'basal cell carcinoma of lower extremity', 'history of malignant neoplasm of eye', 'basal cell carcinoma of neck', 'history of cancer metastatic to skin', 'history of cancer metastatic to brain', 'family history of malignant neoplasm of genital structure', 'basal cell carcinoma of forehead', 'family history of malignant neoplasm of urinary bladder', 'basal cell carcinoma of upper eyelid', 'basal cell carcinoma of chin', 'history of cancer of urethra', 'history of cancer metastatic to bone', 'basal cell carcinoma of ear', 'carcinoma in situ of fundus of stomach', 'basal cell carcinoma of skin', 'carcinoma in situ of skin of face', 'basal cell carcinoma of skin of lip', 'carcinoma in situ of skin of neck', 'carcinoma in situ of body of pancreas', 'family history of malignant neoplasm of kidney', 'basal cell carcinoma of temple', 'basal cell carcinoma of nose', 'family history of malignant neoplasm of testis', 'carcinoma in situ of cardia of stomach', 'basal cell carcinoma of face', 'carcinoma in situ of skin of ear', 'carcinoma in situ of skin of lip', 'secondary malignant neoplasm of lumbosacral plexus', 'history of malignant neoplasm of rectosigmoid junction', 'cancer associated serum antigen', 'adenocarcinoma of stomach', 'cancer cervix screening - not attended', 'cancer cervix screening - wanted', 'cancer cervix screening - not reached', 'cancer cervix screening - up-to-date', 'cancer cervix screening status', 'family history of hereditary nonpolyposis colon cancer', 'cancer cervix screening - not needed', 'cancer cervix screen-no result yet', 'cancer cervix screening and fee claim', 'cancer cervix - screening done', 'screening for malignant neoplasm of breast', 'secondary malignant neoplasm of right lung', 'secondary malignant neoplasm of left lung', 'screening for malignant neoplasm of colon', 'screening for malignant neoplasm of skin', 'family history of breast cancer gene mutation in first degree relative', 'secondary malignant neoplasm of intra-abdominal lymph nodes', 'squamous cell carcinoma of skin of ear', 'squamous cell carcinoma of skin of lower extremity', 'squamous cell carcinoma of skin of face', 'screening for malignant neoplasm of cervix not wanted', 'active surveillance of prostate cancer', 'primary malignant neoplasm of prostate metastatic to bone', 'squamous cell carcinoma of vagina', 'primary malignant neoplasm of appendix', 'malignant tumor of sigmoid colon', 'primary malignant neoplasm of lung', 'malignant tumor of splenic flexure', 'malignant tumor of hepatic flexure', 'malignant tumor of transverse colon', 'malignant tumor of rectosigmoid junction', 'malignant tumor of ascending colon', 'malignant tumor of descending colon', 'familial malignant neoplasm of prostate', 'cervical cancer screening not done', 'colorectal cancer screening not done', 'carcinoma of salivary gland type of breast', 'fatigue associated with malignant neoplastic disease', 'hereditary diffuse carcinoma of stomach', 'claus model lifetime breast cancer risk assessment', 'breast cancer risk assessment tool', 'hereditary breast and ovarian cancer syndrome', 'monitoring following treatment for cancer', 'cancer care review', 'prostate cancer care review', 'prostate cancer care review done', 'prostate cancer screening declined', 'breast cancer screening declined', 'cervical cancer papanicolaou smear screening declined', 'colon cancer screening declined', 'hormone sensitive prostate cancer', 'obstructive nephropathy due to carcinoma of prostate', 'obstructive nephropathy due to bladder cancer', 'reactive oxygen species 1 positive non-small cell lung cancer', 'occupational cancer of skin', 'fear of having cancer of digestive system', 'fear of cancer of respiratory system', 'fear of cancer of endocrine system', 'fear of musculoskeletal cancer', 'fear of hematological cancer', 'squamous non-small cell lung cancer', 'family history of malignant neoplasm of ovary in first degree relative', 'genetic susceptibility to cancer', 'hereditary non-polyposis colon cancer gene mutation positive', 'family history of genetic mutation for hereditary nonpolyposis colon cancer', 'lung cancer screening', 'lung cancer screening declined', 'carrier of high risk cancer mutation gene', 'carrier of heritable cancer', 'cancer antigen 19-9 above reference range', 'fear of genital cancer', 'family history of malignant hematopoietic neoplasm', 'fear of breast cancer', 'family history of malignant neoplasm of ovary in second degree relative', 'high risk for cervical cancer', 'family history of nonleukemic lymphatic malignancy', 'family history of malignant neoplasm of colon over age 50', 'family history of heritable malignancy', 'family history of malignant neoplasm of breast at under age 50 in second degree relative', 'microsatellite instability-high solid malignant tumor', 'chronic pain due to malignant neoplastic disease', 'family history of breast cancer gene brca mutation', 'cancer care plan', 'screening for malignant neoplasm of cervix declined', 'microsatellite instability-high colorectal cancer', 'chronic pain following surgical procedure for cancer', 'suspected vulva cancer', 'suspected ovarian cancer', 'suspected bowel cancer', 'inherited cancer-predisposing syndrome due to biallelic brca2 mutation', 'family history of malignant neoplasm of breast at under age 50 in second degree female relative', 'family history of malignant neoplasm of breast', 'germline brca-mutated human epidermal growth factor receptor 2 negative metastatic carcinoma of breast', 'hereditary site-specific ovarian cancer syndrome', 'gastric adenocarcinoma and proximal polyposis of stomach', 'high grade astrocytoma of brain', 'low grade astrocytoma of brain', 'grade 2 astrocytoma of brain', 'primary differentiated carcinoma of thyroid gland', 'oligodontia and cancer predisposition syndrome', 'secondary malignant neoplasm of colon and/or rectum', 'primary malignant neoplasm of vulva', 'malignant neoplasm of colon and/or rectum', 'familial cutaneous telangiectasia and oropharyngeal cancer predisposition syndrome', 'chronic pain after cancer treatment', 'locally advanced breast cancer', 'anaplastic lymphoma kinase fusion oncogene negative non-small cell lung cancer', 'reactive oxygen species 1 negative non-small cell lung cancer', 'anaplastic lymphoma kinase fusion oncogene positive non-small cell lung cancer', 'primary malignant neoplasm of breast with axillary lymph node invasion', 'at increased risk of malignant neoplasm of breast', 'at risk of hereditary cancer-predisposing syndrome', 'functional assessment of cancer therapy - brain', 'ulcer due to cancer', 'severe manic bipolar i disorder without psychotic features', 'chronic bipolar ii disorder, most recent episode major depressive', 'bipolar i disorder, single manic episode with postpartum onset', 'bipolar i disorder, single manic episode, in full remission', 'severe bipolar disorder with psychotic features', 'bipolar disorder in partial remission', 'bipolar i disorder, single manic episode', 'severe mixed bipolar i disorder with psychotic features, mood-incongruent', 'severe mixed bipolar i disorder with psychotic features', 'severe bipolar ii disorder, most recent episode major depressive, in full remission', 'mild bipolar disorder', 'severe bipolar i disorder, single manic episode with psychotic features, mood-congruent', 'bipolar disorder', 'severe bipolar i disorder, single manic episode without psychotic features', 'bipolar ii disorder, most recent episode major depressive', 'mixed bipolar i disorder', 'bipolar i disorder, most recent episode manic with catatonic features', 'severe bipolar ii disorder, most recent episode major depressive with psychotic features, mood-congruent', 'severe bipolar ii disorder, most recent episode major depressive with psychotic features, mood-incongruent', 'bipolar i disorder, most recent episode depressed with catatonic features', 'depressed bipolar i disorder in full remission', 'bipolar ii disorder, most recent episode major depressive with catatonic features', 'severe depressed bipolar i disorder with psychotic features, mood-incongruent', 'severe bipolar disorder with psychotic features, mood-incongruent', 'severe manic bipolar i disorder with psychotic features', 'moderate bipolar i disorder, single manic episode', 'bipolar i disorder, most recent episode depressed with atypical features', 'severe bipolar ii disorder, most recent episode major depressive with psychotic features', 'bipolar ii disorder, most recent episode major depressive with postpartum onset', 'manic bipolar i disorder in full remission', 'bipolar i disorder, most recent episode hypomanic', 'severe manic bipolar i disorder with psychotic features, mood-incongruent', 'bipolar ii disorder, most recent episode major depressive with melancholic features', 'mixed bipolar i disorder in remission', 'severe bipolar ii disorder, most recent episode major depressive, in remission', 'moderate bipolar ii disorder, most recent episode major depressive', 'mixed bipolar i disorder in partial remission', 'schizoaffective disorder, bipolar type', 'moderate mixed bipolar i disorder', 'mild bipolar i disorder, single manic episode', 'severe bipolar i disorder, single manic episode with psychotic features', 'bipolar disorder in full remission', 'bipolar ii disorder, most recent episode major depressive with atypical features', 'mild mixed bipolar i disorder', 'manic bipolar i disorder in remission', 'severe mixed bipolar i disorder without psychotic features', 'bipolar ii disorder, most recent episode hypomanic', 'depressed bipolar i disorder', 'depressed bipolar i disorder in partial remission', 'chronic bipolar i disorder, most recent episode depressed', 'severe bipolar disorder without psychotic features', 'depressed bipolar i disorder in remission', 'severe depressed bipolar i disorder with psychotic features, mood-congruent', 'bipolar i disorder, most recent episode manic with postpartum onset', 'severe depressed bipolar i disorder with psychotic features', 'severe depressed bipolar i disorder without psychotic features', 'manic bipolar i disorder in partial remission', 'severe mixed bipolar i disorder with psychotic features, mood-congruent', 'bipolar i disorder, most recent episode mixed with postpartum onset', 'moderate depressed bipolar i disorder', 'severe bipolar ii disorder, most recent episode major depressive, in partial remission', 'manic bipolar i disorder', 'severe bipolar disorder with psychotic features, mood-congruent', 'mild bipolar ii disorder, most recent episode major depressive', 'mild manic bipolar i disorder', 'bipolar cells of retina', 'electrocoagulation', 'bipolar i disorder, most recent episode mixed with catatonic features', 'mild depressed bipolar i disorder', 'bipolar i disorder, single manic episode, in remission', 'bipolar i disorder, most recent episode depressed with melancholic features', 'bipolar i disorder, single manic episode, in partial remission', 'severe manic bipolar i disorder with psychotic features, mood-congruent', 'moderate bipolar disorder', 'severe bipolar ii disorder, most recent episode major depressive without psychotic features', 'moderate manic bipolar i disorder', 'bipolar ii disorder', 'bipolar disorder in remission', 'severe bipolar i disorder, single manic episode with psychotic features, mood-incongruent', 'bipolar i disorder, most recent episode depressed with postpartum onset', 'bipolar i disorder, single manic episode with catatonic features', 'mixed bipolar i disorder in full remission', 'family history: manic-depressive state', 'bipolar affective disorder, current episode manic', 'bipolar affective disorder, currently manic, mild', 'bipolar affective disorder, currently manic, moderate', 'bipolar affective disorder, currently manic, severe, with psychosis', 'bipolar affective disorder, currently manic, in full remission', 'bipolar affective disorder, current episode depression', 'bipolar affective disorder, currently depressed, mild', 'bipolar affective disorder, currently depressed, moderate', 'bipolar affective disorder, currently depressed, in full remission', 'mixed bipolar affective disorder', 'mixed bipolar affective disorder, mild', 'mixed bipolar affective disorder, moderate', 'mixed bipolar affective disorder, severe, with psychosis', 'mixed bipolar affective disorder, in full remission', 'bipolar affective disorder, current episode mixed', 'organic bipolar disorder', 'bipolar diathermy', 'bipolar', 'profile of mood states, bipolar', 'bipolar i disorder', 'severe bipolar i disorder', 'severe bipolar disorder', 'severe bipolar ii disorder', 'referral for bipolar disorder', 'severe mixed bipolar i disorder', 'severe depressed bipolar i disorder', 'rapid cycling bipolar i disorder', 'femoral head bipolar component', 'humeral head bipolar component', 'endotherapy electrosurgical coagulator/cutter, bipolar, refurbished', 'bipolar partial shoulder prosthesis', 'laparoscopic electrosurgical forceps, bipolar', 'endotherapy electrosurgical coagulator/cutter, bipolar, reusable', 'severe manic bipolar i disorder', 'planar-resection electrosurgical diathermy bipolar conducting unit', 'universal electrosurgical diathermy system bipolar electrode, reprocessed', 'universal electrosurgical diathermy system bipolar electrode, single-use', 'bipolar clinic', 'partial hip replacement with bipolar prosthesis', 'endoscopic electrosurgical electrode, bipolar, reprocessed', 'endoscopic electrosurgical electrode, bipolar, reusable', 'endoscopic electrosurgical electrode, bipolar, single-use', 'percutaneous electrosurgical probe, spinal-denervation, bipolar', 'laparoscopic electrosurgical forceps, bipolar, reprocessed', 'hysteroscopic bipolar electrosurgical excision of uterine fibroid', 'bipolar type ii disorder currently in full remission', 'bipolar type i disorder currently in full remission', 'robotic single-use bipolar electrosurgical instrument', 'robotic reusable bipolar electrosurgical instrument', 'psychosis and severe depression co-occurrent and due to bipolar affective disorder', 'bipolar disorder, most recent episode depression', 'bipolar disorder, most recent episode manic', 'bipolar affective disorder, most recent episode mixed', 'bipolar i disorder, most recent episode manic', 'bipolar i disorder, most recent episode depression', 'bipolar disorder caused by drug', 'rapid cycling bipolar ii disorder', \"rud's syndrome\", 'thought block', 'history and physical examination, follow-up for emotional or mental disease', 'hospital-based outpatient mental health clinic', 'well in self', 'mental condensation', 'emotionally detached', 'profound intellectual disability', 'hyperphosphatasemia with intellectual disability', 'mental state finding', 'severe intellectual disability', 'medico-legal mental status determination', 'transection of mental nerve', 'avulsion of mental nerve', 'mental handicap', 'structure of mental nerve', 'destruction by neurolytic agent of trigeminal nerve, mental', 'free-standing mental health clinic', 'structure of mental artery', 'cutis laxa-corneal clouding-oligophrenia syndrome', 'cutis laxa, x-linked', 'moderate intellectual disability', 'psychiatric hospital', \"knight's move in thought\", 'concussion with mental confusion and/or disorientation without loss of consciousness', 'borderline intellectual disability', 'initial psychiatric interview with mental status and evaluation', 'rumination - thoughts', 'mild intellectual disability', 'victim of mental abuse', \"kohlschutter's syndrome\", 'substance abuse and mental health services administration drug assay confirmation method', 'mental disorder', 'chronic mental disorder', 'has community mental health team key worker', 'on national service framework mental health register', 'entire mental artery', 'mental welfare officer', 'on examination - mental state', 'on examination - sub-mental lymphadenopathy', 'mental disability assessment score', 'mental disability admission score', 'mental disability in-patient score', 'mental disability discharge score', 'mental disability out-patient score', 'mental disability domiciliary visit score', 'mental handicap problem', 'mental health act examination', 'refer to mental health worker', 'specific nonpsychotic mental disorders following organic brain damage', 'mental disorders during pregnancy, childbirth and the puerperium', 'mental health nurse', 'community mental health nurse', 'community mental health hostel', 'mental defense mechanisms', 'mental health impairment', 'sepsis-associated encephalopathy', 'repositioning of mental nerve', 'local anesthetic mental nerve block', 'intraoral approach to local anesthetic mental nerve block', 'extraoral approach to local anesthetic mental nerve block', 'injection of neurolytic substance to mental nerve', 'injection of neurolytic substance to mental nerve by intraoral approach', 'injection of neurolytic substance to mental nerve by extraoral approach', 'prune belly syndrome with pulmonic stenosis, mental retardation and deafness', 'hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities', 'mental foramen', 'general mental state', 'excessive feelings of mental efficiency', 'mental alertness', 'pregnancy with mental disorders', 'disability assessment - mental', 'mental distress', 'abbreviated mental test score', 'communication assessment profile for adults with a mental handicap', 'glasgow abbreviated mental test score', 'mental status questionnaire', 'mental test score', 'mental test score - long version', 'middlesex elderly assessment of mental state', 'mini-mental state examination', 'modified mini-mental state examination', 'family history: mental handicap', 'psychological abuse of adult', 'entire mental nerve', 'health of the nation outcome scale item 8 - other mental/behavioral problems', 'griffiths mental developmental scale', 'mental function', 'acting out - mental defense mechanism', 'altruism - mental defense mechanism', 'anticipation - mental defense mechanism', 'conversion - mental defense mechanism', 'delusional projection - mental defense mechanism', 'devaluation - mental defense mechanism', 'displacement - mental defense mechanism', 'dissociation - mental defense mechanism', 'humor - mental defense mechanism', 'idealization - mental defense mechanism', 'identification - mental defense mechanism', 'identification with the aggressor - mental defense mechanism', 'intellectualization - mental defense mechanism', 'introjection - mental defense mechanism', 'isolation - mental defense mechanism', 'manic - mental defense mechanism', 'omnipotence - mental defense mechanism', 'passive aggression - mental defense mechanism', 'phobic avoidance - mental defense mechanism', 'primitive idealization - mental defense mechanism', 'psychotic denial - mental defense mechanism', 'rationalization - mental defense mechanism', 'reaction-formation - mental defense mechanism', 'reversal - mental defense mechanism', 'schizoid fantasy - mental defense mechanism', 'suppression - mental defense mechanism', 'splitting - mental defense mechanism', 'turning against the self - mental defense mechanism', 'undoing - mental defense mechanism', 'screening for mental disorders', 'member of mental health review tribunal', 'mental adjustment to cancer scale', 'psychodynamic interventions relating to mental defense mechanisms', 'understanding mental defense mechanisms', 'confronting mental defense mechanisms', 'admission by psychiatrist for mental handicap', 'admission by mental health nurse', 'admission to mental handicap psychiatry department', 'under care of mental health counselor', 'under care of psychiatrist for mental handicap', 'seen by mental health counselor', 'seen by psychiatrist for mental handicap', 'seen by mental handicap psychiatry service', 'referral by mental health counselor', 'referral by psychiatrist for mental handicap', 'referral to mental handicap psychiatry service', 'referral to mental health counseling service', 'referral for mental health counseling', 'referral for mental illness domiciliary visit', 'referral to mental health counselor', 'referral to psychiatrist for mental handicap', 'discharge by mental health counselor', 'discharge by psychiatrist for mental handicap', 'discharge from mental handicap psychiatry service', 'psychiatrist for mental handicap', 'mental handicap psychiatry department', 'mental health counseling service', 'mental handicap psychiatry service', 'mental health counselor', 'developmental academic disorder', 'mental state, behavior / psychosocial function observable', 'mental state', 'mental defense mechanism finding', 'general mental state finding', 'finding of mental alertness', 'regression - mental defense mechanism', 'projection - mental defense mechanism', 'sublimation - mental defense mechanism', 'denial - mental defense mechanism', 'concentration, function', 'repression - mental defense mechanism', 'finding of mental state: drive', 'hereditary insensitivity to pain with anhidrosis', 'mental state, behavior and/or psychosocial function finding', 'mental health history taking assessment', 'history taking, mental health', 'mental health history taking education', 'mental health history taking management', 'mental health promotion', 'mental health screening', 'mental health treatment', 'mental health care', 'emergency mental health assessment', 'planned mental health assessment', 'crisis/short term interventions in mental health care', 'secure and high-dependency mental health care', 'assertive outreach in mental health care', 'mental health crisis resolution', 'homeless mental health care', 'perinatal mental health care', 'mental health addiction programs', 'mental health functional therapies', 'mental health support groups - staff facilitated', \"mental health caregivers' respite\", 'mental health caregiver support', 'mental health support - no facilitation', 'referral to mental health team', 'removed from severe mental illness register', 'mental health healthcare resource groups', 'emergency mental health assessment - 24 hour intensive', 'emergency mental health assessment - 24 hour not intensive', 'emergency mental health assessment - part day : day care', 'planned mental health assessment - 24 hour not intensive', 'planned mental health assessment - full day : day care', 'planned mental health assessment - part day : day care', 'crisis/short term interventions in mental health care - 24 hour intensive', 'crisis/short term interventions in mental health care - 24 hr not intensive', 'crisis/short term interventions in mental health care - full day : day care', 'crisis/short term interventions in mental health care - part day : day care', 'crisis/short term interventions in mental health care - daily intensive', 'mental health crisis resolution - 24 hour not intensive', 'emergency mental health assessment - daily intensive', 'mental health crisis resolution - part day', 'mental health crisis resolution - daily intensive', 'mental health crisis resolution - full day', 'mental health crisis resolution - 24 hour intensive', 'homeless mental health care - full day : day care', 'homeless mental health care - part day : day care', 'on severe mental illness register', 'homeless mental health care - daily intensive', 'homeless mental health care - 3-5 contacts/week', 'mental health addiction programs - 24 hour not intensive', 'mental health addiction programs - 24 hour intensive', 'mental health addiction programs - full day: day care', 'mental health addiction programs - part day: day care', 'mental health addiction programs - daily intensive', 'mental health addiction programs - 3-5 contacts/week', 'mental health addiction programs - 1-2 contacts/week', 'mental health addiction programs - 1-3 contacts/month', 'mental health addiction programs - <1 contact/month', 'mental health support groups staff facilitated - 1-2 contacts/week', 'mental health support groups staff facilitated - 1-3 contacts/month', 'mental health support groups staff facilitated - <1 contact/month', 'mental health support no facilitation - 1-2 contacts/week', 'mental health functional therapies - full day : day care', 'mental health functional therapies - 24 hr not intensive', 'mental health functional therapies - part day : day care', 'mental health functional therapies - daily intensive', 'mental health functional therapies - 3-5 contacts/wk', 'mental health functional therapies - 1-2 contacts/week', 'mental health support no facilitation - 1-3 contacts/month', 'mental health support no facilitation - <1 contact/month', 'mental health functional therapies - 1-3 contacts/month', 'mental health functional therapies - <1 contacts/month', \"mental health caregivers' respite healthcare resource groups\", \"mental health caregivers' support healthcare resource groups\", 'mental health residential care healthcare resource groups', 'perinatal mental health care healthcare resource groups', 'mental health crisis resolution hrgs', 'mental health care coordination', 'mental health assessment', 'neurological mental status determination', 'assessment of mental status by psychiatrist', 'mental handicap', '', 'mental illness', '', 'mental health review', 'did not attend mental health appointment', 'no evidence of mental illness', 'under care of mental health team', 'completion of mental health crisis plan', 'frequent mental health care', 'intensive mental health care', 'self management of mental health problems', 'mental health annual physical examination done', 'adult mental illness - specialty', 'mental health care assessment', 'mental health care education', 'mental health care management', 'mental health promotion assessment', 'mental health promotion education', 'mental health promotion management', 'mental health screening assessment', 'mental health screening education', 'mental health screening management', 'mental health treatment assessment', 'mental health treatment education', 'management of mental health treatment', 'signs/symptoms-mental/emotional education, guidance, and counseling', 'evaluation for signs and symptoms of mental/emotional health problems', 'signs/symptoms-mental/emotional case management', 'signs/symptoms-mental/emotional surveillance', 'mental health medication review', 'mental health registration status', 'mental health problem', 'intellectual disability, congenital heart disease, blepharophimosis, blepharoptosis and hypoplastic teeth', 'under care of community psychiatric nurse', 'seen by community psychiatric nurse', 'caregiver of a person with mental health problem', 'mental health monitoring third letter', 'mental health monitoring invitation', 'mental health monitoring first letter', 'mental health monitoring second letter', 'mental and psychological observations', 'mental health monitoring verbal invitation', 'altered mental status', 'american association on mental retardation adaptive behavior scale', 'x-linked intellectual disability with marfanoid habitus', 'chin structure', 'entire chin', 'cooperative mental state', 'transient altered mental status', 'seen in mental health clinic', 'occupational circumstances assessment interview and rating scale forensic mental health version 4.0', 'level of mental discomfort', 'able to do simple mental arithmetic', 'discharge by mental health primary care worker', 'mental test score', 'assessment using mini-mental state examination', 'occupational circumstances assessment interview and rating scale version 4.0 score for forensic mental health', 'assessment using occupational circumstances assessment interview and rating scale version 4.0 for forensic mental health', 'abbreviated mental test score', 'mini-mental state examination score', 'assessment using middlesex elderly assessment of mental state', 'global assessment of functioning - 1993 diagnostic and statistical manual of mental disorders, fourth edition adaptation', 'structured interview for diagnostic and statistical manual of mental disorders, third edition, personality disorders', 'semicoma', 'stupor', 'drowsy', 'unconscious', 'structured clinical interview for diagnostic and statistical manual of mental disorders-third edition revised', 'perry syndrome', 'blepharophimosis-mental retardation syndrome, say-barber-biesecker-young-simpson type', 'blepharophimosis-intellectual disability syndrome maat-kievit-brunner type', 'suspected mental condition not found', 'relationship problems with family members due to mental condition', 'x-linked mental retardation syndrome, christianson type', 'x-linked intellectual disability-psychosis-macroorchidism syndrome', 'chromosome 2q37 deletion syndrome', 'iris coloboma with ptosis, hypertelorism, and mental retardation', 'x-linked intellectual disability snyder type', 'mental health clinic', 'offering of child and adolescent mental health service choice appointment', 'informing patient of outcome of child and adolescent mental health service choice appointment', 'progressive epilepsy-intellectual disability syndrome finnish type', 'mowat-wilson syndrome', 'x-linked intellectual deficit-dystonia-dysarthria syndrome', 'methyl-cytosine phosphate guanine binding protein-2 duplication syndrome', 'mental health assessment declined', 'impairment of mental alertness', 'no abnormality detected by mental health assessment', 'mental health service', 'short stature-characteristic facies-mental retardation-macrodontia-skeletal anomalies syndrome', 'phencyclidine induced mental problem', 'died in mental health unit', 'assessment using short warwick-edinburgh mental well-being scale', 'short warwick-edinburgh mental well-being scale', 'chromosome 11p13 deletion syndrome', 'assessment using american association on mental retardation adaptive behavior scale', 'intellectual disability, truncal obesity, retinal dystrophy and micropenis syndrome', 'goniodysgenesis with intellectual disability and short stature syndrome', 'assessment using modified mini-mental state examination', 'american association on mental retardation adaptive behavior scale score', 'hypoplasia of corpus callosum and mental retardation with adducted thumbs and spasticity and hydrocephalus syndrome', 'short warwick edinburgh mental well-being scale score', 'mental health care plan', 'assessment using warwick-edinburgh mental well-being scale', 'warwick edinburgh mental well being scale score', 'warwick edinburgh mental well being scale', 'assessment using comprehensive assessment of at-risk mental states', 'comprehensive assessment of at-risk mental states unusual thought content frequency and duration score', 'comprehensive assessment of at-risk mental states non-bizarre ideas frequency and duration score', 'comprehensive assessment of at-risk mental states perceptual abnormalities level of distress score', 'comprehensive assessment of at-risk mental states unusual thought content level of distress score', 'comprehensive assessment of at-risk mental states unusual thought content global rating scale score', 'comprehensive assessment of at-risk mental states disorganized speech frequency and duration score', 'comprehensive assessment of at-risk mental states disorganized speech level of distress score', 'comprehensive assessment of at-risk mental states perceptual abnormalities frequency and duration score', 'comprehensive assessment of at-risk mental states non-bizarre ideas global rating scale score', 'comprehensive assessment of at-risk mental states', 'comprehensive assessment of at-risk mental states non-bizarre ideas level of distress score', 'comprehensive assessment of at-risk mental states perceptual abnormalities global rating scale score', 'comprehensive assessment of at-risk mental states disorganized speech global rating scale score', 'modified mini-mental state examination score', 'cardiocranial syndrome pfeiffer type', 'alopecia, contracture, dwarfism, intellectual disability syndrome', 'brain anomaly, severe mental retardation, ectodermal dysplasia, skeletal deformity, ear anomaly, kidney dysplasia syndrome', 'intellectual disability, enteropathy, deafness, peripheral neuropathy, ichthyosis, keratoderma syndrome', 'intellectual disability, epileptic seizures, hypogonadism and hypogenitalism, microcephaly, obesity syndrome', 'congenital cataract with hypertrichosis and intellectual disability syndrome', 'seizure, sensorineural deafness, ataxia, intellectual disability, electrolyte imbalance syndrome', 'intellectual disability, craniofacial dysmorphism, hypogonadism, diabetes mellitus syndrome', 'assessment of perinatal mental health', 'macrocephaly, obesity, mental disability, ocular abnormality syndrome', 'infantile choroidocerebral calcification syndrome', 'cerebellar ataxia, intellectual disability, optic atrophy, skin abnormalities syndrome', 'entire mental foramen', 'retinitis pigmentosa, intellectual disability, deafness, hypogenitalism syndrome', 'megalocornea with intellectual disability syndrome', 'mental health personal health plan', 'mental health crisis plan', 'mental health care program approach contingency plan', 'mental health risk indicator assessment', 'mental health care program approach crisis plan', 'intellectual disability', 'intellectual disability birk-barel type', 'adult mental health service', 'blepharophimosis and mental retardation syndrome', 'assessment using griffith mental development scale', 'inpatient mental health environment', 'mental retardation, adducted thumbs, shuffling gait, aphasia syndrome', 'mental health and addiction center', 'assessment using psychiatric research interview for substance and mental disorders', 'psychiatric research interview for substance and mental disorders', 'facilitation of access to mental health service', 'excision of tumor of brain meninges', 'focal excision of brain tissue tumor', 'biopsy of brain tissue tumor', 'aspiration of cystic tumor of brain tissue', 'connection from cystic brain tumor to subcutaneous reservoir', 'aspiration of subcutaneous reservoir connecting to cystic brain tumor', 'destruction of brain tumor', 'injection of chemotherapeutic substance into tumor of brain tissue', 'tumor-node-metastasis', 'intracranial tumor', 'glial tumor of brain', 'astrocytoma of brain', 'ependymoma of brain', 'mixed glial tumor of brain', 'embryonal tumor of brain', 'brain tumor invasion status in retinoblastoma staging', 'location of brain tumor', 'tumor-like lesion of brain', 'suspected brain tumor', 'benign neoplasm of brain', 'pt4b: tumor invades any of the following: orbital apex, dura, brain, middle cranial fossa, cranial nerves other than maxillary division of trigeminal nerve, nasopharynx, or clivus', '', 'pt4b: tumor invades any of the following: orbital apex, dura, brain, middle cranial fossa, cranial nerves other than maxillary division of trigeminal nerve, nasopharynx, or clivus', '', 'germ cell tumor of the brain', 'excision of bone of cranium and excision of infratentorial neoplasm of brain', 'history of malignant neoplasm of brain', 'history of benign neoplasm of brain', '', 'abacavir', 'abacavir/lamivudine', 'abacavir/dolutegravir/lamivudine', 'abacavir/lamivudine/zidovudine', 'lamivudine', 'schedule h', 'guanosine', 'morbilliform', 'management of hiv/aids', 'who model list of essential medicines', 'didanosine', 'bioretrosynthesis', 'allopurinol', 'emtricitabine/tenofovir', 'fanconi syndrome', 'reverse-transcriptase inhibitor', 'tenofovir disoproxil', 'bristol myers squibb', 'zalcitabine', 'ciprofloxacin', 'emtricitabine', 'emtricitabine/tenofovir', 'tenofovir alafenamide', 'bictegravir/emtricitabine/tenofovir alafenamide', 'elvitegravir/cobicistat/emtricitabine/tenofovir', 'efavirenz/emtricitabine/tenofovir', 'tenofovir disoproxil', 'pre-exposure prophylaxis', 'emtricitabine/rilpivirine/tenofovir', 'bictegravir', 'lamivudine', 'lamivudine/zidovudine', 'dolutegravir/lamivudine/tenofovir', 'dolutegravir/lamivudine', 'abacavir/lamivudine', 'abacavir/dolutegravir/lamivudine', 'lamivudine/tenofovir', 'lamivudine/raltegravir', 'abacavir/lamivudine/zidovudine', 'who model list of essential medicines', 'stavudine', 'lamivudine/nevirapine/stavudine', 'organic anion transporter 1', 'stampidine', 'lipodystrophy', 'reverse-transcriptase inhibitor', 'metaxalone', 'haplogroup l0 (mtdna)', 'adverse effect', 'nucleoside analogue', 'tenofovir disoproxil', 'emtricitabine/tenofovir', 'tenofovir alafenamide', 'efavirenz/emtricitabine/tenofovir', 'pre-exposure prophylaxis', 'bictegravir/emtricitabine/tenofovir alafenamide', 'dolutegravir/lamivudine/tenofovir', 'elvitegravir/cobicistat/emtricitabine/tenofovir', 'lamivudine/tenofovir', 'efavirenz/lamivudine/tenofovir', 'zidovudine', 'lamivudine/zidovudine', 'abacavir/lamivudine/zidovudine', 'lamivudine', 'who model list of essential medicines', 'reverse transcriptase', 'lamivudine/nevirapine/zidovudine', 'list of antiviral drugs', 'nevirapine', 'glucuronidation', 'isoniazid', 'who model list of essential medicines', 'tuberculosis management', 'isoniazid/rifampicin', 'ethambutol/isoniazid', 'latent tuberculosis', 'rifampicin/isoniazid/pyrazinamide', 'ethambutol/isoniazid/pyrazinamide/rifampicin', 'ethambutol/isoniazid/rifampicin', 'tuberculosis', 'rifampicin', 'who model list of essential medicines', 'isoniazid/rifampicin', 'ethambutol/isoniazid/pyrazinamide/rifampicin', 'tuberculosis management', 'leprosy', 'isoniazid', 'rifampicin/isoniazid/pyrazinamide', 'ethambutol/isoniazid/rifampicin', 'genexpert mtb/rif', 'pyrazinamide', 'ethambutol/isoniazid/pyrazinamide/rifampicin', 'who model list of essential medicines', 'rifampicin/isoniazid/pyrazinamide', 'isoniazid', 'uricosuric', 'streptomycin', 'tuberculosis management', 'rifampicin', 'tuberculosis', 'ethambutol', 'who model list of essential medicines', 'ethambutol/isoniazid/pyrazinamide/rifampicin', 'ethambutol/isoniazid', 'tuberculosis management', 'ethambutol/isoniazid/rifampicin', 'isoniazid', 'enantiopure drug', 'bacteriostatic agent', 'color blindness', 'risperidone', 'olanzapine', 'autistic pride day', 'list of adverse effects of risperidone', 'janssen pharmaceuticals', 'paliperidone', 'atypical antipsychotic', 'quetiapine', 'antipsychotic', 'galactorrhea', 'olanzapine', 'olanzapine/fluoxetine', 'olanzapine/samidorphan', 'atypical antipsychotic', 'list of adverse effects of olanzapine', 'antipsychotic', 'psychotic depression', 'lurasidone', 'quetiapine', 'samidorphan', 'quetiapine', 'antipsychotic', 'atypical antipsychotic', 'appetite stimulant', 'olanzapine', 'psychotic depression', 'lurasidone', 'dibenzothiazepine', 'mirtazapine', 'borderline personality disorder', 'ziprasidone', 'atypical antipsychotic', 'quetiapine', 'potency (pharmacology)', 'amisulpride', 'lurasidone', 'psychomotor agitation', 'aripiprazole', 'antipsychotic', 'paliperidone', 'paliperidone', 'list of antipsychotics', 'antipsychotic', 'risperidone', 'atypical antipsychotic', 'hyperprolactinaemia', 'lurasidone', 'neuroleptic-induced deficit syndrome', 'palmitic acid', 'asenapine', 'lurasidone', 'list of adverse effects of lurasidone', 'cycloserine/lurasidone', 'atypical antipsychotic', 'antipsychotic', 'akathisia', 'extrapyramidal symptoms', 'laryngospasm', '5-ht1a receptor', 'paliperidone', 'everolimus', 'novartis', 'pancreatic neuroendocrine tumor', 'anticonvulsant', 'neuroendocrine tumor', 'targeted therapy', 'exemestane', 'list of largest selling pharmaceutical products', 'tuberous sclerosis', 'sunitinib', 'bevacizumab', 'genentech', 'novartis', 'antivascular endothelial growth factor therapy', 'biosimilar', 'side effect', 'chemotherapy', 'angiogenesis inhibitor', 'sue desmond-hellmann', 'carmen puliafito', 'bevacizumab', 'atezolizumab', 'ranibizumab', 'folfoxiri', 'antivascular endothelial growth factor therapy', 'macular degeneration', 'viatris', 'angiogenesis inhibitor', 'folfiri', 'retinopathy of prematurity', 'carmustine', 'bristol myers squibb', 'nitrosourea', 'list of drugs: bibo', 'carmustine', 'eisai (company)', 'lomustine', 'alkylating antineoplastic agent', 'methotrexate', 'interstitial lung disease', 'cutaneous t cell lymphoma', 'ground-glass opacity', 'crosslinking of dna', 'stomach cancer', 'ac-t (disambiguation)', 't.n.t. (album)', 'ac/dc', 'ac cobra', 'ac-to-ac converter', '.ac', 'lockheed ac-130', 'alternating current', 'douglas ac-47 spooky', 'a.c.t', 'product containing abacavir', 'product containing abacavir and lamivudine and zidovudine', 'product containing precisely abacavir', 'product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet', 'abacavir', 'abacavir sulfate', 'product containing abacavir and lamivudine', 'allergy to abacavir', 'product containing abacavir and lamivudine in oral dose form', 'product containing abacavir in oral dose form', 'product containing abacavir and dolutegravir and lamivudine', 'product containing abacavir and dolutegravir and lamivudine in oral dose form', 'product containing abacavir and lamivudine and zidovudine in oral dose form', 'product containing only abacavir', 'product containing only abacavir and lamivudine', 'product containing only abacavir and dolutegravir and lamivudine', 'product containing only abacavir and lamivudine and zidovudine', 'product containing only abacavir in oral dose form', 'product containing only abacavir and lamivudine in oral dose form', 'product containing only abacavir and dolutegravir and lamivudine in oral dose form', 'product containing only abacavir and lamivudine and zidovudine in oral dose form', 'product containing precisely abacavir', 'product containing precisely abacavir', 'product containing didanosine', 'didanosine adverse reaction', 'allergy to didanosine', 'product containing precisely didanosine 150 milligram/1 each conventional release oral tablet', 'product containing precisely didanosine 25 milligram/1 each conventional release oral tablet', 'product containing precisely didanosine 100 milligram/1 each conventional release oral tablet', 'product containing precisely didanosine 400 milligram/1 each gastro-resistant oral capsule', 'product containing precisely didanosine 250 milligram/1 each gastro-resistant oral capsule', 'product containing precisely didanosine 200 milligram/1 each gastro-resistant oral capsule', 'product containing precisely didanosine 125 milligram/1 each gastro-resistant oral capsule', 'product containing precisely didanosine 200 milligram/1 each conventional release oral tablet', 'product containing precisely didanosine 50 milligram/1 each conventional release oral tablet', 'product containing precisely didanosine 125 milligram/1 each conventional release oral capsule', 'product containing precisely didanosine 200 milligram/1 each conventional release oral capsule', 'product containing precisely didanosine 250 milligram/1 each conventional release oral capsule', 'didanosine', 'product containing didanosine in oral dose form', 'product containing only didanosine', 'product containing only didanosine in oral dose form', 'product containing precisely didanosine 2.5 milligram/1 milliliter conventional release oral solution', 'product containing precisely didanosine 1.67 milligram/1 milliliter conventional release oral solution', 'product containing precisely didanosine 1 milligram/1 milliliter conventional release oral solution', 'product containing precisely didanosine 10 milligram/1 milliliter conventional release oral solution', 'product containing emtricitabine', 'emtricitabine', 'product containing precisely emtricitabine 200 milligram/1 each conventional release oral capsule', 'product containing emtricitabine and tenofovir', 'product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet', 'product containing efavirenz and emtricitabine and tenofovir', 'product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet', 'product containing emtricitabine and rilpivirine and tenofovir', 'product containing efavirenz and emtricitabine and tenofovir in oral dose form', 'product containing emtricitabine and tenofovir in oral dose form', 'product containing emtricitabine in oral dose form', 'product containing cobicistat and elvitegravir and emtricitabine and tenofovir', 'product containing cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form', 'product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet', 'product containing precisely emtricitabine 10 milligram/1 milliliter conventional release oral solution', 'product containing bictegravir and emtricitabine and tenofovir', 'product containing bictegravir and emtricitabine and tenofovir in oral dose form', 'product containing only bictegravir and emtricitabine and tenofovir', 'product containing only cobicistat and elvitegravir and emtricitabine and tenofovir', 'product containing only efavirenz and emtricitabine and tenofovir', 'product containing only emtricitabine', 'product containing only emtricitabine and rilpivirine and tenofovir', 'product containing only emtricitabine and tenofovir', 'product containing only bictegravir and emtricitabine and tenofovir in oral dose form', 'product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form', 'product containing only efavirenz and emtricitabine and tenofovir in oral dose form', 'product containing only emtricitabine and tenofovir in oral dose form', 'product containing only emtricitabine in oral dose form', 'product containing lamivudine', 'product containing abacavir and lamivudine and zidovudine', 'product containing precisely lamivudine 150 milligram/1 each conventional release oral tablet', 'product containing precisely lamivudine 10 milligram/1 milliliter conventional release oral solution', 'product containing precisely lamivudine 5 milligram/1 milliliter conventional release oral solution', 'product containing precisely lamivudine 100 milligram/1 each conventional release oral tablet', 'product containing lamivudine and zidovudine', 'product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet', 'product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet', 'lamivudine', 'product containing precisely lamivudine 300 milligram/1 each conventional release oral tablet', 'product containing abacavir and lamivudine', 'product containing lamivudine and nevirapine and zidovudine', 'product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet', 'product containing lamivudine and stavudine', 'product containing precisely lamivudine 150 milligram and stavudine 40 milligram/1 each conventional release oral tablet', 'product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet', 'product containing precisely lamivudine 150 milligram and stavudine 30 milligram/1 each conventional release oral tablet', 'product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet', 'product containing lamivudine and nevirapine and stavudine', 'product containing precisely lamivudine 30 milligram and zidovudine 60 milligram/1 each conventional release oral tablet', 'product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 30 milligram/1 each conventional release oral tablet', 'product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 40 milligram/1 each conventional release oral tablet', 'product containing abacavir and lamivudine in oral dose form', 'product containing lamivudine in oral dose form', 'product containing lamivudine and nevirapine and stavudine in oral dose form', 'product containing lamivudine and nevirapine and zidovudine in oral dose form', 'product containing lamivudine and zidovudine in oral dose form', 'product containing abacavir and dolutegravir and lamivudine', 'product containing abacavir and dolutegravir and lamivudine in oral dose form', 'product containing abacavir and lamivudine and zidovudine in oral dose form', 'product containing only abacavir and lamivudine', 'product containing only abacavir and dolutegravir and lamivudine', 'product containing only abacavir and lamivudine and zidovudine', 'product containing only abacavir and lamivudine in oral dose form', 'product containing only abacavir and dolutegravir and lamivudine in oral dose form', 'product containing only abacavir and lamivudine and zidovudine in oral dose form', 'product containing lamivudine and stavudine in oral dose form', 'product containing only lamivudine', 'product containing only lamivudine and nevirapine and stavudine', 'product containing only lamivudine and nevirapine and zidovudine', 'product containing only lamivudine and stavudine', 'product containing only lamivudine and zidovudine', 'product containing only lamivudine and nevirapine and stavudine in oral dose form', 'product containing only lamivudine and nevirapine and zidovudine in oral dose form', 'product containing only lamivudine and stavudine in oral dose form', 'product containing only lamivudine and zidovudine in oral dose form', 'product containing only lamivudine in oral dose form', 'product containing only doravirine and lamivudine and tenofovir', 'product containing doravirine and lamivudine and tenofovir', 'product containing doravirine and lamivudine and tenofovir in oral dose form', 'product containing only doravirine and lamivudine and tenofovir in oral dose form', 'product containing precisely abacavir', 'product containing lamivudine and nevirapine and stavudine in oromucosal dose form', 'product containing only lamivudine and nevirapine and stavudine in oromucosal dose form', 'product containing dolutegravir and lamivudine', 'product containing only dolutegravir and lamivudine', 'product containing dolutegravir and lamivudine in oral dose form', 'product containing only dolutegravir and lamivudine in oral dose form', 'product containing stavudine', 'product containing precisely stavudine 15 milligram/1 each conventional release oral capsule', 'product containing precisely stavudine 20 milligram/1 each conventional release oral capsule', 'product containing precisely stavudine 30 milligram/1 each conventional release oral capsule', 'product containing precisely stavudine 40 milligram/1 each conventional release oral capsule', 'product containing precisely stavudine 1 milligram/1 milliliter conventional release oral solution', 'stavudine', 'product containing lamivudine and stavudine', 'product containing precisely lamivudine 150 milligram and stavudine 40 milligram/1 each conventional release oral tablet', 'product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet', 'product containing precisely lamivudine 150 milligram and stavudine 30 milligram/1 each conventional release oral tablet', 'product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet', 'product containing lamivudine and nevirapine and stavudine', 'product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 30 milligram/1 each conventional release oral tablet', 'product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 40 milligram/1 each conventional release oral tablet', 'product containing lamivudine and nevirapine and stavudine in oral dose form', 'product containing stavudine in oral dose form', 'product containing lamivudine and stavudine in oral dose form', 'product containing only lamivudine and nevirapine and stavudine', 'product containing only lamivudine and stavudine', 'product containing only stavudine', 'product containing only lamivudine and nevirapine and stavudine in oral dose form', 'product containing only lamivudine and stavudine in oral dose form', 'product containing only stavudine in oral dose form', 'product containing lamivudine and nevirapine and stavudine in oromucosal dose form', 'product containing only lamivudine and nevirapine and stavudine in oromucosal dose form', 'tenofovir disoproxil fumarate', 'product containing tenofovir', 'product containing precisely tenofovir disoproxil', 'product containing emtricitabine and tenofovir', 'product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet', 'tenofovir disoproxil', 'tenofovir', 'product containing efavirenz and emtricitabine and tenofovir', 'product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet', 'product containing emtricitabine and rilpivirine and tenofovir', 'product containing efavirenz and emtricitabine and tenofovir in oral dose form', 'product containing emtricitabine and tenofovir in oral dose form', 'product containing tenofovir in oral dose form', 'tenofovir alafenamide', 'product containing cobicistat and elvitegravir and emtricitabine and tenofovir', 'product containing cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form', 'product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide 10 milligram/1 each conventional release oral tablet', 'tenofovir alafenamide fumarate', 'product containing bictegravir and emtricitabine and tenofovir', 'product containing bictegravir and emtricitabine and tenofovir in oral dose form', 'product containing only bictegravir and emtricitabine and tenofovir', 'product containing only cobicistat and elvitegravir and emtricitabine and tenofovir', 'product containing only efavirenz and emtricitabine and tenofovir', 'product containing only emtricitabine and rilpivirine and tenofovir', 'product containing only emtricitabine and tenofovir', 'product containing only tenofovir', 'product containing only bictegravir and emtricitabine and tenofovir in oral dose form', 'product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form', 'product containing only efavirenz and emtricitabine and tenofovir in oral dose form', 'product containing only emtricitabine and tenofovir in oral dose form', 'product containing only tenofovir in oral dose form', 'product containing only doravirine and lamivudine and tenofovir', 'product containing doravirine and lamivudine and tenofovir', 'product containing doravirine and lamivudine and tenofovir in oral dose form', 'product containing only doravirine and lamivudine and tenofovir in oral dose form', 'product containing zidovudine', 'product containing abacavir and lamivudine and zidovudine', 'zidovudine adverse reaction', 'allergy to zidovudine', 'product containing precisely zidovudine 100 milligram/1 each conventional release oral capsule', 'product containing precisely zidovudine 250 milligram/1 each conventional release oral capsule', 'product containing lamivudine and zidovudine', 'product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet', 'product containing precisely zidovudine 300 milligram/1 each conventional release oral tablet', 'product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet', 'zidovudine', 'product containing lamivudine and nevirapine and zidovudine', 'product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and zidovudine 300 milligram/1 each conventional release oral tablet', 'product containing zidovudine in parenteral dose form', 'product containing zidovudine in oral dose form', 'product containing precisely lamivudine 30 milligram and zidovudine 60 milligram/1 each conventional release oral tablet', 'product containing precisely zidovudine 60 milligram/1 each conventional release oral tablet', 'anemia caused by zidovudine', 'product containing lamivudine and nevirapine and zidovudine in oral dose form', 'product containing lamivudine and zidovudine in oral dose form', 'product containing abacavir and lamivudine and zidovudine in oral dose form', 'product containing precisely zidovudine 10 milligram/1 milliliter conventional release oral solution', 'product containing only abacavir and lamivudine and zidovudine', 'product containing only abacavir and lamivudine and zidovudine in oral dose form', 'product containing only lamivudine and nevirapine and zidovudine', 'product containing only lamivudine and zidovudine', 'product containing only zidovudine', 'product containing only lamivudine and nevirapine and zidovudine in oral dose form', 'product containing only lamivudine and zidovudine in oral dose form', 'product containing only zidovudine in oral dose form', 'product containing only zidovudine in parenteral dose form', 'poisoning caused by isoniazid', 'product containing isoniazid', 'accidental isoniazid poisoning', 'intentional isoniazid poisoning', 'isoniazid poisoning of undetermined intent', 'isoniazid adverse reaction', 'allergy to isoniazid', 'isoniazid overdose', 'accidental isoniazid overdose', 'intentional isoniazid overdose', 'isoniazid overdose of undetermined intent', 'product containing precisely isoniazid 50 milligram/1 each conventional release oral tablet', 'product containing precisely isoniazid 100 milligram/1 each conventional release oral tablet', 'product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet', 'product containing precisely isoniazid 150 milligram and rifampicin 300 milligram/1 each conventional release oral tablet', 'product containing isoniazid and rifampicin', 'product containing isoniazid and pyrazinamide and rifampicin', 'product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet', 'product containing precisely isoniazid 300 milligram/1 each conventional release oral tablet', 'product containing precisely isoniazid 150 milligram and rifampicin 300 milligram/1 each conventional release oral capsule', 'isoniazid', 'urine isoniazid measurement', 'isoniazid resistant tuberculosis', 'product containing isoniazid in parenteral dose form', 'product containing isoniazid in oral dose form', 'neuropathy caused by isoniazid', 'product containing isoniazid and pyrazinamide and rifampicin in oral dose form', 'product containing isoniazid and rifampicin in oral dose form', 'product containing ethambutol and isoniazid and pyrazinamide and rifampicin in oral dose form', 'product containing ethambutol and isoniazid in oral dose form', 'product containing ethambutol and isoniazid', 'product containing ethambutol and isoniazid and rifampicin', 'product containing ethambutol and isoniazid and pyrazinamide and rifampicin', 'product containing ethambutol and isoniazid and rifampicin in oral dose form', 'product containing precisely isoniazid 10 milligram/1 milliliter conventional release oral solution', 'product containing only ethambutol and isoniazid', 'product containing only ethambutol and isoniazid and pyrazinamide and rifampicin', 'product containing only ethambutol and isoniazid and rifampicin', 'product containing only isoniazid', 'product containing only isoniazid and pyrazinamide and rifampicin', 'product containing only isoniazid and rifampicin', 'product containing only ethambutol and isoniazid and pyrazinamide and rifampicin in oral dose form', 'product containing only ethambutol and isoniazid and rifampicin in oral dose form', 'product containing only ethambutol and isoniazid in oral dose form', 'product containing only isoniazid and pyrazinamide and rifampicin in oral dose form', 'product containing only isoniazid and rifampicin in oral dose form', 'product containing only isoniazid in oral dose form', 'product containing only isoniazid in parenteral dose form', 'product containing precisely isoniazid 25 milligram/1 milliliter conventional release solution for injection', 'product containing rifampicin', 'rifampicin poisoning', 'rifampicin adverse reaction', 'allergy to rifampicin', 'product containing precisely rifampicin 150 milligram/1 each conventional release oral capsule', 'product containing precisely rifampicin 300 milligram/1 each conventional release oral capsule', 'product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet', 'product containing precisely isoniazid 150 milligram and rifampicin 300 milligram/1 each conventional release oral tablet', 'product containing isoniazid and rifampicin', 'product containing isoniazid and pyrazinamide and rifampicin', 'product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet', 'rifampicin', 'urine rifampicin level', 'rifampicin resistant tuberculosis', 'product containing rifampicin in oral dose form', 'product containing rifampicin in parenteral dose form', 'product containing isoniazid and pyrazinamide and rifampicin in oral dose form', 'product containing isoniazid and rifampicin in oral dose form', 'product containing ethambutol and isoniazid and pyrazinamide and rifampicin in oral dose form', 'product containing ethambutol and isoniazid and rifampicin', 'product containing ethambutol and isoniazid and pyrazinamide and rifampicin', 'product containing ethambutol and isoniazid and rifampicin in oral dose form', 'product containing precisely isoniazid 150 milligram and rifampicin 300 milligram/1 each conventional release oral capsule', 'rifampicin sodium', 'product containing precisely rifampicin 600 milligram/1 vial powder for conventional release solution for injection', 'product containing precisely rifampicin 20 milligram/1 milliliter conventional release oral suspension', 'product containing only ethambutol and isoniazid and pyrazinamide and rifampicin', 'product containing only ethambutol and isoniazid and rifampicin', 'product containing only isoniazid and pyrazinamide and rifampicin', 'product containing only isoniazid and rifampicin', 'product containing only rifampicin', 'product containing only ethambutol and isoniazid and pyrazinamide and rifampicin in oral dose form', 'product containing only ethambutol and isoniazid and rifampicin in oral dose form', 'product containing only isoniazid and pyrazinamide and rifampicin in oral dose form', 'product containing only isoniazid and rifampicin in oral dose form', 'product containing only rifampicin in oral dose form', 'product containing only rifampicin in parenteral dose form', 'product containing pyrazinamide', 'pyrazinamide measurement', 'pyrazinamide adverse reaction', 'allergy to pyrazinamide', 'product containing precisely pyrazinamide 500 milligram/1 each conventional release oral tablet', 'product containing isoniazid and pyrazinamide and rifampicin', 'product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet', 'pyrazinamide', 'pyrazinamide resistant tuberculosis', 'product containing isoniazid and pyrazinamide and rifampicin in oral dose form', 'product containing ethambutol and isoniazid and pyrazinamide and rifampicin in oral dose form', 'product containing pyrazinamide in oral dose form', 'product containing ethambutol and isoniazid and pyrazinamide and rifampicin', 'product containing only ethambutol and isoniazid and pyrazinamide and rifampicin', 'product containing only isoniazid and pyrazinamide and rifampicin', 'product containing only pyrazinamide', 'product containing only ethambutol and isoniazid and pyrazinamide and rifampicin in oral dose form', 'product containing only isoniazid and pyrazinamide and rifampicin in oral dose form', 'product containing only pyrazinamide in oral dose form', 'poisoning caused by ethambutol', 'product containing ethambutol', 'ethambutol hydrochloride', 'ethambutol measurement', 'accidental ethambutol poisoning', 'intentional ethambutol poisoning', 'ethambutol poisoning of undetermined intent', 'ethambutol overdose', 'accidental ethambutol overdose', 'intentional ethambutol overdose', 'ethambutol overdose of undetermined intent', 'product containing precisely ethambutol hydrochloride 100 milligram/1 each conventional release oral tablet', 'product containing precisely ethambutol hydrochloride 400 milligram/1 each conventional release oral tablet', 'ethambutol', 'urine ethambutol level', 'ethambutol adverse reaction', 'ethambutol resistant tuberculosis', 'product containing ethambutol and isoniazid and pyrazinamide and rifampicin in oral dose form', 'product containing ethambutol and isoniazid in oral dose form', 'product containing ethambutol and isoniazid', 'product containing ethambutol in oral dose form', 'product containing ethambutol and isoniazid and rifampicin', 'product containing ethambutol and isoniazid and pyrazinamide and rifampicin', 'product containing ethambutol and isoniazid and rifampicin in oral dose form', 'product containing only ethambutol', 'product containing only ethambutol and isoniazid', 'product containing only ethambutol and isoniazid and pyrazinamide and rifampicin', 'product containing only ethambutol and isoniazid and rifampicin', 'product containing only ethambutol and isoniazid and pyrazinamide and rifampicin in oral dose form', 'product containing only ethambutol and isoniazid and rifampicin in oral dose form', 'product containing only ethambutol and isoniazid in oral dose form', 'product containing only ethambutol in oral dose form', 'allergy to ethambutol', 'product containing risperidone', 'risperidone measurement', 'risperidone poisoning', 'accidental risperidone poisoning', 'intentional risperidone poisoning', 'risperidone poisoning of undetermined intent', 'risperidone adverse reaction', 'allergy to risperidone', 'risperidone overdose', 'accidental risperidone overdose', 'intentional risperidone overdose', 'risperidone overdose of undetermined intent', 'product containing precisely risperidone 1 milligram/1 each conventional release oral tablet', 'product containing precisely risperidone 2 milligram/1 each conventional release oral tablet', 'product containing precisely risperidone 3 milligram/1 each conventional release oral tablet', 'product containing precisely risperidone 4 milligram/1 each conventional release oral tablet', 'product containing precisely risperidone 1 milligram/1 milliliter conventional release oral solution', 'product containing precisely risperidone 6 milligram/1 each conventional release oral tablet', 'product containing precisely risperidone 500 microgram/1 each conventional release oral tablet', 'product containing precisely risperidone 250 microgram/1 each conventional release oral tablet', 'risperidone', 'product containing risperidone in oral dose form', 'product containing risperidone in parenteral dose form', 'product containing precisely risperidone 1 milligram/1 each conventional release orodispersible tablet', 'product containing precisely risperidone 2 milligram/1 each conventional release orodispersible tablet', 'product containing precisely risperidone 500 microgram/1 each conventional release orodispersible tablet', 'product containing precisely risperidone 3 milligram/1 each conventional release orodispersible tablet', 'product containing precisely risperidone 4 milligram/1 each conventional release orodispersible tablet', 'product containing precisely risperidone 12.5 milligram/1 vial powder for conventional release suspension for injection', 'product containing precisely risperidone 25 milligram/1 vial powder for conventional release suspension for injection', 'product containing precisely risperidone 37.5 milligram/1 vial powder for conventional release suspension for injection', 'product containing precisely risperidone 50 milligram/1 vial powder for conventional release suspension for injection', 'product containing only risperidone', 'product containing only risperidone in oral dose form', 'product containing only risperidone in parenteral dose form', 'product containing risperidone in oromucosal dose form', 'product containing only risperidone in oromucosal dose form', 'product containing olanzapine', 'olanzapine measurement', 'product containing precisely olanzapine 5 milligram/1 each conventional release oral tablet', 'product containing precisely olanzapine 7.5 milligram/1 each conventional release oral tablet', 'product containing precisely olanzapine 10 milligram/1 each conventional release oral tablet', 'product containing precisely olanzapine 2.5 milligram/1 each conventional release oral tablet', 'product containing precisely olanzapine 5 milligram/1 each conventional release orodispersible tablet', 'product containing precisely olanzapine 10 milligram/1 each conventional release orodispersible tablet', 'product containing precisely olanzapine 20 milligram/1 each conventional release oral tablet', 'product containing precisely olanzapine 15 milligram/1 each conventional release oral tablet', 'product containing precisely olanzapine 20 milligram/1 each conventional release orodispersible tablet', 'olanzapine', 'product containing precisely olanzapine 15 milligram/1 each conventional release orodispersible tablet', 'product containing fluoxetine and olanzapine', 'product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 6 milligram/1 each conventional release oral capsule', 'product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 6 milligram/1 each conventional release oral capsule', 'product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 12 milligram/1 each conventional release oral capsule', 'product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 12 milligram/1 each conventional release oral capsule', 'product containing olanzapine in parenteral dose form', 'product containing olanzapine in oral dose form', 'product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 3 milligram/1 each conventional release oral capsule', 'olanzapine embonate', 'olanzapine embonate monohydrate', 'olanzapine pamoate', 'product containing fluoxetine and olanzapine in oral dose form', 'product containing only fluoxetine and olanzapine', 'product containing only olanzapine', 'product containing only fluoxetine and olanzapine in oral dose form', 'product containing only olanzapine in oral dose form', 'product containing only olanzapine in parenteral dose form', 'product containing olanzapine in oromucosal dose form', 'product containing only olanzapine in oromucosal dose form', 'quetiapine fumarate', 'product containing quetiapine', 'product containing precisely quetiapine', 'product containing precisely quetiapine', 'product containing precisely quetiapine', 'quetiapine', 'product containing precisely quetiapine', 'product containing precisely quetiapine', 'product containing precisely quetiapine', 'measurement of quetiapine', 'product containing precisely quetiapine', 'product containing precisely quetiapine fumarate 400 milligram/1 each conventional release oral tablet', 'product containing precisely quetiapine fumarate 50 milligram/1 each conventional release oral tablet', 'product containing quetiapine in oral dose form', 'product containing only quetiapine', 'product containing only quetiapine in oral dose form', 'product containing precisely quetiapine', 'ziprasidone hydrochloride', 'product containing ziprasidone', 'product containing precisely ziprasidone', 'product containing precisely ziprasidone hydrochloride 40 milligram/1 each conventional release oral capsule', 'product containing precisely ziprasidone', 'product containing precisely ziprasidone hydrochloride 80 milligram/1 each conventional release oral capsule', 'ziprasidone', 'ziprasidone mesilate', 'product containing ziprasidone in parenteral dose form', 'product containing ziprasidone in oral dose form', 'product containing only ziprasidone', 'product containing only ziprasidone in oral dose form', 'product containing only ziprasidone in parenteral dose form', 'product containing precisely ziprasidone', 'paliperidone', 'product containing paliperidone', 'product containing precisely paliperidone 3 milligram/1 each prolonged-release oral tablet', 'product containing precisely paliperidone 6 milligram/1 each prolonged-release oral tablet', 'product containing precisely paliperidone 9 milligram/1 each prolonged-release oral tablet', 'product containing precisely paliperidone 1.5 milligram/1 each prolonged-release oral tablet', 'paliperidone palmitate', 'product containing only paliperidone', 'product containing paliperidone in oral dose form', 'product containing only paliperidone in oral dose form', 'lurasidone hydrochloride', 'lurasidone', 'product containing lurasidone', 'product containing lurasidone in oral dose form', 'product containing only lurasidone', 'product containing only lurasidone in oral dose form', 'product containing bevacizumab', 'bevacizumab', 'product containing bevacizumab in parenteral dose form', 'product containing only bevacizumab', 'product containing only bevacizumab in parenteral dose form', 'product containing precisely bevacizumab 25 milligram/1 milliliter conventional release solution for injection', 'product containing carmustine', 'carmustine poisoning', 'accidental carmustine poisoning', 'intentional carmustine poisoning', 'carmustine poisoning of undetermined intent', 'carmustine adverse reaction', 'allergy to carmustine', 'carmustine overdose', 'accidental carmustine overdose', 'intentional carmustine overdose', 'carmustine overdose of undetermined intent', 'carmustine', 'implantation of carmustine wafer into cerebrum', 'product containing precisely carmustine 100 milligram/1 vial powder for conventional release solution for injection', 'product containing carmustine in parenteral dose form', 'product containing only carmustine', 'product containing only carmustine in parenteral dose form', 'product containing precisely carmustine 7.7 milligram/1 each prolonged-release intralesional implant', 'product containing carmustine in prolonged-release intralesional implant', 'product containing only carmustine in prolonged-release intralesional implant', 'clotting factor v assay', 'coagulation factor v', 'chondroitin ac lyase', 'hemoglobin raleigh', 'hereditary factor v deficiency disease', 'anterior chamber finding', 'ocular accommodation convergence/accommodation ratio', 'air conduction pure tone audiometry, manual with ear phones', 'ethyleneurea,melamineformaldehyde', '', 'alternating current', 'before meal', 'anterior colporrhaphy', 'index of orthodontic treatment need - esthetic component', 'amniocentesis', 'air conduction, function', 'measurement of ratio of accommodative convergence to accommodation', 'ethyleneurea,melamineformaldehyde', '', 'computed tomography of acromioclavicular joint', 'shallow anterior chamber of eye', 'medium depth anterior chamber of eye', 'deep anterior chamber of eye', 'anterior chamber of eye normal', 'anterior chamber of eye structure', 'actinium-224', 'actinium-226', 'actinium-225', 'actinium-227', 'actinium-228', 'actinium-229', '']\n",
      "CPU times: user 236 ms, sys: 28 ms, total: 264 ms\n",
      "Wall time: 271 ms\n"
     ]
    }
   ],
   "source": [
    "%%time\n",
    "import pymedtermino\n",
    "pymedtermino.LANGUAGE = \"en\"\n",
    "pymedtermino.REMOVE_SUPPRESSED_CONCEPTS = True\n",
    "from pymedtermino.all import *\n",
    "from pymedtermino import *\n",
    "\n",
    "from pymedtermino.snomedct import *\n",
    "import wikipedia\n",
    "\n",
    "snomed_senstive_info = []\n",
    "for item in sensitive_diseases:\n",
    "    info = SNOMEDCT.search(item)\n",
    "    snomed_senstive_info.append(info)\n",
    "    \n",
    "snomed_senstive_drug_info = []\n",
    "for item in sensitive_drugs :\n",
    "    info = SNOMEDCT.search(item)\n",
    "    snomed_senstive_drug_info.append(info)\n",
    "\n",
    "#print(snomed_senstive_drug_info)\n",
    "\n",
    "\n",
    "\n",
    "all_snomed_senstive_info=[]\n",
    "for term in snomed_senstive_info:\n",
    "    for term1 in term:\n",
    "        all_snomed_senstive_info.append(term1)\n",
    "#all_snomed_senstive_info     \n",
    "\n",
    "all_snomed_senstive_drug_info=[]\n",
    "for term in snomed_senstive_drug_info:\n",
    "    for term1 in term:\n",
    "        all_snomed_senstive_drug_info.append(term1)\n",
    "#print(all_snomed_senstive_drug_info)  \n",
    "\n",
    "\n",
    "import re\n",
    "string = ' '.join([str(elem) for elem in all_snomed_senstive_info])\n",
    "\n",
    "result1 = re.split(r\"#|\\n\",string.lower())\n",
    "\n",
    "result1\n",
    "result2=[]\n",
    "for i in result1:\n",
    "    res=re.findall(r\"^ snomedct\\[[0-9]+\\]  |^snomedct\\[[0-9]+\\]  \",i)#mached snomedct word\n",
    "    result2.append(res)\n",
    "result2\n",
    "result3=[ele for ele in result2 if ele!=[]]#remove empty list\n",
    "result4=[]\n",
    "for i in result3:\n",
    "    for item in i:\n",
    "        result4.append(item)#make ito a single list\n",
    "\n",
    "#print(result4)\n",
    "result5=[]\n",
    "for j in result1:\n",
    "    if j not in result4:\n",
    "        result5.append(j.strip())#extracting other then snomedct word and number\n",
    "#print(result5)\n",
    "result5=' '.join([str(elem) for elem in result5])\n",
    "result6=re.split(r\"\\(|\\)\", result5)#\n",
    "#print(result6)\n",
    "\n",
    "result7 = re.split(r\"\\(|\\)\",string)\n",
    "\n",
    "#print(result7)\n",
    "result1\n",
    "result8=set()\n",
    "for i in result7:\n",
    "    if '\\n' not in i:\n",
    "        result8.add(str(i).lower())\n",
    "\n",
    "result9=[]\n",
    "for i in result8:\n",
    "    res=re.findall(r\"^(?!snomedct*).+\",i)#mached snomedct word\n",
    "    result9.append(res)\n",
    "#print(result9)\n",
    "result10=[]\n",
    "for i in result9:\n",
    "    for j in i:\n",
    "        if j !=[''] and j !=' ' and j!='':\n",
    "            result10.append(j)\n",
    "\n",
    "\n",
    "snomed_reduced_final_result=[]\n",
    "for i in result6:\n",
    "    if i not in result10:\n",
    "        snomed_reduced_final_result.append(i.strip())\n",
    "#print(snomed_reduced_final_result)\n",
    "\n",
    "\n",
    "\n",
    "import re\n",
    "string = ' '.join([str(elem) for elem in all_snomed_senstive_drug_info])\n",
    "#type(result1)\n",
    "result1 = re.split(r\"#|\\n\",string.lower())\n",
    "\n",
    "#print(result1)\n",
    "result2=[]\n",
    "for i in result1:\n",
    "    res=re.findall(r\"^ snomedct\\[[0-9]+\\]  |^snomedct\\[[0-9]+\\]  \",i)#mached snomedct word\n",
    "    result2.append(res)\n",
    "result2\n",
    "result3=[ele for ele in result2 if ele!=[]]#remove empty list\n",
    "result4=[]\n",
    "for i in result3:\n",
    "    for item in i:\n",
    "        result4.append(item)#make ito a sinle list\n",
    "\n",
    "result4\n",
    "result5=[]\n",
    "for j in result1:\n",
    "    if j not in result4:\n",
    "        result5.append(j.strip())\n",
    "#result5\n",
    "result5=' '.join([str(elem) for elem in result5])\n",
    "result6=re.split(r\"\\(|\\)\", result5)\n",
    "result6\n",
    "\n",
    "result7 = re.split(r\"\\(|\\)\",string)\n",
    "#result1.group(0)\n",
    "result1\n",
    "result8=set()\n",
    "for i in result7:\n",
    "    if '\\n' not in i:\n",
    "        result8.add(str(i).lower())\n",
    "\n",
    "result9=[]\n",
    "for i in result8:\n",
    "    res=re.findall(r\"^(?!snomedct*).+\",i)#mached snomedct word\n",
    "    result9.append(res)\n",
    "\n",
    "result10=[]\n",
    "for i in result9:\n",
    "    for j in i:\n",
    "        if j !=[''] and j !=' ' and j!='':\n",
    "            result10.append(j)\n",
    "\n",
    "\n",
    "snomed_reduced_final_drug_result=[]\n",
    "for i in result6:\n",
    "    if i not in result10:\n",
    "        snomed_reduced_final_drug_result.append(i.strip())\n",
    "snomed_reduced_final_drug_result\n",
    "\n",
    "\n",
    "\n",
    "\n",
    "import wikipedia\n",
    "wikipedia_senstive_info = []\n",
    "for item in sensitive_diseases:\n",
    "    info = wikipedia.search(item)\n",
    "    wikipedia_senstive_info.append(info)\n",
    "#wikipedia_senstive_info\n",
    "\n",
    "wikipedia_senstive_drug_info = []\n",
    "for item in sensitive_drugs:\n",
    "    info = wikipedia.search(item)\n",
    "    wikipedia_senstive_drug_info.append(info)\n",
    "#print(wikipedia_senstive_drug_info)\n",
    "\n",
    "\n",
    "\n",
    "\n",
    "\n",
    "all_wikipedia_senstive_info=[]\n",
    "for term in wikipedia_senstive_info:\n",
    "    for term1 in term:\n",
    "        all_wikipedia_senstive_info.append(term1)\n",
    "all_wikipedia_senstive_info\n",
    "for i in range(len(all_wikipedia_senstive_info)):\n",
    "    all_wikipedia_senstive_info[i] = all_wikipedia_senstive_info[i].lower()\n",
    "\n",
    "\n",
    "\n",
    "all_wikipedia_senstive_drug_info=[]\n",
    "for term in wikipedia_senstive_drug_info:\n",
    "    for term1 in term:\n",
    "        all_wikipedia_senstive_drug_info.append(term1)\n",
    "all_wikipedia_senstive_drug_info\n",
    "for i in range(len(all_wikipedia_senstive_drug_info)):\n",
    "    all_wikipedia_senstive_drug_info[i] = all_wikipedia_senstive_drug_info[i].lower()\n",
    "\n",
    "\n",
    "\n",
    "final_sensitive_info_list = all_wikipedia_senstive_info + snomed_reduced_final_result\n",
    "final_drug_list = all_wikipedia_senstive_drug_info + snomed_reduced_final_drug_result\n",
    "\n",
    "final_sensitive_list = final_sensitive_info_list + final_drug_list\n",
    "\n",
    "\n",
    "print(final_sensitive_list)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "CPU times: user 0 ns, sys: 0 ns, total: 0 ns\n",
      "Wall time: 76.8 s\n"
     ]
    }
   ],
   "source": [
    "%%time\n",
    "import pymedtermino\n",
    "pymedtermino.LANGUAGE = \"en\"\n",
    "pymedtermino.REMOVE_SUPPRESSED_CONCEPTS = True\n",
    "from pymedtermino.all import *\n",
    "from pymedtermino import *\n",
    "\n",
    "from pymedtermino.snomedct import *\n",
    "import wikipedia\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# PREPROCESSING OF A DOCUMENT"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "CPU times: user 0 ns, sys: 0 ns, total: 0 ns\n",
      "Wall time: 177 s\n"
     ]
    }
   ],
   "source": [
    "%%time\n",
    "import nltk\n",
    "import re\n",
    "from nltk.corpus import stopwords\n",
    "from nltk.stem import SnowballStemmer\n",
    "from nltk.stem import WordNetLemmatizer\n",
    "from string import punctuation #special character\n",
    "from autocorrect import spell\n",
    "\n",
    "snowball_stemmer = SnowballStemmer('english')\n",
    "wordnet_lemmatizer = WordNetLemmatizer()\n",
    "\n",
    "class Preprocess:\n",
    "    def __int__(self):\n",
    "        pass\n",
    "\n",
    "    def autospell(self,text):\n",
    "       \n",
    "        #correct the spelling of the word.\n",
    "       \n",
    "        spells = [spell(w) for w in (nltk.word_tokenize(text))]\n",
    "        return \" \".join(spells)\n",
    "\n",
    "    def to_lower(self,text):\n",
    "        \n",
    "       # :param text:\n",
    "        #:return:\n",
    "         #   Converted text to lower case as in, converting \"Hello\" to \"hello\" or \"HELLO\" to \"hello\".\n",
    "        \n",
    "        return text.lower()\n",
    "\n",
    "    def remove_numbers(self,text):\n",
    "        \n",
    "        #take string input and return a clean text without numbers.\n",
    "       # Use regex to discard the numbers.\n",
    "        \n",
    "        output = ''.join(c for c in text if not c.isdigit())\n",
    "        return output\n",
    "\n",
    "    def remove_punct(self,text):\n",
    "      \n",
    "        #take string input and clean string without punctuations.\n",
    "        #use regex to remove the punctuations.\n",
    "       \n",
    "        return ''.join(c for c in text if c not in punctuation)\n",
    "\n",
    "    def remove_Tags(self,text):\n",
    "        \n",
    "        #take string input and clean string without tags.\n",
    "        #use regex to remove the html tags.\n",
    "        \n",
    "        cleaned_text = re.sub('<[^<]+?>', '', text)\n",
    "        return cleaned_text\n",
    "\n",
    "    def sentence_tokenize(self,text):\n",
    "       \n",
    "        #take string input and return list of sentences.\n",
    "       # use nltk.sent_tokenize() to split the sentences.\n",
    "        \n",
    "        sent_list = []\n",
    "        for w in nltk.sent_tokenize(text):\n",
    "            sent_list.append(w)\n",
    "        return sent_list\n",
    "\n",
    "    def word_tokenize(self,text):\n",
    "        \n",
    "        #:param text:\n",
    "        #:return: list of words\n",
    "       \n",
    "        return [w for sent in nltk.sent_tokenize(text) for w in nltk.word_tokenize(sent)]\n",
    "\n",
    "    def remove_stopwords(self,sentence):\n",
    "    \n",
    "        #removes all the stop words like \"is,the,a, etc.\"\n",
    "      \n",
    "        stop_words = stopwords.words('english')\n",
    "        return ' '.join([w for w in nltk.word_tokenize(sentence) if not w in stop_words])\n",
    "\n",
    "    def stem(self,text):\n",
    "       \n",
    "        #:param word_tokens:\n",
    "        #:return: list of words\n",
    "        \n",
    "        stemmed_word = [snowball_stemmer.stem(word) for sent in nltk.sent_tokenize(text)for word in nltk.word_tokenize(sent)]\n",
    "        return \" \".join(stemmed_word)\n",
    "\n",
    "    def lemmatize(self,text):\n",
    "        lemmatized_word = [wordnet_lemmatizer.lemmatize(word)for sent in nltk.sent_tokenize(text)for word in nltk.word_tokenize(sent)]\n",
    "        return \" \".join(lemmatized_word)\n",
    "\n",
    "\n",
    "    def preprocess(self,text):\n",
    "        lower_text = self.to_lower(text)\n",
    "        sentence_tokens = self.sentence_tokenize(lower_text)\n",
    "        word_list = []\n",
    "        for each_sent in sentence_tokens:\n",
    "            lemmatizzed_sent = self.lemmatize(each_sent)\n",
    "            clean_text = self.remove_numbers(lemmatizzed_sent)\n",
    "            clean_text = self.remove_punct(clean_text)\n",
    "            clean_text = self.remove_Tags(clean_text)\n",
    "            clean_text = self.remove_stopwords(clean_text)\n",
    "            word_tokens = self.word_tokenize(clean_text)\n",
    "            for i in word_tokens:\n",
    "                word_list.append(i)\n",
    "        return word_list"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# IMPORT REQUIRED LIBRARIES"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "CPU times: user 22.7 s, sys: 1.14 s, total: 23.9 s\n",
      "Wall time: 1min 12s\n"
     ]
    }
   ],
   "source": [
    "%%time\n",
    "\n",
    "\n",
    "import pandas as pd\n",
    "import spacy\n",
    "from spacy import displacy\n",
    "from scispacy.abbreviation import AbbreviationDetector\n",
    "\n",
    "import en_ner_bc5cdr_md\n",
    "import en_ner_bionlp13cg_md\n",
    "import pdfkit \n",
    "from IPython.core.display import HTML\n",
    "\n",
    "nlp_bc = en_ner_bc5cdr_md.load()\n",
    "nlp_bi = en_ner_bionlp13cg_md.load()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "CPU times: user 0 ns, sys: 0 ns, total: 0 ns\n",
      "Wall time: 52.5 s\n"
     ]
    }
   ],
   "source": [
    "%%time\n",
    "def check_sensitive(file):\n",
    "        f=open(file)\n",
    "        y=f.read()  \n",
    "        pr = Preprocess()\n",
    "        res=pr.preprocess(y)\n",
    "        y=\" \".join(res)\n",
    "        doc_bio = nlp_bi(y)\n",
    "        doc_bc = nlp_bc(y)\n",
    "        #print(doc_bc)\n",
    "        doc_bc_list = [str(item) for i in doc_bc.ents for item in i]\n",
    "        #print(doc_bc_list)\n",
    "        doc_list_bc = [str(item) for i in doc_bio.ents for item in i]\n",
    "        #print(doc_list_bc)\n",
    "        sen_list =  doc_bc_list+doc_list_bc#doc_med7_list \n",
    "        #print(sen_list)\n",
    "        sensitive = False\n",
    "        sen=[]\n",
    "        for item in sen_list:\n",
    "            term1 =  str(item)\n",
    "            if  term1 in final_sensitive_list:\n",
    "                sensitive=True\n",
    "                sen.append(term1)\n",
    "                \n",
    "            \n",
    "        if sensitive is True:\n",
    "            \n",
    "            return True\n",
    "        else:\n",
    "            return False\n",
    "    "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# GENERALIZATION PROCESS"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 68,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "RECORD #####\n",
      "* * * * * * * * * * * * * * * * * * * * * * * * * * * * Admission Date: [DATE] Report Status: Signed\n",
      "Discharge Date: [DATE]\n",
      "ATTENDING: [PERSONS] \n",
      "DISCHARGE DIAGNOSES:\n",
      "Anemia , GI bleed and CHF exacerbation.\n",
      "HISTORY OF PRESENT ILLNESS:\n",
      "This patient is a [61-70] years old gentleman with multiple past\n",
      "cardiovascular medical issues including hypertension , diabetes ,\n",
      "hypercholesterolemia , nonobstructive CAD on prior catheterization\n",
      "of 1993 and idiopathic cardiomyopathy with an ejection fraction\n",
      "reported at baseline from the [HOSPITAL] to be\n",
      "45% , prior echocardiogram in Montsair [HOSPITAL] from\n",
      "1994 reported at 25 to 30% , question alcoholic cardiomyopathy ,\n",
      "atrial fibrillation. He is status post right MCA CVA while on\n",
      "Coumadin for atrial fibrillation and peripheral vascular disease ,\n",
      "history of GI bleed who presented with increased shortness of\n",
      "breath and cough x several weeks. He noted initial shortness of\n",
      "breath and nonproductive cough in the end of 6/4 with a\n",
      "question infiltrate on chest film at that time and the patient\n",
      "was treated with a 10-day course of antibiotics of unknown\n",
      "content question levofloxacin with no improvement. Since late\n",
      "6/4 , the patient reports progressive shortness of breath ,\n",
      "dyspnea on exertion particularly with ambulation of steps and\n",
      "when lying down. Additionally , the patient reports a vague band\n",
      "like pain discomfort over left anterior chest particularly\n",
      "associated with ambulation of steps and when lying supine. Chest\n",
      "pain is associated with shortness of breath , but denies\n",
      "lightheadedness , diaphoresis or recent nausea and vomiting.\n",
      "Symptoms of chest pain and shortness of breath are notably worse\n",
      "over the last one to two weeks through the patient reports\n",
      "resolution over the last 24 hours with question of a new\n",
      "medication that he is unable recall. He denies palpitation or\n",
      "raising heart rate. He does report orthopnea , denies PND , but\n",
      "does report intermittent lower extremity swelling. He denies\n",
      "hematochezia , bright red blood per rectum , hematemesis with\n",
      "question of melanotic stools over the last month. The patient\n",
      "also with a history of prior GI bleed while in Lan , West Virginia 39586 several\n",
      "years prior for which he was transfused 4 units of packed red\n",
      "blood cells. EGD colonoscopy at that time revealed both upper\n",
      "and lower GI lesions including several small AVM and\n",
      "diverticulosis. Additionally , upper GI endoscopy performed at\n",
      "that time revealed duodenitis.\n",
      "The patient was seen in a Pleaermount Medical Center today\n",
      "reportedly in atrial fibrillation and atrial flutter. He had\n",
      "previously been reported to be in this abnormal rhtyhm that\n",
      "converted to normal sinus rhythm while on amiodarone. He was\n",
      "noted to have rapid ventricular response in 120s. He had\n",
      "appeared pale. Hematocrit obtained at that time reportedly 21.4\n",
      "and the patient was admitted to the Nipaul Ingways [HOSPITAL]\n",
      "for further evaluation.\n",
      "REVIEW OF SYSTEMS:\n",
      "Of note , review of systems is positive for recent chills , no\n",
      "fevers , reports intermittent productive cough and weakness and\n",
      "fatigue. No weight loss over the last six months.\n",
      "PAST MEDICAL HISTORY:\n",
      "As given , hypertension , diabetes , hypercholesterolemia ,\n",
      "nonobstructive CAD on prior catheterization in 1993 , IDCM with EF\n",
      "of 30 to 45% , question alcoholic cardiomyopathy , atrial\n",
      "fibrillation on Coumadin , right MCA CVA in 1999 , PVD , peptic\n",
      "ulcer disease , history of GI bleed with duodenitis ,\n",
      "diverticulitis and AVM and right hand partial hemiparesis and\n",
      "depression.\n",
      "MEDICATIONS ON ADMISSION:\n",
      "1. Amiodarone 200 mg p.o. q.d.\n",
      "2. Lasix 80 mg p.o. q.d.\n",
      "3. Digoxin 0.25 mg p.o. q.d.\n",
      "4. Niacin 750 mg p.o. b.i.d.\n",
      "5. Amitriptyline 50 mg p.o. q.day.\n",
      "6. Folate B6.\n",
      "7. Prilosec 20 mg p.o. b.i.d.\n",
      "8. Avandia 4 mg p.o. b.i.d.\n",
      "9. Valsartan 160 mg p.o. q.day.\n",
      "10. Nifedipine 90 mg p.o. q.day.\n",
      "11. Hydrochlorothiazide 25 mg p.o. q.d.\n",
      "12. Bisoprolol 5 mg p.o. q.d.\n",
      "13. Glucophage 500 mg b.i.d.\n",
      "14. Gemfibrozil 600 mg p.o. q.day.\n",
      "15. Zoloft 50 mg p.o. q.d.\n",
      "16. Ambien 10 mg q.h.s.\n",
      "17. Coumadin as needed.\n",
      "18. Lisinopril 40 mg p.o. q.d.\n",
      "ALLERGIES:\n",
      "Reported isosorbide resulting in headache , amlodipine lower\n",
      "extremity edema , Lopressor erectile dysfunction and Viagra , which\n",
      "reportedly does not work for the patient.\n",
      "SOCIAL HISTORY:\n",
      "The patient has a 50-pack-year smoking history , continues to\n",
      "smoke several cigarettes a day. Past alcohol abuse though the\n",
      "patient reports no alcohol in the last 20 years. The patient\n",
      "currently lives with his girlfriend of [41-50] years and is local to\n",
      "O Lasmerflinteans Louis\n",
      "FAMILY HISTORY:\n",
      "Family history is noncontributory. No history of a sudden\n",
      "cardiac death.\n",
      "PHYSICAL EXAMINATION:\n",
      "Vital signs on admission include a temperature of 98 , heart rate\n",
      "of 112 , blood pressure 168/90 , respiratory rate 20 93% on room\n",
      "air. He was in no acute distress though the patient was seen to\n",
      "be in shortness of breath when lying at 20 to 30 degrees. JVP on\n",
      "admission 12 to 15 cm of water , difficult to assess given\n",
      "habitus. The patient additionally with bibasilar rales ,\n",
      "one-third to one-half up with poor air movement. No egophony or\n",
      "consolidation was appreciated. Abdominal exam was unremarkable.\n",
      "Lower extremities were warm and well perfused. He was able to\n",
      "move all extremities , 4/5 strength in his right hand. He had\n",
      "positive peripheral pulses and 1+ lower extremity edema , left\n",
      "greater than right to mid calf.\n",
      "LABORATORY DATA:\n",
      "Laboratory values on admission are significant for creatinine of\n",
      "1.8 of unknown baseline and glucose of 192. LFTs were within\n",
      "normal limit. White count of 8.7 , hematocrit of 21.4 , down from\n",
      "baseline of 30 to 35 and platelets of 351 , 000. MCV on hematocrit\n",
      "was 84.\n",
      "EKG on admission showed irregularly regular rhythm at 120 likely\n",
      "atrial fibrillation versus atrial flutter with variable block , ST\n",
      "segment depression laterally in V5 through V6 , question demand\n",
      "ischemia versus digoxin effect , left bundle branch block which is\n",
      "reportedly the patient's baseline. Chest film with vascular\n",
      "prominence at the hilum bilaterally , question mass infiltrate\n",
      "over left lower lobe with no overt effusions.\n",
      "ASSESSMENT:\n",
      "The patient is a [61-70] years old gentleman with extensive past\n",
      "cardiac and otherwise medical history presenting to the Mahunt Medical Center with CHF exacerbation , anemia with question\n",
      "GI bleed with hematocrit in the 20s and question\n",
      "community-acquired pneumonia.\n",
      "HOSPITAL COURSE BY SYSTEMS:\n",
      "1. Cardiovascular: The patient with no evidence of acute\n",
      "coronary syndrome. On admission , the patient was noted to be in\n",
      "a rapid ventricular response at 120 and with CHF exacerbation.\n",
      "The patient initially with complaint of chest pressure , which was\n",
      "concerning for demand ischemia in the setting significant anemia\n",
      "with increased heart rate and known ventricular dysfunction.\n",
      "Cardiac enzymes were drawn and serially were elevated with a peak\n",
      "troponin I of 4. Subsequent serial cardiac enzymes resolved to\n",
      "baseline values. The patient was initially started on heparin IV\n",
      "drip for concern for unstable plaque , but following consultation\n",
      "with [DOCTOR] in Cardiology , it was recommended anticoagulation\n",
      "be stopped secondary to recent GI bleed and low concern for acute\n",
      "coronary syndrome versus demand ischemia. Additionally , the\n",
      "patient was rate controlled with IV following p.o. Lopressor ,\n",
      "digoxin and amiodarone. Additionally , the patient's ACE\n",
      "inhibitor was continued and titrated up to lisinopril 40. The\n",
      "patient was initially diuresed given significant volume overload\n",
      "with IV Lasix with diuresis of 4 to 8 liters over the hospital\n",
      "course. Echocardiogram obtained during decompensated episode\n",
      "revealed EF of 25 to 30% with global hypokinesis and septal\n",
      "akinesis , was significantly altered from prior echocardiogram of\n",
      "[DATE]obtained at the Wellcamp University Of Medical Center which had\n",
      "revealed an EF of 40 to 45% with mild global HK. However , of\n",
      "note , this echocardiogram was similar to prior echocardiogram in\n",
      "Alehealtdana [HOSPITAL] system from 1994 with no additional\n",
      "wall motion abnormalities. The patient's cardiovascular issues\n",
      "felt to stem secondary to anemia in the setting of increased\n",
      "ventricular response and tachycardia , which led to demand\n",
      "ischemia and subsequent troponin leak causing decompensated CHF.\n",
      "The patient's symptomatology resolved with proper rate control\n",
      "and resuscitation with IV fluids and blood. The patient's heart\n",
      "rate was well controlled in the 60s to 70s and following IV\n",
      "diuresis , the patient's CHF symptomatology resolved. At the time\n",
      "of discharge , the patient was ambulating without difficulty with\n",
      "no oxygen requirement. The patient was transitioned to all p.o.\n",
      "regimen.\n",
      "2. Heme: The patient with recent GI bleed with known both upper\n",
      "and lower GI lesions including AVM and diverticulosis for which\n",
      "the patient has been previously treated. The patient's\n",
      "hematocrit on admission 21.4. The patient received 4 units of\n",
      "packed red blood cells to stable hematocrit of 29 to 30 x 72\n",
      "hours. In addition , the patient was never hemodynamically\n",
      "unstable during admission. GI bleed felt to be a precipitating\n",
      "etiology. The patient was seen by the GI Service , was\n",
      "recommended further outpatient evaluation and upper and lower GI\n",
      "endoscopy evaluation as required. The patient to follow up with\n",
      "[DOCTOR] in the Erpin Medical Center and outpatient EGD\n",
      "and colonoscopy to be scheduled for the next week or two to\n",
      "further evaluate. At the time of discharge , the patient's\n",
      "hematocrit stable at 29 , no evidence of active GI bleed present.\n",
      "Additionally , the patient initially held on Coumadin giving\n",
      "concern for ongoing GI bleed and following stable transfusion ,\n",
      "the patient's Coumadin was restarted at initially 5 and then\n",
      "later 3 mg p.o. q.h.s. with INR goal of 2.8. To be further\n",
      "evaluated as outpatient and INR to be checked on [DATE]in [DOCTOR] office and titration of Coumadin as required.\n",
      "3. GI: As mentioned prior , the patient with GI bleed , thought\n",
      "to be precipitating etiology of the patient's current\n",
      "hospitalization. The patient maintained on IV Protonix b.i.d.\n",
      "and transitioned to p.o. Prilosec 40 mg p.o. b.i.d. As\n",
      "mentioned , prior to GI consult , the patient will receive the\n",
      "outpatient evaluation with EGD and colonoscopy as required for\n",
      "further management.\n",
      "4. Pulmonary: The patient with history of productive cough ,\n",
      "fevers , chills. On admission , previously treated with course of\n",
      "antibiotics , presumably Levaquin for presumed community-acquired\n",
      "pneumonia giving ongoing symptomatology , the patient treated\n",
      "initially with IV antibiotics including ceftriaxone and\n",
      "azithromycin transitioned to cefpodoxime and azithromycin. The\n",
      "patient to complete full 10-day course of antibiotics for\n",
      "presumed community-acquired pneumonia. At the time of discharge ,\n",
      "the patient afebrile , ambulating without difficulty , no dyspnea\n",
      "on exertion and O2 saturation 95% on room air.\n",
      "5. Psychiatry: The patient with long tobacco history given\n",
      "extensive cardiovascular status , the patient received addiction\n",
      "consultation regarding tobacco cessation. Following\n",
      "consultation , the patient showing good promise regarding tobacco\n",
      "cessation. He has expressed interest in doing so. As such , the\n",
      "patient's antianxiety and depression medications have been\n",
      "altered. The patient to decrease Zoloft to 25 mg p.o. q.d. from\n",
      "50 and to continue that for seven days , following which time , he\n",
      "should discontinue his Zoloft. Additionally , the patient started\n",
      "on Wellbutrin initially 150 mg p.o. q.d. x seven days , to\n",
      "transition up to b.i.d. as tolerated within seven days time as\n",
      "Zoloft is discontinued , recommend further outpatient evaluation\n",
      "as needed. The patient with several episodes of sundowning\n",
      "during his hospital course , treated with Haldol with no further\n",
      "incidents.\n",
      "6. Endocrine: The patient with known diabetes , maintained on\n",
      "Regular Insulin sliding scale with good blood sugar control. The\n",
      "patient to continue on outpatient regimen of Avandia and\n",
      "Glucophage. The patient may require additional anti-glycemic\n",
      "medications in future as necessary.\n",
      "7. Renal: The patient with chronicrenal insufficiency on\n",
      "admission with a creatinine of 1.8 presumed baseline. At the\n",
      "time of discharge , the patient's creatinine had resolved to 1.3 ,\n",
      "thought to be secondary to cardiorenal syndrome in the setting of\n",
      "acute CHF decompensation , recommend further outpatient management\n",
      "evaluation. The patient to follow up with [DOCTOR] in the Lumspe Black Healthcare on [DATE]at 1:00 p.m. at which time ,\n",
      "recommend further evaluation of hematocrit , INR , electrolyte as\n",
      "required.\n",
      "DISCHARGE MEDICATIONS:\n",
      "1. Enteric-coated aspirin 81 mg p.o. q.day.\n",
      "2. Amiodarone 200 mg p.o. q.day.\n",
      "3. Lasix 80 mg p q.day.\n",
      "4. Digoxin 0.25 mg p.o. q.day.\n",
      "5. Niacin SR 750 mg p.o. b.i.d.\n",
      "6. Amitriptyline 50 mg p.o. q.day.\n",
      "7. Folate B6.\n",
      "8. Prilosec 40 mg p.o. b.i.d. up from 20 mg p.o. b.i.d.\n",
      "9. Avandia 4 mg p.o. b.i.d.\n",
      "10. Hold valsartan.\n",
      "11. Hold nifedipine.\n",
      "12. Hydrochlorothiazide 12.5 mg p.o. q.d. down from 25 mg q.day.\n",
      "13. Hold bisoprolol , instead substitute Toprol XL 100 mg p.o.\n",
      "q.day.\n",
      "14. Glucophage 500 mg p.o. b.i.d.\n",
      "15. Gemfibrozil 600 mg p.o. q.day.\n",
      "16. Zoloft 25 mg p.o. q.day x seven days after which time it\n",
      "should be discontinued.\n",
      "17. Ambien 10 mg q.h.s.\n",
      "18. Coumadin 3 mg to be titrated outpatient.\n",
      "19. Lisinopril 40 mg q.day.\n",
      "20. Wellbutrin SR 150 mg q.day. x seven days after which time it\n",
      "should be increased to b.i.d.\n",
      "21. Amitriptyline 50 mg q.h.s.\n",
      "22. Nitroglycerin p.r.n.\n",
      "23. K-Dur 20 mEq q.day.\n",
      "24. Azithromycin 500 mg p.o. b.i.d. x five days.\n",
      "25. Cefpodoxime 200 mg p.o. b.i.d. x five days.\n",
      "As mentioned prior , at the time of discharge , the patient\n",
      "afebrile and vital signs stable. The patient ambulating without\n",
      "difficulty and feeling at baseline. The patient's O2 saturation\n",
      "is greater than 95% with ambulation. The patient is to follow up\n",
      "with [DOCTOR] in the Bridplacechael's [HOSPITAL] with further\n",
      "outpatient evaluation for GI bleed as potential source of anemia\n",
      "as well as further cardiac work up including cardiac\n",
      "catheterization at a later time given troponin leak in the\n",
      "setting of demand ischemia. The patient was transitioned to all\n",
      "p.o. regimen.\n",
      "eScription document: 8-2198587 EMSSten Tel\n",
      "Dictated By: [DOCTORS]\n",
      "Attending: [PERSONS] \n",
      "Dictation ID: ********\n",
      "D: [DATE]T: [DATE][report_end]\n",
      "\n",
      "CPU times: user 16 ms, sys: 0 ns, total: 16 ms\n",
      "Wall time: 14.7 ms\n"
     ]
    }
   ],
   "source": [
    "%%time\n",
    "import re\n",
    "import datefinder as df\n",
    "import datetime as dt\n",
    "\n",
    "#function to find the range of age\n",
    "def range_age(s):\n",
    "        ag=s\n",
    "        i=1\n",
    "        j=10\n",
    "        x=''\n",
    "        while i<j and j<150:\n",
    "            if ag in range(i,j+1):\n",
    "                x='['+str(i)+'-'+str(j)+']'\n",
    "                return x\n",
    "           \n",
    "            i+=10\n",
    "            j+=10\n",
    "    \n",
    "\n",
    "#main function to extract and replace\n",
    "def Generalization(file):\n",
    "    s1=re.findall(r'(?:\\d{1,2}[a-z]* )?(?:Jan|Feb|Mar|Apr|May|Jun|Jul|Aug|Sep|Oct|Nov|Dec)[a-z]* (?:\\d{1,2}[a-z]*, )?\\d{4}',file)\n",
    "    s=re.findall(r'\\d{1,2}[/]\\d{1,2}[/]\\d{2}\\s|\\d{1,2}[/]\\d{1,2}[/]\\d{4}',file)\n",
    "    mon=re.findall(r'(?:\\d{1,2} of )?(?:Jan|Feb|Mar|Apr|May|Jun|Jul|Aug|Sep|Oct|Nov|Dec)[a-z]*',file)\n",
    "     #replace date\n",
    "   \n",
    "    for i in range(len(s)):\n",
    "        file=file.replace(s[i],'[DATE]')\n",
    "    if len(s1)>0:\n",
    "     for i in range(len(s1)):\n",
    "         file=file.replace(s1[i],'[DATE]') \n",
    "    if len(mon)>0:\n",
    "        for i in range(len(mon)):\n",
    "            file=file.replace(mon[i],'[MONTH]')\n",
    "    \n",
    "    #extract and replace Record Number\n",
    "    r=file.split()\n",
    "    file=file.replace(r[1],'#####')\n",
    "    \n",
    "    #extract age\n",
    "    age=re.findall(r'[0-9]+[-\\s]year[-\\s]|[0-9]+[-\\s]years[-\\s]',file)\n",
    "    for i in range(len(age)):\n",
    "        a=str(age[i])\n",
    "        \n",
    "        a1=list(a)\n",
    "        age_years=\"\".join(a1[0:2])\n",
    "        dob=range_age(float(age_years))\n",
    "        file=file.replace(age[i],dob+' years ')\n",
    "    \n",
    "    #extract and remove unwanted data\n",
    "    i=2\n",
    "    while(r[i]!='Admission'):\n",
    "        file=file.replace(r[i],'*',1)\n",
    "        i+=1\n",
    "    \n",
    "    #extract and replace patient and doctor name\n",
    "    name=re.findall(r'Mr\\. \\w[A-Za-z]+|Mrs\\. \\w[A-Za-z]+|Ms\\. \\w[A-Za-z]+',file)\n",
    "    for i in range(len(name)):\n",
    "        file=file.replace(name[i],'[PERSON]')\n",
    "    \n",
    "    doctor=re.findall(r'Dr\\.\\s\\w[A-Za-z]+\\s[A-Z][a-z]*|Dr\\.\\s\\w[A-Za-z]+|DR\\.\\s\\w[A-Za-z]+',file)\n",
    "    #print(doctor)\n",
    "    for i in range(len(doctor)):\n",
    "        file=file.replace(doctor[i],\"[DOCTOR]\")\n",
    "   \n",
    "        \n",
    "    #extract and replace Phone number\n",
    "    phno=re.findall(r'\\d{3}[-\\s]+\\d{3}[-\\s]+\\d{4}',file)\n",
    "    for i in range(len(phno)):\n",
    "        file=file.replace(phno[i],'[PHONE NUMBER]')\n",
    "        \n",
    "        \n",
    "     #extract and replace Hospital name\n",
    "    hosp=re.findall(r'[A-Za-z]* Hospital|[A-Za-z]* Hospital [A-Za-z]*',file)\n",
    "    for i in range(len(hosp)):\n",
    "        file=file.replace(hosp[i],\"[HOSPITAL]\")   \n",
    "        \n",
    "    #extract and replace dictated fields and attending fields\n",
    "    d=re.findall(r'Dictated By:\\s[A-Za-z]*\\s.*| Dictated By:\\s[A-Za-z]*\\s.',file)\n",
    "    for i in range(len(d)):\n",
    "        file=file.replace(d[0],'Dictated By: [DOCTORS]')\n",
    "        \n",
    "    a=re.findall(r'Attending:\\s[A-Za-z]*\\s.*| ATTENDING:\\s[A-Za-z]*\\s.*',file)\n",
    "    for i in range(len(a)):\n",
    "        file=file.replace(a[0],'Attending: [PERSONS] ')\n",
    "        \n",
    "    a1=re.findall(r'ATTENDING:\\s[A-Za-z]*\\s.*',file)\n",
    "    for i in range(len(a1)):\n",
    "        file=file.replace(a1[0],'ATTENDING: [PERSONS] ')\n",
    "    \n",
    "    e=re.findall(r'ENTERED BY:\\s[A-Za-z]*\\s.*',file)\n",
    "    for i in range(len(e)):\n",
    "        file=file.replace(e[0],'ENTERED BY: [PERSONS] ')\n",
    "    \n",
    "    id=re.findall(r'Dictation ID\\s.*',file)\n",
    "    for i in range (len(id)):\n",
    "        file=file.replace(id[i],'Dictation ID: ********')\n",
    "        \n",
    "    #extract and replace Batch and Index Number\n",
    "    batch=re.findall(r'Batch:\\s[0-9]+\\sIndex No\\.[-\\s][A-Za-z0-9]+',file)\n",
    "    for i in range(len(batch)):\n",
    "        file=file.replace(batch[i],'batch:''****'+'\\tIndex No.'' *********')\n",
    "  \n",
    "    return(file)\n",
    "\n",
    "f=open(r\"/home/mohit/Documents/finaldocuments/80620\",'r')\n",
    "file=f.read()\n",
    "\n",
    "General_data=Generalization(file)#the modified data is stored in General data....\n",
    "print(General_data)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# SANITIZATION PROCESS"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 69,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "RECORD #####\n",
      "* * * * * * * * * * * * * * * * * * * * Admission Date: [1995] Report Status: Signed\n",
      "Discharge Date: [1995]\n",
      "PRINCIPAL DIAGNOSIS: DEEP VENOUS THROMBOSIS\n",
      "SECONDARY DIAGNOSIS: HEREDITARY ANGIOEDEMA\n",
      "HISTORY OF PRESENT ILLNESS: This is a [75.5] years old white female with\n",
      "hereditary angioedema with recent\n",
      "abdominal surgery presents with 30 hours of severe abdominal pain\n",
      "and tightness , typical of her hereditary angioedema attacks. The\n",
      "patient has had HAE since childhood and recalls having a ring cut\n",
      "off her finger as a child during an attack. She has had three\n",
      "tracheostomies , the last one over [15.5] years ago for laryngeal edema.\n",
      "Symptoms include throat tightness , difficulty talking and\n",
      "swallowing and abdominal pain. She often has attacks at local\n",
      "trauma sites. Over the past several years she has received Human\n",
      "C1 esterase inhibitor as part of a study conducted at CTMC by [DOCTOR] She has done very well with these treatments for acute\n",
      "attacks until recently when she states the inhibitor has stopped\n",
      "working as well as previously. [DOCTOR] has told her she\n",
      "may have an antibody to the inhibitor and her recent events include\n",
      "3/0 admitted with severe abdominal pain , flare of HAE , apparently\n",
      "became hypotensive and acidemic and went to laparotomy emergently ,\n",
      "on pressors without bowel preparation. Colostomy was done for bowel\n",
      "wall edema and was complicated by postoperative abscess requiring\n",
      "drainage. One month ago she had her colostomy taken down which has\n",
      "been complicated by incontinence of stool requiring Depends. At\n",
      "baseline , C4 is 6-10 , normal being 16-34 , C1 inhibitor 5-9 , normal\n",
      "being 25-83. On [1995]at 1:30 p.m. she developed the onset of\n",
      "typical HAE attack with crescendo abdominal pain and throat\n",
      "tightness. She took extra stanozolol but the abdominal pain\n",
      "persisted to where it was intolerable and she presented to the EW\n",
      "with nausea and vomiting. Last bowel movement was [1995],\n",
      "slightly loose , normal urine. In the EW she was given Demerol ,\n",
      "Solu Medrol , Zantac and Benadryl. PAST MEDICAL HISTORY: Includes\n",
      "cholecystectomy , appendectomy , hysterectomy for fibroid , but not\n",
      "bilateral salpingo-oophorectomy. She has a history of renal\n",
      "calculi , history of abnormal liver function tests , unknown cause ,\n",
      "history of AF , now controlled with DIG and Verapamil. She is\n",
      "status post subdural hematoma on Coumadin at therapeutic levels ,\n",
      "hypothyroid on replacement , history of right deep venous\n",
      "thrombosis , history of carpal tunnel syndrome , severe\n",
      "osteoarthritis with cervical spine , lumbosacral spine and right\n",
      "knee involvement. History of cerebrovascular accident , right\n",
      "hemiparesis , now at 90% of baseline , left iridectomy , left drop\n",
      "foot , left thigh numbness and tingling , dizziness and\n",
      "disequilibrium. FAMILY/SOCIAL HISTORY: She has a son and two\n",
      "grandchildren with HAE , three daughterse not effected , lives with\n",
      "husband , daughter , lives upstairs. She uses no tobacco , rare ETOH.\n",
      "MEDICATIONS: Digoxin .125 mg q day , Verapamil 60 mg b.i.d. ,\n",
      "Coumadin 1 mg q day , aspirin 80 mg q day , Synthroid 0.05 mg q day ,\n",
      "Stanozolol 2 mg q day with increased dose as needed. ALLERGIES:\n",
      "Quinidine causes nausea; IV contrast causes rash; propafenone ,\n",
      "migraines; penicillin rash; sulfa rash; novocaine throat swelling.\n",
      "Food allergies are wheat , dairy , chocolate , walnuts and\n",
      "strawberries.\n",
      "PHYSICAL EXAMINATION: On admission this is an ill-appearing woman\n",
      "with a raspy voice. Vital signs , 99.1 , heart\n",
      "rate 116 in atrial fibrillation , blood pressure 132/84 , respiratory\n",
      "rate 18. Head and neck examination , normocephalic , atraumatic ,\n",
      "status post iridectomy on left. The oropharynx is clear , no\n",
      "stridor. Neck , supple , carotids 2+ , stigmata of old thyroid\n",
      "tracheostomy. Lungs , clear to auscultation. Heart , irregularly\n",
      "irregular , tachycardia , I/VI early systolic murmur at left lower\n",
      "sternal border without radiation. Abdomen , recent midline incision ,\n",
      "healing , normal bowel sounds , soft but exquisitely tender to\n",
      "palpation or percussion. There is positive rebound tenderness ,\n",
      "positive shake tenderness. Rectal , guaiac positive per EW.\n",
      "Extremities , no clubbing , cyanosis or edema , pulses are 2+\n",
      "peripherally. She has positive pain to passive motion right knee ,\n",
      "neck not examined. Neuro , alert and oriented x 3 , cranial nerves\n",
      "are intact. Motor is 5/5 throughout except left foot without\n",
      "extension. Sensory , decreased light touch on the left lateral\n",
      "thigh , deep tendon reflexes 2+ throughout , toes right upgoing , left\n",
      "downgoing.\n",
      "LABORATORY DATA: White count 10.2 , hematocrit 41.3 , platelets\n",
      "377 , sodium 140 , potassium 3.8 , chloride 100 ,\n",
      "bicarb 30 , BUN 14 , creatinine 1.5 , glucose 140 , liver function\n",
      "tests normal. PT 13.5 , PTT 24.5. Chest x-ray and KUB without\n",
      "infiltrates , no free air , no ileus , no obstruction. EKG , atrial\n",
      "fibrillation at 117 , normal QRS and QT , unchanged from 10/14 , DIG\n",
      "effect is present.\n",
      "HOSPITAL COURSE: The patient improved dramatically over the first\n",
      "day of admission with decreased abdominal pain ,\n",
      "improving appetite and was started on clear liquids on [1995]late\n",
      "in the day. Initial treatment included Solu Medrol 125 mg IV bolus\n",
      "in the emergency room and Stanozolol 2 mg q.i.d. when first sent to\n",
      "the floor. She also had IV Zantac 50 mg q8 for the first three days\n",
      "of admission. The patient's symptoms continued to improve and diet\n",
      "was advanced over the next several days. Further concerns on this\n",
      "hospitalization were whether or not she would ever be a candidate\n",
      "for further C1 esterase inhibitor replacement , the question being\n",
      "was her hypotension during the last treatment leading to bowel\n",
      "surgery caused by the disease itself or as a response to the\n",
      "inhibitor. As of discharge this question has yet to be settled with\n",
      "[DOCTOR] patient developed left pedal edema by [1995]and\n",
      "although on low dose Coumadin , note is made of past subdurals on\n",
      "therapeutic Coumadin. The patient had a lower extremity noninvasive\n",
      "revealing a left leg deep venous thrombosis located at the\n",
      "bifurcation of the left common and superficial femorals. Given the\n",
      "patient's complications on Coumadin in the past and risk of\n",
      "pulmonary embolus , she was sent for filter placement which was done\n",
      "on 6/19/95. The patient also had the complication of bright red\n",
      "blood per rectum , she said this happens occasionally at home and on\n",
      "examination had moderate external hemorrhoids , no sign of recent\n",
      "bleeding , no internal hemorrhoids , no gross blood on examination.\n",
      "At this point she had normal coagulation studies and her hematocrit\n",
      "was 29.8 on 9/10/95. The patient was kept overnight with stable\n",
      "hematocrit and discharged on 11/5/95.\n",
      "DISPOSITION: The patient was discharged to home. MEDICATIONS:\n",
      "Aspirin 81 mg p.o. q day; Digoxin .125 mg p.o. q day;\n",
      "Synthroid 50 micrograms p.o. q day; Verapamil 60 mg p.o. t.i.d.;\n",
      "Coumadin 1 mg p.o. q day; Stanozolol 2 mg p.o. b.i.d. The patient\n",
      "will followup by telephone with [DOCTOR] CONDITION ON\n",
      "DISCHARGE: Good.\n",
      "Dictated By: [DOCTORS]\n",
      "Attending: [PERSONS]\n",
      "QA950/9889\n",
      "Batch:******\tIndex No. ***** D: [1995]T: [1995][report_end]\n",
      "\n",
      "CPU times: user 12 ms, sys: 0 ns, total: 12 ms\n",
      "Wall time: 261 ms\n"
     ]
    }
   ],
   "source": [
    "%%time\n",
    "import re\n",
    "import datefinder as df\n",
    "import datetime as dt\n",
    "#import time\n",
    "#function to replace age as bin_avg of age\n",
    "def bin_avg(s):\n",
    "    ag=s\n",
    "    i=1\n",
    "    j=10\n",
    "    while i<j and j<150:\n",
    "        if ag in range(i,j+1):\n",
    "            return str((i+j)/2)\n",
    "           \n",
    "        i+=10\n",
    "        j+=10\n",
    "\n",
    "#main function to extract and replace\n",
    "def sanitization(file):\n",
    "    #extract date\n",
    "    s1=re.findall(r'(?:\\d{1,2}[a-z]* )?(?:Jan|Feb|Mar|Apr|May|Jun|Jul|Aug|Sep|Oct|Nov|Dec)[a-z]* (?:\\d{1,2}[a-z]*, )?\\d{4}',file)\n",
    "    s=re.findall(r'\\d{1,2}[/]\\d{1,2}[/]\\d{2}\\s|\\d{1,2}[/]\\d{1,2}[/]\\d{4}',file)\n",
    "    mon=re.findall(r'(?:\\d{1,2} of )?(?:Jan|Feb|Mar|Apr|May|Jun|Jul|Aug|Sep|Oct|Nov|Dece)[a-z]*',file)\n",
    "    month=['4/30','6/30','9/30','11/30']\n",
    "    month1=['4/31','6/31','9/31','11/31']\n",
    "    #replace date\n",
    "    for i in range(len(s)):\n",
    "        y=\"\".join(s[i])\n",
    "        y_1=y\n",
    "        for i in range(len(month)):\n",
    "            if month[i] in y:\n",
    "                y=y.replace(month[i],'5/30')\n",
    "        y=y.replace('0/','1/')\n",
    "        for i in range(len(month1)):\n",
    "            if month1[i] in y:\n",
    "                y=y.replace(month1[i],'5/30')\n",
    "        mat=list(df.find_dates(y))\n",
    "        rep=str(dt.datetime.date(mat[0]).year)\n",
    "        rep='['+rep+']'\n",
    "        file=file.replace(y_1,rep)\n",
    "    if len(s1)>0:    \n",
    "        for i in range(len(s1)):\n",
    "            y1=\"\".join(s1[i])\n",
    "            mat1=list(df.find_dates(s1[i]))\n",
    "            #print(mat)\n",
    "            rep1=str(dt.datetime.date(mat1[0]).year)\n",
    "            rep1='['+rep1+']'\n",
    "            file=file.replace(y1,rep1)\n",
    "    if len(mon)>0:\n",
    "        for i in range(len(mon)):\n",
    "            file=file.replace(mon[i],\"[MONTH] \")\n",
    "   \n",
    "    #extract and replace Record Number\n",
    "    r=file.split()\n",
    "    file=file.replace(r[1],'#####')\n",
    "    \n",
    "    #extract and replace patient and doctor name\n",
    "    name=re.findall(r'Mr\\. \\w[A-Za-z]+|Mrs\\. \\w[A-Za-z]+|Ms\\. \\w[A-Za-z]+',file)\n",
    "    #print(name)\n",
    "    for i in range(len(name)):\n",
    "        file=file.replace(name[i],\"[PERSON]\")\n",
    "    doctor=re.findall(r'Dr\\.\\s\\w[A-Za-z]+\\s[A-Z][a-z]*|Dr\\.\\s\\w[A-Za-z]+|DR\\.\\s\\w[A-Za-z]+',file)\n",
    "    #print(doctor)\n",
    "    for i in range(len(doctor)):\n",
    "        file=file.replace(doctor[i],\"[DOCTOR]\")\n",
    "    \n",
    "    #extract and remove unwanted data\n",
    "    i=2\n",
    "    while(r[i]!='Admission'):\n",
    "        #print(r[i])\n",
    "        file=file.replace(r[i],'*',1)\n",
    "        i+=1\n",
    "    #extract and replce Hospital name\n",
    "    hosp=re.findall(r'[A-Za-z]* Hospital|[A-Za-z]* Hospital [A-Za-z]*',file)\n",
    "    for i in range(len(hosp)):\n",
    "        file=file.replace(hosp[i],\"[HOSPITAL]\")\n",
    "    \n",
    "    #extract and replace dictated fields and attending fields\n",
    "    d=re.findall(r'Dictated By:\\s[A-Za-z]*\\s.*|DICTATED By:\\s[A-Za-z]*\\s.*',file)\n",
    "    #print(d)\n",
    "    for i in range(len(d)):\n",
    "        file=file.replace(d[i],'Dictated By: [DOCTORS]')\n",
    "    a=re.findall(r'Attending:\\s[A-Za-z]*\\s.*|ATTENDING:\\s[A-Za-z]*\\s.*|ENTERED BY:\\s[A-Za-z]*\\s.*',file)\n",
    "    #print(a)\n",
    "    for i in range(len(a)):\n",
    "        file=file.replace(a[i],'Attending: [PERSONS]')\n",
    "\n",
    "\n",
    "    id=re.findall(r'Dictation ID\\s.*',file)\n",
    "    for i in range(len(id)):\n",
    "        file=file.replace(id[i],'Dictation ID ********')\n",
    "    \n",
    "    #extract age\n",
    "    age=re.findall(r'[0-9]+[-\\s]year[-\\s]|[0-9]+[-\\s]years[-\\s]',file)\n",
    "    #print(age)\n",
    "    for i in range(len(age)):\n",
    "        a=str(age[i])\n",
    "        a1=list(age[i])\n",
    "        age_years=\"\".join(a1[0:2])\n",
    "        dob=bin_avg(float(age_years))\n",
    "        years='['+dob+']'\n",
    "        file=file.replace(age[i],years+' years ')\n",
    "        \n",
    "    #extract and replace Phone number\n",
    "    phno=re.findall(r'\\d{3}[-\\s]+\\d{3}[-\\s]+\\d{4}',file)\n",
    "    #print(phno)\n",
    "    for i in range(len(phno)):\n",
    "        file=file.replace(phno[i],\"[PHONE NUMBER]\")\n",
    "        \n",
    "    #extract and replace Batch and Index Number\n",
    "    batch=re.findall(r'Batch:\\s[0-9]+\\sIndex No\\.[-\\s][A-Za-z0-9]+',file)\n",
    "    #print(batch)\n",
    "    for i in range(len(batch)):\n",
    "        file=file.replace(batch[i],'Batch:******\\tIndex No. *****')\n",
    "    \n",
    "    #extract and replace eScription document\n",
    "    doc=re.findall(r'eScription document:\\s.*',file)\n",
    "    for i in range(len(doc)):\n",
    "        file=file.replace(doc[i],\"eScription document: ******\")\n",
    "   \n",
    "    return(file)\n",
    "\n",
    "#read and write the file \n",
    "f=open(r\"/home/mohit/Documents/finaldocuments/741398\",'r')\n",
    "file=f.read()\n",
    "#st=time.time()\n",
    "#call the sanitization function\n",
    "synthetic_data=sanitization(file)#the modified data is stored in synthetic data....\n",
    "#end=time.time()\n",
    "#print(\"Time taken:\",end-st)\n",
    "print(synthetic_data)    "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# IMPORT MED7 LIBRARY"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "import spacy\n",
    "med7 = spacy.load('en_core_med7_lg')\n",
    "# create distinct colours for labels\n",
    "col_dict = {}\n",
    "seven_colours = ['#CEF6F5 ', '#5DADE2', '#a6e7ff', '#82E0AA', '#CCCCFF  ', '#45B39D', '#D289E3 ']\n",
    "for label, colour in zip(med7.pipe_labels['ner'], seven_colours):\n",
    "    col_dict[label] = colour\n",
    "\n",
    "options = {'ents': med7.pipe_labels['ner'], 'colors':col_dict}"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# SAN_SUMMARIZATION PROCESS"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 70,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "#summarization module for sanitized document changes are reflected in RECORD;ADMISSION DATE;DISCHARGE DATE;DICTATED BY,ATTENDING\n",
    "def san_summarization(filename):\n",
    "    def listToString(s):  \n",
    "                                                        # initialize an empty string \n",
    "        str1 = \"\"                                       # traverse in the string   \n",
    "        for ele in s:  \n",
    "            str1 += ele                                 # return string   \n",
    "        return str1\n",
    "    \n",
    "    def content(pattern):\n",
    "                                                        #pattern='PRINCIPAL DIAGNOSIS:(.*?)(:)'\n",
    "        temp_var = re.search(pattern,text).group(0)\n",
    "                                                        #Identifying the last label\n",
    "        result = re.search('[ a-zA-Z]+\\:$',temp_var).group(0)\n",
    "                                                        #splitting each sentence based on full stop\n",
    "        result_1=temp_var.split(\".\")\n",
    "                                                        #creating a list having only principal diagnosis\n",
    "        text_list=[]\n",
    "        for i in result_1:\n",
    "            if i != result:\n",
    "                text_list.append(i)\n",
    "                                                        #text_list\n",
    "        final_result = '.'.join(text_list)\n",
    "        final= final_result+'.'\n",
    "        return final\n",
    "    \n",
    "    text=''\n",
    "    with open(filename,\"r\") as a_file:\n",
    "        for line in a_file:\n",
    "            stripped_line = line.replace(\"\\n\",\" \")\n",
    "            text+=stripped_line\n",
    "    \n",
    "    \n",
    "    import re\n",
    "    p_d=\"\"\n",
    "    h_p_i=\"\"\n",
    "    p_m_h=\"\"\n",
    "    m_o_a=\"\"\n",
    "    allergies=\"\"\n",
    "    p_e_a=\"\"\n",
    "    p_m=\"\"\n",
    "    a=\"\"\n",
    "    d=\"\"\n",
    "    if 'RECORD' in text:\n",
    "        r=text.split()\n",
    "        text=text.replace(r[1],'#####')\n",
    "    if 'Admission Date:' in text:    \n",
    "        a_d = re.findall(r\"Admission Date: [DATE]\", text)\n",
    "    if 'Discharge Date:' in text:    \n",
    "        d_d = re.findall(r\"Discharge Date: [DATE]\", text)    \n",
    "    if 'PRINCIPAL DIAGNOSIS ON DISCHARGE:' in text:\n",
    "        p_d = 'PRINCIPAL DIAGNOSIS ON DISCHARGE:(.*?)([a-bA-Z]:)'\n",
    "        p_d = content(p_d)\n",
    "    if 'HISTORY OF PRESENT ILLNESS:' in text:\n",
    "        h_p_i='HISTORY OF PRESENT ILLNESS:(.*?)([a-bA-Z]:)'\n",
    "        h_p_i=content(h_p_i)\n",
    "    if 'PAST MEDICAL HISTORY:' in text:\n",
    "        p_m_h='PAST MEDICAL HISTORY:(.*?)([a-bA-Z]:)'\n",
    "        p_m_h=content(p_m_h)\n",
    "    if 'MEDICATIONS ON ADMISSION:' in text:\n",
    "        m_o_a='MEDICATIONS ON ADMISSION:(.*?)([a-bA-Z]:)'\n",
    "        m_o_a=content(m_o_a)\n",
    "    if 'PREOPERATIVE MEDICATIONS:' in text:\n",
    "        p_m = 'PREOPERATIVE MEDICATIONS:(.*?)([a-bA-Z]:)'\n",
    "        p_m = content(p_m)\n",
    "    if 'ALLERGIES:' in text:\n",
    "        allergies='ALLERGIES:(.*?)([a-bA-Z]:)'\n",
    "        allergies=content(allergies)\n",
    "    if 'PHYSICAL EXAMINATION ON ADMISSION:' in text:\n",
    "        p_e_a='PHYSICAL EXAMINATION ON ADMISSION:(.*?)([a-bA-Z]:)'\n",
    "        p_e_a=content(p_e_a)\n",
    "    if 'Attending:'in text:\n",
    "        a=re.findall(r\"Attending: \\[PERSONS]\",text)\n",
    "    if 'Dictated By:' in text:\n",
    "        d=re.findall(r\"Dictated By: \\[DOCTORS]\",text)\n",
    "    \n",
    "    #appending the strings to make a new file\n",
    "    res = r[0]+\" \"+r[1]+\"\\n\"+listToString(a_d)+\"\\n\"+listToString(d_d)+\"\\n\"+p_d+\"\\n\"+h_p_i+\"\\n\"+p_m_h+\"\\n\"+m_o_a+\"\\n\"+p_m+\"\\n\"+allergies+\"\\n\"+p_e_a+\"\\n\"+listToString(a)+\"\\n\"+listToString(d)+\"\\n\"\n",
    "    res1 = res.split('\\n')\n",
    "    \n",
    "    with open('summerization.txt',\"w\") as f:\n",
    "        for lis in res1:\n",
    "            if lis != \" \":\n",
    "                f.write('%s\\n' %lis)\n",
    "    return res1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 71,
   "metadata": {},
   "outputs": [],
   "source": [
    "summarized_text=san_summarization(\"static/files/generalization.txt\")\n",
    "#removal of blank spaces\n",
    "while(\"\" in summarized_text) : \n",
    "    summarized_text.remove(\"\")\n",
    "joined_string = \"\\n\".join(summarized_text)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# GEN_SUMMARIZATION"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 72,
   "metadata": {},
   "outputs": [],
   "source": [
    "#summarization module for sanitized document changes are reflected in RECORD;ADMISSION DATE;DISCHARGE DATE;\n",
    "def gen_summarization(filename):\n",
    "    def listToString(s):  \n",
    "                                                        # initialize an empty string \n",
    "        str1 = \"\"                                       # traverse in the string   \n",
    "        for ele in s:  \n",
    "            str1 += ele                                 # return string   \n",
    "        return str1\n",
    "    \n",
    "    def content(pattern):\n",
    "                                                        #pattern='PRINCIPAL DIAGNOSIS:(.*?)(:)'\n",
    "        temp_var = re.search(pattern,text).group(0)\n",
    "                                                        #Identifying the last label\n",
    "        result = re.search('[ a-zA-Z]+\\:$',temp_var).group(0)\n",
    "                                                        #splitting each sentence based on full stop\n",
    "        result_1=temp_var.split(\".\")\n",
    "                                                        #creating a list having only principal diagnosis\n",
    "        text_list=[]\n",
    "        for i in result_1:\n",
    "            if i != result:\n",
    "                text_list.append(i)\n",
    "                                                        #text_list\n",
    "        final_result = '.'.join(text_list)\n",
    "        final= final_result+'.'\n",
    "        return final\n",
    "    \n",
    "    text=''\n",
    "    with open(filename,\"r\") as a_file:\n",
    "        for line in a_file:\n",
    "            stripped_line = line.replace(\"\\n\",\" \")\n",
    "            text+=stripped_line\n",
    "    \n",
    "    #print(text)\n",
    "    import re\n",
    "    p_d=\"\"\n",
    "    h_p_i=\"\"\n",
    "    p_m_h=\"\"\n",
    "    m_o_a=\"\"\n",
    "    allergies=\"\"\n",
    "    p_e_a=\"\"\n",
    "    p_m=\"\"\n",
    "    a=\"\"\n",
    "    d=\"\"\n",
    "    if 'RECORD' in text:\n",
    "        r=text.split()\n",
    "        text=text.replace(r[1],'#####')\n",
    "    if 'Admission Date:' in text:    \n",
    "        a_d = re.findall(r\"Admission Date: \\[DATE]\", text)\n",
    "    if 'Discharge Date:' in text:    \n",
    "        d_d = re.findall(r\"Discharge Date: \\[DATE]\", text)     \n",
    "    if 'PRINCIPAL DIAGNOSIS ON DISCHARGE:' in text:\n",
    "        p_d = 'PRINCIPAL DIAGNOSIS ON DISCHARGE:(.*?)([a-bA-Z]:)'\n",
    "        p_d = content(p_d)\n",
    "    if 'HISTORY OF PRESENT ILLNESS:' in text:\n",
    "        h_p_i='HISTORY OF PRESENT ILLNESS:(.*?)([a-bA-Z]:)'\n",
    "        h_p_i=content(h_p_i)\n",
    "    if 'PAST MEDICAL HISTORY:' in text:\n",
    "        p_m_h='PAST MEDICAL HISTORY:(.*?)([a-bA-Z]:)'\n",
    "        p_m_h=content(p_m_h)\n",
    "    if 'MEDICATIONS ON ADMISSION:' in text:\n",
    "        m_o_a='MEDICATIONS ON ADMISSION:(.*?)([a-bA-Z]:)'\n",
    "        m_o_a=content(m_o_a)\n",
    "    if 'PREOPERATIVE MEDICATIONS:' in text:\n",
    "        p_m = 'PREOPERATIVE MEDICATIONS:(.*?)([a-bA-Z]:)'\n",
    "        p_m = content(p_m)\n",
    "    if 'ALLERGIES:' in text:\n",
    "        allergies='ALLERGIES:(.*?)([a-bA-Z]:)'\n",
    "        allergies=content(allergies)\n",
    "    if 'PHYSICAL EXAMINATION ON ADMISSION:' in text:\n",
    "        p_e_a='PHYSICAL EXAMINATION ON ADMISSION:(.*?)([a-bA-Z]:)'\n",
    "        p_e_a=content(p_e_a)\n",
    "    if 'Attending: 'in text:\n",
    "        a=re.findall(r\"Attending: \\[PERSONS]\",text)\n",
    "    if 'Dictated By: ' in text:\n",
    "        d=re.findall(r\"Dictated By: \\[DOCTORS]\",text)\n",
    "    \n",
    "    #appending the strings to make a new file\n",
    "    res = r[0]+\" \"+r[1]+\"\\n\"+listToString(a_d)+\"\\n\"+listToString(d_d)+\"\\n\"+p_d+\"\\n\"+h_p_i+\"\\n\"+p_m_h+\"\\n\"+m_o_a+\"\\n\"+p_m+\"\\n\"+allergies+\"\\n\"+p_e_a+\"\\n\"\n",
    "    res1 = res.split('\\n')\n",
    "    res2=\"\\n\"+listToString(a)+\"\\n\"+listToString(d)+\"\\n\"\n",
    "    res3 = res2.split('\\n')\n",
    "    emp=[]\n",
    "    res4 = res1+emp+res3\n",
    "    #print(res2)\n",
    "    f= open('summerization.txt',\"w\") \n",
    "    for lis in res1:\n",
    "        if lis != \" \":\n",
    "            f.write('%s\\n' %lis)\n",
    "            f.write(\"\\n\")\n",
    "    for lis in res2:\n",
    "        if lis != \" \":\n",
    "            f.write('%s\\n' %lis)\n",
    "    \n",
    "    return res4"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 73,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['RECORD #####', 'Admission Date: [DATE]', 'Discharge Date: [DATE]', '', 'HISTORY OF PRESENT ILLNESS: The patient is a [41-50] years old former triage nurse who has suffered from degenerative joint disease since 1977 when she was hit by a Amasa Di Cison bus. She was hospitalized at that time and had a left calf deep venous thrombosis secondary to extended bedrest. Her joint disease involved primarily the L4 to S1 vertebra ( comprising two joint spaces , and she reported this to have been exacerbated by an attempted rape in 1980. At present , the patient suffers considerable daily pain inhibiting her ability to work. The patient recently received a facet block in [MONTH] of 1991 at the Dukey [HOSPITAL] by the Pain Service which only seemed to increase her pain. She described steadily worsening pain in recent months and an increased portion of her time is therefore now spent at bedrest due to her decreased mobility. The patient described first experiencing left calf pain one and a half weeks prior to this admission which manifested itself as a crampy pain of short duration. She apparently saw her private medical doctor at this time , [DOCTOR] , who sent her out on nonsteroidal anti-inflammatory drugs. On 9/11 , five days prior to admission , the patient awoke at night with severe right leg cramping. She , at that time , went to the [HOSPITAL] Emergency Room where a noninvasive vascular study was positive for non obstructive peroneal vein thrombosis. She was discharged on Anaprox. On 8/8 , the patient returned to the DMC Emergency Room complaining of increased pain and with great anxiety due to her perceived risk of pulmonary embolus. The patient has had this condition in the past and was quite concerned about it. Noninvasive vascular studies at that time showed the lesion to be obstrutive in the peroneal vein. However , there was no evidence of deep venous thrombosis at that time. She was discharged on Coumadin , 5 mg q day. On 1/24 , the patient experienced further worsening pain and came to the Versteo University Medical Center for a second opinion. She was heparinized in the Emergency Room and admitted to the Medical Service.', 'PAST MEDICAL HISTORY: Occasional migraine headaches. L4-5 ruptured disc status post bus accident in 1977. As stated above , she had a left lower extremity deep venous thrombosis following that hospitalization. Previous positive PPD , she had one year of treatment. Mugging in 1980 with exacerbation of her joint disease. Emergency Room admission in 1988 for questionable cholecystitis. Facet block times two in 1986 and 1991. Periods of incremental menorrhagia. She is followed by [DOCTOR] at the Warestar Medical Center .  Endometrial biopsy recently performed was negative. Asthma. Gastritis. Appendectomy.', '', '', 'ALLERGIES: FISH. ERYTHROMYCIN. LACTOSE INTOLERANCE.', '', '', '', '', 'Dictated By: [DOCTORS]', '']\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "RECORD #####\n",
       "Admission Date: [DATE]\n",
       "Discharge Date: [DATE]\n",
       "HISTORY OF PRESENT ILLNESS: The patient is a [41-50] years old former triage nurse who has suffered from degenerative joint disease since 1977 when she was hit by a Amasa Di Cison bus. She was hospitalized at that time and had a left calf deep venous thrombosis secondary to extended bedrest. Her joint disease involved primarily the L4 to S1 vertebra ( comprising two joint spaces , and she reported this to have been exacerbated by an attempted rape in 1980. At present , the patient suffers considerable daily pain inhibiting her ability to work. The patient recently received a facet block in [MONTH] of 1991 at the Dukey [HOSPITAL] by the Pain Service which only seemed to increase her pain. She described steadily worsening pain in recent months and an increased portion of her time is therefore now spent at bedrest due to her decreased mobility. The patient described first experiencing left calf pain one and a half weeks prior to this admission which manifested itself as a crampy pain of short duration. She apparently saw her private medical doctor at this time , [DOCTOR] , who sent her out on nonsteroidal anti-inflammatory drugs. On 9/11 , five days prior to admission , the patient awoke at night with severe right leg cramping. She , at that time , went to the [HOSPITAL] Emergency Room where a noninvasive vascular study was positive for non obstructive peroneal vein thrombosis. She was discharged on Anaprox. On 8/8 , the patient returned to the DMC Emergency Room complaining of increased pain and with great anxiety due to her perceived risk of pulmonary embolus. The patient has had this condition in the past and was quite concerned about it. Noninvasive vascular studies at that time showed the lesion to be obstrutive in the peroneal vein. However , there was no evidence of deep venous thrombosis at that time. She was discharged on Coumadin , 5 mg q day. On 1/24 , the patient experienced further worsening pain and came to the Versteo University Medical Center for a second opinion. She was heparinized in the Emergency Room and admitted to the Medical Service.\n",
       "PAST MEDICAL HISTORY: Occasional migraine headaches. L4-5 ruptured disc status post bus accident in 1977. As stated above , she had a left lower extremity deep venous thrombosis following that hospitalization. Previous positive PPD , she had one year of treatment. Mugging in 1980 with exacerbation of her joint disease. Emergency Room admission in 1988 for questionable cholecystitis. Facet block times two in 1986 and 1991. Periods of incremental menorrhagia. She is followed by [DOCTOR] at the Warestar Medical Center .  Endometrial biopsy recently performed was negative. Asthma. Gastritis. Appendectomy.\n",
       "ALLERGIES: FISH. ERYTHROMYCIN. LACTOSE INTOLERANCE.\n",
       "Dictated By: [DOCTORS]"
      ]
     },
     "execution_count": 73,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "\n",
    "summarized_text=gen_summarization(\"static/files/generalization.txt\")\n",
    "print(summarized_text)\n",
    "#removal of blank spaces\n",
    "while(\"\" in summarized_text) : \n",
    "    summarized_text.remove(\"\")\n",
    "joined_string = \"\\n\".join(summarized_text)\n",
    "\n",
    "d1=med7(joined_string)\n",
    "d1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# NON SUMMARIZATION"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 74,
   "metadata": {},
   "outputs": [],
   "source": [
    "#summarization module for non-sensitive document changes are reflected in RECORD;ADMISSION DATE;DISCHARGE DATE;\n",
    "def non_summarization(filename):\n",
    "    def listToString(s):  \n",
    "                                                        # initialize an empty string \n",
    "        str1 = \"\"                                       # traverse in the string   \n",
    "        for ele in s:  \n",
    "            str1 += ele                                 # return string   \n",
    "        return str1\n",
    "    \n",
    "    def content(pattern):\n",
    "                                                        #pattern='PRINCIPAL DIAGNOSIS:(.*?)(:)'\n",
    "        temp_var = re.search(pattern,text).group(0)\n",
    "                                                        #Identifying the last label\n",
    "        result = re.search('[ a-zA-Z]+\\:$',temp_var).group(0)\n",
    "                                                        #splitting each sentence based on full stop\n",
    "        result_1=temp_var.split(\".\")\n",
    "                                                        #creating a list having only principal diagnosis\n",
    "        text_list=[]\n",
    "        for i in result_1:\n",
    "            if i != result:\n",
    "                text_list.append(i)\n",
    "                                                        #text_list\n",
    "        final_result = '.'.join(text_list)\n",
    "        final= final_result+'.'\n",
    "        return final\n",
    "    \n",
    "    text=''\n",
    "    with open(filename,\"r\") as a_file:\n",
    "        for line in a_file:\n",
    "            stripped_line = line.replace(\"\\n\",\" \")\n",
    "            text+=stripped_line\n",
    "    \n",
    "    \n",
    "    import re\n",
    "    p_d=\"\"\n",
    "    h_p_i=\"\"\n",
    "    p_m_h=\"\"\n",
    "    m_o_a=\"\"\n",
    "    allergies=\"\"\n",
    "    p_e_a=\"\"\n",
    "    p_m=\"\"\n",
    "    a=\"\"\n",
    "    d=\"\"\n",
    "    if 'RECORD' in text:\n",
    "        r=text.split()\n",
    "        text=text.replace(r[1],'#####')\n",
    "    if 'Admission Date:' in text:    \n",
    "        a_d= re.findall(r\"Admission Date: [\\d]{1,2}/[\\d]{1,2}/[\\d]{2,4}\", text)    \n",
    "    if 'Discharge Date:' in text:   \n",
    "        d_d = re.findall(r\"Discharge Date: [\\d]{1,2}/[\\d]{1,2}/[\\d]{2,4}\", text)   \n",
    "    if 'PRINCIPAL DIAGNOSIS ON DISCHARGE:' in text:\n",
    "        p_d = 'PRINCIPAL DIAGNOSIS ON DISCHARGE:(.*?)([a-bA-Z]:)'\n",
    "        p_d = content(p_d)\n",
    "    if 'HISTORY OF PRESENT ILLNESS:' in text:\n",
    "        h_p_i='HISTORY OF PRESENT ILLNESS:(.*?)([a-bA-Z]:)'\n",
    "        h_p_i=content(h_p_i)\n",
    "    if 'PAST MEDICAL HISTORY:' in text:\n",
    "        p_m_h='PAST MEDICAL HISTORY:(.*?)([a-bA-Z]:)'\n",
    "        p_m_h=content(p_m_h)\n",
    "    if 'MEDICATIONS ON ADMISSION:' in text:\n",
    "        m_o_a='MEDICATIONS ON ADMISSION:(.*?)([a-bA-Z]:)'\n",
    "        m_o_a=content(m_o_a)\n",
    "    if 'ALLERGIES:' in text:\n",
    "        allergies='ALLERGIES:(.*?)([a-bA-Z]:)'\n",
    "        allergies=content(allergies)\n",
    "    if 'PHYSICAL EXAMINATION ON ADMISSION:' in text:\n",
    "        p_e_a='PHYSICAL EXAMINATION ON ADMISSION:(.*?)([a-bA-Z]:)'\n",
    "        p_e_a=content(p_e_a)\n",
    "    if 'Attending:'in text:\n",
    "        a=re.findall(r\"Attending: \\[PERSONS]\",text)\n",
    "    if 'Dictated By:' in text:\n",
    "        d=re.findall(r\"Dictated By: \\[DOCTORS]\",text)\n",
    "    \n",
    "    #appending the strings to make a new file\n",
    "    res = r[0]+\" \"+r[1]+\"\\n\"+listToString(a_d)+\"\\n\"+listToString(d_d)+\"\\n\"+p_d+\"\\n\"+h_p_i+\"\\n\"+p_m_h+\"\\n\"+m_o_a+\"\\n\"+allergies+\"\\n\"+p_e_a+\"\\n\"+listToString(a)+\"\\n\"+listToString(d)+\"\\n\"\n",
    "    res1 = res.split('\\n')\n",
    "    \n",
    "    with open('summerization.txt',\"w\") as f:\n",
    "        for lis in res1:\n",
    "            if lis != \" \":\n",
    "                f.write('%s\\n' %lis)\n",
    "    return res1"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# SUPRESSION PROCESS"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 75,
   "metadata": {},
   "outputs": [],
   "source": [
    "import re\n",
    "def supression(file):\n",
    "#extract and replace Record Number\n",
    "    r=file.split()\n",
    "    file=file.replace(r[1],'#####')\n",
    "    \n",
    "#extract and replace patient and doctor name\n",
    "    name=re.findall(r'Mr\\. \\w[A-Za-z]+|Mrs\\. \\w[A-Za-z]+|Ms\\. \\w[A-Za-z]+',file)\n",
    "#print(name)\n",
    "    for i in range(len(name)):\n",
    "        file=file.replace(name[i],\"[#####]\")\n",
    "#extract and replace Phone number\n",
    "    phno=re.findall(r'\\d{3}[-\\s]+\\d{3}[-\\s]+\\d{4}',file)\n",
    "    #print(phno)\n",
    "    for i in range(len(phno)):\n",
    "        file=file.replace(phno[i],\"[#####]\")\n",
    "    return file\n",
    "#read and write the file \n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# DEMONSTRATION "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      " * Serving Flask app \"__main__\" (lazy loading)\n",
      " * Environment: production\n",
      "\u001b[31m   WARNING: This is a development server. Do not use it in a production deployment.\u001b[0m\n",
      "\u001b[2m   Use a production WSGI server instead.\u001b[0m\n",
      " * Debug mode: on\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " * Running on http://127.0.0.1:5000/ (Press CTRL+C to quit)\n",
      "127.0.0.1 - - [25/Jun/2021 23:10:27] \"\u001b[37mGET / HTTP/1.1\u001b[0m\" 200 -\n",
      "127.0.0.1 - - [25/Jun/2021 23:10:27] \"\u001b[33mGET /stylea.css HTTP/1.1\u001b[0m\" 404 -\n",
      "127.0.0.1 - - [25/Jun/2021 23:10:27] \"\u001b[33mGET /stylea.css HTTP/1.1\u001b[0m\" 404 -\n",
      "127.0.0.1 - - [25/Jun/2021 23:10:30] \"\u001b[37mGET /authentication HTTP/1.1\u001b[0m\" 200 -\n",
      "127.0.0.1 - - [25/Jun/2021 23:10:38] \"\u001b[37mPOST /authentication HTTP/1.1\u001b[0m\" 200 -\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "file uploaded successfully\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "127.0.0.1 - - [25/Jun/2021 23:11:17] \"\u001b[37mPOST /success HTTP/1.1\u001b[0m\" 200 -\n",
      "127.0.0.1 - - [25/Jun/2021 23:11:19] \"\u001b[32mPOST /anonimization HTTP/1.1\u001b[0m\" 302 -\n",
      "127.0.0.1 - - [25/Jun/2021 23:11:19] \"\u001b[37mGET /summarization HTTP/1.1\u001b[0m\" 200 -\n",
      "127.0.0.1 - - [25/Jun/2021 23:11:22] \"\u001b[37mPOST /summarization HTTP/1.1\u001b[0m\" 200 -\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Loading page (1/2)\n",
      "[>                                                           ] 0%\r",
      "[======>                                                     ] 10%\r",
      "[============>                                               ] 21%\r",
      "[==================>                                         ] 31%\r",
      "[=========================>                                  ] 42%\r",
      "[==============================>                             ] 50%\r",
      "[============================================================] 100%\r",
      "Printing pages (2/2)                                               \n",
      "[>                                                           ] \r",
      "Done                                                           \n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "127.0.0.1 - - [25/Jun/2021 23:11:23] \"\u001b[37mGET /return-sensitive_file_gen HTTP/1.1\u001b[0m\" 200 -\n",
      "127.0.0.1 - - [25/Jun/2021 23:12:03] \"\u001b[37mGET /summarization HTTP/1.1\u001b[0m\" 200 -\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "file uploaded successfully\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "127.0.0.1 - - [25/Jun/2021 23:12:38] \"\u001b[37mPOST /success HTTP/1.1\u001b[0m\" 200 -\n",
      "127.0.0.1 - - [25/Jun/2021 23:12:39] \"\u001b[32mPOST /anonimization HTTP/1.1\u001b[0m\" 302 -\n",
      "127.0.0.1 - - [25/Jun/2021 23:12:39] \"\u001b[37mGET /summarization HTTP/1.1\u001b[0m\" 200 -\n",
      "127.0.0.1 - - [25/Jun/2021 23:12:42] \"\u001b[37mPOST /summarization HTTP/1.1\u001b[0m\" 200 -\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Loading page (1/2)\n",
      "[>                                                           ] 0%\r",
      "[======>                                                     ] 10%\r",
      "[===========>                                                ] 19%\r",
      "[================>                                           ] 28%\r",
      "[======================>                                     ] 37%\r",
      "[============================>                               ] 47%\r",
      "[==============================>                             ] 50%\r",
      "[============================================================] 100%\r",
      "Printing pages (2/2)                                               \n",
      "[>                                                           ] \r",
      "Done                                                           \n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "127.0.0.1 - - [25/Jun/2021 23:12:43] \"\u001b[37mGET /return-sensitive_file_gen HTTP/1.1\u001b[0m\" 200 -\n",
      "127.0.0.1 - - [25/Jun/2021 23:13:03] \"\u001b[37mGET /summarization HTTP/1.1\u001b[0m\" 200 -\n"
     ]
    }
   ],
   "source": [
    "%%time\n",
    "from flask import * \n",
    "from flask import flash\n",
    "import spacy\n",
    "import os\n",
    "import pymysql\n",
    "from fpdf import FPDF\n",
    "#database connection\n",
    "connection = pymysql.connect(host=\"localhost\",user=\"root\",passwd=\"\",database=\"hospitallogin\" )\n",
    "cursor = connection.cursor()\n",
    "\n",
    "app = Flask(__name__)  \n",
    "#app.secret_key =\"abc\"\n",
    "app.config['CLIENT_PDF'] = 'static/files'\n",
    "pics_folder = os.path.join(\"static\",\"pics\")\n",
    "app.config[\"UPLOAD_FOLDER\"] = pics_folder\n",
    "@app.route('/')\n",
    "def start():\n",
    "    return render_template('finalmain.html')\n",
    "\n",
    "@app.route('/project_description')\n",
    "def project_description():\n",
    "    return render_template('projectdescription.html')\n",
    "@app.route('/project_phases')\n",
    "def project_phases():\n",
    "    return render_template('projectphases.html')\n",
    "@app.route('/project_team')\n",
    "def project_team():\n",
    "    return render_template('projectteam.html')\n",
    "@app.route('/authentication', methods =[\"GET\", \"POST\"])\n",
    "def authentication():\n",
    "        Name = request.form.get(\"name\")\n",
    "        Id = request.form.get(\"u_id\")\n",
    "        Password = request.form.get(\"password\")\n",
    "        retrive = \"Select * from med_user;\"\n",
    "        cursor.execute(retrive)\n",
    "        \n",
    "        rows = cursor.fetchall()\n",
    "        flag = 0\n",
    "        for row in rows:\n",
    "            if str(row[3])==Password:\n",
    "                flag=1\n",
    "         \n",
    "        if flag==1:\n",
    "            return render_template(\"file_upload_form.html\") \n",
    "        else:\n",
    "            #flash(\"Invalid id or password\")\n",
    "            return render_template(\"login.html\",Id=Id,as_attachment=True,cache_timeout=0)\n",
    "        return render_template(\"login.html\",Id=Id,as_attachment=True,cache_timeout=0)\n",
    "#@app.route('/upload',, methods =[\"GET\", \"POST\"])  \n",
    "#def upload():  \n",
    "#   return render_template(\"file_upload_form.html\")  \n",
    " \n",
    "@app.route('/summarization', methods=['GET', 'POST'])\n",
    "def summarization():\n",
    "    if request.method == 'POST':\n",
    "        if request.form.get('Yes') == 'Yes':\n",
    "            if g_s==1:\n",
    "                summarize = gen_summarization('static/files/generalization.txt')\n",
    "                doc = ' '.join([str(elem+'\\n') for elem in summarize])\n",
    "                doc =med7(doc)\n",
    "                html =  displacy.render(doc, style='ent', page=True,jupyter = False,options=options)\n",
    "                with open(\"output1.html\", 'w+', encoding=\"utf-8\") as fp:\n",
    "                    fp.write(html)\n",
    "                final_output_file_path = 'static/files/'+fname+'_gen_sen.pdf'\n",
    "                pdfkit.from_file('output1.html', final_output_file_path) \n",
    "                fp.close()  \n",
    "                return render_template(\"download_gen_sen.html\",name = file_nam)  \n",
    "            if g_s==0:\n",
    "                summarize = san_summarization('static/files/sanitization.txt')\n",
    "                doc = ' '.join([str(elem+'\\n') for elem in summarize])\n",
    "                doc = med7(doc)\n",
    "                html =  displacy.render(doc, style='ent', page=True,jupyter = False,options=options)\n",
    "                with open(\"output1.html\", 'w+', encoding=\"utf-8\") as fp:\n",
    "                    fp.write(html)\n",
    "                final_output_file_path = 'static/files/'+fname+'_san_sen.pdf'\n",
    "                pdfkit.from_file('output1.html', final_output_file_path) \n",
    "                fp.close()   \n",
    "                \n",
    "                return render_template(\"download_san_sen.html\",name = file_nam)  \n",
    "        else:\n",
    "            if g_s==1:\n",
    "                pdf = FPDF()\n",
    "                pdf.add_page()\n",
    "                pdf.set_font(\"Arial\",size=8)\n",
    "                f = open(\"static/files/generalization.txt\",\"r\")\n",
    "                for x in f:\n",
    "                     pdf.cell(60,5,txt=x,ln=1,align='L')\n",
    "                pdf.output('static/files/'+fname+\"_nonsum.pdf\")\n",
    "                \n",
    "            if g_s==0:\n",
    "                pdf = FPDF()\n",
    "                pdf.add_page()\n",
    "                pdf.set_font(\"Arial\",size=8)\n",
    "                f = open(\"static/files/sanitization.txt\",\"r\")\n",
    "                for x in f:\n",
    "                    pdf.cell(60,5,txt=x,ln=1,align='L')\n",
    "                pdf.output('static/files/'+fname+\"_nonsum.pdf\")\n",
    "            \n",
    "            return render_template(\"downloadnonsummerize.html\",name = file_nam)             \n",
    "        \n",
    "    return render_template(\"summarization.html\") \n",
    "    \n",
    "@app.route('/anonimization', methods=['GET', 'POST'])\n",
    "def analymaization():\n",
    "    if request.method == 'POST':\n",
    "        if request.form.get('Generalization') == 'Generalization':\n",
    "            #print(\"Generalization\")\n",
    "            f=open(file_nam,'r')\n",
    "            file1=f.read()\n",
    "            generalige = Generalization(file1)\n",
    "            generalige = generalige.split('\\n')\n",
    "            global g_s\n",
    "            g_s = 1\n",
    "            \n",
    "            with open('static/files/generalization.txt',\"w\") as f:\n",
    "                for lis in generalige:\n",
    "                    f.write('%s\\n'%lis)\n",
    "                    \n",
    "            \n",
    "            \n",
    "                        \n",
    "            return  redirect(url_for('summarization'))\n",
    "      \n",
    "        elif  request.form.get('Sanitization') == 'Sanitization':\n",
    "            #print(\"Sanitization\")\n",
    "            f=open(file_nam,'r')\n",
    "            file1=f.read()\n",
    "            sanitize = sanitization(file1)\n",
    "            sanitize = sanitize.split('\\n')\n",
    "            g_s=0\n",
    "            with open('static/files/sanitization.txt',\"w\") as f:\n",
    "                for lis in sanitize:\n",
    "                    f.write('%s\\n'%lis)\n",
    "            return redirect(url_for('summarization'))   \n",
    "            \n",
    "        return render_template(\"return-sensitive_files.html\")\n",
    "      \n",
    "@app.route('/success', methods=['GET', 'POST'])  \n",
    "def success():  \n",
    "    if request.method == 'POST':  \n",
    "        f = request.files['file']  \n",
    "        #file = f.filename+str(f) \n",
    "        print('file uploaded successfully')\n",
    "        \n",
    "        global fname\n",
    "        fname = str(f.filename)\n",
    "        global file_nam\n",
    "        \n",
    "        file_nam = \"/home/mohit/Documents/finaldocuments/\"+fname\n",
    "        #session['file_name']=file\n",
    "        \n",
    "        res = check_sensitive(file_nam)\n",
    "        if res == True:\n",
    "            return render_template(\"ananimization.html\", name = file_nam)\n",
    "        else:\n",
    "            \n",
    "            f=open(file_nam,'r')\n",
    "            file=f.read()\n",
    "            suppresion = supression(file)\n",
    "            \n",
    "            suppresion1 = suppresion.split('\\n')\n",
    "            \n",
    "            with open('static/files/suppresion.txt',\"w\") as f:\n",
    "                for lis in suppresion1:\n",
    "                    f.write('%s\\n'%lis)\n",
    "                    \n",
    "            res =  non_summarization('static/files/suppresion.txt')\n",
    "            \n",
    "            doc = ' '.join([str(elem+'\\n') for elem in res])\n",
    "            doc =med7(doc)\n",
    "            html =  displacy.render(doc, style='ent', page=True,jupyter = False,options=options)\n",
    "            with open(\"output1.html\", 'w+', encoding=\"utf-8\") as fp:\n",
    "                fp.write(html)\n",
    "            final_output_file_path = 'static/files/'+fname+'_non_sum.pdf'\n",
    "            pdfkit.from_file('output1.html', final_output_file_path) \n",
    "            fp.close()\n",
    "            \n",
    "            return render_template(\"download_nonsen.html\",name = file_nam)  \n",
    "        \n",
    "@app.route('/nonsumerization')\n",
    "def return_files_nonsum():\n",
    "    \n",
    "        file_path = fname+\"_nonsum.pdf\"\n",
    "        \n",
    "        return send_from_directory(app.config['CLIENT_PDF'],filename= file_path,as_attachment=True,cache_timeout=0)\n",
    "    \n",
    "@app.route('/return-sensitive_file_gen')\n",
    "def return_files_tut_gen():\n",
    "       \n",
    "        file_path = fname+'_gen_sen.pdf'\n",
    "        \n",
    "        return send_from_directory(app.config['CLIENT_PDF'],filename= file_path,as_attachment=True,cache_timeout=0)\n",
    "@app.route('/return-sensitive_file_san')\n",
    "def return_files_tut_san():\n",
    "        \n",
    "        file_path = fname+'_san_sen.pdf'\n",
    "        \n",
    "        return send_from_directory(app.config['CLIENT_PDF'],filename= file_path,as_attachment=True,cache_timeout=0)\n",
    "@app.route('/return-nonsenitive_file')\n",
    "def return_files_tut1():\n",
    "    \n",
    "        file_path = fname+'_non_sum.pdf'\n",
    "       \n",
    "        return send_from_directory(app.config['CLIENT_PDF'],filename= file_path,as_attachment=True,cache_timeout=0)\n",
    "    \n",
    "if __name__ == '__main__':  \n",
    "    app.run(debug = True, port=\"5000\" , use_reloader=False)\n",
    "      \n",
    "del file_nam\n",
    "del fname\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
